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Welcome to the Weinstein 2010 meeting 
in Amsterdam the Netherlands 
 
On behalf of the organizing committee, we would like to welcome you to the 2010 Weinstein 
Cardiovascular Development Conference. Since its first rendezvous in 1994, the Weinstein 
conference has evolved into the largest annual meeting for scientists investigating the 
development of the cardiovascular system. We are proud to be able to organize the 
Weinstein Meeting, outside the United States, in the city of Amsterdam.  
 
The conference building is part of the Colonial Institute, which was originally founded to 
promote trade and industry in the Dutch colonial territories. Today, the institute's role is more 
an educational one and the museum next door houses an anthropological collection 
illustrating its historical connections with the former colonies. 
 
Amsterdam is Holland’s largest city (roughly 750.000 inhabitants) although relatively small by 
international standards. Therfore, you will be pleasantly surprised to find a comfortably 
secure city center, with a lively atmosphere and relaxed feel about it. In fact, Amsterdam is 
one of the safest cities in the world. Even at night Amsterdam is a safe city to wander 
through and you will very rarely find yourself alone on the streets, even in the earliest hours. 
As in almost any bustling city in the world, pickpockets and petty thieves will take advantage 
of the careless, the best defense being simple common sense. Don't leave your bags and 
belongings unattended. Don't walk around with a lot of valuables. Don't put your valuables in 
your rucksack or shoulder bag hanging on your back, but keep them on you or in a money 
belt. Pay extra attention in crowded areas.  
 
We are proud to announce that we have 383 participants this year, with 195 from Europe, 
149 from North America, 35 from Asia, 2 from Australia, and 2 from Africa. From the 246 
abstracts submitted, an expert panel of reviewers has selected [from blinded copies] 49 
abstracts for platform presentation. As the presenters of many excellent abstracts could not 
be honored with a platform presentation, we expect to have three exciting and engaging 
poster sessions. The late afternoon session on Friday will have a more tutorial/educational 
emphasis, focusing on 3D image analysis en 3D presentation. 
 
In contrast to other years we have two keynote speakers. Our first keynote speaker is Prof 
Denis Duboule. Prof Duboule is considered one of the world’s leading specialists in 
developmental biology. His pioneering work on Hox gene clusters, revealing their basic 
mechanistic functions during developmental processes, launched forth a line of research 
which remains today one of the most intensively studied systems in biology.  Our second 
keynote speaker Prof Frank Grosveld. Prof Grosveld has carried out pioneering work on 
many aspects of gene regulation from concluding that DNA methylation inhibits gene 
expression via an indirect mechanism, to the first description of a locus control region (LCR). 
Both topics are very pertinent to cardiovascular development. 
 
On Saturday, as part of our evening's entertainment and to give you a different view of 
Amsterdam, we will embark on canal boats to see the city from water-level whilst enjoying 
cheese and wine. The boats will take us by canal to the party venue, the Olaf Chapel, which 
was built in 1440. Here we will eat and continue our evening with live music and dance. 
 
We hope you will have a memorable and inspiring experience in Amsterdam. 
 
The Local Organizing Committee 
Maurice van den Hoff, Katherine Yutzey, Ruth van der Gaag, Antoon Moorman,  
Alexandre Soufan, Phil Barnett, Vincent Christoffels, Alex Postma and Yigal Pinto 
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General Announcements and Information 
 
Platform presentations 
Oral presentations are limited to a total of 20 minutes: being 15 minutes presentation at the 
most, followed by 5 minutes for questions and discussion. Please do not exceed the 
allotted time. Your presentation should be uploaded at least 15 minutes before your session 
starts. All the presentations will be given in the great Hall. There are no parallel sessions. 
 
Posters 
All posters will be on display for one day only. There are 3 poster sessions. In the abstract 
book you will find the session in which your poster should be presented. Posters for session 
"A" should be presented on Thursday; those for session "B" should be presented on Friday 
and those for session "C" should be presented on Saturday. 
The posters should be hung on the boards before the morning session of that day starts and 
should be taken down after the last afternoon session of that day. 
Your abstract and its associated number will be posted on the boards to indicate where you 
should put your poster. 
 
Catering 
There will be morning coffee and tea, but no food from 8.00-9.00 before the morning 
sessions start, so please remember to eat breakfast before you come to the meeting. 
During each break there will be coffee, tea and water and biscuits 
For lunch an assortment of bread rolls with cheese, meat and other fillings will be available, 
which will be accompanied by coffee, tea, milk, butter milk, juice and water. 
On Thursday evening there will be a buffet dinner in the Marble Hall of the Tropenmuseum. 
Saturday evening's banquet will take place in Olaf Chapel of the Barbizon Palace hotel. 
Tickets for all events and for 14 consumption tokens will be given when you register. Cash 
can also be payed for extra drinks at the bar. 
 
Business Meeting 
A business meeting to discuss future conference sites, amendments and modifications to the 
Weinstein Charter and selection of an ad hoc member to serve a 3-year term on the 
Weinstein Committee will be held in the Great Hall on Friday 21st May from 8.00-9.00. 
 
Evaluations 
Please fill out and return the evaluation form provided to you when you registered. These 
forms provide important feedback to help future organizers improve the Weinstein 
Cardiovascular Development Conference. These forms also provide information that is 
important for fundraising, which helps defray the cost of the meeting, allowing greater 
accessibility to the Conference by students and postdoctoral fellows. 
 
Acknowledgements 
We are very grateful to the many people at the Heart Failure Research Center, the Royal 
Tropical Institute and NH Hoteles who have worked so hard behind the scenes to make this 
meeting a success.  We thank all the reviewers for the selection of anonymized abstracts for 
the oral presentations. We thank Prof Denis Duboule and Prof Frank Grosveld for serving as 
the Keynote Speakers this year. We also thank Dr. Constance Weinstein for her continued 
dedication to the mission of this meeting. 
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Floor plan Royal Tropical Institute 
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Condensed Schedule 
 
Thursday 20 May 2010 
8.00 - 10.00  Registration + tea/coffee + putting up posters for session A 
10.10 - 10.20  Welcome and Opening  
10.20 - 12.00 Platform session TRANSCRIPTION REGULATION I 
12.00 - 14.00  Lunch + Poster session A  
14.00 - 15.40 Platform session TRANSCRIPTION REGULATION II 
15.40 - 16.20  Break 
16.20 - 17.40 Platform session CARDIAC PROGENITOR CELLS 
17.40 - 18.30 KEYNOTE LECTURE by Prof Denis Duboule:  
18.30 - 19.30 ESC-WG DAP Meeting 
18.30 - 20.00 Drinks  
20.00 - 23.00 Buffet dinner + taking down of Posters of session A 
 
 
Friday 21 May 2010 
8.00 - 9.00 tea/coffee + putting up posters for session B 
8.00 - 9.00 Weinstein Business meeting 
9.00 - 10.40 Platform session EPICARDIUM 
10.40 - 11.20 Break 
11.20 - 13.00 Platform session CARDIAC SIGNALLING 
13.00 - 14.30 Lunch + Poster session B 
14.30 - 16.30 
ESC-WG DAP session  
GENETICS & CARDIOVASCULAR MALFORMATIONS 
16.30 - 17.00 Break + optional taking down of  Posters of session B 
17.00 - 18.40 Technical session 3D AND IMAGING TECHNIQUES 
18.45 -  Free evening + taking down of  Posters of session B 
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Saturday 22 May 2010 
8.00 - 9.00 tea/coffee + putting up posters for session C 
8.00 - 9.00 NIH presentation Dr Charlene Schramm 
9.00 - 11.00 Platform session VALVE DEVELOPMENT 
11.00 - 11.45 Break 
11.45 - 12.25 Platform session HEART FIELDS 
12.25 - 13.05 KEYNOTE LECTURE by Prof. Frank Grosveld 
13.05 - 14.30 Lunch + Poster session C 
14.30 - 16.10 Platform session NEURAL CREST & CONDUCTION SYSTEM 
16.10 - 16.40 Break + taking down of  Posters of session C 
16.40 - 17.40 Platform session CARDIOMECHANICS 
17.40 - 17.50 Kathrine Yutzey Introducing the Weinstein Conference 2011 in 
Cincinnati 
17.50 - 18.00 Closure of the Scientific Part of the Meeting (Antoon? Maurice?) 
18.00 -18.30 taking down of  Posters of session C 
18.30 - 20.00 "Floating wine and cheese party"  
Boat trip through the canals of Amsterdam to the Hotel Barbizon Palace 
20.00 - 01.00 Farewell dinner party in the Olaf chapel (Hotel Barbizon Palace) 
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 Weinstein Cardiovascular Development Conference Charter 
 
Scope of the Conference 
The Weinstein Cardiovascular Development Conference is an annual meeting for scientists 
investigating normal and abnormal development of the heart and vasculature as it may 
ultimately relate to human disease. It is a freestanding meeting, unaffiliated with any society 
or parent organization. Interested individuals or groups from host institutions organize it on a 
rotating basis. The intent of the meeting is to advance the overall field of cardiovascular 
development through the sharing of information and the facilitation of collaborative 
investigations. True to the vision of Dr. Constance Weinstein, who first organized this 
conference, the meeting is intended to include as many perspectives as possible. 
Investigators in any relevant area that can provide contributions to our understanding of heart 
and vascular development are welcome to contribute. 
 
Organization of the Conference 
In order to provide continuity and to maintain quality the conference, the participants of the 
1998 meeting voted to form an organizing committee called the "Weinstein Committee". The 
makeup of the committee is composed of a single representative from each of the three 
previous local organizing committees, a single member from the current host site local 
organizing committee, and a single representative from each of the next two proposed 
meeting sites. In addition, two "At-Large" members, who are selected by a vote by the 
conference participants, will serve a three-year term. The charge to the Committee is to 
assist the local organizing committee with meeting arrangements and organization and to 
help secure funding. Any institution should have a maximum of one member serving on the 
Weinstein Committee at any given time. 
In addition, the Committee is charged with solliciting and vetting nominations for future 
meeting sites and host institutions. Prospective host institutions should bid to host a future 
Weinstein meeting three years prior to the year that they desire to host the meeting. 
Prospective host institutions should submit a preliminary application to the two At-Large 
Weinstein Committee members at least one month prior to bidding to host a future meeting. 
The preliminary application should contain details of the prospective local organizing 
committee, prospective site for the meeting, and a fundraising plan. The purpose of early 
submission of a preliminary application is to allow the At-Large members of the committee to 
resolve any potential issues or missing details prior to review of the applications by the entire 
Weinstein Committee at the annual business meeting. The Weinstein Committee will 
evaluate all bids for feasibility to host the conference effectively in terms of fundraising and 
organizational and scientific capacity. The Weinstein Committee will select a maximum of 
three bids to be put to a vote the following day by all conference attendees. Meeting sites will 
be selected by vote such that the future local organizing committee will have a three-year 
lead-time. The Weinstein Committee may solicit additional applications from prospective host 
institutions as needed. In the event that multi-year funding is sought from the National 
Institutes of Health or other national sources, the Weinstein Committee will participate in this 
process. 
 
Local Organizing Committee 
To provide a varied flavor and the opportunity for new approaches, each host institution will 
form a local organizing committee to select a meeting venue and format and to participate in 
fundraising. The site should be selected for its potential to optimize informal communication 
and interaction. As a way to emphasize new and topical information, organizers from the host 
institution should select speakers from among the submitted abstracts. Scheduling should 
include opportunities for new voices and encourage the development of students, fellows, 
and younger faculty. Ample time for discussion is to be provided. 
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Obligations of the Participants 
One of the most important aspects of the Weinstein Conference has been the willingness of 
the participants to share new and unpublished information. This has provided opportunities 
for the participants to devise new experiments and develop new hypotheses in a 
collaborative manner. It is expected that all participants will participate in a collegial and 
ethical manner with respect to information obtained at the Weinstein Conference. Permission 
should be obtained before disclosure of another investigator's unpublished data. 
Similarly, investigators pursuing similar experiments should inform a presenter if the divulged 
information has a bearing on their own work. All participants in the conference should be 
willing to share their expertise and reagents in the collective advancement of the area of 
cardiovascular development. 
 
Annual Business Meeting 
Each Weinstein Conference will include time set aside for a business meeting and time for a 
subsequent vote on a future conference site by conference participants. At the Business 
Meeting, Weinstein Committee members may consider changes in the direction of the 
conference or its organization. At the 1999 meeting in Tucson, Arizona, this Charter was 
distributed to the participants and ratified. Its provisions commenced at the business meeting 
of the 1999 Tucson, Arizona Conference. The Charter will remain in effect until modified by a 
vote of the Weinstein Committee at the annual business meeting. 
 
2010 Weinstein Members 
 
Weinstein Committee (Term expiration indicated in parentheses) 
Loren Field, Ph.D., Indiana University School of Medicine (2010)  
Organizer, 2007 Weinstein Conference  
James F. Martin, M.D., Ph.D., Texas A&M IBT, Houston (2011)  
Organizer, 2008 Weinstein Conference  
H. Joseph Yost, Ph.D., University of Utah (2011)  
At-Large Member  
Brian L. Black, Ph.D., University of California, San Francisco (2012)  
Organizer, 2009 Weinstein Conference  
Ray Runyan, Ph.D., University of Arizona (2012)  
At-Large Member  
Maurice van den Hoff, Ph.D, HFRC, Amsterdam (2013)  
Organizer, 2010 Weinstein Conference  
Katherine Yutzey, Ph.D., University of Cincinnati (2014)  
Organizer, 2011 Weinstein Conference  
Eric Svensson, M.D., University of Chicago (2015)  
Organizer, 2012 Weinstein Conference  
 
Local Committee Members 2010: 
Maurice van den Hoff, Ph.D., Chair  
Antoon Moorman, Ph.D., Co-Chair  
Yigal Pinto, M.D. Ph.D., Co-Chair  
Katherine Yutzey, Ph.D., Overseas Co-Chair  
Ruth van der Gaag, Ph.D., Manager  
Vincent Christoffels, Ph.D., Member  
Alex Postma, Ph.D., Member  
Phil Barnett, Ph.D., Member  
Alexandre Soufan, Ph.D., Website Administrator  
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Weinstein Conference Host Institutions and Sites 
1. Medical University of South Carolina (Charleston, 1994)  
2. University of Rochester (Rochester, 1995)  
3. University of Pennsylvania (Philadelphia, 1996)  
4. University of Cincinnati (Cincinnati, 1997)  
5. Vanderbilt University (Nashville, 1998)  
6. University of Arizona (Tucson, 1999)  
7. Washington University (St. Louis, 2000)  
8. University of Texas, Southwestern Medical School (Dallas, 2001)  
9. University of Utah (Salt Lake City, 2002)  
10. Harvard University (Cambridge, 2003)  
11. Leiden University (Leiden, Netherlands, 2004)  
12. University of Arizona (Tucson, 2005)  
13. University of South Florida (Tampa/St. Petersburg, 2006)  
14. Indiana University School of Medicine (Indianapolis, 2007)  
15. Texas A&M University (Houston, 2008)  
16. University of California, San Francisco (San Francisco, 2009)  
17. University of Amsterdam, Netherlands (Amsterdam, 2010)  
18. University of Cincinnati (Cincinnati, 2011)  
19. University of Chicago (Chicago, 2012)  
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2010 Weinstein Cardiovascular Development Conference 
Keynote Speakers  
 
Denis Duboule, PhD 
Professor Federal Institute of Technology 
Chair of the Department of Zoology and Animal Biology, University of Geneva 
Chair for the national center of research ‘Frontiers in Genetics’ and current full professor at 
the Federal Institute of Technology (EPFL) in Lausanne. 
Denis Duboule is considered one of the world’s key 
specialists in developmental biology. His pioneering work on 
Hox gene clusters, revealing their basic mechanistic functions 
during developmental processes, launched forth a line of 
research which remains today one of the most intensively 
studied systems in biology.  
Born in Geneva in 1955, Denis Duboule retains a dual 
French-Swiss nationality. Studying at the University of 
Geneva he received his doctorate of sciences in 1984. He 
then spent 10 years abroad, first at the medical faculty in 
Strasbourg (France), then at the European Laboratory for 
Molecular Biology (EMBL) in Heidelberg, Germany, as a 
group leader. In 1992 he took up the seat as full professor of 
Biology at the University of Geneva. A regularly feature guest 
author and editorial writer for Nature and Science, Denis Duboules original works, have to 
date been cited in excess of 10,000 times, top citation being entitled ‘The structural and 
functional organization of the murine HOX gene family resembles that of Drosophila 
homeotic genes’, published in the EMBO Journal in 1989. He has been a member of the 
Sciences-Cité Foundation's Board since 2000 and the chairman of Geneva's Cantonal 
Committee for Animal Protection since 2002. His honours and awards number many and 
include the Latsis Prize in 1994, the Louis-Jeantet Prize for Medicine in 1998, the Marcel 
Benoist Prize in 2003, and the French Academy of Science's Leopold Meyer Grand Prize in 
Biology in 2004. In 2005, he was awarded the Order of Chivalry in France's National Order of 
Merit (Ordre national du Mérite, founded by Charles de Gaulle, 1963).  
Denis himself says he had a ‘cool time at University’ considering himself ‘... not a good 
example for real vocational science’. Although he may now reflect on his younger aspiration 
to be a sports teacher, the path he has chosen has certainly has allowed him to take a 
winning position in his track and field. 
 
Selection of papers:  
Papers cited more than 200 times: 
Duboule D, Dollé P. (1989)The structural and functional organization of the murine HOX gene family resembles 
that of Drosophila homeotic genes. EMBO J. 8:1497-1505. 
Dollé P, Izpisúa-Belmonte JC, Falkenstein H, Renucci A, Duboule D. (1989)Coordinate expression of the murine 
Hox-5 complex homoeobox-containing genes during limb pattern formation. Nature 342:767-772 
Preitner N, Damiola F, Lopez-Molina L, Zakany J, Duboule D, Albrecht U, Schibler U. (2002) The orphan nuclear 
receptor REV-ERBalpha controls circadian transcription within the positive limb of the mammalian 
circadian oscillator. Cell 110:251-60 
Dollé P, Dierich A, LeMeur M, Schimmang T, Schuhbaur B, Chambon P, Duboule D. (1993) Disruption of the 
Hoxd-13 gene induces localized heterochrony leading to mice with neotenic limbs. Cell 75:431-441. 
Izpisúa-Belmonte JC, Tickle C, Dollé P, Wolpert L, Duboule D. (1991) Expression of the homeobox Hox-4 genes 
and the specification of position in chick wing development. Nature 350:585-589. 
Price M, Lemaistre M, Pischetola M, Di Lauro R, Duboule D. (1991) A mouse gene related to Distal-less shows a 
restricted expression in the developing forebrain. Nature 351:748-751. 
Morgan BA, Izpisúa-Belmonte JC, Duboule D, Tabin CJ. (1992) Targeted misexpression of Hox-4.6 in the avian 
limb bud causes apparent homeotic transformations. Nature 358:236-239 
Price M, Lazzaro D, Pohl T, Mattei MG, Rüther U, Olivo JC, Duboule D, Di Lauro R. (1992) Regional expression 
of the homeobox gene Nkx-2.2 in the developing mammalian forebrain. Neuron 8:241-255. 
Duboule D, Morata G. (1994) Colinearity and functional hierarchy among genes of the homeotic complexes. 
Trends Genet. 10:358-64. 
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Frank Grosveld, PhD 
Professor Erasmus University Rotterdam 
Chair of the Department of Cell Biology 
Frank Grosveld is Chair of Cell Biology at the Erasmus 
University Rotterdam, where "Mechanisms of gene regulation 
and epigenetic phenomena" have been the primary focus of his 
research. His group carried out pioneering work in many aspects 
of gene regulation from concluding that DNA methylation inhibits 
gene expression via an indirect mechanism, to the first 
description of a locus control region (LCR), visualizing the 
primary transcription process in the nucleus and most recently 
the description of 3D interactions in the nucleus. His group has 
filed a considerable number of patents and has closely 
collaborated with industrial partners.  
Frank Grosveld studied biochemistry at the University of 
Amsterdam (MSc) and subsequently obtained a PhD from McGill 
University (1976) for his thesis work on the structure of 
bacteriophage S13. After two postdoctoral periods, one in Zurich under Charles Weissmann 
and the other in London at the National Institute for Medical Research under Richard Flavell. 
He went on to become Head of the division of Gene Structure and Expression at this NIMR 
in 1983. Since 1993 he is Chair of the Department Cell Biology at the Erasmus University 
Rotterdam, the Netherlands. 
Frank Grosveld received the Jeantet prize for medicine in 1991 and the prestigious Spinoza 
prize in 1995. He is chairman of the Research School "Medical Genetic Centre" (MGC) and 
board member of the top research school "Centre for Biomedical Genetics" (CBG). He is and 
has been on the advisory board of many research councils, institutes and companies and is 
co-founder of four spin-off companies, he is scientific director of both Minos Biosystems Ltd 
and Harbour Antibodies BV.. He was recently appointed as Professor of the Royal Academy 
of Sciences (KNAW) in the Netherlands 
 
Selection of papers:  
Papers cited more than 200 times: 
Rodriguez P, Bonte E, Krijgsveld J, Kolodziej KE, Guyot B, Heck AJ, Vyas P, de Boer E, Grosveld F, Strouboulis 
J (2005) GATA-1 forms distinct activating and repressive complexes in erythroid cells. EMBO J 
6;24(13):2354-66  
Meier N, Krpic S, Rodriguez P, Strouboulis J, Monti M, Krijgsveld J, Gering M, Patient R, Hostert A, Grosveld F 
(2006). Novel binding partners of Ldb1 are required for haematopoietic development. Development 
133(24):4913-23  
Jhunjhunwala S, van Zelm MC, Peak MM, Cutchin S, Riblet R, van Dongen JJ, Grosveld FG, Knoch TA, Murre C 
(2008).The 3D structure of the immunoglobulin heavy-chain locus: implications for long-range genomic 
interactions. Cell 133:265-79  
de Laat W, Klous P, Kooren J, Noordermeer D, Palstra RJ, Simonis M, Splinter E, Grosveld F (2008). Three-
dimensional organization of gene expression in erythroid cells. Curr Top Dev Biol 82:117-39  
Monkhorst K, Jonkers I, Rentmeester E, Grosveld F, Gribnau J (2008). X inactivation counting and choice is a 
stochastic process: evidence for involvement of an X-linked activator. Cell 132:410-421  
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Places in Amsterdam to eat and drink 
 
Since the places listed below are but a selection of what Amsterdam has to offer, here are some 
broader tips of areas in general.  
The area immediately surrounding the Spui has many good restaurants and bars. The 
Zeedijk/Nieuwmarkt area has an oriental emphasis, but is a good place for lower budget meals and in 
general high quality.  
An area to try and avoid is the Leidseplein. Although the food here is cheap and some places are ok, 
the area is a typical city tourist trap, a feature very much reflected in the quality of food served, which 
in general is pretty poor. 
For those with a slightly larger budget and looking for a more up market area to dine we recommend 
checking out the area surrounding the 'Concertgebouw' which has some nice restaurants. 
More information can be found on http://www.iamsterdam.com/en/visiting/visitingportal . 
 
 
SOME FAVOURITE BARS IN AMSTERDAM, THOUGH NOT FOR TOO LARGE A GROUP 
During the week most bars close at 1am, last orders at the bar are typically around 12:30am. On 
Friday & Saturday most places close later at around 2-3am. 
Schutter Typical student bar. Very friendly atmosphere http://www.deschutter.nl/  
Beijaard A good view of the trams as they speed by. Friendly bar, good beer,    
 reasonable food http://www.beiaardgroep.eu/amsterdam/spui/spuhome/  
Fonteijn Popular bar, very mixed crowd. http://www.cafefonteyn.nl/   
De Jaren A large open bar, little bit pretentious, but has some nice views over the water 
 http://www.diningcity.nl/cafedejaren/    
t Smalle A very 'Jordaneese' small bar. No music, but famous and popular http://www.t-smalle.nl/   
Gollem A nice Belgian type beer bar, serving over 200 different bottled beers. Small, but very cosy and 
 popular http://cafegollem.nl/      
de Zotte A little gem behind the tourist trap of the Leidseplein. Good selection of  beers and reasonable 
 food http://www.dezotte.nl/   
Eik en Linde A very typical 'brown' cafe. Friendly, even though its full of locals. http://www.eikenlinde.nl/  
Sluyswacht A nice bar which is built on an old 'sluis' (lock-gate). Used to be the  gate keepers house in the 
 17th century.  http://www.sluyswacht.nl/   
Heeren van Amstel  A very Dutch bar with live music late in the evenings. Friday and Saturday you will have to 
 pay to get in after 10pm.  www.deheerenvanaemstel.nl/     
 
PLACES TO EAT 
New King http://www.newking.nl/      Chinese 
Bird  http://www.thai-bird.nl/      Thai 
Pakhuis  www.hetpakhuis.nl       Dutch 
Rose's Cantina http://www.dobson-uzcudun.com/mexican/roses_cantina.htm  Mexican 
Humphreys http://www.humphreys.nl/      Dutch 
Kantijl Tijger   http://www.kantjil.nl/restaurant.htm     Indonesian 
De Waag http://www.indewaag.nl/      Dutch 
Spargo   (opposite the Tropenmuseum) www.cafespargo.nl   Dutch 
De Vijf Vliegen  http://www.thefiveflies.com     Dutch  
Haesje Claes http://www.haesjeclaes.nl      Dutch 
Yam yam www.yamyam.nl       Italian 
Felicita  www.felicita.nl         Italian, no pizza 
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Weinstein 2010 sponsors 
 
The Weinstein conference in Amsterdam would not have been possible without the 
financial support from: 
 
Our platinum sponsors 
HeartRepair; EU's 6th Framework Programme LSHM-CT-2005-018630 
National Institutes of Health Research Grant # 5 R13 HL91580-03.  
Funded by the National Heart, Lung, and Blood Institute and  
the Eunice Kennedy Shriver National Institute of Child Health and Human Development. 
Royal Netherlands Academy of Arts and Sciences 
Company of Biologists [Development and Disease Models & Mechanisms] 
Netherlands Heart Foundation 
 
Our gold sponsors 
AMC - Heart Failure Research Center 
American Heart Association’s Council on Cardiovascular Surgery and 
Anesthesia 
European Society of Cardiology - WG Developmental Anatomy and Pathology 
Genentech 
 
Our silver sponsors 
Abcam 
American Association of Anatomists 
Amsterdam Tourism and Convention Board 
Developmental Dynamics 
Fisher Scientific 
International Society for Differentiation 
Medtronic 
Merck Sharp & Dohme 
National March of Dimes 
PerkinElmer 
RiboTask 
Roche 
R&D Systems 
Schering-Plough 
Thermo Scientific 
Visualsonics 
  Weinstein 2010 Sponsors 
 
page 17
Our bronze sponsors 
Boston Scientific 
European Microscopy Society 
Greiner Bio-one 
Leica-Microsystems 
Servier 
 
Our Weinstein Friends 
Canon 
Chooli Fashion 
Invitrogen (Life Technologies) 
Tebu-Bio 
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Detailed Schedule Weinstein Conference 2010 
 
Great Hall of the Royal Tropical Institute, Amsterdam, the Netherlands 
 
Thursday 20 May 2010 
8.00 - 10.00  Registration  
+ tea/coffee  
+ putting up posters for session A 
10.10 - 10.20  Welcome and Opening  
Maurice van den Hoff (Local organizing committee chair) 
Platform session TRANSCRIPTION REGULATION I 
Chairs: Phil Barnett & Tony Firulli 
10.20 -10.40 Conditional Disruption of Phosphoregulation of Hand1 Results in Outflow Tract Defects 
Beth Firulli*, Joshua W. Vincetz, Ralston M. Barnes, Anthony B. Firulli 
 
10.40 - 11.00 Tbx2 and Tbx3 induce cushion formation and are required for AVC patterning Reena Singh*, Willem M.H. Hoogaars, Thomas Grieskamp, Sameer Rana, Vincent M. 
Christoffels and Andreas Kispert 
 
11.00 - 11.20 The Cardiac Transcription Network Driven by the Interplay of Transcription Factors, Histone Modifications and microRNAs 
Jenny Schlesinger*, Markus Schueler, Marcel Grunert, Jenny J. Fischer, Qin Zhang, 
Tammo Krueger, Martin Lange, Martje Tönjes, Ilona Dunkel, Silke R. Sperling 
 
11.20 - 11.40 A MEF2C-Myocardin complex directly regulates the cardiac metabolic master regulatory gene Ampk α2 through a conserved myocardial-specific enhancer  
Courtney M. Anderson*, Analeah B. Heidt, Shan-Mei Xu, Brian L. Black 
 
11.40 - 12.00 Inhibition of cardiac myocyte apoptosis by Zac1, an essential cardiac transcription factor 
Shinsuke Yuasa*, Takahiko Nishiyama, Owen W.J. Prall, Richard P. Harvey, Keiichi 
Fukuda 
 
12.00 - 14.00  Lunch + Poster session A 
Platform session TRANSCRIPTION REGULATION II 
Chairs: Vincent Christoffels & Brian Black 
14.00 - 14.20 Hand2 loss-of-function in Hand1-expressing cells Reveals Distinct Roles In Heart And Coronary Vascular Development 
Ralston M. Barnes*, Beth A. Firulli, Josh W. Vincentz, Peter Cserjesi, Simon J. Conway, 
Anthony B. Firulli 
 
14.20 - 14.40 Direct Reprogramming of Cardiac Fibroblasts into Functional Cardiomyocytes by Defined Factors 
Masaki Ieda*, Jidong Fu, Vasanth Vedantham, Benoit G. Bruneau, and Deepak 
Srivastava 
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14.40 - 15.00 Sox4 cooperates with Tbx3 in the regulation of T-box-gene targets C.J.J. Boogerd*, L.Y.E. Wong, M. van den Boogaard, M.L. Bakker, P.A.C. ’t Hoen, A.F. 
Moorman, V.M. Christoffels and P. Barnett. 
 
15.00 - 15.20 Prdm1, encoding the Blimp1 transcriptional repressor, genetically interacts with Tbx1 during distal outflow tract morphogenesis. 
Stéphane D. Vincent*, Sachiko Miyagawa-Tomita and Margaret Buckingham 
 
15.20 - 15.40 A Direct microRNA Target Screen Reveals Alternate Regions of Complementarity that Mediate Repression in cardiac homeostasis 
Eva Samal*, Vasanth Vedantham, Ru-Fang Yeh, Nathan Salomonis, YuanYuan Xiao, 
Morgan Von-Drehle, Linda van Laake, Yong Zhao, David J. Erle Deepak Srivastava 
 
15.40 - 16.20  Break 
Platform session CARDIAC PROGENITOR CELLS 
Chairs: Christine Mummery & Scott Baldwin 
16.20 - 16.40 Endothelial progenitors contribute to the heart endocardium and play key roles in cardiac development 
Michal Milgrom-Hoffman*, Napoleone Ferrara, Elazar Zelzer and Eldad Tzahor 
 
16.40 - 17.00 Identification of micro RNAs involved in cardiac specification in mESCs Alexandre Colas*, Wesley McKeithan, Mark Mercola 
 
17.00 -17.20 Regulation of cardiac progenitor cells during heart development Francesca Rochais* and Robert G. Kelly 
 
17.20 - 17.40 Hematopoietic cell contribution to embryonic mouse valve development and adult valve homeostasis 
Zoltan Hajdu*, Roger R Markwald, Christopher C Drake, Imre Olah, Richard P Visconti 
 
17.40 - 18.30 KEYNOTE LECTURE 
Chair: Maurice van den Hoff 
Prof Denis Duboule:  Genetic Control of Vertebrate   
    Morphogenesis and Evolution 
University of Geneva, Geneva & School of Life Sciences, Lausanne, Switzerland. 
18.30 - 19.30 ESC-WG DAP Meeting  
18.30 - 20.00 Drinks  
20.00 - 23.00 Buffet dinner 
+ taking down of Posters of session A 
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Friday 21 May 2010 
8.00 - 9.00 tea/coffee 
+ putting up posters for session B 
8.00 - 9.00 Weinstein Business meeting 
Platform session EPICARDIUM 
Chairs: Thomas Brand & Takashi Mikawa 
9.00 - 9.20 Epicardial fate and Notch signaling Thomas Grieskamp, Carsten Rudat, Julia Norden, Andreas Kispert* 
 
9.20 - 9.40 Loss of the Type III Transforming Growth Factor-β Receptor decreases Hyaluronic Acid responsiveness in Epicardial Cells 
Nora S. Sánchez*, Evisabel Craig, Joseph D. Love, Todd Camenisch, and Joey V. 
Barnett 
 
9.40 - 10.00 NFATc1 in epicardium-derived cells is required for fibrous skeleton and intramyocardial coronary vessel development 
Michelle D. Combs*, Caitlin M. Braitsch, and Katherine E. Yutzey 
 
10.00 -10.20 PDGF Signaling is Required for Epicardial Functions and New Blood Vessel Formation in Regenerating Zebrafish Hearts 
Qiong Wu, Yolanda Zhang, Jieun Kim, Katie M. Wiens, Hiro Shimada, Robert I. Handin, 
Michael Y. Chao, Tai-Lan Tuan, Vaughn A. Starnes and Ching-Ling Lien* 
 
10.20 - 10.40 PDGFR signaling in the epicardium is required for epicardial EMT and coronary VSMC and cardiac fibroblast development 
Christopher L. Smith*, Seung Tae Baek,and Michelle D. Tallquist 
 
10.40 - 11.20 Break 
Platform session CARDIAC SIGNALLING 
Chairs: Paul Riley & Richard Harvey 
11.20 - 11.40 Inhibition of Bmp signaling by Smad6 is required for terminal differentiation of ventricular cardiomyocytes. 
Emma de Pater and Jeroen Bakkers* 
 
11.40 - 12.00 The BMP Pathway Acts to Regulate Tbx20 in the Developing Heart Erin Kaltenbrun*, Elizabeth Mandel, Thomas Callis, Da-Zhi Wang and Frank Conlon 
 
12.00- 12.20 Bmp-signaling regulates myocardial differentiation from cardiac progenitors through a micro RNA-mediated mechanism 
Jun Wang*, Margarita Bonilla-Claudio, Jue Zhang, Yan Bai, Zheng Huang, Brian L. 
Black, Fen Wang, and James F. Martin 
 
12.20 -12.40 Cardiac Laterality is Controlled by Multiple Rho Kinase Signaling Pathways in Ciliated Cells 
Guangliang Wang, Fiona C. Foley, Duck Soo Jang, Jeffrey D. Amack* 
 
12.40 - 13.00 Mitochondrial structure and function during cardiac myocyte differentiation George A. Porter, Jr.*, Jennifer Hom, Rodrigo Quintanilla, David Hoffman, Bentley 
Karen, Shey-Shing Sheu 
 
13.00 - 14.30 Lunch + Poster session B 
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ESC-WG DAP session GENETICS & CARDIOVASCULAR MALFORMATIONS 
Chairs: Diego Franco & Alex Postma 
14.30 - 14.50 Dysregulation of the PDGFRA gene causes inflow tract anomalies including TAPVR: Integrating evidence from human genetics and model organisms 
Steven B. Bleyl*, Yukio Saijoh, Noortje A.M. Bax, Adriana C. Gittenberger-de Groot, 
Lambertus J. Wisse, Shigehito Yamada, Kohei Shiota and Gary C. Schoenwolf. 
 
14.50 - 15.10 Effects of conditional deletion of hypoxia-inducible factor (hif) and hypoxic stress on mouse heart morphogenesis 
Hongbin Liu and Steven A. Fisher* 
 
15.10 - 15.30 p53-related p63 transcription factor is essential for cardiac morphogenesis Alain Medawar, Matthieu Rouleau, Laurent Hamon, Huiqing Zhou, Hans van Bokhoven, 
Caterina Missero, Eleonora Candi, Cedric Blanpain, Gerry Melino, Michel Puceat and 
Daniel Aberdam* 
 
15.30 - 15.50 Copy Number variations (CNV) in left sided congenital heart disease Marc-Phillip Hitz*, Louis-Philippe Lemieux-Perreault, Christian R. Marshall, Bert 
Overduin, Maryse Thibeault, Alexandre F. R. Stewart, Stephen W. Scherer, Andrea 
Richter, Marie-Pierre Dubé, Gregor Andelfinger 
 
15.50 - 16.10 The role of FKbp12-notch1 mediated regulation in ventricular trabeculation and compaction 
Hanying Chen*, Wenjun Zhang, Xiao-Xin Sun, Zhuang Chen, Kryn Stankunas, 
Yongzhen He, Weidong Yong, Wuqiang Zhu, Simon Conway, Ching-Pin Chang, Loren 
J. Field, Nadia Carlesso, Weinian Shou 
 
16.10 - 16.30 MCTP2 is a novel gene causing aortic coarctation 
S.M. Ware*, X. Wang, L. Potocki, G. Zapata, M. Bray, A.C. Chinault, B.A. Boggs, E.K. 
Brundage, J.A. Towbin, A. Patel, S.D. Fernbach, S.L. Hamilton, K.L. McBride, J.W. 
Belmont, S.R. Lalani. 
 
16.30 - 17.00 Break + taking down of  Posters of session B 
Netherlands Heart Foundation Technical session 3D AND IMAGING TECHNIQUES  
Chairs: Jan Ruijter & Tim Mohun  
17.00 - 17.20 3D Modelling of heart development: looking to the future Tim Mohun  
 
17.20 - 17.40 Imaging in the Embryonic Heart: morphodynamic studies with Optical Coherence Tomography (OCT) 
Mesud Yelbuz 
 
17.40 - 18.00 How to quantify in 3D: 3D imaging of gene expression patterns and morphogenetic parameters in the embryonic heart. 
Jan M. Ruijter*, Alexandre T. Soufan, Jaco Hagoort, and Antoon F.M. Moorman 
 
18.00 - 18.20 How to place a section: automated fitting of histological sections into a high resolution 3D reference model of a developing mouse heart 
Bouke A de Boer*, Frans PJM Voorbraak, Maurice JB van den Hoff, Antoon FM Moorman, Jan M 
Ruijter 
 
18.20 - 18.40 How to make a 3D pdf: from 3D-reconstruction to interactive 3D-pdf; a protocol for biologists. 
Jaco Hagoort*, Alexandre Soufan, Bouke de Boer, Antoon Moorman 
 
18.45 -  Free evening + taking down of  Posters of session B 
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Saturday 22 May 2010 
8.00 - 9.00 tea/coffee 
+ putting up posters for session C 
8.00 - 9.00 NIH presentation Dr Charlene Schramm 
Platform session VALVE DEVELOPMENT 
Chairs: Katherine Yutzey & Andy Wessels 
9.00 - 9.20 MiR-23 is essential to restrict endothelial-to-mesenchymal transition during cardiac valve formation. 
Anne Karine Lagendijk*, Jeroen Bakkers 
 
9.20 - 9.40 Cardiac valve malformations: new insights from Pdlim7, an unexpected suspect in heart development 
Jennifer Krcmery*, Rudyard Sadleir, Rajesh Gupta, Chrissy Kamide, Sol Misener, Doug 
Losordo, and Hans-Georg Simon 
 
9.40 - 10.00 Krox20 is required during valve remodeling and maturation Sarah Arab, Frank Kober, Piotr Topilko, Monique Bernard, Patrick Charnay, Patrick 
Cozzone and Stéphane Zaffran* 
( 
10.00 -10.20 The Metalloprotease ADAMTS5 Plays A Critical Role In ECM Stratification And Cusp Sculpting During Semilunar Valve Maturation 
Christine B. Kern*, Daniel R. McCulloch, Jessica D. McGarity, Alexandra Bahan, Loren 
E. Danese, Courtney M. Nelson, Andy Wessels, and Suneel S. Apte 
 
10.20 - 10.40 Induction of a developmental gene program in pediatric and adult aortic valve disease 
Elaine Wirrig*, Jonathan Cheek, Christina Alfieri, Walter Merrill, Robert Hinton, 
Katherine Yutzey 
 
10.40 - 11.00 Reduced Sox9 function promotes heart valve calcification in vivo Jacqueline D Peacock*, Agata K Levay, and Joy Lincoln 
 
11.00 - 11.45 Break 
Platform session HEART FIELDS 
Chairs: Margaret Buckingham & Jim Martin 
11.45 - 12.05 Tbx5 is required in the Second Heart Field for Atrioventricular Septation Linglin Xie, Joshua M. Friedland-Little, Andrew D. Hoffmann, and Ivan P. Moskowitz* 
 
12.05 - 12.25 Cooperative roles of Tbx1 and Tbx3 during early outflow tract development Karim Mesbah*, M. Sameer Rana, Laure Lo Ré, Virginia Papaioannou, Vincent M. 
Christoffels, Robert G. Kelly 
 
12.25 - 13.05 KEYNOTE LECTURE 
Chair Yigal Pinto 
Prof. Frank Grosveld:   Interactions in the genome 
Dept of Cell Biology, Erasmus Medical Center, Rotterdam, the Netherlands 
13.05 - 14.30 Lunch + Poster session C 
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Platform session NEURAL CREST & CONDUCTION SYSTEM 
Chairs: Margaret Kirby  & Ivan Moskowitz 
14.30 - 14.50 
Trigenic neural crest-restricted Smad7 over-expression results in congenital 
craniofacial and cardiovascular defects 
Sunyong Tang, Paige Snider and Simon J. Conway * 
 
14.50 - 15.10  
Cardiac Neural Crest Nibble Their Way to the Heart 
Mary R. Hutson*, Ann Marie Scholl, Elizabeth B. Kuhn, Asako Sato, Harriett A. Stadt, 
Jennifer R. Decker, Kelly Pegram, and Margaret L. Kirby 
*Department of Pediatrics, Neonatal-Perinatal Research Institute, Duke University 
Medical Center, Durham, NC, USA 
15.10 - 15.30 Origins of Cardiac Pacemaking Cells in Avians Michael Bressan*, Alicia Navetta, Takashi Mikawa 
 
15.30 - 15.50 The role of Tbx3 and Nkx2-5 in the adult atrioventricular conduction system Mathilda T.M. Mommersteeg*, Bas J. Boukens, Saskia van der Velden, Corrie de Gier-
de Vries, Richard P. Harvey, Antoon F.M. Moorman, Vincent M. Christoffels 
 
15.50 - 16.10 Delayed atrioventricular conduction in adrenergic-deficient embryonic mouse hearts: Uncovering a role for retinoic acid 
Kingsley Osuala, David G. Taylor, Celines Martinez, Ha-Long Nguyen, Tu-Suong 
Nguyen, Anupama Natarajan, Peter Molnar, James Hickman, and Steven N. Ebert* 
 
16.10 - 16.40 Break + taking down of  Posters of session C 
Platform session CARDIOMECHANICS 
Chair: Roger Markwald & Ray Runyan 
16.40 - 17.00 Shear stress modulates transcriptional regulation and cushion endoMT in the developing heart 
Beerend P. Hierck*, Anastasia D. Egorova, Simone van de Pas, Marie José Goumans, 
Peter ten Dijke, Robert E. Poelmann 
 
17.00 - 17.20 Integrative computational modeling and imaging approach to study the effects of abnormal hemodynamic conditions on cardiac development. 
Sandra Rugonyi*, Ruikang Wang and Kent Thornburg 
 
17.20 - 17.40 Knockdown of embryonic myosin heavy chain causes defective electrical activities and calcium signalling within the developing heart 
Catrin Rutland, Luis Polo-Parada, Aziza Alibhai, Aaran Thorpe and Siobhan Loughna* 
 
17.40 - 17.50 Kathrine Yutzey Introducing the Weinstein Conference 2011 in Cincinnati 
17.50 - 18.00 Closure of the Scientific Part of the Meeting  
18.00 -18.30 Taking down of  Posters of session C 
18.30 - 20.00 "Floating wine and cheese party"  
Boat trip through the canals of Amsterdam to the Hotel Barbizon Palace 
20.00 - 01.00 Farewell dinner party in the Olaf chapel (Hotel Barbizon Palace) 
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ORAL SESSIONS  
THURSDAY 20 MAY 
 
 
 
Location:  Great Hall  
 
 
10.20 - 12.00 Transcription Regulation I 
14.00 - 15.40 Transcription Regulation II 
16.20 - 17.40 Cardiac Progenitor Cells 
17.40 - 18.30 Keynote Lecture I  
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Transcription Regulation I 
 
136. Conditional Disruption of Phosphoregulation of Hand1 Results in Outflow Tract 
Defects 
Beth Firulli*, Joshua W. Vincetz, Ralston M. Barnes, Anthony B. Firulli 
Riley Heart Research Center, Wells Center for Pediatric Research, Division of Pediatric Cardiology, 
Indiana Medical School 
 
The Twist family of bHLH transcription factors are broadly expressed within mesenchymal cell 
populations and convey tissue specific transcriptional output to numerous organ systems such as the 
heart and neural crest-derived cardiac outflow tract. We hypothesize that dimer choice regulation 
conveys tissue-specific function by regulating the bHLH dimer pool within the cell. Dimer regulation is 
in part controlled by phosphoregulation of evolutionarily conserved threonine and serine residues 
within Helix 1 of the HLH domain. Indeed mutations that hobble phosphoregulation of Twist1 are 
causative to the human disease Saethre Chotzen Syndrome and involve a dimer modulation 
relationship with Hand2. To begin to understand more clearly how phosphoregulation of Twist-proteins 
affects biological outputs, we have conditionally targeted both hypo-phosphorylation and 
phosphorylation mimic alleles for Hand1. Activating the of expression of these Hand1 point mutant 
alleles within the neural crest via intercross with the Wnt1-cre driver results in cardiac outflow tract 
defects that result in neonatal death. Surprisingly, the observed phenotypes are more severe then 
neural crest specific ablation of Hand1, indicating that a compound heterozygous mouse with a single 
wildtype and complementary phospho-mutant Hand1 allele is more deleterious to survival then a 
neural crest Hand1 conditionally null mouse. 
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137. Tbx2 and Tbx3 induce cushion formation and are required for AVC patterning 
Reena Singh* (1), Willem M.H. Hoogaars (2), Thomas Grieskamp (1), Sameer Rana (2), Vincent M. 
Christoffels (2) and Andreas Kispert (1) 
(1) Institut für Molekularbiologie, Medizinische Hochschule Hannover, Hannover, Germany (2) Heart 
Failure Research Center (T.H., V.W., A.F.M.M., V.M.C.), Academic Medical Center, Amsterdam, The 
Netherlands. 
 
The complex four-chambered heart is an outcome of regionalization, patterning and differentiation 
during embryonic development. In the developing heart, chamber myocardium of atrium and ventricles 
are separated and bordered by non-chamber myocardium of the atrioventricular canal (avc) and 
outflow tract (oft). The avc myocardium is required for aligning the atrial and ventricular chambers and 
for mesenchymal cushion formation. Cushion tissues are subsequently deployed in the formation of 
valves and septa. Work from the last decade has shown that T-box proteins, which are expressed in 
different compartments of the developing heart in exclusive and sometimes overlapping fashion, are 
downstream effectors of several signaling morphogens, particularly BMPs, and play crucial role in 
cardiac regionalization. Tbx2 is expressed in and required for the formation of the avc (Harrelson 2004; 
Aanhaanen 2009). However, Tbx2 mutants showed variable phenotypes with incomplete penetrance. 
Since the closely related paralog Tbx3 is co-expressed with Tbx2 in the avc, we generated and 
analyzed Tbx2/Tbx3 double mutants in order to eliminate the effect of redundancy. Our analysis 
indeed suggested that Tbx2 in combination with Tbx3 is crucial for avc establishment by suppressing 
chamber myocardial gene programs in this particular domain of the heart. Simultaneously, we also 
observed the insufficiency of double mutants to maintain Bmp2 expression and to induce cardiac jelly, 
the very first step of cushion formation. By gain of function studies we could show that Tbx2 and Tbx3 
are individually sufficient for inducing cushion formation by activating Bmp2 and thereby acting in a 
feed-forward loop. 
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138. The Cardiac Transcription Network Driven by the Interplay of Transcription 
Factors, Histone Modifications and microRNAs 
Jenny Schlesinger* (1), Markus Schueler (1,2), Marcel Grunert (1), Jenny J. Fischer (1), Qin Zhang (1), 
Tammo Krueger (1), Martin Lange (1), Martje Tönjes (1), Ilona Dunkel (1), Silke R. Sperling (1) 
(1) Group Cardiovascular Genetics, Department of Vertebrate Genomics, Max Planck Institute for 
Molecular Genetics, Germany (2) Department of Computational Molecular Biology, Max Planck 
Institute for Molecular Genetics, Germany 
 
Heart development is controlled by an evolutionarily conserved transcription factor network connecting 
signaling pathways with respective genes. In addition to the transcriptional machinery, epigenetic and 
post-transcriptional mechanisms contribute to the establishment of cardiac cell fates. We present a 
systems-level study integrating mRNA profiles with DNA-binding events of transcription factors (Gata4, 
Mef2a, Nkx2.5 and Srf), activating histone modifications (H3ac, H4ac, H3K4me2 and H3K4me3) and 
microRNA profiles obtained in wildtype and RNAi mediated knockdown. We confirmed conclusions 
primarily obtained in cardiomyocyte cell culture in a time course of cardiac maturation in mouse 
around birth. The high-throughput data have been generated using microarrays and next generation 
sequencing technology, whereas confirmation experiments were performed by luciferase reporter 
gene assays and quantitative real-time PCR. We provide insights for the combinatorial regulation by 
transcription factors and show that they partially compensate each other’s function. Further, histone 3 
acetylation has a significant impact on the regulation of Srf and Gata4 dependent genes, and 
moreover buffers the downregulation of Srf target gene expression in its knockdown. In accordance 
with others, we found that a high proportion of differentially expressed genes in RNAi experiments are 
indirect targets. On the example of Srf, we show that 43% of the altered mRNA profile can be 
explained by the impact of microRNA alterations. In summary, we show that the different levels 
regulating cardiac mRNA profiles, such as DNA-binding transcription factors, histone modifications 
and microRNAs, have an high degree of interdependency and the potential to buffer each other. 
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139. A MEF2C-Myocardin complex directly regulates the cardiac metabolic master 
regulatory gene Ampk α2 through a conserved myocardial-specific enhancer  
Courtney M. Anderson*, Analeah B. Heidt, Shan-Mei Xu, Brian L. Black 
Cardiovascular Research Institute, University of California, San Francisco, USA 
 
The MADS domain transcription factor MEF2C is essential for cardiovascular development in mice. 
During embryogenesis, Mef2c is expressed at the onset of cardiac muscle differentiation, and Mef2c-
null embryos die by E10 with severe cardiac morphogenetic and differentiation defects. MEF2C is a 
signal-dependent transcription factor that can function as either an activator or a repressor, depending 
on cofactor interactions. Myocardin and Myocardin-related transcription factors are SAP domain 
proteins that are potent coactivators for the MADS domain transcription factor SRF. Recently, a 
specific splice isoform of Myocardin, Myocardin-935, has been identified as a potent coactivator of 
MEF2C activity, yet the targets of MEF2C-Myocardin and the transcriptional mechanisms that control 
Myocardin coactivation of MEF2C remain unresolved. In this study, we identified a highly conserved 
transcriptional enhancer from the Ampka2 gene that is sufficient to direct expression exclusively to the 
myocardium during development and in adulthood. Ampka2 encodes a subunit of the 5’-AMP-
activated protein kinase (AMPK), an energy-sensing enzyme that maintains cellular energy 
homeostasis and controls cardiac metabolism by regulating fatty acid oxidation, glycolysis, and 
glucose uptake. We show that the Ampka2 myocardial enhancer requires a MEF2C-Myocardin 
complex for activity in vivo and in vitro, and that this complex regulates Ampka2 expression through 
two essential, highly conserved MEF2 sites in the enhancer. Importantly, these results are the first to 
demonstrate the transcriptional regulation of Ampka2 in the heart in vivo, and we have identified a 
general mechanism by which MEF2C and Myocardin form a complex and regulate transcription of 
cardiac genes. 
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140. Inhibition of cardiac myocyte apoptosis by Zac1, an essential cardiac 
transcription factor 
Shinsuke Yuasa*, Takahiko Nishiyama, Owen W.J. Prall, Richard P. Harvey, Keiichi Fukuda 
Department of Cardiology, Department of Internal Medicine Center for Integrated Medical Research, 
Keio University School of Medicine Victor Chang Cardiac Research Institute University of New South 
Wales 
 
The transcriptional mechanisms are poorly understood in the heart, despite the identification of several 
essential cardiac transcription factors. We found that Zac1, which encodes a zinc-finger-type 
transcription factor and is a maternal imprinting gene, was strongly expressed throughout the murine 
heart from embryonic stage 8.5. Zac1 was a potent activator of several cardiac genes and bound 
directly to the atrial natriuretic peptide promoter, upon which Zac1 exerted a strong synergistic 
transcriptional activity and a physical interaction with Nkx2.5. Nkx2.5 also activated the Zac1 promoter, 
and Nkx2.5-null hearts showed decreased Zac1 expression. Zac1-mutated mice showed decreased 
levels of several cardiac genes and severe cardiac malformation. The absence of Zac1 expression 
resulted in increasing the number of apoptotic cells in the heart. These data indicate that Zac1 is an 
essential cardiac transcription factor that acts both independently and co-operatively with Nkx2.5. 
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Transcription Regulation II 
 
141. Hand2 loss-of-function in Hand1-expressing cells Reveals Distinct Roles In Heart 
And Coronary Vascular Development 
Ralston M. Barnes*(1), Beth A. Firulli(1), Josh W. Vincentz(1), Peter Cserjesi(2), Simon J. Conway(1), 
Anthony B. Firulli (1) 
(1) Riley Heart Research Center, Wells Center for Pediatric Research, Division of Pediatric Cardiology, 
Indiana Medical School (2) Department of Cell & Molecular Biology, Tulane University, New Orleans, 
LA, USA 
 
Hand1 and Hand2, members of the Twist-family of bHLH transcription factors, are expressed in a 
partially overlapping and complimentary profile in the developing heart. Hand2 expression persists 
throughout the entire linear heart tube and then downregulated within the left ventricle at the onset of 
cardiac looping. In contrast, Hand1 is expressed at the arterial and venous poles of the linear heart 
tube at E8.0-8.5 becoming robust within the developing left ventricle and outflow tract. To investigate 
Hand factor function in the heart, we engineered a Hand1 allele expressing Cre Recombinase for 
lineage analysis. We show that cardiac Hand1 expression is largely limited to cells of the primary heart 
field revealing little temporal overlap with Hand2. Surprisingly, we identify transient Hand1 expression 
domain within the septum transversum that marks the future proepicardium, epicardium, and 
derivatives. To look precisely at coexpression of Hand1 and Hand2, we conditionally delete Hand2 
from Hand1-expressing cells (H2CKO). H2CKOs die at E14.5. Defects include oligodactyly and 
syndactlyly of the digits, persistent truncus arteriosis and double outled right ventricle of the outflow 
tract that is attributed to defective PDGF signaling, and abnormal cardiovascular maturation. Strikingly, 
we observe Hand2 deletion from the proepicardium, which results in faulty epicardialization, impaired 
Fn1 fibril assembly, and leads to a failure to establish coronary arteries. Ablation of Hand2 within the 
Wt1-lineage recapitulates observed epicardial defects and time of death. Together, these data show a 
hierarchal relationship where transient Hand1 expression within the septum transversum defines 
epicardial precursors that are dependent on Hand2 function. 
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142. Direct Reprogramming of Cardiac Fibroblasts into Functional Cardiomyocytes by 
Defined Factors 
Masaki Ieda* (1,2,3), Jidong Fu (1,2,3), Vasanth Vedantham (1,2,3), Benoit G. Bruneau (1,2,4), and 
Deepak Srivastava (1,2,3) 
(1)Gladstone Institute of Cardiovascular Disease; (2)Department of Pediatrics; (3)Department of 
Biochemistry and Biophysics, (4)Cardiovascular Research Institute, University of California, San 
Francisco, CA 94158, USA. 
 
The reprogramming of fibroblast cells to induced pluripotent stem (iPS) cells by a combination of 
defined factors demonstrated that somatic cells can be induced to alter their cell fate. A large pool of 
fibroblast cells exists in the post-natal heart, yet no single “master regulator” of cardiac reprogramming 
has been identified. Here, we report that a combination of three developmental transcription factors 
rapidly and efficiently reprogrammed post-natal cardiac fibroblasts directly into differentiated 
cardiomyocytes. Induced cardiomyocytes expressed cardiac-specific markers, had a global gene 
expression profile similar to cardiomyocytes, and contracted spontaneously. Fibroblast cells 
transplanted into mouse hearts one day after transduction of the three factors differentiated into 
cardiomyocytes in vivo. These findings demonstrate that functional cardiomyocytes can be directly 
reprogrammed from differentiated somatic cells by defined factors. Reprogramming of endogenous or 
explanted cardiac fibroblast cells might provide a source of cardiomyocytes for regenerative 
approaches. 
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143. Sox4 cooperates with Tbx3 in the regulation of T-box-gene targets 
C.J.J. Boogerd* (1), L.Y.E. Wong (1), M. van den Boogaard (1), M.L. Bakker (1), P.A.C. ’t Hoen (2), 
A.F. Moorman (1), V.M. Christoffels (1) and P. Barnett (1). 
(1) Heart Failure Research Centre, Academic Medical Centre, University of Amsterdam, Meibergdreef 
15, 1105AZ Amsterdam, The Netherlands. (2) Center for Human and Clinical Genetics, Leiden 
University Medical Center, P.O. Box 9600, 2300 RC Leiden, The Netherlands. 
 
Tbx3 plays essential roles during early development, regulating key steps in development of the heart 
and other organ systems. To gain insight into the molecular aspects of the function of Tbx3, we 
employed the two-hybrid system to identify novel protein interaction partners of Tbx3. From this screen 
we identified the HMG-box containing transcription factor Sox4. We found that the patterns of 
expression of Tbx3 and Sox4 during cardiac development display considerable overlap, indicating 
potential sites of functional interaction. Using GST pulldown assays and a nuclear colocalization study, 
we verified the direct protein interaction. By performing genome wide Tbx3 ChIP-seq studies in mouse 
hearts and comparing this data to Sox4 ChIP-chip studies, we identified putative downstream gene 
targets of this interaction. Several of these promoter fragments were shown to be bound by Tbx3 and 
Sox4 by performing ChIP assays on embryonic mouse heart. We identified a possible role for these 
proteins in the cooperative regulation of Gja1 encoding Cx43 gap junction protein, via a novel 
enhancer positioned in the intron of Gja1, providing new molecular insights into the regulation of this 
key cardiac conduction protein. 
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144. Prdm1, encoding the Blimp1 transcriptional repressor, genetically interacts with 
Tbx1 during distal outflow tract morphogenesis. 
Stéphane D. Vincent* (1), Sachiko Miyagawa-Tomita (2) and Margaret Buckingham (1) 
(1) Institut Pasteur, Departement of Developmental Biology, Paris, France (2) Tokyo Women's Medical 
University, Pediatric Cardiology, Tokyo, Japan 
 
The Prdm1/Blimp1 protein acts as a transcriptional repressor by recruiting co-repressors leading to 
direct repression and indirect activation of gene expression. Prdm1 is dynamically expressed during 
development and, strikingly, has been shown to control specific differentiation programs in each of the 
different domains studied to date. During heart formation, Prdm1 is expressed in the second heart field 
(SHF). In this context, like Tbx1, Prdm1 is also expressed in the adjacent endoderm where it is 
required to support the growth of the mesenchymal cells of the branchial arches 2 to 6. As a result, 
Prdm1-/- mutant embryos display heart septation defects. In order to analyse a cell-autonomous 
function in the SHF, we carried out a conditional deletion of Prdm1 using MesP1Cre (early cardiac 
mesoderm) and Mef2cCre (anterior SHF) lines. Mesp1Cre mutants die at birth and display defects in 
structures of the distal OFT, derived from the SHF: uneven semilunar valves, misalignment of the 
great arteries and aortic arch patterning defects. Mef2cCre conditional mutants are viable, but display 
also mild aortic arch patterning defects. Our results suggest that Prdm1 plays an essential early 
regulatory role in controlling the proliferation of mesodermal progenitor cells of the SHF that contribute 
to morphogenesis of the arterial pole of the heart. The expression profiles and the mutant phenotypes 
of Prdm1 and Tbx1 are very similar, suggesting that these genes could be acting in the same pathway 
during heart development. We show here that Prdm1 and Tbx1 genetically interact during arterial pole 
development. 
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145. A Direct microRNA Target Screen Reveals Alternate Regions of Complementarity 
that Mediate Repression in cardiac homeostasis 
Eva Samal* (1, 4), Vasanth Vedantham (1,2), Ru-Fang Yeh (3), Nathan Salomonis (1), YuanYuan 
Xiao (3), Morgan Von-Drehle (1), Linda van Laake (5), Yong Zhao (6), David J. Erle (2) Deepak 
Srivastava (1,4) 
(1) Gladstone Institute of Cardiovascular Disease and Departments of Biochemistry and Biophysics (2) 
Medicine (3) Biostatistics (4) Pediatrics, University of California, San Francisco, CA, 94158, (5) 
University of Utrecht, The Netherlands. (6) Department of Genetics and Genomic Sciences, Mt Sinai 
School of Medicine, NY, USA 
 
Distinct signature patterns of microRNAs (miRNAs) in healthy versus diseased hearts combined with 
their ability to regulate specific aspects of cardiac function offer precedence for using miRNAs as 
therapeutic agents for heart dysfunction. However, accurate determination of miRNA targets is a 
prerequisite before miRNA-based approaches can be employed in the management of heart disease. 
This has remained a challenge due to imperfect miRNA::mRNA base-pairing. Bioinformatic 
approaches based on sequence complementarity among the first eight nucleotides of miRNAs known 
as a “seed” sequence have been useful but cannot account for all phenotypes observed with 
dysregulation of miRNA dosage. Here we describe an unbiased direct experimental screen for miRNA 
target identification. Using this screen, we validated numerous novel miR-1 interacting cardiac mRNAs 
including those with canonical 5′ seed matches and several with imperfect seed matches. Surprisingly, 
our screen also revealed a subset of mRNA targets with very limited 5′ base-pairing but extensive 
complementarity to the mid-portion of the miRNA. This region of alternate complementarity was 
required for miRNA mediated repression. The novel targets were validated in vivo and correlated with 
in vivo function of miR-1 thus providing a molecular basis for perturbations in cell cycle control, 
cardiogenesis and cardiac conduction abnormalities such as long QT syndrome and associated 
torsades de pointes observed with misregulation of miR-1 levels. The experimental strategy described 
here offers an efficient approach to identify physiologically relevant miRNA targets and also reveal an 
alternate region of complementarity that could direct miRNA-mediated repression of gene expression. 
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Cardiac Progenitor Cells 
 
92. Endothelial progenitors contribute to the heart endocardium and play key roles in 
cardiac development 
Michal Milgrom-Hoffman*(1), Napoleone Ferrara(3), Elazar Zelzer(2) and Eldad Tzahor(1) 
(1) Department of Biological Regulation,Weizmann Institute of Science, Rehovot, Israel (2) 
Department of Molecular Genetics, Weizmann Institute of Science, Rehovot, Israel (3) Genentech, Inc., 
San Francisco, California, USA 
 
The primitive heart is composed of two cell layers, the myocardium, which contributes to cardiac 
muscle tissue, and the endocardium, which covers the inner lumen of the heart. While significant 
progress has been made towards elucidating the embryonic origins of the myocardium, the embryonic 
origins of the endocardium are far less clear. Myocardial and endocardial progenitors are thought to 
arise from both uni- and multipotent cardiovascular progenitors within the cardiac crescent. Here, 
using cellular and molecular analyses in chick embryos, we identified an endocardial-forming field 
residing outside the cardiac crescent, in a continuum with the endothelial plexus. Strikingly, embryonic 
endothelial cells implanted into the cardiac environment specifically contributed to the endocardium. 
To further investigate the endothelial origins of the endocardium, and the necessity of endothelial 
progenitors for heart development in the mouse, we conditionally ablated vascular endothelial growth 
factor receptor 2 (Flk1) in cardiac and endothelial progenitors. Ablation of Flk1 in both cardiac and 
endothelial mesoderm progenitors using MesP1Cre led to complete loss of the endocardium, as well 
as broader defects in second heart field derivatives. In contrast, the endocardium was not affected 
upon ablation of Flk1 only within the cardiac crescent using Isl1Cre, suggesting that Flk1 expression in 
Isl1+ cardiovascular progenitors has a minor impact on the endocardial cell lineage in vivo. 
Collectively, our findings suggest that the endocardium derives from an endothelial origin, and that 
endothelial progenitors play key roles in the morphogenesis of the heart. 
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93. Identification of micro RNAs involved in cardiac specification in mESCs 
Alexandre Colas*, Wesley McKeithan, Mark Mercola 
Muscle Development and Regeneration Program, Sanford|Burnham Medical Research Institute, La 
Jolla, CA, USA 
 
MicroRNAs (miRs) are naturally-occurring, small non-coding RNAs that regulate many aspects of cell 
biology by influencing the stability and translation of target mRNAs. Recent studies have highlighted 
their importance during cardiogenesis. However, defining the precise roles they play has been limited 
by the difficulty of performing large-scale functional studies in higher vertebrate embryos. In this study, 
we have developed a mouse embryonic stem cell (mESC)-based cardiogenesis miR screen in defined 
media. mESC cultures were differentiated to induce uncommitted mesoderm (day 3) and transfected 
with a library of 328 miRs and cardiogenesis was quantified by measuring the fluorescence of eGFP 
under the control of the cardiac specific a-MHC promoter. Four families of miRs showed a robust 
ability to induce cardiogenesis in mESCs. Among them, the miR-18 family displayed the most potent 
pro-cardiac activity. In order to gain insight into the molecular mechanism of action, we tested whether 
validated or TargetScanMouse5.1-predicted mRNA targets could phenocopy the cardiogenic action of 
miR-18. Smad2 is a predicted target of miR-18 that is conserved across vertebrates. Smad2-siRNA-
mediated knockdown was found sufficient to induce cardiogenesis at similar levels to miR-18, while 
the knockdown of two validated targets (Runx1, ESR1) alone or in combination did not. Moreover we 
showed that miR-18 is able to bind a Smad2-3’UTR-GFP sensor and induce its degradation and 
down-regulate Smad2 mRNA in differentiating mESCs. Altogether, these results suggest that Smad2 
is likely to be the principal relevant target of miR-18 involved in enhancing cardiogenesis. Attenuation 
of the TGFb/Nodal pathway, after mesoderm and endoderm induction has occurred, has been 
correlated with enhanced cardiogenesis in mESCs. However, the biological processes that leads to 
the corresponding increase in cardiogenesis is not fully understood. Here we show that in both miR-18 
gain of function and Smad2 siRNA-mediated knockdown, Flk-1 expression was dramatically up-
regulated two days after transfection, leading to the subsequent up-regulation of several cardiac 
specific makers (Nkx2.5, Isl-1, MEF2C, GATA-4) at day 6. Altogether these data suggest that miR-18 
attenuates TGFb/Nodal signaling via Smad2to specifying Flk-1+ cardiovascular progenitors 
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94. Regulation of cardiac progenitor cells during heart development 
Francesca Rochais* and Robert G. Kelly 
Developmental Biology Institute of Marseilles-Luminy, CNRS UMR 6216-Université de la Méditerranée, 
13288 Marseille, France. 
 
Cardiac progenitor cells of the second heart field (SHF) contribute to the poles of the elongating 
embryonic heart and express genes encoding the fibroblast growth factor Fgf10 and transcription 
factor Isl1. Perturbations of SHF development lead to congenital heart defects. Recent studies have 
demonstrated the existence, in the later heart, of resident cardiac progenitors derived from the SHF 
that specifically express Isl1 and have the potential to differentiate into cardiomyocytes, smooth 
muscle and endothelial cells. Through analysis of a transgene integration site position effect we 
identified Hes1, a member of the Notch signaling pathway, as a novel regulator of SHF development. 
Hes1 is expressed in the SHF during heart tube elongation. Hes1-/- hearts present outflow tract 
alignment defects (overriding aorta and ventricular septal defects). At earlier developmental stages, 
mutant embryos display SHF proliferation defects, elevated levels of the cell cycle inhibitor p27kip1, a 
reduction in cardiac neural crest cells and fail to completely extend the outflow tract. Given the 
importance of Isl1 as a marker of resident progenitor cells in the later heart we investigated whether 
other SHF regulators (Fgf10 and Hes1) contribute to myocardial progenitor cell fate in the fetal heart. 
Preliminary results reveal impaired proliferation of fetal cardiomyocytes in Fgf10-/- hearts while Isl1-
positive cell numbers are increased. In contrast, Hes1 deletion impacts negatively on Isl1-positive cell 
numbers. Together, our results identify Hes1 as a novel regulator of SHF deployment and reveal that 
Fgf10 and Hes1 may regulate cardiac progenitor cell fate and cardiac growth during the fetal period. 
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95. Hematopoietic cell contribution to embryonic mouse valve development and adult 
valve homeostasis 
Zoltan Hajdu* (1), Roger R Markwald (1), Christopher C Drake (1), Imre Olah (2), Richard P Visconti 
(1) 
(1) Regenerative Medicine & Cell Biology and the Cardiac Developmental Biology Center, Medical 
University of South Carolina, Charleston, SC, USA (2) Human Morphology and Developmental Biology, 
Semmelweis University, Budapest, Hungary 
 
Heart valve interstitial cells are traditionally thought to originate from the embryonic endocardium 
through epithelial to mesenchymal transformation. Contribution of neural crest-derived and 
epicardially-derived cells has also been described. Here we report that cells of hematopoietic origin 
contribute to avian cushion/valve development. Using immunohistochemical analyses, we detected 
CD45+ (common leukocyte antigen) cells in chicken endocardial cushions starting from HH st 23-24. 
Their numbers peak at HH st 29 but CD45+ cells persist throughout embryonic development. These 
cells exhibit a specific atrial-side localization in the AV valves and ventricular-side localization in the 
semilunar valves. Quail-chick chimeric experiments, combined with QH1 immunolabeling, provided 
further support for the hematopoietic origin of embryonic valve cells. Next we investigated the 
contribution of hematopoietic-derived cells to mouse embryonic valve development. To accomplish 
this, we performed immunoluorescence analysis of CD45+ cells in mouse endocardial cushions from 
9.5 dpc through post-natal life. The dynamics of CD45+ cell localization were similar to that observed 
in the avian system. We detected cells of hematopoietic origin in the cushions starting from 11.5 dpc 
and peaking by day 13.5 dpc. Moreover, the specific localization pattern observed in chicken valves 
was present in the mouse from embryonic stages through post-natal life. These findings support our 
previous reports where transplanted EGFP+ bone marrow cells were shown to contribute to the adult 
murine valve interstitial cell population in recipient mice. Collectively, our findings suggest that 
hematopoietic-derived cells contribute to valve development and homeostasis during both pre- and 
post-natal life and may contribute to valve pathologies. 
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Epicardium 
 
31. Epicardial fate and Notch signaling 
Thomas Grieskamp, Carsten Rudat, Julia Norden, Andreas Kispert* 
Institute for Molecular Biology, Medizinische Hochschule Hannover, Hannover, Germany 
 
Lineage-tracing studies in chick demonstrated that epicardial cells give rise to endothelial and support 
cells of the coronary vasculature, and cardiac fibroblasts. Genetic fate mappings in the mouse have 
recently suggested that a substantial fraction of ventricular cardiomyocytes may also be of epicardial 
origin. This finding is relevant in the light of experiments that showed that the epicardium represents a 
cellular source for revascularization during cardiac regeneration in the zebrafish. It is therefore an 
exciting challenge to search for signaling pathways that mediate epicardial differentiation and to 
exploit their potential in the wounded adult mammalian heart. Given the controversy on epicardial cell 
fates in mammals, we reevaluated this problem by using a genetic lineage tracing system in the 
mouse. The Tbx18 gene is expressed in the left ventricle and ventricular septum, and the epicardium. 
Thus, a Cre Knock-in into the Tbx18 locus allows to trace the fate of epicardial cells overlying the right 
ventricle in mice double heterozygous for Tbx18Cre and a suitable reporter gene. Double 
immunofluorescence analysis of differentiation markers and a sensitive GFP reporter did not detect 
any right ventricular cardiomyocytes to be of epicardial origin. We will describe the cell types to which 
epicardial cells were found to contribute using this lineage system. Since Notch signaling has been 
implicated in vascular development, we wanted to explore the role of this pathway in epicardial 
differentiation and coronary vessel formation. We used both conditional Tbx18Cre mediated loss-of-
function and gain-of function strategies. We will report on our findings that Notch signaling is required 
and sufficient for differentiation of certain cell lineages of the embryonic epicardium in the mouse. 
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32. Loss of the Type III Transforming Growth Factor-β Receptor decreases Hyaluronic 
Acid responsiveness in Epicardial Cells 
Nora S. Sánchez* (1), Evisabel Craig (2), Joseph D. Love (1), Todd Camenisch (2, 3), and Joey V. 
Barnett (1) 
(1) Department of Pharmacology, Vanderbilt University Medical Center, Nashville, TN 37232 
(2)Department of Pharmacology and Toxicology, (3) Steele Children's Research Center and Bio5 
Institute, The University of Arizona, Tucson, Arizona, USA 
 
Mice lacking Tgfbr3 die at E14.5 due to failure of coronary vessel formation. Epicardial cells contribute 
to the formation of coronary vessels. Hyaluronic acid, a major extracellular matrix (ECM) component of 
the embryonic heart, has recently been reported to regulate epicardial cell signaling, specifically 
regulating invasion and differentiation. To determine if altered sensitivity to the ECM occurs after loss 
of Tgfbr3, we used immortalized epicardial cell lines from E11.5 embryos to determine the invasive 
potential of epicardial cells in response to high molecular weight hyaluronic acid (HMW-HA) using a 
modified Boyden chamber assay. Tgfbr3+/+ cells demonstrate a dose dependent response to HMW-
HA from 0-300 µg/ml, whileTgfbr3-/- cells do not. Incubation of Tgfbr3+/+ cells with 300 µg/ml HMW-
HA induced a 3.78-fold increase in invasion, relative to vehicle, into a collagen 1 matrix. Tgfbr3+/- and 
Tgfbr3-/- cells showed a 2.39 and 2.30-fold increase in invasion, respectively. Since growth factors like 
TGFβ can induce transformation and differentiation, we next asked if HMW-HA could induce 
differentiation. In Tgfbr3+/+ cells, HMW-HA induces a 40-fold increase in Smooth Muscle α-actin 
(SmαA) expression, but no change in the smooth muscle markers, Smooth Muscle 22α (SM22α) or 
calponin. In Tgfbr3-/- cells, SMA increased only 6.8 fold. HMW-HA does not induce the endothelial 
markers Tie2, Flk1, or VE-cadherin in either genotype. These data demonstrate that Tgfbr3 is required 
for the maintenance of epicardial cell responsiveness to hyaluronic acid. Loss of responsiveness to 
this ECM component may contribute to phenotype seen in Tgfbr3-/- mice. 
 
  Oral sessions Friday 21 May page 45
33. NFATc1 in epicardium-derived cells is required for fibrous skeleton and 
intramyocardial coronary vessel development 
Michelle D. Combs*(1), Caitlin M. Braitsch(1), and Katherine E. Yutzey(2) 
(1) Molecular and Developmental Biology Graduate Program, University of Cincinnati, Cincinnati, OH 
45229 (2) Division of Molecular Cardiovascular Biology, Cincinnati Children’s Hospital Medical Center, 
Cincinnati, OH 45229, USA 
 
The proepicardial organ (PE) contributes cells to the epicardium, coronary vasculature, and fibrous 
skeleton. During heart looping, PE cells migrate over the myocardium to form the epicardium. A subset 
of epicardial cells, epicardium-derived cells (EPDCs), undergo EMT, migrate into the subepicardial 
space and invade the myocardium. NFATc1 is a transcription factor integral to the transition from 
endocardial cushion growth to valve leaflet remodeling. NFATc1 also is expressed in mouse and chick 
PE, epicardium and EPDCs. We hypothesize that NFATc1 promotes epicardial cell proliferation and 
EPDC invasion via ECM remodeling enzyme expression. NFATc1-/- mice have decreased epicardial 
cell proliferation at E10.5. WT1-Cre mice were bred with NFATc1-flox mice to determine the role of 
NFATc1 in EPDC development. Epicardial loss of NFATc1 leads to loss of fibrous skeleton and 
intramyocardial coronary vessels at E17.5 as well as perinatal lethality. Loss of NFATc1 in EPDCs 
also decreases Cathepsin K (CtsK), an enzyme associated with myocardial invasion. In Chick PE cell 
cultures RANKL treatment increases expression of CtsK via a Calcineurin-dependent mechanism, as 
in remodeling valves. These data are consistent with NFATc1 regulation of EPDC invasion required for 
coronary vessel and fibrous skeleton development. Overall, these analyses demonstrate a critical role 
for NFATc1 in epicardial cell proliferation and ECM remodeling analogous to that observed in the 
developing valves. 
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34. PDGF Signaling is Required for Epicardial Functions and New Blood Vessel 
Formation in Regenerating Zebrafish Hearts 
Qiong Wu (1), Yolanda Zhang (1), Jieun Kim (1), Katie M. Wiens (1), Hiro Shimada (2), Robert I. 
Handin (3), Michael Y. Chao (4), Tai-Lan Tuan (1), Vaughn A. Starnes (1) and Ching-Ling Lien*(1) 
(1) Department of Surgery, (2) Department of Pathology, Keck School of Medicine, University of 
Southern California; The Saban Research Institute of Childrens Hospital Los Angeles (3) Hematology 
Division, Department of Medicine, Brigham & Woman’s Hospital, Harvard Medical School, Harvard 
Stem Cell Institute, Boston (4) Department of Biology, California State University San Bernardino, USA 
 
A zebrafish heart can fully regenerate after amputation of up to 20% of its ventricle. During this 
process, new coronary blood vessels form to revascularize the regenerating tissue. The formation of 
new coronary blood vessels during zebrafish heart regeneration likely recapitulates embryonic 
coronary vessel development, which involves the activation and proliferation of the epicardium 
followed by an epithelial-to-mesenchymal transition (EMT). The molecular and cellular mechanisms 
underlying these processes are not well understood. Here, we examine the role of platelet-derived 
growth factor (PDGF) signaling in explant-derived primary cultured epicardial cells in vitro and in 
regenerating zebrafish hearts in vivo. We observe that EMT and mural cell markers are upregulated in 
the regenerating hearts. The epicardium of 7 dpa (days post amputation) and 4 dpa regenerating heart 
explants undergoes EMT and proliferation, respectively, and PDGF signaling is both necessary and 
sufficient for these processes in vitro. PDGF-induced EMT is mediated by Rho associated protein 
kinase (ROCK), whereas epicardial cell proliferation is mediated by PI3 kinase. Inhibition of PDGF 
signaling in vivo blocks epicardial cell proliferation, EMT, and blood vessel formation. Our data 
suggest that PDGF signaling plays important roles in epicardial cells that contribute to heart 
regeneration in zebrafish. 
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35. PDGFR signaling in the epicardium is required for epicardial EMT and coronary 
VSMC and cardiac fibroblast development 
Christopher L. Smith*, Seung Tae Baek,and Michelle D. Tallquist 
Department of Molecular Biology, University of Texas Southwestern Medical School, Dallas, TX, USA 
 
Coronary vascular smooth muscle cells (cVSMC) and cardiac fibroblasts are epicardial derived cell 
(EPDC) populations essential for normal coronary artery development and are important mediators of 
myocardial pathogenesis. These cells form when a subset of epicardial cells undergoes an epithelial-
to-mesenchymal transition (EMT) and migrate into the myocardium. The two PDGF receptors 
(PDGFRα and PDGFRβ) are both expressed in the embryonic epicardium and in EPDC. To examine 
their function during heart development we generated mice with epicardial specific deletions of the 
PDGF receptors. Interestingly, each receptor was required for development of a unique epicardial 
derivative, PDGFRβ for cVSMC and PDGFRα for cardiac fibroblasts. When both PDGF receptors 
were deleted, we observed a complete loss of EPDC. Ex vivo tracing of epicardial cells confirmed a 
failure of migration. PDGF receptor mutant hearts also exhibited decreased vimentin expression in the 
epicardium, suggesting an EMT defect. We determined that transcriptional markers of EMT (Snai1, 
Snai2, Sox9) were reduced in E12.5 hearts and primary epicardial cultures. TGFβ and PDGF 
stimulation of mutant epicardial cultures also showed defective EMT activation. Our current data 
suggests Sox9 is induced by PDGF signaling and that expression of Sox9 partially rescues the mutant 
EMT phenotype. Additionally, PDGF stimulation leads to phosphorylation of Sox9 and combined with 
TGFβ, induces a transcriptional complex with Smad2/3 and Snai1. These data establish PDGF 
signaling through Sox9 as a novel pathway essential for epicardial EMT and demonstrate a unique 
requirement for each receptor in the formation of cVSMC and cardiac fibroblasts. 
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Cardiac Signalling 
 
1. Inhibition of Bmp signaling by Smad6 is required for terminal differentiation of 
ventricular cardiomyocytes. 
Emma de Pater (1) and Jeroen Bakkers (1,2) 
(1) Hubrecht Institute-KNAW & University Medical Center Utrecht (2) Interuniversity Cardiology 
Institute of the Netherlands, 3584CT Utrecht, The Netherlands 
 
Using zebrafish as a vertebrate model to study mechanisms that regulate growth of the embryonic 
heart tube we previously identified two distinct phase when new cardiomyocytes are added to the 
growing linear heart tube; first a continuous phase of cardiomyocyte addition starts in the ventricle and 
ends in the atrium followed by a later phase when cells are added to the arterial pole. Although we 
identified Isl1 and Fgf signaling to be essential for specific steps during these processes we had not 
yet identified the signal that regulates the continuous recruitment of new cardiomyocytes. Here we 
show, using novel and existing zebrafish mutants and transgenic lines, that Bmp signaling is essential 
for the continuous recruitment process and that this requirement for Bmp signaling is independent 
from its role in dorsoventral patterning. Analysis of Bmp signaling in the lateral plate mesoderm during 
cardiomyocyte differentiation revealed heightened signaling prior to differentiation, followed by a rapid 
down-regulation of Bmp signaling in differentiating ventricular myocytes. Using a loss-of-function 
approach we have demonstrated that Smad6 is responsible for mediating the down-regulation of Bmp 
signaling in differentiating myocytes. In addition, forced Bmp activation in differentiating myocytes 
prevents terminal differentiation and results in hearts with smaller ventricles. In conclusion our data 
demonstrates a biphasic role for Bmp signaling during elongation of the linear heart tube by first 
inducing cardiomyocyte specification followed by an active repression of BMP signaling to allow their 
terminal differentiation. 
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2. The BMP Pathway Acts to Regulate Tbx20 in the Developing Heart 
Erin Kaltenbrun* (1, 2), Elizabeth Mandel (1, 2), Thomas Callis (1, 4), Da-Zhi Wang (1, 4, 5) and Frank 
Conlon (1, 2, 3) 
(1) Department of Biology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA  
(2) McAllister Heart Institute, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA  
(3) Department of Genetics, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA  
(4) Department of Cell and Developmental Biology, University of North Carolina at Chapel Hill, Chapel 
Hill, NC, USA  
(5) Current Address: Department of Cardiology, Children’s Hospital, Boston, Harvard Medical School, 
Boston, MA, USA 
 
TBX20 has been shown to be essential for vertebrate heart development. Mutations within the Tbx20 
coding region are associated with human congenital heart disease, and the loss of Tbx20 in a wide 
variety of model systems leads to cardiac defects and eventually heart failure. Despite the critical role 
of TBX20 in a range of cardiac cellular processes, the signal transduction pathways that act upstream 
of Tbx20 remain unknown. Here we have identified and characterized a conserved 334bp Tbx20 
cardiac regulatory element and shown that this element is directly activated by the BMP/SMAD1 
signaling pathway. We demonstrate that this element is both necessary and sufficient to drive cardiac-
specific expression of Tbx20 in Xenopus, as well as in the mouse, and that blocking SMAD1 signaling 
in vivo specifically abolishes Tbx20 transcription in the developing heart while having no effect on 
other cardiac markers including Tbx5, myosin heavy chain, and tropomyosin. We further demonstrate 
that activation of Tbx20 by SMAD1 is mediated by both canonical and non-canonical SMAD-binding 
sites in vitro and have gone on to show that phospho-SMAD1 directly binds sites within this element in 
vivo. Collectively, our findings define Tbx20 as a direct transcriptional target of the BMP/SMAD1 
signaling pathway during cardiac maturation. 
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3. Bmp-signaling regulates myocardial differentiation from cardiac progenitors 
through a micro RNA-mediated mechanism 
Jun Wang* (1) , Margarita Bonilla-Claudio (1), Jue Zhang(1), Yan Bai (1), Zheng Huang (1), Brian L. 
Black (2), Fen Wang (1), and James F. Martin (1) 
1 Institute of Biosciences and Technology, Texas A&M System Health Science Center, 2121 W. 
Holcombe Blvd, Houston, Texas 2 Cardiovascular Research Institute and Department of Biochemistry 
and Biophysics, University of California, San Francisco CA, USA 
 
MicroRNA’s (miRNA) are small, non-coding RNA’s that regulate gene expression post-transcriptionally. 
Because the signals that regulate miRNA expression remain poorly understood, we investigated Bone 
Morphogenetic Protein (Bmp)-signaling in miRNA regulation in Isl1-lineage cardiac progenitors. Our 
findings indicate that Bmp2 and Bmp4 regulate OFT myocardial differentiation via regulation of the 
miRNA 17-92 cluster. In Bmp mutant embryos, expression of multiple miRNAs encoded by the miRNA 
17-92 cluster was reduced. Importantly, we uncovered functional miRNA 17 family seed sequences 
within the 3’ UTR of the cardiac progenitor gene Isl1. In Bmp mutants, Isl1 expression failed to be 
silenced and myocardial differentiation was disrupted. Transfection experiments indicated that miRNA 
17 and miRNA 20a repressed Isl1 expression. Moreover, genetic interaction studies uncovered a 
synergistic interaction between miRNA 17-92 cluster and Bmp4 providing direct in vivo evidence for 
the Bmp-miRNA 17-92 regulatory pathway. Together, our findings indicate a novel, miRNA-mediated 
effector mechanism for Bmp-regulated cardiac progenitor differentiation. 
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4. Cardiac Laterality is Controlled by Multiple Rho Kinase Signaling Pathways in 
Ciliated Cells 
Guangliang Wang, Fiona C. Foley, Duck Soo Jang, Jeffrey D. Amack* 
Department of Cell and Developmental Biology, State University of New York Upstate Medical 
University, Syracuse, NY, USA 
 
Asymmetric fluid flow generated by embryonic ciliated cells conveys laterality signals to the developing 
heart. In zebrafish, asymmetric flow is produced by a ciliated epithelium in Kupffer’s vesicle (KV), 
which provides a useful model for identifying pathways regulating the ciliated cells that control cardiac 
laterality. Taking a candidate approach, we analyzed the role of Rho kinase signaling in KV. Rho 
kinase (Rock) proteins are effectors of Rho GTPases that control several cell behaviors and can 
mediate planar cell polarity (PCP) signals. Interfering with Rho kinase signaling via dominant negative 
Rock constructs or antisense morpholino (MO) knockdown of the zebrafish Rock homologs rock2a or 
rock2b altered asymmetric Nodal signaling and randomized heart laterality. Videomicroscopy of beads 
injected into KV demonstrated that asymmetric flow was disrupted in rock2a and rock2b morphants. 
Cilia were truncated in rock2a morphants, consistent with a role for PCP signaling during KV 
ciliogenesis. However, cilium length was unaffected in rock2b morphants. Analysis of the cellular 
architecture of KV showed that the arrangement of cells along the anterior-posterior (AP) axis was 
disrupted by rock2b knockdown. In wild-type embryos >60% of ciliated cells were tightly packed into 
the anterior region of KV, the site of strong asymmetric flow. This anterior-biased distribution was lost 
in rock2b morphants. Time-lapse imaging of embryos expressing GFP in KV cells revealed that rock2b 
regulates cell morphologies that appear to mediate KV architecture. Our results uncover a Rho kinase 
signaling pathway that controls ciliogenesis and a second pathway involved in establishing AP 
asymmetry in KV. 
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5. Mitochondrial structure and function during cardiac myocyte differentiation 
George A. Porter, Jr.* (1,2,3), Jennifer Hom (1), Rodrigo Quintanilla (1,2), David Hoffman(1), Bentley 
Karen (4), Shey-Shing Sheu (2) 
(1) Department of Pediatrics, (2) Department of Pharmacology and Physiology, (3) Aab 
Cardiovascular Research Institute, (4) Department of Pathology and Laboratory Medicine, University 
of Rochester Medical Center, Rochester, NY, USA 
  
Although oxidative metabolism provides energy in the mature cardiac myocyte, the early embryo is 
thought rely mainly on anaerobic glycolysis and not aerobic, mitochondrial respiration. However, little 
is known about cardiac energetics and mitochondrial function in the embryo, and we hypothesize that 
changes in mitochondrial structure and function during embryonic cardiac development are critical for 
normal myocyte differentiation and cardiac morphogenesis. To test this hypothesis, we measured 
respiration and examined mitochondrial structure and function in whole embryonic hearts and cultured 
myocytes using light and electron microscopy. Mitochondria of embryonic day (E) 9.5 ventricular 
myocytes had an electron-lucent matrix and immature inner mitochondrial membrane (IMM) 
architecture, were shorter in length and less branched, and did not associate closely with the 
contractile apparatus but resided primarily around the nucleus and cell periphery. By E13.5, 
mitochondria had a dense matrix and mature IMM ultrastructure and were longer, branched, 
networked, and more closely associated with the contractile apparatus. Functional measurements 
demonstrated dramatic increases in mitochondrial membrane potential, calcium uptake, and electron 
transport chain activity and decreases in oxidative stress as the heart developed. These structural and 
functional and data suggested an increase in IMM permeability, and closure of the mitochondrial 
permeability transition pore using cyclosporin A or cyclophilin-D null embryos caused premature 
maturation of mitochondrial structure and function. Taken together, these data suggest that maturation 
of mitochondrial structure and function may regulate cardiac myocyte differentiation. 
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ESC-WG DAP session Genetics & Cardiovascular Malformations 
 
204. Dysregulation of the PDGFRA gene causes inflow tract anomalies including 
TAPVR: Integrating evidence from human genetics and model organisms 
Steven B. Bleyl* (1,3), Yukio Saijoh (2,3), Noortje A.M. Bax (4), Adriana C. Gittenberger-de Groot (4), 
Lambertus J. Wisse (4), Shigehito Yamada (5), Kohei Shiota (5) and Gary C. Schoenwolf (3). 
(1) Departments of Pediatrics, (2) Human Molecular Biology and Genetics, and (3) Department of 
Neurobiology and Anatomy, University of Utah School of Medicine, Salt Lake City, UT, USA. (4) 
Department of Anatomy & Embryology, Leiden University Medical Center, Leiden, The Netherlands. (5) 
Department of Anatomy and Developmental Biology, Graduate School of Medicine, Kyoto University, 
Kyoto, Japan. 
 
Congenital heart defects (CHD) usually occur sporadically via interplay between genetic and/or 
environmental factors. For most CHD, pinpointing these factors has proven problematic. We used a 
combined approach in humans and model organisms to identify a susceptibility factor for one such 
CHD, total anomalous pulmonary venous return (TAPVR). We report genetic analyses in TAPVR 
patients that implicate the PDGFRA gene in the development of TAPVR. Gene expression studies in 
mouse and chick embryos for both the Pdgfra receptor and its ligand Pdgf-a show temporal and 
spatial patterns consistent with a role in pulmonary vein (PV) development. Functional knockdown of 
PDGF-signaling in both chick and mouse during the period of PV formation causes a spectrum of 
inflow tract defects, including TAPVR, that involve the dorsal mesocaridal protrusion (DMP) supporting 
a role for PDGF-signaling in second heart field (SHF) development. These defects occur with low 
penetrance (~7% for TAPVR and ~30% for intermediate anomalies) suggesting the interaction of other 
genetic or environmental factors. Failure of a specific human PDGFRA BAC transgene to rescue 
inflow tract defects of Pdgfranull/null embryos further supports dysregulation of PDGFRA in human 
TAPVR. We also show that the TAPVR seen in chick and mouse is highly similar to that discovered in 
an abnormal early stage embryo from the Kyoto human embryo collection. Taken together, these data 
from human genetics and animal models support a role for PDGF-signaling in normal PV development 
and provide important insight into the embryogenesis and molecular pathogenesis of TAPVR, a CHD 
with complex inheritance. 
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205. Effects of conditional deletion of hypoxia-inducible factor (hif) and hypoxic stress 
on mouse heart morphogenesis 
Hongbin Liu and Steven A. Fisher* 
Depts of Medicine (Cardiology) and Physiology, Case Western University, Cleveland, Ohio, USA 
 
Oxygen gradients have been identified in mid-gestation avian and mouse heart tissues, with the OFT, 
AVJ and IVS myocardium and cushion mesenchyme relatively hypoxic. We hypothesize that: 1) 
hypoxia/HIF is required for the remodeling of these tissues in the transition to the mature four 
chambered heart. This is supported by the lethality of germ line inactivation of HIF-1 at ~E11.5, while 
its cell-specific function has not been identified 2) these tissues in this developmental window are most 
susceptible to hypoxic stress. This is supported by epidemiologic studies showing increased 
prevalence of CHDs in Tibetans living at very high altitudes. We conditionally inactivated HIF-1a in the 
mouse with Cre drivers (cKO) and tested for gene-environment interactions with hypobaric hypoxic 
stress (0.5 ATM) in the proposed window of vulnerability (E10-13). HIF-1a cKO in neural crest 
(Wnt1Cre) caused postnatal lethality with high penetrance; the few surviving mice were severely 
runted without major CHDs. OFT defects were observed in E16.5 mice with low penetrance. HIF-1a 
cKO in second heart field myocardium (MEF2cCre) also resulted in low penetrance of OFT defects. 
HIF-1a flox mice were crossed with Tamoxifen-inducible b-actin Cre and treated with Tamoxifen at 
E10 for temporally regulated HIF-1 inactivation; this data will be presented. Mice exposed to hypobaric 
hypoxia (0.5 ATM) from E10.5-13.5 showed a high incidence of VSD and other outlet defects at E15.5 
with no apparent genotype-phenotype interactions. We propose that hypoxia/HIF plays a critical role in 
morphogenesis of outlet structures of the mid-gestation mouse heart, and that this process is 
susceptible to hypoxic stress. Gene or cell compensations may moderate the effects of hypoxic stress 
or HIF-1a inactivation. 
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206. p53-related p63 transcription factor is essential for cardiac morphogenesis 
Alain Medawar(1,2), Matthieu Rouleau(1,2), Laurent Hamon(3), Huiqing Zhou(4), Hans van 
Bokhoven(4), Caterina Missero(5,6), Eleonora Candi(7), Cedric Blanpain(8), Gerry Melino(7,9), Michel 
Puceat(3) and Daniel Aberdam* (1,2,10) 
(1) INSERM U898, Nice, France (2) University of Nice-Sophia Antipolis, Nice, France (3) INSERM 
avenir team Evry, France (4) Department of Human Genetics, Nijmegen Centre for Molecular Life 
Sciences, Radboud University Nijmegen Medical Centrum, Geert Grooteplein Zuid 10, 6525 GA 
Nijmegen, The Netherlands (5) Fondazione SDN, Napoli, Italy (6) CEINGE Biotecnologie Avanzate, 
Napoli, Italy (7) Biochemistry Laboratory IDI-IRCCS and University of Rome "Tor Vergata", 00133 
Rome, Italy (8) Université Libre de Bruxelles, Belgium (9) MRC Toxicology Unit, Leicester LE1 9HN, 
UK (10) INSERTECH, Bruce Rappaport Institute of the Technion, Haifa, Israel 
 
The transcription factor p63, a member of the p53 family, is essential for skin morphogenesis and 
epithelial stem cell maintenance. Indeed, p63-deficient mice lack epidermis and feature many defects 
in epithelial development. Here, we report an unexpected role of p63 in heart development. p63 null 
mice exhibit severe defects in embryonic cardiac development, including pronounced dilation of both 
ventricles, a defect in trabeculation and abnormal septation. This was accompanied by myofibrillar 
disarray, mitochondrial disorganization and reduction in spontaneous calcium spikes. The use of 
embryonic stem (ES) cells, that recapitulate in vitro the main steps of embryogenesis, shows that p63 
deficiency prevents expression of pivotal cardiac genes and in turn cardiogenesis, resulting in the 
absence of beating cardiomyocytes. Coculture of p63 knock-down ES cells with wild type ES cells, 
supplementation with Activin A or overexpression of GATA-6 rescue cardiac gene expression and 
beating activity of ES cell derived cardiomyocytes. These observations indicate that p63 acts in a non-
cell-autonomous manner by modulating expression of endodermal factors. Accordingly, p63 is 
expressed by sox-17-positive endodermal cells and binds to the Activin A regulatory sequences in vivo. 
Our findings uncover a critical role for p63 in cardiovascular function and indicate that congenital heart 
defects could be an underdiagnozed feature of human p63-related syndromes. 
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207. Copy Number variations (CNV) in left sided congenital heart disease 
Marc-Phillip Hitz* (1), Louis-Philippe Lemieux-Perreault (2), Christian R. Marshall (3), Bert Overduin 
(4), Maryse Thibeault (1), Alexandre F. R. Stewart (5), Stephen W. Scherer (3), Andrea Richter (6), 
Marie-Pierre Dubé (2), Gregor Andelfinger (1) 
(1) Cardiovascular Genetics, Sainte Justine Hospital, Montreal, Quebec, Canada (2) Research Centre, 
Montreal Heart Institute, Montreal, Quebec, Canada (3) Centre for Applied Genomics, Hospital for Sick 
Children, Toronto, Ontario, Canada (4) European Bioinformatics Institute, Hinxton, Cambridge, UK (5) 
Heart Institute, University of Ottawa, Ottawa, Ontario, Canada (6) Medical Genetics, Sainte Justine 
Hospital, Montreal, Quebec, Canada 
 
Purpose: Left sided congenital heart disease encompass a spectrum ranging from bicuspid aortic 
valve to hypoplastic left heart syndrome. We hypothesized that rare de novo and rare familial Copy 
Number variations (CNV) explain a considerable amount of the complex genetic traits seen in its 
pathogenesis. Methods: We genotyped 396 individuals in 44 families at high resolution (Affymetrix 6.0 
N affected = 193, N unaffected = 203). Unaffected individuals from the same cohort and a cohort with 
myocardial infarction (N=862), but no valve disease were used as controls. Results: Our analysis 
revealed 33 rare CNVs. 30 have been only detected in a single individual or family. 3 have been 
identified in independent families. Public databases and gene chip data show cardiac and/or 
endothelial expression for genes adjacent to or overlapping with the identified CNVs. Among the 
genes identified several showed a GTPase regulator activity and a role in chromosomal maintenance. 
Preliminary functional experiments in Xenopus laevis support a distinct role for the identified genes in 
the cardiovascular development. Conclusions: The high prevalence of private CNVs is suggestive of 
genetically heterogeneous determinants contributing to congenital left sided heart defects. Functional 
data and in silico analysis of the genes identified point to a role in cardiac pathogenesis. Our approach 
holds great promise for the further genetic dissection of congenital heart disease especially aortic 
valve disease as a complex trait caused by rare alleles with major effects. 
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208. The role of FKbp12-notch1 mediated regulation in ventricular trabeculation and 
compaction 
Hanying Chen* (1), Wenjun Zhang(1), Xiao-Xin Sun(1), Zhuang Chen(1), Kryn Stankunas(2), 
Yongzhen He(1), Weidong Yong(1), Wuqiang Zhu(1), Simon Conway(1), Ching-Pin Chang(2), Loren J. 
Field, Nadia Carlesso, Weinian Shou(1) 
(1)Riley Heart Research Center, Herman B Wells Center for Pediatric Research, Department of 
Pediatrics, Indiana University School of Medicine, Indianapolis, USA (2)Division of Cardiovascular 
Medicine, Stanford University, USA 
 
Ventricular trabeculation and compaction are important cardiac morphogenetic processes and are 
critical to the formation and function of ventricular wall. Hypertrabeculation and noncompaction are two 
main characteristics of a unique type of congenital heart defect, Noncompaction of the Left Ventricular 
Myocardium (NLVM). Despite its essential role in cardiac formation, the molecular mechanism is 
largely unknown. One of the best known mouse models is the FK506 binding protein 12 (Fkbp1) 
mutant mice, which mimics the NLVM phenotype. It has been an assumption that hypertrabeculation 
and noncompaction are cardiomyocyte-autonomous defect. However, our initial attempt to rescue 
Fkbp1-deficient mice using cardiomyocyte-restricted Fkbp1 transgenic mice was failed, indicating that 
cardiomyocyte may not be the only cause of cardiac hypertrabeculation and noncompaction in Fkbp1-
deficient mice. Therefore, we went on to have generated a series of Fkbp1 conditional knockouts, 
including cardiomyocyte specific (Fkbp1ckomc), endothelial specific (Fkbp1ckoen), neural crest cell 
specific (Fkbp1ckonc), and epicardial specific (Fkbp1ckoep). While all these different strains of mutant 
mice have normal cardiovascular phenotypes, only endothelial specific Fkbp1ckoen mice embryo 
produced ventricular hypertrabeculation and noncompaction. Further analysis of potential molecular 
mechanism for this striking phenotype revealed that Fkbp12 is involved in regulating NICD1 stability. 
NICD protein level was significantly upregulated in Fkbp1ckoen endocardial endothelium. This is 
further confirmed by Hes1-luciferase assay. In contrast, overexpression of Fkbp12 significantly 
shortens NICD1 half-life. Taken together, our finding suggests that the endocardial endothelium is 
critical in controlling the ventricular trabeculation and/or compaction and that Fkbp12-Notch mediated 
signaling pathway plays an important role in this intercellular communication. 
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209. MCTP2 is a novel gene causing aortic coarctation 
S.M. Ware (1)*, X. Wang (2), L. Potocki (2), G. Zapata (2), M. Bray (2), A.C. Chinault (2), B.A. Boggs 
(2), E.K. Brundage (2), J.A. Towbin (1), A. Patel (2), S.D. Fernbach (2), S.L. Hamilton (3), K.L. 
McBride (4), J.W. Belmont (2), S.R. Lalani (2). 
(1) Division of Molecular Cardiovascular Biology, Cincinnati Children's Hospital, Cincinnati, OH (2) 
Dept of Molecular and Human Genetics; Baylor College of Medicine, Houston, TX (3) Dept of 
Molecular Physiology and Biophysics; Baylor College of Medicine, Houston, TX (4) Nationwide 
Children’s Hospital, Columbus, OH, USA 
 
Coarctation of the aorta (CoA) accounts for one tenth of all congenital heart anomalies. Despite the 
frequency, the causative genes underlying this relatively common left ventricular outflow tract (LVOT) 
defect remain largely unknown. We identified two half-siblings with CoA with a 2.2 Mb genomic 
deletion involving 15q26.2, inherited from their mother, who was mosaic for this deletion. This interval 
contains a single evolutionary conserved gene, MCTP2 (multiple C2-domains with two transmembrane 
regions 2). Using MCTP2-targeted array CGH screening, another individual with non- syndromic CoA 
and hypoplastic left heart was found to have a de novo intragenic tandem duplication within MCTP2, 
predicted to result in premature truncation of the protein, p.F697X. We then sequenced the MCTP2 
gene in 142 patients with LVOTO and found five missense variants not found in 200 ethnically 
matched controls. In vitro functional analysis of two of these missense variants within the C2A domain 
of the protein showed altered Ca2+ binding affinity. To further investigate the role of MCTP2 in cardiac 
development, we carried out loss of function experiments by injecting Xenopus laevis embryos with a 
splice blocking antisense morpholino oligonucleotide. Morphant embryos showed failure of 
endocardial cushion formation throughout the developing common outflow tract, confirming the 
functional importance of this gene in cardiogenesis. Our results identify MCTP2 as a novel genetic 
cause of CoA and related cardiac malformations. 
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Netherlands Heart Foundation session 3D-Techniques and Imaging  
 
 
169. 3D Modelling of heart development: looking to the future 
Tim Mohun  
Developmental Biology Division, MRC National Institute for Medical Research, London, UK 
 
 
The complexity of heart morphogenesis remains peculiarly challenging, whether the goal is to better 
understand normal development or to establish the origins of cardiac malformations. However until 
relatively recently, 3D modelling of the developing heart has been largely restricted to illustrative 
purposes rather than a significant research tool. The past few years have seen important changes, 
driven by the dramatic increase in easily accessible computing power and the development of novel or 
newly adapted 3D imaging techniques. As a result, it is now realistic for 3D analysis to be adopted as 
an investigative tool that can be allied to more conventional molecular and cellular analysis of cardiac 
development. 
However, it is also clear that, for the moment, the experience and expertise in such modelling remains 
confined to a small number of laboratories. As the first Weinstein meeting to schedule a specific 
session on 3D analysis and to help in its adoption by a wider range of labs, it is timely to try and 
suggest some of the key lessons and challenges of this work. Integrating 3D analysis (whether of gene 
expression, morphological development or embryonic heart function) into existing research also raises 
particular problems of data handling, including common approaches for data analysis and methods for 
simplifying data presentation or publication. Central to both is the sheer quantity of data generated by 
3D analysis and the opportunities this presents if appropriate ways can be found to share this 
information. 
 
  Oral sessions Friday 21 May page 60
 
170. Imaging in the Embryonic Heart: morphodynamic studies with Optical Coherence 
Tomography (OCT) 
Mesud Yelbuz 
Pediatric Cardiology & Intensive Care, Hannover Medical School, Hannover, Germany 
 
In vivo analysis of cardiac physiology and non-invasive imaging of the beating early embryonic heart in 
2D and 3D remain a challenge in cardiovascular development research. Further, high-resolution 3D 
and 4D in vivo imaging of early phases of cardiovascular development over long periods of time under 
constant physiological conditions (e.g. temperature, humidity) is another challenge in these studies. 
Without appropriate maintenance of temperature, for example, the embryonic heart rate declines 
rapidly and often results in an increase in regurgitant flow. However, preload, afterload, and the effects 
of blood flow on cardiac morphodynamics are critical parameters that have to be examined more 
closely for a better understanding of normal and abnormal cardiovascular development. I will give in 
this talk a short overview on optical coherence tomography (OCT) as a non-invasive high-resolution 
imaging tool for studies in cardiovascular development. I will share examples of data to demonstrate 
the first realization of an OCT system integrated into a new environmental incubation chamber to 
facilitate real-time in vivo imaging of cardiovascular development in chick embryos under stable 
physiological conditions during examination of the embryos. Because uncovering of the pumping 
mechanism of tubular embryonic hearts requires detailed information about the hemodynamics as well 
as morphological dynamics of their pump action, I’ll also show some results from our studies related to 
this end for early stages of cardiac development using OCT and ist component M-mode OCT. Finally, 
I’ll share the first 4D-OCT movies of the beating early embryonic heart in chick embryos acquired with 
a novel technique that uses a rotational scan mode of a swept-source OCT system (Thorlabs) using 
retrospective gating. 
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171. How to quantify in 3D: imaging of gene expression patterns and morphogenetic 
parameters in the embryonic heart. 
Jan M. Ruijter, Alexandre T. Soufan, Jaco Hagoort, Bouke A. de Boer and Antoon F.M. Moorman 
Department of Anatomy, Embryology & Physiology, Heart Failure Research Center, Academic Medical 
Center, Amsterdam, the Netherlands 
 
Gene expression profiling projects have provided us with increasing knowledge about overall gene 
activity levels in developing, healthy, and diseased tissue. For the functional interpretation of this 
wealth of information, the need to know in which part of the organ or tissue these genes are expressed 
becomes more and more pressing. Specific histological staining of proteins (with ICC) or mRNAs (with 
ISH) is therefore used to visualize these gene products, and thus the level of gene expression, in 
sections. Similarly, morphogenetic processes, like cell proliferation and apoptosis, can be visualized 
with histological procedures.  In structurally complex organs the interpretation of the resulting 
sections is hampered by the loss of 3D morphology. The required level of detail and the limited 
penetration of staining agents in whole mount staining procedures dictate the use of serially sectioned 
biological material and make the use of 3D computer reconstructions unavoidable.  
It is also our contention that ongoing discussions in embryology and anatomy will only be resolved by 
making 3D reconstructions of the dynamic and complex morphology of the (developing) heart, 
associated with the patterns of relevant genes. The 3D reconstruction protocol can be broken down 
into parallel qualitative (i.e. morphology) and quantitative (i.e. cell proliferation) methods. The 
qualitative method identifies the organ or tissue of interest (i.e. cardiac muscle cells), resulting in a 
surface reconstruction. The quantitative method relies on a specific staining method to identify 
individual (i.e. proliferating) nuclei. The number of nuclei is then systematically measured, providing 
local 3D information on i.e cell proliferation rate. Mapping of these local data onto the morphological 
surface reconstruction results in a reconstruction that not only conveys morphological information, but 
also quantitative morphogenetic data. Similarly local measurement can be applied on the staining 
intensity resulting from ICC and ISH staining and can thus be used to quantitatively reconstruct gene 
expression information in association with morphogenetic parameters.  
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172. How to place a section: Automated fitting of histological sections into a high 
resolution 3D reference model of a developing mouse heart 
Bouke A de Boer* (1,2), Frans PJM Voorbraak (2), Maurice JB van den Hoff (1), Antoon FM Moorman (1), Jan M 
Ruijter (1) 
(1) Heart Failure Research Center, Dept. Anatomy, Embryology & Physiology, Academic Medical Center, 
Amsterdam (2) Dept. Medical Informatics, Academic Medical Center, Amsterdam, NL 
 
The rapid morphological change of the developing heart makes it difficult to position a single section within a heart. 
This seriously hampers the interpretation of the section in its spatial context. To retrieve the postion of a single 
section through a heart, we developed a program (TRACTS) which fits arbitrary histological sections into a high 
resolution episcopic 3D heart model. We implemented a straightforward brute force pixel-based approach, where 
the (2D) input section is compared to a selection of virtual (2D) cross sections of the (3D) reference model. Model 
cross sections are selected on basis of four image features: size, overall density, regional density and center of 
mass. We describe how the performance of the program was tested. The performance is assessed using virtual 
cross-sections in arbitrary directions from a second, episcopic, dataset. To check whether the results are valid for 
paraffin embedded material, the program was also tested using paraffin sections taken from reconstructed in situ 
hybridization datasets. A third and last test involved a panel of morphological experts, who manually fitted a 
subsample of the episcopic input set to the reference model. The program outperformed the individual experts 
and, in about 30 seconds per section, fits just as well as the best fits found by five morphological experts. The 
results show that the program is quite robust for differences in developmental stage. The use of the program will 
help proper annotation of structures in sections and therefore improve interpretation and communication on 
experimental results. 
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173. How to make a 3D pdf: From 3D-reconstruction to interactive 3D-pdf; a protocol 
for biologists. 
Jaco Hagoort*, Alexandre Soufan, Bouke de Boer, Antoon Moorman 
Department of Anatomy, Embryology & Physiology, Heart Failure Research Center, Academic Medical Center, 
Amsterdam, NL 
 
Anatomical and embryological studies heavily rely on three-dimensional (3D) data sets, which allow the proper 
understanding of complex morphogenetic processes and changing patterns of gene expression. These 3D data 
lead to new insights, which may be accurately discussed within the research group because the right tools (i.e. 
proper software) are on hand. However, dissemination of such data is severely hampered due to the inherently 
2D paper medium used for publication. This is very unfortunate, as many insights are very hard to convey without 
interaction with the 3D data. An opportunity to remedy this has presented itself, as Adobe Acrobat Pro Extended 
allows to embed 3D objects into a pdf document. The read-only freeware version Adobe Reader is universally 
used and virtually all scientific papers are distributed in this format. Using Adobe Reader to interact with 3D 
objects is reasonably straightforward; creating such objects, however, is not. Therefore, we developed a protocol 
that describes how one can embed a 3D object into a pdf file and enhance it with more functionality. We will show 
-step by step- how to create a basic 3D-pdf which is useful for quick exchange of scientific findings. Some more 
advanced additions will be applied, resulting in a 3D-pdf that is ideally suited for presentation or publication. 
Enriching documents with 3D objects is perfect in the sense that it is universal; every reader can interact with the 
3D content. Furthermore, it enables researchers to better convey the ideas resulting from their 3D analyses, 
whereby miscommunication is reduced. 
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Valve Development 
 
69. MiR-23 is essential to restrict endothelial-to-mesenchymal transition during 
cardiac valve formation. 
Anne Karine Lagendijk* (1), Jeroen Bakkers (1,2) 
(1)Cardiac development and genetics group, Hubrecht Institute-KNAW & University Medical Center 
Utrecht, Utrecht, NL (2)Interuniversity Cardiology Institute of the Netherlands, Utrecht, NL 
 
Endothelial-to-mesenchymal transition (endo-MT) in the endocardial cushions (ECs) is a critical step 
during valvulogenesis. Although several factors have been identified that induce and/or are required 
for endo-MT, very little is know about mechanisms that restrict endo-MT to the ECs located in the AV 
canal. MicroRNAs (miRs) are small non-coding RNAs and we found that miRs of the miR-23,24,27 
clusters are highly expressed in ECs of the zebrafish embryo. Analysis of dicer mutants, which lack all 
mature miRs, revealed unrestricted endo-MT occurring in the entire endocardium of the chambers. 
Knock-down of individual miRs showed that miR-23 is both necessary and sufficient to restrict the 
number of endothelial cells in the endocardium that transdifferentiate and contribute to valvulogenesis. 
Furthermore, our results demonstrate that miR-23 is required to dampen and eventually stop the 
transdifferentiation response in the ECs. Using an in vitro approach we show that miR-23 can target 
hyaluronan synthase 2 (has2), an enzyme producing extracellular hyaluronan, which is essential for 
endo-MT. In addition our genetic rescue experiments demonstrate that the upregulation of Has2 
activity seen in embryos lacking miR-23 is responsible for the enhanced and ectopic endo-MT. Since 
miR-23 is highly expressed in ECs after endo-MT has been initiated we propose a model in which 
induction of miR-23 expression in ECs provides a negative feedback mechanism to restrict and 
dampen the endo-MT process allowing maturation of the valve leaflets. 
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70. Cardiac valve malformations: new insights from Pdlim7, an unexpected suspect in 
heart development 
Jennifer Krcmery* (1), Rudyard Sadleir (1), Rajesh Gupta (2), Chrissy Kamide (2), Sol Misener (2), 
Doug Losordo (2), and Hans-Georg Simon (1) 
(1) Department of Pediatrics, Northwestern University Feinberg School of Medicine, and Children’s 
Memorial Research Center, Chicago, IL, USA (2) Department of Medicine, Northwestern University 
Feinberg School of Medicine, and Feinberg Cardiovascular Research Institute, Chicago, IL, USA 
 
PDZ-LIM proteins contain multiple binding domains, facilitating interactions with the actin cytoskeleton, 
nuclear factors, and signaling molecules, thereby allowing the proteins to carry out diverse biological 
functions. Here, we characterize a new family member, Pdlim7 that appears to have important 
functions during cardiac development, as evidenced by specific malformations resulting from 
inactivation in zebrafish and mouse models. Knock-down of Pdlim7 in the zebrafish causes 
misregulation of genes in the atrioventricular (AV) canal leading to heart looping defects and valve 
malformations. Extending these studies to the mouse, we generated a Pdlim7 knock-out allele using a 
gene-trap approach with the insertion of lacZ between exons 2 and 3. Pdlim7 is expressed in a spatial 
and temporal manner in the developing mouse heart and its activity is extended into adulthood. Pdlim7 
null embryos reveal misregulation of AV canal genes and increased AV cushion tissue during early 
valvulogenesis, resulting in impaired maturation leading to hypertrophic adult AV valves. 3-
dimensional reconstructions from adult heart serial sections demonstrate these morphological 
changes following loss of Pdlim7. Supporting the structural problems in adult mice, echocardiography 
studies of Pdlim7 mutant mice reveal increased tricuspid and mitral annulus dimensions with 
decreased left ventricular (LV) diastolic function. The cardiac problems observed in adult mice lacking 
Pdlim7 proteins appear to result from early problems in cardiogenesis that manifest themselves 
postnatally. Thus, these findings establish Pdlim7 as an important player in heart development and 
suggest that the Pdlim7 knock-out mouse may provide a new model for cardiac valve disease 
progression. 
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71. Krox20 is required during valve remodeling and maturation 
Sarah Arab (1), Frank Kober (2), Piotr Topilko (3), Monique Bernard (2), Patrick Charnay (3), Patrick 
Cozzone (2) and Stéphane Zaffran* (1) 
(1) Inserm UMR_S910, Faculté de Médecine de Marseille, 27 Bd Jean Moulin, 13005 Marseille, 
France. (2) Centre de Résonance Magnétique Biologique et Médicale, CNRS, Faculté de Médecine de 
Marseille, 27 Bd Jean Moulin, 13005 Marseille, France. (3) Biologie Moléculaire du Développement, 
Inserm U784, ENS, 75005 Paris, France. 
 
Heart valve replacement is the second most common cardiac surgery in the industrialized countries, 
and the majority of replaced aortic valves have congenital malformations. Two processes can affect 
the aortic valve – aortic stenosis and aortic insufficiency (also called aortic regurgitation). Despite high 
prevalence of these diseases the causes of valve developmental anomalies and associated 
dysfunction have not been identified. Using genetically modified mouse models, we found that the 
transcription factor Krox20 (also called Egr2) is expressed in leaflets of the cardiac valves, and its 
expression is maintained after birth. Krox20 inactivation results in lethality at birth due to a respiratory 
defect. No role of Krox20 in the heart development has yet been identified. Using high temporal and 
spatial resolution cine-MRI we examined the cardiac function of Krox20+/- adult mice and found that 
60% of them have cardiac defects, including bicuspid aortic valve (BAV) and aortic regurgitation. 
Interestingly, Krox20-deficient embryos (E12.5) and fetuses (E17.5) exhibit reduction of mesenchymal 
cell proliferation and dysregulation of interstitial cell differentiation in the cardiac valves respectively. 
Conditional inactivation of Krox20 in endothelial-derived cells with Tie2Cre results in high percentage 
incidence of aortic regurgitation. Krox20 has been shown to be a target of the NRG1/ErbB signaling 
pathway in Schwann cells. We are employing the explants culture system to determine if the epithelial 
mesenchymal transition (EMT) is affected in Krox20-deficient hearts and if the NRG/ErbB signaling 
during this process regulates Krox20. This study reveals an important role of Krox20 in heart valves 
remodeling and maturation. 
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72. The Metalloprotease ADAMTS5 Plays A Critical Role In ECM Stratification And 
Cusp Sculpting During Semilunar Valve Maturation 
Christine B. Kern* (1), Daniel R. McCulloch (2), Jessica D. McGarity (1), Alexandra Bahan (1), Loren E. 
Danese (1), Courtney M. Nelson (3), Andy Wessels (1), and Suneel S. Apte (3) 
(1) Department of Regenerative Medicine and Cell Biology, 171 Ashley Avenue, Medical University of 
South Carolina, Charleston, SC 29425, USA (2) Deakin University, Geelong Victoria 3217, Australia (3) 
Department of Biomedical Engineering, Lerner Research Institute (ND-20), Cleveland Clinic, 9500 
Euclid Avenue, Cleveland OH 44195, USA 
 
The extracellular matrix (ECM) undergoes dramatic remodeling during valve maturation, resulting in 
formation of the specialized ECM layers required to regulate blood flow in the adult heart. Since the 
loss of ECM stratification and accumulation of proteoglycans is a hallmark of valve disease, 
uncovering processes that regulate normal valve maturation is clinically significant. Here we 
investigate the role of the ECM protease ADAMTS5 (A Disintegrin-like And Metalloprotease domain 
with ThromboSpondin-type 1 motifs) that is expressed by the endocardium and a subset of 
mesenchymal cells in the hinge region of developing semilunar valves. A known substrate of 
ADAMTS5 in the developing heart, the ECM proteoglycan versican, is highly expressed and critical for 
early valve formation, but has limited and restricted expression in adult valves. We report that 
ADAMTS5 deficient mice develop severely enlarged and malformed semilunar valves with 
dramatically decreased versican processing reflected by accumulation of intact versican. Reduced 
mesenchymal cell compaction and increased cell proliferation further contribute to the enlarged 
semilunar valves in ADAMTS5 deficient mice. The “balloon-like” shape of the developing mutant cusps 
may also result from poor organization of fibrous ECM in ADAMTS5 nulls compared to wild type 
littermates. Increased nuclear phospho-Smad2 immunoreactivity strongly suggests that TGFβ 
signaling may be a consequence of Adamts5 deficiency, and contribute to abnormal valve 
development in ADAMTS5 deficient embryos. These studies identify a novel role for ADAMTS5 and 
versican cleavage in sculpting the cusps and stratifying the ECM during fetal valve maturation and 
identify a novel candidate gene for congenital valve defects. 
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73. Induction of a developmental gene program in pediatric and adult aortic valve 
disease 
Elaine Wirrig* (1), Jonathan Cheek (1), Christina Alfieri (1), Walter Merrill (2), Robert Hinton (1), 
Katherine Yutzey (1) 
(1) The Heart Institute, Cincinnati Children's Hospital Medical Center (2) Department of Surgery, 
University of Mississippi Medical Center, USA 
 
Congenital heart valve malformations, including latent defects such as bicuspid aortic valve, are 
estimated to affect 1-2% of the United States population. There is increasing evidence that aortic valve 
(AoV) disease has a basis in development, and congenital valve malformations are prevalent in 
patients undergoing valve replacement surgery. The progression of AoV disease includes: activation 
of valvular interstitial cells (VICs), valve sclerosis due to abnormal ECM production/remodeling, 
followed by calcification of sclerotic lesions. Previous studies have defined a shared gene program 
between valve and bone progenitor cells. We hypothesize that reactivation of these genes during AoV 
disease constitutes an osteogenic-like process in VICs, leading to valve calcification. Explanted 
human pediatric and adult diseased AoVs were obtained following valve replacement surgery. 
Preliminary studies revealed increased expression of the proliferation marker phospho-histone H3 and 
alpha smooth muscle actin, indicating activated VICs, in areas of diseased valves displaying ECM 
disorganization. Pre-calcified regions of diseased adult AoVs have increased expression of Twist1, 
Mef2c, Msx2, Sox9, and phospho-SMAD 1/5/8, factors critical for valve progenitor and pre-osteoblast 
development. Calcified regions of diseased adult AoVs exhibit Runx2 expression, a marker of 
osteogenic bone formation. In pediatric valves, expression of both Mef2c and Twist1 is increased, 
however calcification and late osteogenic gene markers are not observed. These results demonstrate 
the expression of early markers of bone and heart valve development in diseased valves, supporting 
the hypothesis that a common developmental gene program related to embryonic valve progenitors 
and osteogenesis is reactivated during human pediatric and adult AoV disease. 
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74. Reduced Sox9 function promotes heart valve calcification in vivo 
Jacqueline D Peacock*, Agata K Levay, and Joy Lincoln 
Molecular and Cellular Pharmacology, University of Miami Miller School of Medicine, Miami, Florida, 
USA 
 
Heart valve calcification is the third leading cause of adult heart disease, however, the mechanisms of 
onset and progression are unclear. Normal heart valves share molecular phenotypes with cartilage 
tissue, while calcified valves express osteogenic genes, suggesting similarities with bone development. 
During skeletogenesis, Sox9 promotes cartilage formation by positively promoting expression of 
cartilage-associated genes. In persistent cartilage, Sox9 inhibits activity of the osteoblast transcription 
factor RUNX2, therefore repressing activation of osteogenic target genes. The purpose of this study 
was to test the hypothesis that in heart valves, Sox9 is required to maintain extracellular matrix 
homeostasis by promoting cartilaginous phenotypes and preventing osteogenic processes. Heart 
valves from mice with reduced Sox9 function in a subset of valve cells express decreased levels of 
cartilage-associated proteins, and develop calcific lesions on the surface of mitral, tricuspid and aortic 
valve leaflets. This calcification is associated with increased expression of osteogenic genes including 
runx2, osteopontin, and osteonectin at 12 months, similar to findings in human calcified valves. To 
determine the direct downstream targets of Sox9 that mediate this osteogenic phenotype in heart 
valves, we have employed combinatory ChIP-on-ChIP and microarray approaches, along with Sox9 
knockdown and overexpression studies in heart valves and cartilage tissue. Using these approaches 
we have identified novel putative targets of sox9 regulation osteopontin (spp1), cingulin (cgn), and 
arginase (arg1). Ongoing studies will further define the roles of these candidate genes in heart valve 
calcification. Collectively these studies have identified reduced Sox9 function as a developmental 
origin for adult calcific valve disease. 
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120. Tbx5 is required in the Second Heart Field for Atrioventricular Septation 
Linglin Xie, Joshua M. Friedland-Little, Andrew D. Hoffmann, and Ivan P. Moskowitz* 
Departments of Pediatrics and Pathology, Committees on Genetics and Developmental Biology, The 
University of Chicago, Chicago, IL, 60637, USA 
 
Tbx5 haploinsufficiency causes Holt–Oram syndrome in humans, characterized by atrioventricular 
septal defects in the heart. We observed atrioventricular septal defects in 40% of late gestation mouse 
embryos with germline Tbx5 haploinsufficiency. However, no septation defects were observed in 
embryos with conditional Tbx5 haploinsufficiency in myocardial cells, using Tnt:Cre, or in endocardial 
cells, using Tie2:Cre, suggesting that the requirement for Tbx5 in cardiac septation may lie outside the 
heart. Recent work from our laboratory and others has implicated the posterior second heart field in 
atrial septation. We observed Tbx5 expression in a domain overlapping progenitors for the atrial 
septum in the posterior second heart field. Furthermore, atrioventricular septal defects were observed 
in 40% of embryos with conditional Tbx5 haploinsufficiency in the posterior second heart field, using 
the Hedgehog (Hh) signaling-responsive Gli1:Cre, suggesting that Tbx5 and Hh-signaling are required 
for atrial septation in the same lineage. We found that Tbx5 and Hh-signaling components genetically 
interact: Decreasing Hh signaling caused increased penetrance of atrioventricular septal defects in 
Tbx5 mutant mice. Furthermore, constitutive activation the Hh-signaling rescued atrioventricular 
septation in Tbx5 mutant mice. Using Genetic Inducible Fate Mapping, we demonstrated that Tbx5 is 
specifically required for proliferation of Hh-receiving atrial septal progenitors in the posterior second 
heart field. We conclude that Tbx5 is required in the posterior second heart field, not in the heart, for 
cardiac septation. We present a molecular pathway including Tbx5 and Hh signaling required for 
cardiac progenitor cell specification that informs the ontogeny of atrial septal defects. 
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121. Cooperative roles of Tbx1 and Tbx3 during early outflow tract development 
Karim Mesbah* (1), M. Sameer Rana (2), Laure Lo Ré (1), Virginia Papaioannou (3), Vincent M. 
Christoffels (2), Robert G. Kelly (1) 
(1) Developmental Biology Institute of Marseilles - Luminy, UMR 6216 CNRS-Université de la 
Méditerranée, Campus de Luminy, Case 907, 13288 Marseille Cedex 9, France (2) Department of 
Anatomy, Embryology & Physiology, Academic Medical Center, University of Amsterdam, 
Meibergdreef 15   L2-108, 1105 AZ Amsterdam, The Netherlands (3) Department of Genetics and 
Development, Columbia University, 701 W 168th St., New York, USA 
 
In the early embryo progenitor cells of the second heart field (SHF) contribute to rapid growth of the 
heart tube. SHF cells in pharyngeal mesoderm are adjacent to pharyngeal ectoderm and endoderm 
and SHF deployment is concomitant with neural crest cell migration. Tbx1, the major DiGeorge 
syndrome candidate gene and Tbx3, encoding a transcriptional repressor, are required for outflow 
tract development. These two genes have complementary expression profiles in the pharyngeal region; 
Tbx1 is expressed in the lateral pharyngeal endoderm, ectoderm and mesoderm (including the SHF) 
while Tbx3 is expressed in ventral pharyngeal endoderm and neural crest cells. Tbx3 transcript levels 
are decreased in neural crest cells in the caudal pharynx of Tbx1 null embryos suggesting that Tbx3 
expression may be regulated by Tbx1 dependent signals originating from pharyngeal epithelia or 
mesoderm. We are investigating potential interaction between these genes by a genetic cross. 
Pharyngeal arch artery defects in double heterozygous Tbx1 Tbx3 mutant embryos are similar in 
severity and frequency to those in Tbx1 heterozygous embryos. However, double homozygous Tbx1 
Tbx3 mutant embryos have impaired development and display lethality at midgestation. These 
embryos are characterized by pericardial edema associated with a failure of heart tube elongation and 
looping. This phenotype is more severe than that of Tbx1 or Tbx3 homozygous mutant embryos 
suggesting a cooperative role of these two factors during early heart morphogenesis. Altered 
expression of Tbx2 is also observed in Tbx1 mutant embryos. We are currently analyzing the 
molecular phenotype of double homozygous Tbx1 Tbx3 embryos.molecular phenotype of double 
homozygous Tbx1 Tbx3 embryos. 
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Neural Crest 
 
59. Trigenic neural crest-restricted Smad7 over-expression results in congenital 
craniofacial and cardiovascular defects 
Sunyong Tang, Paige Snider and Simon J. Conway * 
Herman B Wells Center for Pediatric Research, Indiana University School of Medicine, Indianapolis, IN 
46202 USA. 
 
Smad7 is a negative regulator of TGFβ superfamily signaling. Using a three-component triple 
transgenic system, expression of the inhibitory Smad7 was induced via doxycycline within the NCC 
lineages at pre- and post-migratory stages. Consistent with its role in negatively regulating both TGFβ 
and BMP signaling in vitro, induction of Smad7 within the NCC significantly suppressed 
phosphorylation levels of both Smad1/5/8 and Smad2/3 in vivo, resulting in subsequent loss of NCC-
derived craniofacial, pharyngeal and cardiac OFT cushion cells. At the cellular level, increased cell 
death was observed in pharyngeal arches. However, cell proliferation and NCC-derived smooth 
muscle differentiation were unaltered. NCC lineage mapping demonstrates that cardiac NCC 
emigration and initial migration are not affected, but subsequent colonization of the OFT was 
significantly reduced. Induction of Smad7 in post-migratory NCC results in cardiac OFT anomalies and 
interventricular septal chamber septation defects, suggesting that TGFβ superfamily signaling is also 
essential for cardiac NCC at post-migratory stages to govern normal cardiac development. Taken 
together, the data show that tightly regulated TGFβ superfamily signaling plays an essential role 
during craniofacial and cardiac NCC colonization and cell survival in vivo. 
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60. Cardiac Neural Crest Nibble Their Way to the Heart 
Mary R. Hutson*, Ann Marie Scholl, Elizabeth B. Kuhn, Asako Sato, Harriett A. Stadt, Jennifer R. 
Decker, Kelly Pegram, and Margaret L. Kirby 
*Department of Pediatrics, Neonatal-Perinatal Research Institute, Duke University Medical Center, 
Durham, NC, USA 
Cardiac neural crest ablation causes abnormal development of the secondary heart field with 
consequent abnormal cardiac looping and malalignment defects of the cardiac arterial pole. 
Malalignment is caused by excess FGF8 signaling. It is unknown how cardiac crest cells normally 
decrease FGF8 signaling in the caudal pharynx. We show that cardiac crest cells use a retinoic acid 
signal to reduce endodermal fgf8 production. In addition, the crest cells use receptor-mediated 
endocytosis to amass FGF8 protein for degradation. Further, we show that FGF8 is chemokinetic for 
cardiac crest cells via FGF receptors 1 and 3 and MAPK/ERK intracellular signaling, and that a site of 
forced overexpression of ectopic FGF8b by the pharyngeal endoderm becomes surrounded by cardiac 
crest cells. Because of the protective effect of neural crest, ectopic overexpression of FGF8 results in 
only subtle arterial pole defects, not involving malalignment. Protection of the pharynx from abnormal 
signaling by endocytosis represents a new role for neural crest cells. 
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193. Origins of Cardiac Pacemaking Cells in Avians 
Michael Bressan*, Alicia Navetta, Takashi Mikawa 
Cardiovascular Research Institute, University of California San Francisco, San Francisco, CA, USA 
 
Rhythmic heartbeat is controlled by action potentials originating from pacemaking cells of the 
Sinoatrial Node (SAN). Despite the importance of pacemaker cells for the initiation and rhythmicity of 
heartbeat, little is known regarding their developmental origins or mechanisms of specification and 
differentiation. Here we report our direct cell tracing studies, mapping the origins of SAN precursors to 
a small region in the lateral plate mesoderm posterior to the developing primary and secondary heart 
fields. These cells take over pacing from primary heart field-derived cells between E2.5-E3 in Chick. 
Furthermore, they continued to act as the dominant pacing center throughout the dramatic 
morphogenetic processes of cardiac looping and septation, finally incorporating into the atrium by E12. 
To address the underlying mechanism of SAN precursor specification and differentiation, the 
precardiac fields (PCFs) and SAN precursor mesoderm were isolated at HH stage 8 and cultured ex 
vivo. PCF explants underwent tube formation and looping remarkably similar to hearts in vivo, and 
displayed spontaneous heartbeat over the first 2 days in culture, however, both beat rate and 
rhythmicity decreased significantly afterwards. In striking contrast, co-culture of PCF explants with 
SAN precursor mesoderm resulted in maintenance of rhythmicity through 3 days in culture. 
Interestingly, SAN precursors when cultured alone displayed increased beat rate and rhythmicity. 
Collectively, these data suggest that the fate of SAN precursors is specified by HH stage 8 and proper 
differentiation of these pacemaking cells does not require PCF cells. Supported in part by grants from 
NIH-NHLBI. 
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194. The role of Tbx3 and Nkx2-5 in the adult atrioventricular conduction system 
Mathilda T.M. Mommersteeg* (1), Bas J. Boukens (1), Saskia van der Velden (1), Corrie de Gier-de 
Vries (1), Richard P. Harvey (2), Antoon F.M. Moorman (1), Vincent M. Christoffels (1) 
(1) Heart Failure Research Center, Academic Medical Center, Amsterdam, The Netherlands (2) Victor 
Chang Cardiac Research Institute, University of New South Wales, Darlinghurst, Australia. 
 
The coordinated contraction of the heart is precisely timed by the cardiac conduction system. The 
conduction system expresses Tbx3, which is required for the specification of the sinus node and of the 
atrioventricular (AV) conduction system during development. In human, heterozygous TBX3 mutations 
cause congenital defects belonging to the ulnar-mammary syndrome. The consequences of 
heterozygous loss of Tbx3 in the heart, however, are still unknown. Quantitative and 3D 
morphometrical analysis of AV node and bundle showed a significant smaller AV bundle in adult Tbx3 
heterozygous mutants compared to wild-type mice, whereas the size of the AV node was unchanged. 
Furthermore, functional analysis showed a significant shortening of the AV conduction time in 
heterozygous Tbx3 mutant mice. Tbx3 has been shown to physically interact with Nkx2-5 to repress 
target genes in the cardiac conduction system. Similar as in Tbx3 heterozygous mice, the AV bundle 
was significantly smaller in Tbx3/Nkx2-5 and Nkx2-5 heterozygous mice in comparison to the wild-type 
situation. In contrast to earlier reports, we found that the size of the AV node was not affected in 
heterozygous Nkx2-5 mutants. Heterozygous loss of Nkx2-5 or of Tbx3 and Nkx2-5 caused complete 
AV block in a significant number of mice. Interestingly, also atrial ectopic beats were found in both 
groups of heterozygous Nkx2-5 mutant mice, suggesting the possibility of expansion of pacemaker 
cells into the atrium as previously observed in Nkx2-5 hypomorphic embryos. Our data indicate that 
normal levels of Tbx3 and Nkx2-5 are independently required for AV bundle formation and 
homeostasis. 
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195. Delayed atrioventricular conduction in adrenergic-deficient embryonic mouse 
hearts: Uncovering a role for retinoic acid 
Kingsley Osuala (1), David G. Taylor (1), Celines Martinez (1), Ha-Long Nguyen (1), Tu-Suong 
Nguyen (1), Anupama Natarajan (2), Peter Molnar (2), James Hickman (2), and Steven N. Ebert* (1) 
(1) Burnett School of Biomedical Sciences, University of Central Florida College of Medicine, Orlando, 
FL (2) Nanoscience Technology Center, University of Central Florida, Orlando, FL, USA 
 
Dopamine-β-hydroxylase (Dbh) is a key enzyme in the adrenergic hormone synthesis pathway and is 
critical for cardiac development and survival past embryonic day 10.5 (E10.5) in the mouse. We have 
previously shown that intrinsic cardiac adrenergic cells populate regions of the heart associated with 
the conduction system. To investigate physiological mechanisms of action for adrenergic hormones in 
cardiac conduction system development, we evaluated E10.5 adrenergic-deficient (Dbh-/-) and 
adrenergic-competent (Dbh+/+) mouse hearts cultured on microelectrode arrays (MEAs, 8x8, 200 
microns apart). Our results show that although mean heart rates were similar in the two groups, 
atrioventricular conduction time was significantly slowed in the Dbh-/- hearts when compared to 
controls (31.4+6.4 vs. 15.4+1.7 ms, respectively; p < 0.05). To identify potential molecular pathways 
mediating this process, we evaluated gene expression profiles of E10.5 Dbh-/- and Dbh+/+ hearts 
using Affymetrix Mouse Genome 430A 2.0 Arrays. Of the more than 22,000 genes on the array, we 
found that significant differences of 2-fold or greater magnitude occurred in 22 genes (~0.1% of total). 
Notably, several of these genes are involved in retinoic acid synthesis and signaling, including: retinol 
dehydrogenase-12, ubiquinone, beta carotene monooxygenase-1, and fibroblast growth factor-20 
(FGF-20). Importantly, retinoic acid signaling has been shown to be critical for heart development 
during the mid-gestation period, and genetic disruption of retinoic acid receptors has been shown to 
lead to atrioventricular conduction block. Thus, our results show that adrenergic hormones may 
influence cardiac conduction system development via regulation of retinoic acid signaling in the 
embryonic heart. 
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20. Shear stress modulates transcriptional regulation and cushion endoMT in the 
developing heart 
Beerend P. Hierck* (1), Anastasia D. Egorova (1), Simone van de Pas (1), Marie José Goumans (2), 
Peter ten Dijke (2), Robert E. Poelmann (1) 
(1) Dept. of Anatomy and Embryology Leiden University Medical Center, Leiden, The Netherlands (2) 
Dept. of Molecular Cell Biology, Leiden University Medical Center, Leiden, The Netherlands 
 
Proper cardiovascular development depends on biomechanical stimuli, among which the fluid shear 
stress exerted by blood flow. Endothelial cells (EC) are particularly sensitive to shear stress and 
translate this force into functional and phenotypic responses, which include calcium signaling, NO 
production, and gene expression regulation. The latter is largely coordinated by the transcription factor 
Krüppel-like factor 2 (Klf2). We described earlier that endocardial Klf2 expression delineates areas of 
high shear stress in the embryonic heart, and that experimentally altered flow in vivo in the venous clip 
model leads to changes in expression patterns of Klf2 and downstream targets. Here we describe that 
the model also presents with a 50% loss of atrioventricular cushion mesenchyme due to a lack of 
endothelial to mesenchymal transition (endoMT). Since transforming growth factor β (Tgfβ) plays a 
central role in cushion endoMT we analysed the relation between shear stress, Klf2 expression, and 
activation of Tgfβ signalling in embryonic endothelial cells. In adult EC shear stress results in 
downregulation of Tgfβ signalling through Klf2-mediated induction of the inhibitory Smad7. We provide 
evidence that in embryonic EC Tgfβ signalling through the type I receptor Alk5 is necessary for flow-
stimulated induction of Klf2, and leads to a rapid phosphorylation of the receptor Smad2 in vitro and in 
vivo. The induction of Klf2 could be abrogated with inhibitors for Alk5 and Mek5 kinase activity. 
Herewith we identify shear stress as an important modulator of cushion endoMT in the developing 
heart through activation of TGFβ signalling and Klf2. 
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21. Integrative computational modeling and imaging approach to study the effects of 
abnormal hemodynamic conditions on cardiac development. 
Sandra Rugonyi* (1), Ruikang Wang (1) and Kent Thornburg (2) 
(1) Biomedical Engineering, Oregon Health & Science Universtity, Portland, OR. (2) Heart Research 
Center, Oregon Health & Science University, Portland, OR, USA. 
 
It is well accepted that hemodynamic forces modulate cardiac growth during embryonic development, 
with abnormal hemodynamic forces leading to heart defects. However, the mechanisms that regulate 
cardiac growth in response to hemodynamic stimuli have remained elusive, in part due to the lack of 
methodologies to accurately assess the forces exerted by blood flow on cardiac tissue. To calculate 
the forces to which cardiac cells are subjected during the cardiac cycle we are employing a 
combination of imaging and computational modeling. Our studies use the chick embryonic heart, 
focusing on the heart outflow tract (OFT) at early stages of development – HH18 to HH24 – when the 
heart is a looped tube, because at these stages the OFT is very sensitive to hemodynamic forces. We 
use optical coherence tomography (OCT) to simultaneously acquire structural and Doppler 
tomographic image sequences of the beating heart in vivo. OCT image sequences are acquired at 
different locations that together span the OFT. 4D images of the beating heart are then reconstructed 
and segmented from structural images (using our developed algorithms), and blood flow velocities 
computed from Doppler OCT images. To determine the influence of wall motion on blood flow 
dynamics, as well as distributions of shear stresses on the walls of the OFT, we use computational 
models. We found that curvature, and the distribution of cardiac cushions (protrusions of extra-cellular 
matrix into the OFT lumen) affect the spatial distribution of blood flow velocities and wall shear 
stresses, which could lead to differential cardiac growth and remodeling. 
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22. Knockdown of embryonic myosin heavy chain causes defective electrical activities 
and calcium signalling within the developing heart 
Catrin Rutland(1), Luis Polo-Parada(2), Aziza Alibhai(1), Aaran Thorpe(1) and Siobhan Loughna* (1) 
(1) School of Biomedical Sciences, University of Nottingham, UK. (2) Department of Medical 
Pharmacology and Physiology. Dalton Cardiovascular Research Center, University of Missouri, USA 
. 
Our group has previously shown that embryonic myosin heavy chain (eMHC) morpholino knockdown 
in chicks at HH14 results in aberrant cardiac development including abnormal atrial septation and 
decreased ventricular wall thickness. Therefore, to provide functional insights the electrical activity and 
calcium signalling were analysed. Knockdown of eMHC was performed at HH14 (harvested HH19). 
Electrical activity studies were carried out by intracellular recordings of intact hearts and single cell 
cultures were incubated with fluorescent dyes to detect intracellular Ca2+ transients. eMHC 
knockdown hearts exhibited abnormal beating patterns characterized by the absence and/or weak 
contraction of the ventricle. Although the atria displayed normal contraction, the action potentials (APs) 
of the cells exhibited decreases in amplitude, maximal rate of rise and increase in duration. In contrast, 
no AP was recorded in 75-80% of ventricular cells. In the cells that exhibited spontaneous APs, small 
amplitude, long duration and slow rate of rise was observed when compared with control hearts. 
Knockdown hearts also showed erratic amplitudes and/or frequencies of [Ca2+]. The atrial cells 
displayed a large variability in the duration of the Ca2+ transient, including superimposition of a 
second or third maximal Ca2+ peak, and small or aborted Ca2+ transient peaks. In the ventricular 
cells, eMHC knockdown induced small changes in Ca2+ transient frequency. This data demonstrates 
that eMHC plays critical roles during cardiogenesis, specifically with normal ventricular and atrial 
function. Novel insights into the role that the structural protein eMHC plays in the electrical activity and 
calcium signalling within the developing heart are provided. 
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Session A - Cardiac Signalling 
 
1. Inhibition of Bmp signaling by Smad6 is required for terminal 
differentiation of ventricular cardiomyocytes. 
Emma de Pater (1) and Jeroen Bakkers (1,2) 
(1) Hubrecht Institute-KNAW & University Medical Center Utrecht (2) 
Interuniversity Cardiology Institute of the Netherlands, 3584CT Utrecht, The 
Netherlands 
For abstract, see in oral presentation section page 48 
 
 
 
2. The BMP Pathway Acts to Regulate Tbx20 in the Developing Heart 
Erin Kaltenbrun* (1, 2), Elizabeth Mandel (1, 2), Thomas Callis (1, 4), Da-Zhi 
Wang (1, 4, 5) and Frank Conlon (1, 2, 3) 
(1) Department of Biology, University of North Carolina at Chapel Hill, Chapel 
Hill, NC, USA (2) McAllister Heart Institute, University of North Carolina at 
Chapel Hill, Chapel Hill, NC, USA (3) Department of Genetics, University of 
North Carolina at Chapel Hill, Chapel Hill, NC, USA (4) Department of Cell and 
Developmental Biology, University of North Carolina at Chapel Hill, Chapel Hill, 
NC, USA (5) Current Address: Department of Cardiology, Children’s Hospital, 
Boston, Harvard Medical School, Boston, MA, USA 
For abstract, see in oral presentation section page 49 
 
 
 
3. Bmp-signaling regulates myocardial differentiation from cardiac 
progenitors through a micro RNA-mediated mechanism 
Jun Wang* (1) , Margarita Bonilla-Claudio (1), Jue Zhang(1), Yan Bai (1), Zheng 
Huang (1), Brian L. Black (2), Fen Wang (1), and James F. Martin (1) 
1 Institute of Biosciences and Technology, Texas A&M System Health Science 
Center, 2121 W. Holcombe Blvd, Houston, Texas 2 Cardiovascular Research 
Institute and Department of Biochemistry and Biophysics, University of 
California, San Francisco CA, USA 
For abstract, see in oral presentation section page 50 
 
 
 
4. Cardiac Laterality is Controlled by Multiple Rho Kinase Signaling 
Pathways in Ciliated Cells 
Guangliang Wang, Fiona C. Foley, Duck Soo Jang, Jeffrey D. Amack* 
Department of Cell and Developmental Biology, State University of New York 
Upstate Medical University, Syracuse, NY, USA 
For abstract, see in oral presentation section page 51 
 
 
 
 
 
5. Mitochondrial structure and function during cardiac myocyte 
differentiation 
George A. Porter, Jr.* (1,2,3), Jennifer Hom (1), Rodrigo Quintanilla (1,2), David 
Hoffman(1), Bentley Karen (4), Shey-Shing Sheu (2) 
(1) Department of Pediatrics, (2) Department of Pharmacology and Physiology, 
(3) Aab Cardiovascular Research Institute, (4) Department of Pathology and 
Laboratory Medicine, University of Rochester Medical Center, Rochester, NY, 
USA 
For abstract, see in oral presentation section page 52 
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6. BMP-mediated inhibition of FGF signaling lies at the heart of 
differentiation 
Libbat Tirosh-Finkel (1), Amit Zeisel (2), Miriam Brodt-Ivenshitz (1), Ayelet 
Shamai (1), Zhong Yao (1), Rony Seger (1), Eytan Domany (2), and Eldad 
Tzahor* (1) 
(1) Department of Biological Regulation, and (2) Department of Physics of 
Complex Systems Weizmann Institute of Science, Rehovot 76100, Israel 
 
The transition from progenitors to differentiated cells is critical for successful 
organogenesis; alterations in this process can lead to serious developmental 
disorders. The anterior heart field (AHF) encompasses a niche in which cardiac 
progenitors maintain their multipotent and undifferentiated nature in response to 
signals from surrounding tissues. Here we investigate the shift from proliferating 
cardiac progenitors to differentiating cardiomyocytes in chick embryos. Genomic 
and systems biology approaches as well as perturbations of signaling molecules, 
in vitro and in vivo, reveal tight crosstalk between the bone morphogenic protein 
(BMP) and fibroblast growth factor (FGF) signaling pathways within the AHF: 
BMP4 promotes myofibrillar gene expression and cardiomyocyte contraction, by 
blocking FGF signaling. Furthermore, inhibition of the FGF-ERK pathway is both 
sufficient and necessary for these processes, suggesting that FGF signaling 
blocks premature differentiation of cardiac progenitors in the AHF. Investigating 
the molecular mechanisms downstream of BMP signaling revealed that BMP4 
induced a set of neural crest-related genes; including MSX1. Overexpression of 
Msx1 was sufficient to repress FGF gene expression and cell proliferation, 
thereby promoting cardiomyocyte differentiation. Hence, BMP and FGF 
signaling pathways act via inter- and intra-regulatory loops in multiple tissues, to 
coordinate the balance between proliferation and differentiation of cardiac 
progenitors. 
 
 
 
 
 
 
 
 
 
 
 
 
 
7. Involvement of the MEKK1 Signaling Pathway in the Regulation of 
Epicardial Cell Behavior by Hyaluronan 
Evisabel A. Craig* (1), Patti Parker (1), Anita F. Austin (2), Joey V. Barnett (2), 
and Todd D. Camenisch (2)    
(1) Department of Pharmacology and Toxicology, The University of Arizona, 
Tucson, Arizona (2) Department of Pharmacology, Vanderbilt University Medical 
Center, Nashville, Tennessee, USA 
 
During embryonic development, cells comprising the outermost layer of the 
heart or epicardium play a critical role in the formation of the coronary 
vasculature. Thus, uncovering the molecular mechanisms that govern epicardial 
cell behavior is imperative to better understand the etiology of cardiovascular 
diseases. In this study, we investigated the function of hyaluronan (HA), a major 
component of the extracellular matrix, in the modulation of epicardial signaling. 
We show that stimulation of epicardial cells with high molecular weight HA 
(HMW-HA) promotes the association of MEKK1 with the HA receptor CD44 and 
induces MEKK1 phosphorylation. This leads to the activation of two distinct 
pathways, one ERK-dependent and another NFkB-dependent. Furthermore, 
HMW-HA stimulates epicardial cells to differentiate and invade, as suggested by 
increased vimentin expression and enhanced invasion through a collagen matrix. 
Blockade of CD44, transfection with a kinase inactive MEKK1 construct or the 
use of ERK1/2 and NFkB inhibitors significantly abrogates the invasive response 
to HMW-HA. Together, these findings suggest an important role for HA in the 
regulation of epicardial cell fate via activation of MEKK1 signaling cascades. 
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8. Wnt/ß-catenin signaling and miRNAs regulate Notch signaling in heart 
morphogenesis 
Alexandra Klaus, Walter Birchmeier 
Cancer Research, Max Delbrueck Center for Molecular Medicine, Berlin, 
Germany 
 
In this study, we ablated the Wnt effector ß-catenin, the Notch mediator RBPJ 
and the miRNA processor Dicer in the developing heart of mice using MesP1-
cre, which acts in mesoderm progenitors that contribute to first and second heart 
field (FHF, SHF). Conditional ablation of ß-catenin by MesP1-cre affected 
cardiac looping and right ventricle formation due to defective expansion of Isl1-
expressing SHF progenitor cells. Moreover, loss of ß-catenin promotes the 
expression of Notch target genes, indicating that ß-catenin controls the level of 
Notch signaling in the developing heart. In MesP1-cre; RBPJ lox/lox mutants, 
the formation of the right ventricle as well as the expression of the right 
ventricular cardiomyocyte marker dHand were affected. Remarkably, the 
expression of Gata4 and Mef2c in SHF derivatives was abolished and we 
detected increased cellular death. Our data indicate that Notch signaling 
promote the differentiation and survival of SHF cells required for SHF derivative 
formation. Although Notch signaling has previously been shown to be essential 
for heart development, only little is known about the spatiotemporal regulation of 
Notch signaling in SHF cells. Emerging evidence suggest that miRNAs can 
function as regulators of Notch signaling in various tissues. Interestingly, in 
MesP1-cre; Dicer lox/lox mutants the expression of Notch ligand and target 
genes, like Jag1, Hrt2, Mef2c, dHand is elevated in SHF cells. Together, these 
results suggest a Wnt/ß-catenin-Notch crossregulation in heart formation 
possibly involving the activation of specific miRNAs or Notch inhibitors. 
 
 
 
 
 
 
 
 
9. Identification of Thymosin Beta 4 Protein Interactors Using a Yeast Two-
Hybrid Screen 
Karina Dubé*, Paul Riley, Nicola Smart 
Molecular Medicine Unit, Institute of Child Health, London, UK 
 
Thymosin beta 4 (Tβ4), a 43 amino acid peptide, plays an important role in 
cardiac, neural and gastrointestinal tract development. In the embryo, Tβ4 
knockdown studies have demonstrated an essential requirement for Tβ4 in 
coronary vasculogenesis and in systemic vasculature development. In addition, 
Tβ4 has numerous roles in biological processes including, but not limited to, 
inflammation, wound healing, cardioprotection, regeneration, angiogenesis, 
metastasis, and hair follicle growth. The developmental role of Tβ4 is 
recapitulated in the adult, inducing neovascularization post myocardial infarction. 
Thus, Tβ4 is of considerable interest due to its potential in cardiac regenerative 
therapy. As well as its prominent role in actin polymerization, Tβ4 has been 
postulated to regulate proteases, cytokines, chemokines, matrix molecules, 
survival kinases and inflammatory molecules. Yet, the precise molecular 
mechanisms through which Tβ4 acts in signal transduction remain equivocal. An 
intracellular actin-binding role for Tβ4 is well established. Both in vitro and in 
vivo studies show strong evidence that Tβ4 also acts extracellulary through 
paracrine signalling. Moreover there is evidence that Tβ4 is internalized. To help 
understand the precise mechanisms through which Tβ4 functions we are 
performing a yeast two hybrid screen using full length Tβ4 cDNA as a bait to 
identify potential Tβ4 regulatory proteins from an embryonic day 11 library. 
Deciphering Tβ4 signal transduction pathways will advance our understanding 
of its role in normal human development and help unlock its full therapeutic 
potential. 
  Poster session A Thursday 20 May 
   
page 88 
10. Loss of Sphingosine-1-Phosphate Receptor S1P1 Disrupts Cardiac 
Development. 
Ryan R. Poulsen, Carolyn McClaskey, Sarah Renzi, and Christopher C. 
Wendler* 
Section of Developmental Endocrinology and Biology, Yale Child Health 
Research Center, Department of Pediatrics, Yale University School of Medicine, 
New Haven, CT, USA 
 
Sphingosine-1-phosphate (S1P) is a biologically active sphingolipid metabolite 
that influences numerous cellular events including differentiation, proliferation 
and migration. S1P acts through cell surface receptors S1P1-5, with S1P1 
having the highest expression level in the developing heart. S1P1 signaling is 
critical for vascular maturation, however its role during cardiac development is 
not well known. To determine the role of S1P signaling during heart 
development, we performed morphological analysis on S1P1 and S1P3 
knockout mice. Examination of E10.5 S1P1-/- embryos revealed that although 
the embryos were not smaller than S1P1+/+ and S1P1+/- littermates, the hearts 
were smaller and malformed. Hearts of S1P1-/- embryos have shortened AV 
canal cushions and irregular trabeculae. However, S1P3-/- embryos examined 
at E10.5 showed no differences in the overall size of the embryos or in heart 
morphology among the different S1P3 genotypes. At E12.5, although no 
difference in embryo size was observed between the different genotypes, S1P1-
/- hearts were smaller with the apex of the heart rounded compared to a normal 
V-shape for S1P1+/+ hearts. The average length of the S1P1-/- hearts was 
22.7% less than the S1P1+/+ hearts when measured from the AV canal to the 
apex of the heart. In addition, the S1P1-/- hearts had 21% less ventricular 
myocardial tissue than S1P1+/+ hearts. Immunostaining with the cardiac marker 
alpha-sarcomeric actin revealed disrupted morphology of the heart wall and 
trabeculae, with a thickening of the outer compact layer. This report indicates 
that S1P signaling through the S1P1 receptor is critical for cardiac development. 
 
 
 
 
11. Microcirculation alteration in aged-hearts 
Tania Zaglia*(1), Valentina Mazzariol (2), Silvia Mainente (2), Mayan Seri (2), 
Tullio Pozzan (1,2), Stefano Schiaffino (1,2) and Marco Mongillo (1) 
(1) Department of Biomedical Sciences, University of Padova (2) VIMM 
(Venetian Institute of Molecular Medicine), Padova, Italy 
 
Introduction: The cardiac Sympathetic Nervous System (SNS) modulates 
coronary vasodilatation, heart frequency and contractility. A functional 
impairment of SNS occurs with aging and contributes to the pathophysiology of 
several cardiovascular diseases. However, it is not yet clear whether the 
interactions between sympathetic terminals (STs) and target cells change with 
aging and whether these alterations affect myocardial morphology and 
functionality. Aims of the study: We aimed to: i) provide a morphological 
description of the interaction between STs, vasculature and cardiomyocytes; ii) 
investigate how this relationship changes with aging and the functional 
consequences of such alteration. Results: Using immunofluorescence analysis 
we demonstrated that in normal adult mouse hearts STs are distributed at each 
anatomical level with a greater density in the atria and the right ventricle. STs 
were found in proximity to coronary vessels, cardiomyocytes and to capillaries. 
Similar analysis on hearts from aged mice demonstrated a significant reduction 
of sympathetic myocardial innervation with morphological alterations of STs. 
STs were shorter and fragmented in aged hearts. In addition, hearts from aged 
mice showed cardiomyocyte atrophy, increased capillary density and reduced 
capillary size. Sympathectomized adult hearts reproduced the same phenotype 
observed in aged hearts, with about a 20% decrease in cardiomyocyte size, as 
compared to controls, and altered capillary organization. Conclusions: The 
structural and functional integrity of SNS is crucial in the maintenance of 
cardiomyocte trophism and capillary organization in the postnatal mouse heart. 
Future development of these studies will aim to determine the molecular 
pathways involved in the aging-related SNS impairment. 
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12. Gene Profiling In Hgf-Stimulated Early Postnatal Heart. 
Tiziana Crepaldi* (1), Stefano Gatti (1), Christian Leo (1), Valentina Sala (1), 
Ilan Riess (1), Simona Gallo (1), Enrico Bucci (2), Daniela Cantarella (3), Enzo 
Medico (3) 
(1) Department of Anatomy, Pharmacology and Forensic Medicine, University of 
Turin, Italy (2) BioDigitalValley, Pont Saint Martin (AO), Italy (3) Institute for 
Cancer Research and Treatment, University of Turin, Italy 
 
We investigated the role of HGF in cardiomyocytes in vivo, by using animals 
with cardiac-specific HGF overexpression and full genome DNA microarray 
analysis. We performed microarray analysis of mouse heart at two distinct 
developmental ages (postnatal days P2 and P7), which correspond to the 
transition between the plastic and post-plastic phase. When comparing HGF-
expressing hearts versus wild-type hearts at P7 we found ~200 genes 
significantly upregulated more than 1.7-fold. Several of these genes play a role 
in cell cycle regulation, translation, signal transduction, transcriptional regulation, 
cytoskeleton/extracellular matrix and membrane vescicle traffic. The majority of 
these genes were downregulated from day 2 to day 7 in the wild-type heart. 
Thus, gene upregulation induced by HGF opposed at physiological 
downregulation. We confirmed that in vivo treatment with HGF increased Ki67 
expression by 3-fold during day 7, indicating that HGF prolongs the plastic 
phase in neonatal mouse heart. As adults, the mice with cardiac-specific HGF 
overexpression develop a systolic contractile defect, even when HGF 
expression is suppressed after birth. Conclusions: The analysis of global gene 
expression in the whole heart may be useful in understanding the orchestrated 
process of postnatal development or terminal differentiation in the cardiac 
environment. These data are likely to be helpful in studying the Developmental 
Origins of Cardiac Disease. 
 
 
 
 
 
13. Pro-hypertrophic signaling mechanisms downstream of mutant Shp2 
associated with Noonan / LEOPARD Syndrome 
Michelle Edwards, Ashley Kramer, Maike Krenz* 
Department of Medical Pharmacology and Physiology / Dalton Cardiovascular 
Research Center, University of Missouri-Columbia, USA 
 
The protein tyrosine phosphatase Shp2 is essential for normal prenatal 
development. In mice, complete deletion of Shp2 protein is embryonic lethal. In 
humans, loss-of-function (LOF) mutations in Shp2 are primarily found in Noonan 
or LEOPARD Syndrome families. These overlapping syndromes are 
characterized by congenital heart defects such as pulmonary stenosis and 
hypertrophic cardiomyopathy (HCM). Unfortunately, the underlying disease 
mechanisms in particular with regard to HCM are not clearly understood. In 
normal cardiomyocytes, Shp2 dephosphorylates focal adhesion kinase (FAK) 
resulting in reduced signaling through mammalian target of rapamycin (mTOR), 
thus limiting cell size. We hypothesize that mutant Shp2 fails to down-regulate 
FAK-related signaling and thereby stimulates cardiomyocyte growth. Our studies 
focused on the LOF mutation Q510E-Shp2, which causes a particularly 
aggressive form of HCM in humans. We examined the influence of Q510E-Shp2 
on cell size in cultured neonatal cardiomyocytes. Adenoviral expression of 
Q510E-Shp2 resulted in a 40% increase in average cell area. The FAK / src 
inhibitor PP2 blocked Q510E-Shp2’s effect. Similarly, co-expression of the 
endogenous FAK inhibitor FRNK abolished the pro-hypertrophic effect of 
Q510E-Shp2. Rapamycin, but not the PI3kinase inhibitor LY294002, also 
prevented the Q510E-Shp2-induced cell area increase, showing that mTOR is a 
specific mediator downstream of FAK. Interestingly, the MEK1 inhibitor U0126 
also attenuated the cell size increase due to Q510E-Shp2 expression. This 
indicates at least a partial role for MEK1/ERK signaling either parallel to or 
downstream of FAK. In summary, Q510E-Shp2 acts as a potent stimulator of 
cardiomyocyte growth mediated by signaling through FAK / mTOR and 
MEK1/ERK. 
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14. Notch Signalling in Cardiogenesis: 3D Image Analysis 
Gonzalo del Monte*(1) and José Luis de la Pompa(1) 
(1)Cardiovascular Developmental Biology Department. Centro Nacional de 
Investigaciones Cardiovasculares (CNIC-ISCIII) Madrid, SPAIN 
Notch is a local cell signalling system that regulates cell fate specification and 
tissue patterning during development and adult tissue homeostasis. We are 
carrying out a 3D image analysis of Notch expression in the developing heart, to 
get an insight into the mechanism of Notch signalling activity in this organ. We 
are also trying to determine which elements are crucial for signaling during early 
heart development, focusing in the processes of trabeculation and 
valvulogenesis. Our hypothesis, attending to our initial results, is that the 
activation pattern of the Notch1 receptor is not only due to the action of the 
Delta4 ligand as during trabeculae formation, other Notch ligands or modulators 
may restrict Notch1 activation. In addition, expression of the Jag1 ligand in the 
myocardium and the absence of any Notch receptor in this tissue, suggests a 
possible intercommunication between endocardium and myocardium that may 
pattern Notch activity in the developing chamber. Functional analysis will 
determine which ligands or modulators are important for the Notch signalling 
during the early stages of heart development. 
 
 
 
 
 
 
 
 
15. Platelet-Derived Growth Factor Receptor β is Critical for Zebrafish 
Intersegmental Vessel Formation 
Katie M. Wiens* (1), Hyuna L. Lee (1), Hiro Shimada (2), Anthony E. Metcalf (3), 
Michael Y. Chao (3), Ching-Ling Lien (1) 
(1) Department of Surgery, Keck School of Medicine, University of Southern California and 
The Saban Research Institute of Childrens Hospital Los Angeles, Los Angeles, CA, USA 
(2) Department of Pathology, Childrens Hospital Los Angeles, Los Angeles, CA, USA (3) 
Department of Biology, California State University San Bernardino, San Bernardino, CA, 
USA 
Coronary heart disease is among the leading causes of disability and mortality 
in the United States and worldwide. In contrast to humans, zebrafish hearts fully 
regenerate after amputation of up to 20% of the ventricle. During this 
regeneration process, new coronary blood vessels form to revascularize the  is 
a)regenerating tissue. Platelet-derived growth factor receptor β (PDGFRβ 
tyrosine kinase receptor known to affect vascular development. The zebrafish is 
an excellent model to study specific regulators of vascular development and 
regeneration, yet the role of PDGF signaling has not been determined in 
zebrafish embryos or during adult zebrafish heart regeneration. Furthermore, 
vascular mural cells, in which PDGFRβ functions cell autonomously in other 
systems, have not been identified in zebrafish embryos younger than 72 hours 
post fertilization. To investigate the role of PDGFRβ in zebrafish vascular 
development, we cloned the highly conserved zebrafish homolog of PDGFRβ. 
We found that pdgfrβ is expressed in the dorsal aorta, posterior cardinal vein, 
and intersegmental vessels of the developing zebrafish vasculature. A similar 
expression pattern was observed for pdgf-b, the predominant ligand for 
PDGFRβ. Using a PDGFR tyrosine kinase inhibitor and a morpholino 
oligonucleotide specific to PDGFRβ, we found that PDGFRβ is necessary for 
angiogenesis of intersegmental vessels while having no role on formation of the 
dorsal aorta or posterior cardinal vein. Our data provide the first evidence that 
PDGFRβ signaling is required for zebrafish developmental angiogenesis. We 
propose a novel mechanism for zebrafish PDGFRβ signaling that regulates 
vascular angiogenesis in the absence of mural cells. 
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16. Role of Hedgehog signaling on the developing avian vascular system 
Carlos M. Morán and Paul A. Krieg 
Department of Cell Biology and Anatomy, The University of Arizona, Tucson, AZ, 
USA. 
 
The first blood vessels in the embryo are formed through the process called 
vasculogenesis. This process involves assembly of angioblasts (vascular 
endothelial precursor cells) in to a loose cord, followed by establishment of close 
cell contacts and formation of a vascular lumen. Within the developing avian 
embryo, the dorsal aorta is the first major blood vessel to form. Lumenization of 
the dorsal aorta occurs at approximately the 7-9 somite stage (Hamilton and 
Hamburger (HH) stage 9) of development. A rostral-caudal progression is 
observed during this process, where the anterior part of the dorsal aorta shows 
a tube morphology while the posterior portion is a cellular cord. Previous work in 
our lab has shown a role of the growth factor sonic hedgehog (Shh) during blood 
vessel formation. Own initial conclusions are that Hedgehog (Hh) is required for 
vascular remodeling (angiogenesis) but not vascular tubulogenesis. Inhibition of 
Hedgehog pathway by a hedgehog inhibitor, cyclopamine, caused irregular 
dorsal aortae and a discontinuous vascular plexus without alter the endothelial 
cell proliferation in vivo. In addition Hedgehog pathway is necessary to form the 
intersomitic vessels. Consistent with this result, use of Smoothened Agonist 
(SAG) shows that activation of Hedgehog is able to induce vascular growth and 
amount of fenestration. These effects are independent of Notch and Bone 
Morphogenetic Proteins 4 (BMP4) signaling. However Hedgehog signaling is 
able to regulate VEGF expression. These studies contribute to our 
understanding of Hedgehog’s role in vascular development. 
 
 
 
 
 
 
 
 
 
 
 
 
17. PDK1 regulates cardiomyocyte proliferation, epithelial-mesenchymal 
transition and chamber formation in heart development 
Zhongzhou Yang*, Qiuting Feng, Ruomin Di, Zai Chang, Shuangshuang Lu 
Laboratory of Cardiovascular Development, MOE Key Laboratory of Model 
Animal for Disease Study, Model Animal Research Centre of Nanjing University, 
Nanjing, China 
 
One essential downstream signaling pathway of receptor tyrosine kinases such 
as VEGFR and Tie2 receptor, is the PI3K-PDK1-Akt/PKB cascade that plays a 
critical role in development and tumorigenesis. However, the role of PDK1 in 
cardiovascular development remains unknown. Here, we deleted PDK1 
specifically in cardiac progenitors, endothelial cells and the second heart field, 
respectively in mice. These mice displayed cardiac hypoplasia, hemorrhage and 
hydropericardium, and defective chamber formation, and died from E9.5 to 
E14.5. Histological analysis revealed reduced cardiomyocyte proliferation, 
defective vascular remodeling and development, and disrupted integrity 
between endothelium and trabeculae/myocardium in the heart. The 
atrioventricular canal (AVC) cushion and valves failed to form indicating a defect 
in endothelial-mesenchymal transition (EMT). Consistently, ex vivo AVC explant 
culture showed impeded mesenchymal outgrowth. Increased apoptosis was 
found in endothelial cells. Snail protein was reduced and was absent from 
nucleus in AVC cells. Furthermore, adenoviral Akt delivery and dominant-
negative Snail rescued EMT defects in AVC explant culture. Deletion of Pten 
rendered normal development of AVC cushion in PDK1 deficient heart by E11.5 
and survival of the mice. Taken together, these results have revealed an 
essential role of PDK1 in cardiovascular development through activation of Akt. 
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18. Conditional ablation of Hif1α in the mouse reveals new insight into 
coronary vascular development 
Kathryn L. Dwyer, Dorina Arapi, Paul T. Schumacker and Robert W. Dettman 
Department of Pediatrics, Northwestern University, Chicago IL, USA 
 
HIF-1α is a basic helix-loop-helix (bHLH)-PAS family transcription factor that is 
rapidly degraded under normoxic conditions. In hypoxia, degradation of HIF-1α 
is inhibited, allowing accumulation in the cytosol and translocation to the nucleus 
where along with ARNT (Hif1β) transcriptionally regulates genes mediating 
processes including blood vessel maintenance and growth. Hif1α is known to 
play a role in cardiac and blood vessel development during embryogenesis. 
Homozygous null mutants for Hif-1α die by embryonic day 10.5 (E10.5) with 
severe cardiovascular defects. However, this lethal phase has precluded 
investigation into Hif1α’s functions during later heart development. Here we 
tested the hypothesis that Hif-1α plays critical roles in development of the 
coronary circulation, which occurs after E10.5. To carry out this study we used 
cell specific expression of Cre to ablate an allele of Hif-1α containing loxP sites 
flanking exon 2, which contains the bHLH domain. We used Wt1-Cre to induce 
recombination in epicardium and Myh6-CreESR to induce recombination in 
myocardium. To avoid the early requirements of Hif1α in myocardium, we 
activated Cre after E9.5 with tamoxifen. When Hif1α was ablated in myocardial 
cells we observed alterations to the formation of blood islands on the surface of 
the heart at E13.5. Here mutants had larger, flattened blood filled lumens, 
compared to Cre- littermates, which had spherical, protruding blood islands. 
When Hif1α was ablated in epicardial cells we observed alterations to vessel 
wall thickness in weaned juvenile mice, compared to littermates. Together, 
these findings indicate that Hif1α performs distinct functions in myocardium and 
epicardium to regulate different phases of coronary vessel development. 
 
 
 
 
19. CHAP, a calcineurin regulated protein essential for striated muscle 
function 
Abdelaziz Beqqali* (1), Jantine Monshouwer-Kloots (1), Rui Monteiro (2), Jeroen 
Bakkers (3), Elisabeth Ehler (4), Leon de Windt (5), Derk Frank (6), Norbert Frey 
(7), Arie Verkleij (8), Christine Mummery (1), Robert Passier (1) 
(1) Leiden University Medical Center, Department of Anatomy and Embryology, 
Einthovenweg 20, 2333 ZC Leiden, The Netherlands (2) Molecular Hematology Unit, 
Weatherall Institute of Molecular Medicine (WIMM), Oxford, UK. (3) Hubrecht Institute 
Developmental Biology and Stem Cell Research, Uppsalalaan 8, 3584 CT Utrecht, the 
Netherlands. (4) The Randall Division of Cell & Molecular Biophysics and the 
Cardiovascular Division, King’s College London, SE1 1UL London, UK (5) Department of 
Cardiology, Cardiovascular Research Institute Maastricht, Maastricht University, 
Maastricht, The Netherlands (6) Department of Internal Medicine III, University of 
Heidelberg, INF 410, 69120 Heidelberg (7) Department of Cardiology and Angiology, 
University of Kiel, Kiel 24105, Germany (8) Department of Cellular Architecture and 
Dynamics, Institute of Biomembranes, Utrecht University, Padualaan 8, 3584 CH Utrecht, 
The Netherlands 
 
In recent years, the perception of Z-disc function has changed from a passive 
anchor for myofilaments that allows transmission of force, to a dynamic 
multicomplex structure, capable of sensing and transducing extracellular signals. 
Since heart failure is the number one cause of mortality and morbidity worldwide, 
the identification of new components, the precise molecular mechanisms of the 
Z-disc and its role in signalling has become critical for understanding the 
regulation of muscle function and disease. We described a new Z-disc protein, 
which we named CHAP (cytoskeletal ¬heart-enriched ¬¬actin-associated 
protein), expressed in differentiating heart- and skeletal muscle. Interestingly, in 
addition to its sarcomeric localisation, CHAP was also able to translocate to the 
nucleus. Knockdown of CHAP in zebrafish resulted in aberrant cardiac and 
skeletal muscle development and function. These findings suggest that CHAP is 
a critical component of the sarcomere with an important role in muscle 
development. Since Z-disc proteins are often associated with heart disease, we 
investigated whether CHAP is regulated in cardiac hypertrophy. Importantly, 
activation of calcineurin, a central modulator of cardiac hypertrophy and disease, 
led to translocation of CHAP from the Z-disc to the nucleus in cultured 
embryonic mouse cardiomyocytes. CHAP expression was dramatically 
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upregulated in transgenic mice expressing constitutively active calcineurin in the 
heart. Furthermore, CHAP nuclear localization was associated with the 
transcription factor NFATc2, a downstream mediator of calcineurin signalling. 
Our data suggest that CHAP may be involved in transcriptional regulation of 
striated muscle development and disease and represents a candidate gene for 
genetic (cardio-) myopathies. 
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20. Shear stress modulates transcriptional regulation and cushion endoMT 
in the developing heart 
Beerend P. Hierck* (1), Anastasia D. Egorova (1), Simone van de Pas (1), Marie 
José Goumans (2), Peter ten Dijke (2), Robert E. Poelmann (1) 
(1) Dept. of Anatomy and Embryology Leiden University Medical Center, Leiden, 
The Netherlands (2) Dept. of Molecular Cell Biology, Leiden University Medical 
Center, Leiden, The Netherlands 
For abstract, see in oral presentation section page 80 
 
 
 
21. Integrative computational modeling and imaging approach to study the 
effects of abnormal hemodynamic conditions on cardiac development. 
Sandra Rugonyi* (1), Ruikang Wang (1) and Kent Thornburg (2) 
(1) Biomedical Engineering, Oregon Health & Science Universtity, Portland, OR. 
(2) Heart Research Center, Oregon Health & Science University, Portland, OR, 
USA. 
For abstract, see in oral presentation section page 81 
 
 
 
22. Knockdown of embryonic myosin heavy chain causes defective 
electrical activities and calcium signalling within the developing heart 
Catrin Rutland(1), Luis Polo-Parada(2), Aziza Alibhai(1), Aaran Thorpe(1) and 
Siobhan Loughna* (1) 
(1) School of Biomedical Sciences, University of Nottingham, UK. (2) 
Department of Medical Pharmacology and Physiology. Dalton Cardiovascular 
Research Center, University of Missouri, USA 
For abstract, see in oral presentation section page 82 
 
 
 
 
23. Actinin-Associated Protein Palladin contributes to the Development of 
Normal Embryonic Ventricular Chambers 
Huang-Tian Yang*(1), Hong Gao(1), Xue-Song Liu(2,3), Ang Guo(1), Zhu-Gang 
Wang(1-3) 
(1)Key Laboratory of Stem Cell Biology, Institute of Health Sciences, Shanghai 
Institutes for Biological Sciences, Chinese Academy of Sciences & Shanghai 
Jiao Tong University School of Medicine, Shanghai (SJTUSM) Shanghai 
(2)State Key Laboratory of Medical Genomics, Rui-Jin Hospital, SJTUSM, 
Shanghai (3)Department of Medical Genetics, SJTUSM, Shanghai, China 
 
a-Actinin-associated cytoskeletal proteins are involved in the developmental 
pathway for ventricular cardiomyopathy. Palladin is an a-actinin-associated 
cytoskeletal protein localized at stress fibers, focal adhesions, and other actin-
based structures. It plays important roles in actin stress fiber formation, cell 
adhesion and migration. It is also expressed in the embryonic heart and 
downregulated in the adult heart, however, its role in the myocardium is 
unknown. Here we compared the development of embryonic hearts from wide-
type (Palld+/+) and palladin-knockout (Palld-/-) mice as well as analyzed the 
characteristics of embryonic cardiomyocytes (ECMs) from these two type hearts. 
We found that Palld-/- mice died around E12.5-15.5 with ventricular chamber 
dilation and wall thinning. These alterations were associated with impaired cell 
contraction. We then analyzed potential mechanisms underlying the altered 
contractility. The data reveal a novel role for the cytoskeletal protein palladin in 
the organization of myofilaments with consequences on the development of 
ventricular chambers and contractile function (Grants: the Major State Basic 
Research Development Program of China (2007CB512100, 2006CB0F0900), 
and the National Natural Science Foundation of China (30871420). 
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24. Optical Coherence Tomography of the Looping Embryonic Heart: 
Mechanosensing Mechanisms 
Barbara Garita (1), Mingda Han (1), Michael W. Jenkins (2), Steven H. 
Seeholzer (3), Chao Zhou (4), Michael VanAuker (5), Andrew M. Rollins (2), 
Michiko Watanabe (6), James G. Fujimoto (4), Kersti K. Linask* (1). 
(1) USF/ACH The Children's Research Institute, Dept. of Pediatrics, St. Petersburg, FL, 
USA (2)Case Western Reserve University, Dept. of Biomedical Engineering, Cleveland, 
OH, USA (3) The Children's Hosptial of Philadelphia, Proteomics Core, PA, USA (4) MIT, 
Dept of EECS and Research Laboratory of Electronics, Cambridge, MA, USA (5) USF, 
Dept. of Chemical Engineering, Tampa, FL, USA (6) Rainbow Babies and Children's 
Hospital, Dept. of Pediatrics, Case Western Reserve University, Cleveland, OH, USA 
 
Rationale: Interrelationships between the endocardium, myocardium and 
cardiac jelly compartments during heart looping have been difficult to resolve 
due to limitations of technologies to visualize the beating embryonic heart. 
These limitations have been overcome by 4D- optical coherence tomography 
(OCT). Objective: In this study using proteomics to identify cell proteins in avian 
looping hearts and 4D-OCTcombined with other imaging modalities, our study 
addressed mechanotransducing mechanisms in the developing heart. Methods 
and Results: Using 3-D image reconstructions, the localization of fibronectin 
(FN), tenascin-C, alpha-tubulin, and nonmuscle myosin-II (NMHC-II) deposition 
were correlated with structures detected by dynamic OCT data. Another new 
imaging modality, optical coherence microscopy (OCM), was used to visualize 
detailed cardiac architecture of the mouse heart. Our results show: cell 
processes/fibrils are radially oriented within the cardiac jelly (CJ) connecting the 
endocardium with myocardium. Cyclical deformations of the endocardium are 
likely to stretch and create stress on these cell processes/ fibers during the 
cardiac cycle. The cells/fibers are positioned to transduce strains into 
biochemical changes. A CJ cell network forms at sites defining ventricular 
trabeculation post-looping. Lastly, the myocardium during looping slides along 
the enveloping splanchopleural membrane and the associated cardiomyocyte 
microcilia are positioned to transduce the external forces into myocyte 
responses. Conclusions: On the external surface of the myocardium of the 
beating embryonic heart and on the surface facing the CJ, cellular structures 
and networks exist whose deformations during the cardiac cycle are likely to be 
involved in translating biophysical forces into signals for cardiomyocyte 
differentiation and organ morphogenesis. 
 
 
 
25. Type III TGFβ Receptor Heterozygous Null Mice have Abnormal 
Cardiac Function 
Jonathan H. Soslow* (1), Joseph D. Love (2), and Joey V. Barnett (2) 
(1) Department of Pharmacology, Vanderbilt University Medical Center, 
Nashville, TN 37232, USA (2) Department of Pediatrics, Vanderbilt University 
Medical Center, Nashville, TN 37232, USA 
 
The Type III TGFβ receptor (TGFβR3) binds TGFβ and several Bone 
Morphogenic Protein (BMP) ligands. Several lines of evidence suggest TGFβR3 
plays a unique and nonredundant role in signaling. Tgfbr3-/- mice have double 
outlet right ventricle, ventricular septal defects, and a thinned myocardium. 
Embryos die at E14.5 due to failed coronary vessel development. Tgfbr3+/- 
mice display no overt phenotype. Given the pervasive role of TGFβ and BMP in 
the regulation of development and tissue homeostasis, we asked whether 
Tgfbr3+/- mice have a cardiac phenotype. We performed unsedated 
echocardiograms on 3 month old Tgfbr3+/+ and Tgfbr3+/- littermates; the 
Tgfbr3+/- mice had significantly decreased fractional shortening (FS) 43.1% ± 
0.8 and ejection fraction (EF) 80.7% ± 0.7 (n=8) compared to their Tgfbr3+/+ 
littermates 48.8% ± 1.0 and 85.7% ± 0.8 (n=8) (p=0.001 for FS, p<0.001 for EF; 
normal FS>45% for unsedated mice in our cardiovascular core). We next 
demonstrated that this phenotype existed in mice as early as 6 weeks of age, 
with FS 40% ± 0.4 and EF 77% ± 0.5 (n=6) in Tgfbr3+/- mice versus FS 47.3% ± 
1.3 and EF 84.5% ± 1.1 (n=5) in Tgfbr3+/+ littermates (p<0.001 for FS and EF). 
The Tgfbr3+/- mice did not have significant chamber dilation or display 
significant differences in wall thickness, heart rate, or blood pressure when 
compared with Tgfbr3+/+ littermates. Our data demonstrate that Tgfbr3+/- mice 
have altered cardiac function, as measured by decreased fractional shortening 
and ejection fraction, that is not associated with hypertrophy or chamber dilation. 
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26. Myocardin-related transcription factor B regulates mechanical stress-
induced cardiac hypertrophy. 
Masato Kimura*(1, 2), Yusuke Watanabea and Toshihiko Oguraa. 
(1) Developmental Neurobiology, Institutes of Development, Aging and Cancer, 
Tohoku University, Japan (2) Department of Pediatrics,Tohoku University 
Graduate School of Medicine, Japan 
 
Myocardin-related transcription factors (MRTFs) are cofactors of serum 
responsive factor (SRF) which is a crucial transcription factor of cardiac and 
skeletal muscle differentiation and development. MRTFs respond to extracellular 
stimuli through RhoA / Rho kinase pathway, and translocate to the nucleus to 
activate SRF-dependent transcription. It is known that MRTF-B plays roles 
during heart and outflow tract development, however, its function in adult heart 
is still unknown. Increased mechanical stress or pressure overload induces 
cardiac hypertrophy and reactivation of the so–called fetal gene program, which 
is very similar between fetal and failing hearts. To examine if MRTF-B responds 
to mechanical stress in adult failing heart, we performed Transverse aortic 
constriction (TAC) surgery in wild type and MRTF-B mutant mice. As results, we 
identified MRTF-B mutant mice had a greater cardiac hypertrophic response to 
TAC than wild type mice, which was accompanied with cardiac fibrosis. 
Hypertrophic marker genes, such as ANF, BNP, were increased. Furthermore, 
we observed that MRTF-B translocated to the nucleus by TAC within an hour, 
and it lasted four weeks. The colocalization ratio of MRTF-B with nucleus in left 
ventricular cardiomyocyte rose about twice after TAC. These results indicate 
that MRTF-B responds to mechanical stress and translocates to the nucleus in 
adult heart, which regulates gene expression and would be important for 
maintaining heart against pressure overload. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
27. The sarcomeroskeleton: a basic framework for myofibril assembly? 
Elisabeth Ehler 
BHF Centre of Research Excellence, The Randall Division of Cell and Molecular 
Biophysics and The Cardiovascular Division, King’s College London, Guy’s 
Campus, London SE1 1UL, United Kingdom 
 
Actin and myosin filaments are arranged to the paracrystalline sarcomeres in 
striated muscle. Two prominent transverse structures can be distinguished in 
the sarcomere, the Z-disc at its borders and the M-band in the middle. We have 
suggested previously that a basic cytoskeletal framework is required for the 
precise assembly, which consists of sarcomeric alpha-actinin at the Z-disc, 
myomesin at the M-band and titin filaments spanning in-between and have 
termed this framework the “sarcomeroskeleton”. Using RNAi to knock down 
alpha-actinin and myomesin in long-term cultures of neonatal rat 
cardiomyocytes (NRC) we can discern two phenotypes: Alpha-actinin 
knockdown has little effect on the Z-discs also in long-term cultures and only 
seems to affect the premyofibril regions, this is partly due to upregulation of non 
muscle alpha-actinin isoforms. Knockdown of myomesin expression has 
dramatic consequences for myofibril integrity. Our experiments show that this 
effect depends on the composition of the M-band as well as on beating activity. 
Taken together our results demonstrate that the M-band of the myofibril is the 
major focal point of the sarcomere that has to deal with the management of 
forces that arise from active contraction, while the Z-disc probably plays a more 
passive, structural role. 
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28. Qualitative and quantitative analyses of the morphological-dynamics of 
early cardiac pump action using video densidometry and optical 
coherence tomography (OCT) 
Jörg Männer*(1), Lars Thrane (2), Jan Thommes (3), Christoph M. Happel (4), T. 
Mesud Yelbuz (4) 
(1) Department of Anatomy and Embryology, Georg-August-University of Göttingen, 
Göttingen, Germany (2) DTU Fotonik, Department of Photonics Engineering, Technical 
University of Denmark, Denmark (3) Institute of Mechatronic Systems, Leibniz University 
Hannover, Hannover, Germany (4) Pediatric Cardiology and Intensive Care Medicine, 
Hannover Medical School, Hannover, Germany 
 
During the initial phase of its pump action, vertebrate embryonic hearts are seen 
as valveless tubular pumps. It was traditionally thought that these tubular hearts 
generate unidirectional blood flow via peristalsis. Recently, however, the 
pumping mechanism of early embryonic hearts has become a matter of dispute. 
Uncovering of the pumping mechanism of tubular embryonic hearts requires 
detailed information about the hemodynamics as well as morphological 
dynamics of their pump action. We have therefore analyzed the morphological 
dynamics of cardiac pump action in chick embryos (HH-stages 16-18) in shell-
less culture using densidometric analyses of high-speed video recordings and 
by M-mode optical coherence tomography (OCT). The high-speed video camera 
and the OCT probe were integrated into an environmental chamber, which 
provided stable physiological conditions during examination of the embryos. We 
have recorded striking differences in the contraction behavior (e.g. contraction 
speed, duration of systolic occlusion of heart lumen) of the embryonic heart 
segments (common atrium, AV-canal, embryonic ventricles, outflow tract). 
Moreover, we show, for the first time, the pump action of tubular embryonic 
chick hearts in frontal views, which provide a much better understanding of early 
cardiac pump action than the traditional right or left lateral views. 
 
 
 
 
 
 
 
 
29. Changes of hemodynamics in early quail embryos after acute hypoxic 
exposure 
Shi Gu (1), Michael W. Jenkins* (1), Lindsy M. Peterson (1), Michiko Watanabe 
(2), and Andrew M. Rollins (1) 
(1) Department of Biomedical Engineering, Case Western Reserve University, 
Cleveland, Ohio 44106 (2) Department of Pediatrics, Case Western Reserve 
University, Cleveland, Ohio 44106 
 
During vertebrate embryonic development, regions of the embryo are hypoxic, 
which contributes to the normal development of the cardiovascular system. 
Perturbation of the oxygen concentration, therefore, can cause abnormal 
development of the cardiovascular system. Previous efforts were mostly focused 
on its long-term effect on the structure of the heart, the patterning of the vessels, 
and the expression changes of genes related to cardiovascular development. 
However, it is recently demonstrated that mechanical forces exerted by blood 
flow plays important roles in early cardiovascular development. We hypothesize 
that short-term exposure to hypoxia could affect these mechanical forces, and in 
turn affect the cardiovascular system. Using optical coherent tomography (OCT), 
we obtained M-mode Doppler images from the vitelline arteries of quail embryos 
at stage 20 (72 hours after incubation). Three different hypoxia levels (5%, 10%, 
and 15% O2) were applied during ex ovo culture for 1 hour, and a significant 
increase of pulsatility index (PI) was observed after only 5-10 minutes of 
exposure. The increase of PI is the result of the increase of duration and extent 
of retrograde blood flow in the vitelline arteries. With B-mode Doppler OCT, we 
also observed similar increase of PI in the outflow tract of the heart. Prolonged 
exposure (30 minutes) to moderate or severe hypoxia also causes arrhythmia 
(bradycardia and skipping beats), which follows a different time-course 
suggesting that it is independent from the increase of pulsatility index. These 
findings demonstrated that hypoxia could change the hemodynamics in the 
short term, and potentially affect heart development in the long term. 
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30. Cardiac Myosin is Required for Proper Sarcomere Assembly 
Daniel C. Schnurr*, Matthew C. Salanga, Paul A. Krieg 
Cell Biology and Anatomy Department, University of Arizona, Tucson, AZ, USA 
 
Though dynamic by nature, actin filament lengths are highly regulated within the 
context of the cardiac sarcomere. What is the basis for such uniformity? Several 
mechanisms have been proposed to regulate sarcomeric actin dynamics, all of 
which involve interactions with other proteins to regulate thin filament length. 
Studies to rigorously test these models have mostly relied on cell culture. Animal 
models such as mouse knock outs do exist for certain sarcomeric proteins; 
however, many of these studies are hindered either by multiple isoforms for a 
particular protein or early embryonic lethality. In the context of myosin heavy 
chain, the Xenopus system bypasses both these limitations. Xenopus embryos 
are able to survive for days in the absence of a functional heartbeat, and only 
one myosin heavy chain isoform (Myh6) is expressed in the developing heart. 
We are using standard morpholino methods to block translation of Myh6 and 
thus knock out myosin expression. Xenopus embryos without Myh6 fail to 
develop a heartbeat. Embryos are still able to swim normally, indicating that 
skeletal muscle is unaffected. Most importantly, embryos lacking cardiac myosin 
heavy chain have disorganized z-lines and disregulation of thin filament length. 
Our studies argue that myosin thick filament assembly is required both for 
proper z-line assembly and for regulation of actin dynamics. We will confirm our 
results in a true genetic background using muzak frogs, which possess a 
nonsense mutation in the Myh6 gene. 
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Session A - Epicardium 
 
31. Epicardial fate and Notch signaling 
Thomas Grieskamp, Carsten Rudat, Julia Norden, Andreas Kispert* 
Institute for Molecular Biology, Medizinische Hochschule Hannover, Hannover, 
Germany 
For abstract, see in oral presentation section page 43 
 
 
 
 
32 Loss of the Type III Transforming Growth Factor-β Receptor decreases 
Hyaluronic Acid responsiveness in Epicardial Cells 
Nora S. Sánchez* (1), Evisabel Craig (2), Joseph D. Love (1), Todd Camenisch 
(2, 3), and Joey V. Barnett (1) 
(1) Department of Pharmacology, Vanderbilt University Medical Center, 
Nashville, TN 37232 (2)Department of Pharmacology and Toxicology, (3) Steele 
Children's Research Center and Bio5 Institute, The University of Arizona, 
Tucson, Arizona, USA 
For abstract, see in oral presentation section page 44 
 
 
 
 
33. NFATc1 in epicardium-derived cells is required for fibrous skeleton 
and intramyocardial coronary vessel development 
Michelle D. Combs*(1), Caitlin M. Braitsch(1), and Katherine E. Yutzey(2) 
(1) Molecular and Developmental Biology Graduate Program, University of 
Cincinnati, Cincinnati, OH 45229 (2) Division of Molecular Cardiovascular 
Biology, Cincinnati Children’s Hospital Medical Center, Cincinnati, OH 45229, 
USA 
For abstract, see in oral presentation section page 45 
 
 
 
 
34. PDGF Signaling is Required for Epicardial Functions and New Blood 
Vessel Formation in Regenerating Zebrafish Hearts 
Qiong Wu (1), Yolanda Zhang (1), Jieun Kim (1), Katie M. Wiens (1), Hiro 
Shimada (2), Robert I. Handin (3), Michael Y. Chao (4), Tai-Lan Tuan (1), 
Vaughn A. Starnes (1) and Ching-Ling Lien*(1) 
(1) Department of Surgery, (2) Department of Pathology, Keck School of 
Medicine, University of Southern California; The Saban Research Institute of 
Childrens Hospital Los Angeles (3) Hematology Division, Department of 
Medicine, Brigham & Woman’s Hospital, Harvard Medical School, Harvard Stem 
Cell Institute, Boston (4) Department of Biology, California State University San 
Bernardino, USA 
For abstract, see in oral presentation section page 46 
 
 
 
 
35. PDGFR signaling in the epicardium is required for epicardial EMT and 
coronary VSMC and cardiac fibroblast development 
Christopher L. Smith*, Seung Tae Baek,and Michelle D. Tallquist 
Department of Molecular Biology, University of Texas Southwestern Medical 
School, Dallas, TX, USA 
For abstract, see in oral presentation section page 47 
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36. VEGF-C regulates nuclear localization of Prox-1 in epicardial cells 
Ganga Karunamuni (1, 2), Shi Gu (3), Yong Qiu Doughman (1), David Bader (5), 
and Peter Scacheri (4), Michiko Watanabe (1, 2, 4)* 
(1) Dept. Pediatrics,(2) Dept. Anatomy,(3) Dept. Biomedical Engineering, (4) 
Dept. Genetics, Case Western Reserve University, Cleveland OH 44106 (5) Cell 
and Developmental Biology, Vanderbilt University, Nashville, TN 37232, USA 
 
We previously demonstrated that adult rat and embryonic mouse epicardial cell 
lines and primary cultures of avian epicardial cells express the lymphatic 
markers Prox-1, LYVE-1, and VEGFR-3 in a subset of cells (Karunamuni et al., 
2009). We also observed that in WT1-cre/ROSA mice, epicardial cells and their 
descendants express lymphatic markers in situ. In this study, we explored the 
mechanisms that may push these pluripotent epicardial cells into the lymphatic 
phenotype. Adult rat epicardial cells (ARECs) treated with the lymphangiogenic 
growth factor VEGF-C, underwent a dramatic increase in the level of nuclear-
localized Prox-1 and phosphorylated ERK. The accumulation of Prox-1 in the 
nuclei occurred within minutes and appeared to be factor-specific because it 
was not observed after FGF or VEGF-A treatment. The MEK inhibitor UO126 
that inhibits the phosphorylation/activation of ERK induced a reduction of Prox-1 
in the cell nuclei in both untreated and VEGF-C treated cells, suggesting that 
phosphorylated ERK may regulate Prox-1 nuclear translocation. VEGF-C 
application in embryonic heart explant cultures induced Prox-1 nuclear 
expression within 30 minutes in a subset of epicardial cells at the atrioventricular 
sulcus. Genes potentially downstream of Prox-1 in a VEGF-C activated 
epicardial cell line were identified by ChIP-Seq, in which DNA fragments 
containing binding sites for Prox-1 were immunoprecipitated and sequenced. 
We propose that the lymphangiogenic growth factor VEGF-C binds to VEGFR-3 
and acts via the ERK pathway to stimulate the translocation of Prox-1, 
considered to be a “master lymphangiogenic gene”, into the nuclei of epicardial 
cells. 
 
 
 
 
 
 
 
 
 
 
37. Retinoic Acid Signaling Regulates Ventricular Compact Zone 
Formation through Induction of Hepatic Erythropoietin 
Thomas Brade*, Sandeep Kumar, Christina Chatzi, Thomas J Cunningham, 
Xianling Zhao, Pilar Ruiz-Lozano and Gregg Duester 
Development and Aging Programm, Sanford-Burnham Medical Research 
Institute, La Jolla, CA, USA 
 
Epicardial retinoic acid (RA) signaling has been implicated in the formation -/-
αof the compact zone myocardium. In this study we used Raldh2-/- and RXR 
embryos to clarify the role of RA signaling in this developmental process. We  
mutants areαshow that the morphological heart phenotypes of the Raldh2 and 
RXR very similar, characterized by a prominent defect in compact zone growth. 
Examination of the RARE-lacZ RA-reporter transgene revealed that active RA 
signaling in cardiac tissues is severely diminished in Raldh2 mutants but not  
mutant embryos. We concluded that RA signaling inαsignificantly altered in RXR 
the epicardium is dispensable for compact zone formation and that RA-mediated 
target gene transcription in non-cardiac tissues is required for this process. RT-
PCR and ChIP analysis showed that erythropoietin (EPO) is a valid RA target 
gene in hepatic tissues. It is known that genetic loss of EPO function impairs 
compact zone formation although the glycoprotein hormone is not expressed in 
the heart. We are currently investigating downstream targets of epicardial EPO 
signaling. Taken together we present a new mechanism for compact zone 
formation. Paracrine RA signaling in hepatic tissues induces EPO secretion 
which then binds to its cognate receptor in the epicardium. In turn EPO signaling 
activates epicardial mitogen production and cardiomyocyte proliferation. 
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38. Epicardial fate and Notch signaling 
Thomas Grieskamp*, Carsten Rudat, Julia Norden, Andreas Kispert 
Institute for Molecular Biology, Medizinische Hochschule Hannover, Hannover, 
Germany 
 
Lineage-tracing studies in chick demonstrated that epicardial cells give rise to 
endothelial and support cells of the coronary vasculature, and cardiac fibroblasts. 
Genetic fate mappings in the mouse have recently suggested that a substantial 
fraction of ventricular cardiomyocytes may also be of epicardial origin. This 
finding is relevant in the light of experiments that showed that the epicardium 
represents a cellular source for revascularization during cardiac regeneration in 
the zebrafish. It is therefore an exciting challenge to search for signaling 
pathways that mediate epicardial differentiation and to exploit their potential in 
the wounded adult mammalian heart. Given the controversy on epicardial cell 
fates in mammals, we reevaluated this problem by using a genetic lineage 
tracing system in the mouse. The Tbx18 gene is expressed in the left ventricle 
and ventricular septum, and the epicardium. Thus, a Cre Knock-in into the 
Tbx18 locus allows to trace the fate of epicardial cells overlying the right 
ventricle in mice double heterozygous for Tbx18Cre and a suitable reporter 
gene. Double immunofluorescence analysis of differentiation markers and a 
sensitive GFP reporter did not detect any right ventricular cardiomyocytes to be 
of epicardial origin. We will describe the cell types to which epicardial cells were 
found to contribute using this lineage system. Since Notch signaling has been 
implicated in vascular development, we wanted to explore the role of this 
pathway in epicardial differentiation and coronary vessel formation. We used 
both conditional Tbx18Cre mediated loss-of-function and gain-of function 
strategies. We will report on our findings that Notch signaling is required and 
sufficient for differentiation of certain cell lineages of the embryonic epicardium 
in the mouse. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
39. Differential contribution of epicardial derived cells during vertebrate 
coronary vessel formation 
Víctor Portillo Sánchez*, Rita Carmona, Juan Antonio Guadix, Ramón Muñoz-
Chápuli, José María Pérez-Pomares 
Animal Biology Department. University of Málaga. Spain 
 
Coronary vessels arise during cardiac development to meet the increasing 
metabolic demands of the developing myocardium. As in any other vascular bed, 
the coronary vasculature is composed by two different kinds of vessels, namely 
arteries and veins. Different studies have proposed the epicardium or the sinus 
venosus endocardium as the source of the coronary vasculature progenitors. In 
this study we combine a variety of cell tracing techniques, in vitro cultures and 
protein and mRNA expression methods. We suggest that epicardial derived 
cells give rise preferentially to coronary arteries through a vasculogenic process, 
while the outline of the venous component of the coronary vasculature is formed 
by angiogenesis from the sinus venosus endocardium. Evidences are provided 
on the specific, autonomous gene regulation of coronary arterial versus venous 
differentiation by ephrinB2 and COUP-TFII. 
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40. Epicardium-derived progenitor cells: tools towards cardiovascular 
drug discovery? 
Joaquim Miguel Vieira* (1), Stephen Caddick (2), Paul R. Riley (1) 
(1) UCL-Institute of Child Health, London, WC1N 1EH, UK (2) Department of 
Chemistry, UCL, London, WC1H 0AJ, UK 
 
The transplantation of bone marrow stem cells in clinical trials on patients 
following myocardial infarction (MI) has, thus far, resulted in only modest 
improvement in cardiac function. Hence, there continues to be an urgent need to 
identify the most promising cardiovascular stem cells for achieving therapeutic 
regeneration. A major hurdle in implementing a cell-based regenerative therapy 
is the inefficient differentiation of cardiomyocytes or coronaries from either 
endogenous or exogenous stem cell sources. A novel approach to increase 
cardiovascular cell yields is the use of small molecules to stimulate proliferation, 
migration, differentiation and maturation, either in cultures prior to cell 
transplantation or acting directly on resident cardiac progenitors. Here we report 
the preliminary findings arising from an unbiased chemical genetics screen on 
both embryonic and adult epicardium-derived progenitor cells (EPDCs). We 
identify two phenotypic hits in lineage-traced EGFP+ EPDCs induced to form 
FAP1/alphaSMA+ myofibroblasts (embryo) and a PECAM+ vascular plexus 
(adult) by classes of compounds previously reported to be cardiogenic(1). 
Myofibroblast formation in a naive embryonic environment suggests molecular 
activation of a fundamental pathway, which if inhibited in the adult may promote 
wound healing post-MI, whereas the stimulation of an organised endothelial cell 
network is indicative of a potentially therapeutic neovascular response. Affinity 
chromatography and mass spectrometry studies are ongoing for target 
deconvolution and (novel) pathway identification. Phenotypic screens to identify 
active molecules, in this regard, are powerful tools towards accelerating drug-
discovery(2) and the development of stem-cell-based myocardial and 
neovascular therapies. 
 
 
 
 
 
 
 
41. Transcription factor heterogeneity in proepicardial and epicardium-
derived cell populations during embryonic heart development 
Caitlin M. Braitsch*, Michelle D. Combs, Katherine E. Yutzey 
Division of Molecular Cardiovascular Biology, Cincinnati Children's Hospital 
Medical Center, Cincinnati, OH, USA 
 
During embryonic development, the proepicardium (PE) migrates over the 
myocardium to form the epicardium. Epicardial cells undergo epithelial-to-
mesenchymal transition to form epicardium-derived cells (EPDCs), which invade 
the myocardium and differentiate into fibroblasts, smooth muscle and 
endothelial cells. The PE and EPDCs are comprised of heterogeneous cell 
populations, which differentially express transcription factors including NFATc1, 
WT1, and Tbx18. To what extent these factors correlate with cell fate in EPDCs 
is unknown. We hypothesize that the localized expression of NFATc1, WT1 and 
Tbx18 in PE cells and EPDCs influences EPDC cell fate. Chick embryonic day 4 
(E4) PE and E7 epicardium were explanted to compare NFATc1, WT1 and 
Tbx18 function in PE cells and EPDCs, respectively. NFATc1, WT1 and Tbx18 
are expressed in subsets of cultured PE cells and EPDCs. Therefore, these 
culture systems will be used to investigate cell type diversity in PE cells versus 
EPDCs. In a subset of cultured PE cells, NFATc1 expression colocalizes with 
the endothelial marker Flk1, which suggests that NFATc1 marks endothelial 
precursors in vitro. Tbx18 and WT1 are each expressed in subsets of EPDCs, 
but the fate of these cells is unknown. In addition, loss of Tbx18 function, using 
Tbx18 specific siRNA, significantly decreases EPDC proliferation, as detected 
by BrdU incorporation assay. These data suggest that NFATc1, WT1 and Tbx18 
mark different cell lineages in PE and EPDC cultures, and that Tbx18 regulates 
EPDC proliferation. Our long-term goal is to define the molecular mechanisms 
that regulate PE and EPDC proliferation and cell lineage specification. 
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42. The Type III Transforming Growth Factor-β Receptor Regulates 
Proliferation and Apoptosis in Epicardial Cells 
Nora S. Sánchez* (1), Anita F. Austin (1), Leigh A. Compton (1), Joseph D. Love 
(1), Jonathan H. Soslow (2), Andras Czirok (3) and Joey V. Barnett (1) 
(1) Department of Pharmacology, Vanderbilt University Medical Center, 
Nashville, TN 37232 (2) Department of Pediatrics, Vanderbilt University Medical 
Center, Nashville, TN 37232 (3) Department of Anatomy and Cell Biology 
University of Kansas Medical Center Kansas City, KS 66160, USA 
 
Epicardial cells undergo transformation and form coronary vessels. Tgfbr3-/- 
embryos have an irregular epicardium, few coronary vessels, and die at E14.5. 
To explore TGFβR3 signaling, we used immortalized epicardial cell lines from 
E11.5 embryos. Tgfbr3+/+, Tgfbr3+/-, and Tgfbr3-/- cells form a tight epithelium. 
TGFβ1 or TGFβ2 (250 pM) causes transformation and induces the smooth 
muscle marker, SM22α in all genotypes. To determine the role of TGFβR3 in 
TGFβ-induced growth inhibition, dose response curves were generated for 
TGFβ1 or TGFβ2. All genotypes display TGFβ1-induced growth inhibition. 
Tgfbr3-/- cells have decreased sensitivity to TGFβ2-induced growth inhibition. 
Circular wounds were made in cell monolayers and the percent wound closure 
calculated. Tgfbr3+/+ and Tgfbr3+/- cells closed the wound by 48h. Tgfbr3-/- 
cells required 72h (p<0.05). Tgfbr3+/+ and Tgfbr3+/- cells gave similar 
proliferation rates when measured by BrdU, peaking at 48h (33.1% and 33.93%) 
and returning to basal levels (19.9% and 20.85%) by 72h. Tgfbr3-/- cells 
sustained a basal proliferation rate 13% lower at 48h (p=0.001). As a second 
measure of proliferation, we used the MTS assay. Tgfbr3-/- cells had a rate of 
proliferation 2-fold lower at 48h and 2.6 fold lower at 72h (p<0.05). Preliminary 
data indicates decreased proliferation in E13.5 epicardium in vivo. Apoptosis 
was determined by Apo-One Caspase 3/7 Homogenous assay. The apoptosis 
rate in Tgfbr3-/- cells was 1.8, 3.3 and 5.9- fold higher than Tgfbr3+/+ cells at 24, 
48, 72h, respectively (p<0.05). In summary, TGFβR3 is not required for smooth 
muscle differentiation in epicardial cells, but does regulate proliferation and 
apoptosis. 
 
 
 
 
 
 
43. The Type III Transforming Growth Factor-β Receptor to Regulates 
Invasion in Epicardial Cells 
Nora S. Sánchez*, Joseph D. Love, and Joey V. Barnett 
Department of Pharmacology, Vanderbilt University Medical Center, Nashville, 
TN 37232, USA 
 
A subset of epicardial cells undergoes transformation, invades the subepicardial 
space, and gives rise to the coronary vessels. Tgfbr3-/- embryos fail to develop 
coronary vessels, have an irregular epicardium, and die at E14.5. We used 
immortalized epicardial cell lines from E11.5 embryos to determine the invasive 
potential of epicardial cells in response to TGFβ stimulation in a modified 
Boyden chamber assay. Tgfbr3+/+, Tgfbr3+/-, and Tgfbr3-/- cells invade a 
collagen 1 matrix in response to 250pM TGFβ1 or TGFβ2, however, Tgfbr3+/- 
and Tgfbr3-/- cells show reduced invasion. Overexpression of TGFβR3 in 
Tgfbr3-/- cells restored invasion in response to TGFβ2. TGFβR3 lacking the 
cytoplasmic domain fails to support invasion. The three C-terminal amino acids 
– STA - are required for binding to the PDZ domain containing protein, GAIP-
interacting protein, C terminus (GIPC) and are reported to be required to 
regulate cell migration. TGFβR3 lacking these 3 residues does not support 
invasion. We next asked if ALK5 is downstream of TGFβR3. Constitutively 
active ALK5 is sufficient to induce invasion In Tgfbr3-/- cells. Incubation of 
Tgfbr3+/+ cells with the ALK5 kinase inhibitor SB 431452 (2.5µM) or 
Calbiochem 616451 (4 µM) reduces TGFβ2-stimulated invasion by ~40%. The 
addition of 2.5µM SB 431452 inhibited invasion in response to TGFβ2 in Tgfbr3-
/- cells overexpressing TGFβR3 demonstrating that ALK5 is downstream of 
TGFβR3. These data demonstrate that TGFβR3 regulates epicardial cell 
invasion via the GIPC-binding domain and that ALK5 acts downstream of 
TGFβR3. 
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44. Migration and differentiation of epicardial cells stimulated by TGFβ1, 
TGFβ2, or BMP-2 does not require the Type III Transforming Growth Factor 
β receptor 
Cynthia R. Hill* (1), Anita F. Austin (1), Leigh A. Compton (1), Joseph D. Love 
(1), Nora S. Sanchez (1), Christopher B. Brown (2), and Joey V. Barnett (1) 
(1) Department of Pharmacology, Vanderbilt University Medical Center, 
Nashville, TN 37232 (2) Department of Pediatrics, Vanderbilt University Medical 
Center, Nashville, TN 37232, USA 
 
Transforming Growth Factor β (TGFβ) Receptor III (TGFβR3) binds all three 
TGFβ ligands, inhibin, and Bone Morphogenic Protein-2 (BMP-2). Since TGFβ 
causes epicardial cell differentiation into smooth muscle in vitro we asked if 
Tgfbr3-/- epicardial cells differentiate in response to TGFβ or BMP-2. Tgfbr3+/+ 
and Tgfbr3-/- immortalized mouse epicardial cells (ED 11.5) were cultured in the 
presence or absence of ligands for 72 hours and scored by 
immunohistochemistry, qRT-PCR, and a LacZ reporter assay for Smooth 
Muscle 22 alpha (SM22α). Tgfbr3+/+ and Tgfbr3-/- cells lose epithelial character 
and undergo smooth muscle differentiation in response to 250 pM TGFβ1 or 
TGFβ2 as scored by upregulation of smooth muscle markers SM22α, smooth 
muscle α-actin (SMαA) or calponin. Induction of SM22α in Tgfbr3+/+ cells 
occurred with an EC50 of 12.5 pM. BMP-2 (5 nM) induced epithelial to 
mesenchymal transformation (EMT) characterized by the loss of Zonula 
Occludens-1 (ZO-1), but failed to induce SM22α, SMαA, or calponin. Inhibition 
of activin receptor-like kinase (ALK) 5 activity, a Type I TGFβ receptor that may 
act downstream of TGFβR3, with 2.5 µM SB431542 blocked the effects of 
TGFβ1 and TGFβ2, but not BMP-2. Pre- and co-incubation of cells with 5 nM 
BMP-2 reduced the level of smooth muscle marker induction by 250 pM TGFβ1 
or TGFβ2. These data demonstrate that BMP2 induces epicardial cell motility 
without smooth muscle differentiation and that TGFβR3 is not required for 
epicardial cell responsiveness to TGFβ or BMP-2. 
 
 
 
 
 
 
45. Isolation and characterisation of mouse embryonic epicardially-derived 
cells in engineered 3D fibrin/collagen matrices 
Algirdas Ziogas*(1),José Maria Pérez-Pomares(2),Franz Weber(1), Maurice van 
den Hoff(3), Andreas H. Zisch(1),Martin Ehrbar(1) 
University Hospital Zurich, Zurich, Switzerland(1), University of Malaga, Malaga, 
Spain(2),Academic Medical Center, Amsterdam, The Netherlands(3) 
 
In the developing heart the epicardium surrounding the heart as a result of 
epithelial-to-mesenchymal transformation generates precursor cells that invade 
the myocardium and subsequently become smooth muscle, endothelial and 
interstitial cells. Currently only a few effector proteins and mechanisms that 
guide differentiation of epicardially derived cells (EPDC) are well understood. 
Because most processes in vivo occur within 3D tissues rather than on 2D 
surfaces, modern 3D tissue-based culture systems require to mimic certain 
aspects of in vivo-like scaffolding and reconstruction of cell adhesion, motility 
and cell-cell communication. The aim of this study was the development of an in 
vitro 3D model that would allow concomitant investigations of 
migration/proteolytic activity and morphogenetic abilities of EPDCs in response 
to matrix-bound growth factors. Eight immortalized, clonally expanded cell 
strands from embryonic mouse epicardium were investigated. Single cells or cell 
spheroids were embedded in fibrin matrices engineered with covalently bound 
growth factors. The spheroids of certain cell strands exhibited multicellular 
sprouts into fibrin and fast outward migration upon their culture with matrix-
bound BMP-2, VEGF. We found that some cell strands exhibited an 
extraordinary proteolytic capacity, which resulted in rapid consumption of the 
surrounding fibrin. Molecular analysis revealed expression of numerous cell 
surface markers including Eph receptors, VEGFR1, CD44, CD106, CD140. Our 
present experiments focus on the influence of interstitial flow and matrix-bound 
growth factors on the spatio-temporal patterning of epicardial cells. In conclusion, 
we have developed an in vitro 3D cell system that allows the recapitulation of 
certain aspect of epicardial cell behavior. 
  Poster session A Thursday 20 May 
   
page 105 
46. Transforming Growth Factor beta ligands play essential roles in 
epicardium and epicardial cardiac progenitor cells during heart 
development 
Mohamad Azhar* (1), Simon J. Conway (2), Tom Doetschman (1) 
(1) BIO5 Institute, University of Arizona, Tucson, AZ, USA (2) Riley Heart 
Research Center, Herman B. Wells Center for Pediatric Research, Indiana 
University School of Medicine, Indianapolis, IN, USA. 
 
The epicardial epithelial-mesenchymal transition (EMT) is hypothesized to 
generate epicardium-derived progenitor cells that differentiate into coronary 
smooth muscle, cardiac endothelium, cardiac fibroblasts and cardiomyocytes. 
The presence of Transforming Growth Factor beta2 (TGFbeta2) gene 
expression in the proepicardium and the gene expression of all three TGFbeta 
ligands in epicardium from E11.5-E12.5 onward suggest a role of TGFbeta 
ligands in epicardium-dependent cardiac morphogenesis. Here, we showed that 
TGFbeta2-deficient and not TGFbeta1- or TGFbeta3-deficient mice had reduced 
WT1+-epicardial progenitor cells and thinning of the ventricular myocardium at 
mid-gestation. TGFbeta2-deficiency resulted in reduced levels TGFbeta 
signaling activity (i.e., pSMAD2) in epicardium and epicardial progenitor cells. In 
vitro analysis using collagen gel assays indicated reduced epicardial EMT in 
TGFbeta2-deficient hearts. Simultaneous gene-targeted deletion of both 
TGFbeta2 and TGFbeta3 resulted in epicardial detachment, a phenotype that 
was not seen in TGFbeta2-deficient embryos. The data also identified impaired 
coronary vascular development in TGFbeta2-deficient embryos which was 
further attenuated in TGFbeta2/TGFbeta3-deficient embryos. The defect in 
epicardial progenitor cell differentiation in the TGFbeta2/TGFbeta3-deficient 
hearts was associated with a significant induction in the levels of di-
phosphorylated ERK-MAP kinases. Collectively, these data indicate that 
TGFbeta2 is required for epicardium-dependent cardiac mophogenesis. 
TGFbeta3 plays specific role in epicardial progenitor cell migration into the heart 
by inducing epicardial attachment to the heart. These new insights into the 
molecular mechanisms regulating epicardial progenitor cells function will shed 
light on the pathogenesis of heart diseases and may help the development of 
novel regenerative approaches to heart failure. (Funding: R01HL92508-
Conway-Doetschman; ABRC: 0901 & Schneider/Gieszl Award-Azhar) 
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47. Characterisation of the wickham mutant identifies a novel gene in 
cardiac looping 
Kelly A. Smith (1,2), Carol Wicking (1) and Jeroen Bakkers (2,3) 
(1) Institute for Molecular Bioscience, University of Queensland, Australia (2) Hubrecht 
Institute-KNAW & University Medical Center, Utrecht, The Netherlands (3) Interuniversity 
Cardiology Institute of the Netherlands, 3584CT Utrecht, The Netherlands 
 
Cardiac looping is a morphogenetic event that converts the symmetrical linear 
heart tube into an asymmetric looped heart. Defects that occur during heart 
development, including cardiac looping, are the underlying cause of congenital 
heart defects, emphasizing the importance of understanding the cellular and 
molecular regulators of cardiac morphogenesis. We have utilized the model 
organism, zebrafish, and its’ amenability in forward genetic screens to identify 
novel genes in the process of cardiac looping. The mutant, wickham, undergoes 
normal formation of the linear heart tube but fails to loop, never forming an S-
looped heart. Wickham hearts display normal myocardial structure and 
contractility suggesting a normal cardiac output at the time of looping. 
Furthermore, anf/nppa and tbx2b are expressed in a comparable manner 
between mutants and siblings, suggesting normal chamber differentiation and 
initiation of the myocardial AV canal boundary, respectively. In addition, no 
significant difference was found in myocardial cell numbers between 
wickham/Tg(cmlc2:dsRed) siblings and mutants (n=6; p < 0.681). In contrast 
with these negative findings, has2 expression was expanded in wickham 
mutants compared with siblings, suggesting that this defect may be endocardial 
in origin. Together these findings indicate that the wickham gene plays a specific 
role in vertebrate heart tube morphogenesis. Positional cloning of wickham 
identified a putative transmembrane protein with no prior ascribed function. 
Wickham RNA was highly expressed in a restricted manner in the mouse 
endocardium, providing additional evidence of an endocardial-derived defect. 
Based on these findings, we propose that wickham represents a novel, 
endocardial-expressed gene involved in cardiac morphogenesis. 
 
48. Alk3 is required for cardiac specification and asymmetry 
Kelly A. Smith (1, 2), Sonja Chocron (2), Ingrid Thurlings (2) & Jeroen Bakkers 
(2,3). 
(1) Institute for Molecular Bioscience, The University of Queensland, Australia (2) 
Hubrecht Institute-KNAW & University Medical Center, Utrecht, The Netherlands (3) 
Interuniversity Cardiology Institute of the Netherlands, 3584CT Utrecht, The Netherlands 
 
During formation of the linear tube, the heart undergoes asymmetric positioning, 
relative to the left-right (LR) axis. LR asymmetry is established in the embryo by 
a Nodal-BMP signaling cascade, which is then interpreted by the cardiac field. 
Asymmetric positioning of the heart tube is necessary for the subsequent 
morphogenesis and correct looping of the heart. We have identified the 
zebrafish mutant, linkspoot, from a forward genetic screen, which has a 
symmetrical linear heart tube phenotype that is partially penetrant 
(approximately 1/3 of mutants). Positional cloning identified a missense mutation 
(L337R) in the bmp receptor, alk3a. We hypothesised that the partially penetrant 
phenotype resulted from compensation from the alk3a paralogue, alk3b (from 
duplication in the zebrafish). To test this, we screened a mutagenesis library and 
identified a premature stop-codon in the ligand-binding domain of alk3b. To test 
for redundancy, double carriers (alk3a+/-, alk3b+/-) were incrossed and the 
progeny phenotyped and genotyped. A gene dosage affect was observed, 
whereby the more copies of alk3a/b lost, the greater the penetrance of the 
cardiac laterality phenotype. Interestingly, double mutant embryos were unable 
to be scored for laterality as there was no detectable cardiac field using markers 
cmlc2 (cardiac myosin light chain), nkx2.5 and hand2. These phenotypes in 
double mutants and compound heterozygous animals indicate that while the 
specification of the heart field fails to occur only in the complete absence of Alk3, 
the morphogenesis of the heart tube is exquisitely sensitive to reductions in Alk3 
dose. 
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49. Tenascin C may regulate recruitment of mural cells during coronary 
arterial development. 
Kyoko Imanaka-Yoshida(1), Katsumi Ando(2), Toshiyuki Yamagishi(3), 
Toshimichi Yoshida(3), Yuji Nakajima(3), Sachiko Miyagawa-Tomita(4) 
(1) Pathology and Matrix Biology Mie University Graduate School of Medicine, Tsu Japan 
(2) Health Sciences Saitama Prefectural University, Saitama, Japan (3)Anatomy and Cell 
Biology Osaka City University Graduate School of Medicine, Osaka, Japan (4)Tokyo 
Women’s Medical University, Tokyo, Japan 
 
Tenascin C (TNC) is a unique extracellular glycoprotein, transiently expressed 
at distinct sites, and thought to play important roles in tissue remodeling during 
embryonic development and under pathological condition in adult. Several lines 
of evidnce have suggested that TNC may be involved in angiogenesis in cancer 
stroma and tissue repair after myocardial infarction. To elucidate a role of TNC 
in coronary vessel development, we investigated spatiotemporal expression 
patterns of TNC during the establishment of proximal region of coronary arteries. 
Coronary precursor cells were traced using proepicardial organ quail-chick 
chimera. Immunohistochemistry showed that TNC was deposited in the aortic 
wall where endothelial invaded to form primordial coronary stems. At ED8, when 
a single orifice of coronary stem was completed and smooth muscle actin 
(SMA)-positive mural cells originated proepicardium were recruited, TNC was 
extensively deposited surrounding the coronary arterial wall. When nascent 
epicardium was cultured on dish coated with purified TNC, the cells 
differentiated into smooth muscle cell phenotype expressing SMA. Epicardial 
cells cultured without TNC showed a typical cobblestone appearance with 
expressing endothelial marker QH1. These results revealed that TNC plays a 
significant role in coronary artery development, especially recruitment of mural 
cells by accelerating differentiation of epicardial mesenchymal cells to SMA 
positive cells. 
 
 
 
 
 
 
50. Type XIV collagen is required for myocardial function in vivo 
Agata K. Levay (1), Jacqueline D. Peacock (1), Jose R. Pinto (1), Manuel Koch 
(2), David E. Birk (3) and Joy Lincoln (1) 
(1) Department of Molecular and Cellular Pharmacology, University of Miami Miller School 
of Medicine, Miami, Florida, USA (2) Center for Biochemistry and Department of 
Dermatology, Medical Faculty, University of Cologne, Cologne, Germany (3) Department 
of Pathology & Cell Biology, University of South Florida, College of Medicine, Tampa, 
Florida, USA 
 
Type XIV collagen (Col14) is a fibril-associated collagen with interrupted triple 
helix (FACIT) required for fibrillogenesis in tissues of high mechanical stress. 
The purpose of this study was to define its role in cardiac function. We show that 
Col14 is highly expressed within the extracellular matrix of the working 
myocardium from late embryonic stages through adulthood. From three months 
of age Col14a1-/- mice exhibit significant defects in myocardial function, as 
determined by echocardiography. This is indicated by increased left ventricular 
chamber volume (and diameter) during diastole (23%, p=0.04) and systole (43%, 
p=0.02) in conjunction with an overall 23% and 28% decrease in ejection 
fraction and fraction shortening respectively. These functional studies suggest 
that Col14a1-/- mice have moderate ventricular dilation and significantly 
impaired contractility. At the molecular level, ventricles from Col14a1-/- mice 
express significantly reduced levels of genes associated with cell-cell and cell-
matrix interactions including type VI collagen (1.9-fold, p=0.02), integrin alpha-2 
(3.7-fold, p=0.03) and laminin beta-3 (1.6-fold, p=0.03). This apparent decrease 
in structural integrity within the ventricle of Col14a1-/- mice likely reflects the 
observed pathologic alteration in function. Ongoing studies include 
biomechanical approaches to determine the maximal and passive force of 
individual muscle fibers from Col14a1-/- mice, as well as electron microscopy to 
examine the ultrastructure of extracellular matrix assembly within the ventricles 
of null animals. These current studies suggest that Col14 is required for 
cytoskeleton integrity, and function of the working myocardium in vivo. 
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51. Results of a forward genetic screen to identify new genes that regulate 
heart morphogenesis 
Ina Strate*, Federico Tessadori, Jeroen Bakkers 
Cardiac development and genetics, Hubrecht Institute, Utrecht, Netherlands 
 
Morphogenesis of the vertebrate heart is characterized by looping and leftward 
positioning of the heart tube. We and others have shown that, in zebrafish, this 
is a BMP and Nodal regulated process. During early heart morphogenesis in 
zebrafish, an asymmetric positioning of the heart takes place, resulting in the 
positioning of the future venous pole towards the left side of the body axis while 
the arterial pole remains at the midline. Following leftward positioning, rightward 
looping takes place; a repositioning of the developing atrial and ventricular 
chambers relative to one another occurs, bringing the chambers closer in lateral 
alignment. This is accompanied by ballooning of the two chambers and a 
constriction between the atrium and ventricle to form the atrioventricular canal. 
By forward genetic screening in zebrafish, putative novel genes that have 
important functions during cardiac positioning and looping have been identified. 
Embryos that are mutant for these putative genes can be divided into three 
classes based on their phenotypes. Class I mutants display defects in cardiac 
positioning and looping combined with endodermal laterality defects. Class II 
mutants show defective cardiac positioning and looping while the laterality of the 
gut is unaffected. Class III mutants display cardiac looping defects combined 
with a normal gut morphology. Standard genetic mapping approaches will be 
used to identify the genes underlying the mutant phenotypes. Genes that can be 
mapped to regions on the genome that do not harbour known regulators of heart 
morphogenesis will undergo further analysis. 
 
 
 
 
 
 
 
 
52. Mechanotransduction and Erbb2 Signaling in Cardiac Trabecular 
Formation 
Jiandong Liu (1,3), David Staudt* (1,3), Michael Bressan (3), Takashi Mikawa 
(3), Didier Stainier (1,2,3,4) 
(1) Department of Biochemistry and Biophysics, (2) Programs in Developmental 
Biology, Genetics, and Human Genetics, (3) Cardiovascular Research Institute, 
and (4) Liver Center, University of California, San Francisco, San Francisco, CA 
94158, USA 
 
Cardiac trabeculae are highly organized sheet-like muscular structures that 
protrude into the ventricular chambers.  Trabeculae have been suggested to 
enhance contractility and intraventricular conduction.  However, the 
mechanisms that orchestrate cardiac trabecular development remain largely 
unknown.  Here we show that mechanosensing mechanisms are required for 
cardiac trabecular formation. Trabeculae fail to form in silent heart (sih/ctnnt2) 
mutant embryos, in which the cardiomyocytes fail to contract leading to 
circulation failure. In addition, transplanted non-contractile cells in wildtype 
ventricles fail to incorporate into the trabeculae. Interestingly, myocardial cells 
that overexpress an activated form of RhoA, a known mediator of 
mechanosensitive changes, are exclusively detected in the trabeculae. Similar 
to silent heart, mutants for erbb2, which encodes an epidermal growth factor 
(EGF) receptor family member, also fail to form trabeculae. In addition, 
transplanted erbb2 mutant myocardial cells in wildtype ventricles do not 
incorporate into the trabeculae.  BrdU labeling demonstrates that ErbB2 is 
required for myocardial proliferation during trabecular forming stages. However, 
lineage-tracing studies along with the presence of isolated BrdU+ trabecular 
cells suggest that directional migration, in addition to proliferation, contributes to 
trabeculation. These observations suggest that mechanotransduction and ErbB2 
signaling are required for the detachment of prospective trabecular myocardial 
cells from the ventricular wall. 
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53. Obscurin promotes the targeted localization and stabilization of the 
dystrophin associated glycoprotein complex and participates 
development of the costameres, and the myotendinous and 
neuromuscular junctions 
Maide Ö. Raeker* (1) and Mark W. Russell (1, 2) 
(1) Department of Pediatrics and Communicable Diseases, (2) Department of 
Cell and Developmental Biology, University of Michigan, Ann Arbor, MI, USA 
 
Obscurin is a giant protein with multiple structural and signaling domains that 
plays a pivotal role in the cellular organization of skeletal and cardiac myocytes. 
It surrounds the myofibril at the M and Z bands and recruits other cytoskeletal 
and transmembrane proteins to those domains. Given obscurin’s role in cellular 
patterning, we hypothesized that it would promote organization of specialized 
membrane compartments overlying the sarcomere. To test this hypothesis, we 
used antisense morpholino oligonucleotides to diminish obscurin A in 
developing zebrafish embryos and characterized the effect on specialized 
membrane compartments that are dependent upon dystrophin and the 
dystrophin-associated glycoprotein complex (DGC). In the obscurin-depleted -
dystroglycan expression was not noted at theαembryos, glycosylated  
myotendinous junctions suggesting a specific destabilization of DGC. 
Ultrastructural analysis indicated that obscurin depletion resulted in reduced 
affinity of the myofibril for the sarcolemma, and wheat germ agglutinin staining 
supported a lack of costamere organization and development in the obscurin-
morphant embryos. The obscurin-depleted embryos also had reduced numbers 
and organization of neuromuscular junctions as indicated by -bungarotoxin. The 
findings suggest that obscurinαimmunolabeling with participates in the 
organization and development of dystrophin/DGC-dependent membrane 
compartments. The DGC is a vital transmembrane link between the subcortical 
cytoskeleton and the basal lamina and has been implicated in the etiology of 
several muscular dystrophies. Understanding obscurin’s role in the assembly 
and organization of these specialized membrane compartments may have 
important implications for the treatment of patients with a wide range of 
myopathies and muscular dystrophies. 
 
 
 
 
 
 
 
 
 
 
54. The role of the small GTPase Cdc42 in the Drosophila heart during 
morphogenesis and function 
Georg Vogler* (1), Li Qian (2), Jiandong Liu (3), Rolf Bodmer (1) 
(1) Sanford-Burnham Medical Research Institute, La Jolla, CA, USA (2) 
Gladstone Institute of Cardiovascular Disease, UCSF, San Francisco, CA, USA 
(3) University of California, San Francisco, CA, USA 
 
The formation of the heart during Drosophila embryogenesis requires the 
coordinated alignment of the myocardial and pericardial cells. One important 
aspect of heart morphogenesis is therefore the establishment and maintenance 
of cell polarity. A number of factors, including the secreted protein Slit and its 
receptor Robo localize in a polarized manner during and after heart alignment 
and further morphogenesis of the heart. It is currently not known which factors 
create or maintain this polarized distribution and localization of factors. From a 
screen for genetic interactors with the cardiac determinant tinman we identified 
the small GTPase Cdc42 as being required for correct adult heart function. In 
addition, we find that it governs cardioblast cell polarity during embryonic heart 
morphogenesis. Perturbing cell polarity by either loss of Cdc42 or expression of 
constitutively active Cdc42 disrupts heart morphogenesis in the embryo. As a 
consequence, multiple heart lumina are formed. We have screened for factors 
that influence cardiac cell polarity in a Cdc42-dependent manner, in order to 
understand the mechanisms of cardiac morphogenesis. 
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55. Structural determinants of material properties of fetal and adult 
porcine mitral heart valves 
Agnes Nagy Mehesz* (1), Vladimir Kasyanov (2), Ricardo Moreno (1), Thomas 
Trusk (1), Xuejun Wen (3), Zoltan Hajdu (1), Yongren Wu (3), Yuhua Zhang (1), 
Iveta Ozolanta (2), Janis Pavars (2), Peteris Stradins (2) Russell Norris (1), Amy 
Bradshaw (1), Hai Yao (3), Richard P Visconti (1), Roger R Markwald (1), 
Vladimir Mironov (1) 
(1) Regenerative Medicine & Cell Biology and the Cardiac Developmental Biology Center, 
Medical University of South Carolina, Charleston, SC, USA (2) Riga Stradins University, 
Riga Latvia (3) Clemson-MUSC Bioengineering Program, Department of Bioengineering, 
Clemson University, Clemson, SC, USA 
 
The proper material properties and withstanding life long cyclic mechanical 
loading is essential for maintaining of normal mitral heart valve function. Material 
properties of heart valve must also constantly adapt to changes in 
cardiovascular hemodynamics during embryonic and postnatal development. 
Inadequate or suboptimal mechanical properties of heart valve tissues can 
compromise them and lead to heart failure. The main goal of this work is to 
estimate material properties of porcine mitral heart valve in fetal, postnatal and 
adult stage and identify their structural determinants. Using tensile test we have 
shown that material properties of porcine mitral heart valves are progressively 
improved and heart valve became more strengthen with increasing modulus of 
elasticity. Transmission electron microscopy demonstrated the increase in 
diameter of collagen fibrils in adult valve as compared to fetal heart valve. 
Collagen content based on hydroxyproline test increases 5 times as compared 
fetal to adult heart valve. Level of collagen cross-linking is lower in fetal heart 
valve then in adult heart valve based on estimation of thermal denaturation 
temperature by differential scanning calorimetry. Thus, structural determinants 
of progressive age-related changes in material properties of heart valves include 
increasing of collagen type 1 content, diameter of collagen fibrils and level of 
collagen cross-linking. These data provide necessary control and important 
insight on mechanisms of embryonic and postnatal valvulogenesis, 
pathogenesis of heart valvulopathies and they are essential in designing of 
functional tissue engineered heart valves. 
 
 
 
56. Matrix engineering for the formation of artificial tissues 
Martin Ehrbar* (1), Ana Sala (2), Franz E. Weber (2) 
(1)Department of Obstetrics, University Hospital Zurich, Switzerland (2)Oral Biotechnology 
and Bioengineering, Department of Craniomaxillofacial Surgery, University Hospital Zurich, 
Zurich, Switzerland 
 
Naturally derived matrices have well been established as 3D culture systems. 
One mayor limitation of these hydrogel materials in engineering applications is 
their innate biological functions regarding proteolytic susceptibility and integrin 
ligand presentation. We have in recent years developed completely synthetic 
matrices that are modularly designed and can be adapted towards specific 
biological applications. These materials are based on star shaped poly (ethylene 
glycol) PEG, a polymer known to be biologically inert. In order to obtain 
biological functionality the materials can be made sensitive towards proteolytic 
digestion and decorated with specific integrin ligand domains or covalently 
immobilized morphogenetic cues that might direct cell behaviour. Here we show 
that cells can be encapsulated inside these materials and that by variation of the 
matrix composition cell migration behaviour can be enabled or prohibited in vitro. 
As these matrices allow the covalent tethering and presentation of growth 
factors, they can not only be used to control distribution and migration of cells, 
but also provide them with instructive cues. Initial attempts have been made to 
control the 3D arrangement of cells, matrices and growth factors to generate 
tissue-like structures by means of layer by layer assembly or printing. These 
constructs were shown to convert over time to become tissue like constructs 
with defined arrangement. We believe that our novel materials platform can 
serve to generate tissue mimicking structures that can be used to study 
fundamental biological questions such as cell differentiation, tissue 
morphogenesis, cell-cell and cell-matrix interactions that are important during 
development. 
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57. The Novel Transmembrane Protein Frv is Essential for the 
Coordination of Myocardial and Endocardial Morphogenesis 
Ronald Totong (1), Thomas Schell (1), Fabienne Lescroart (1), Tomasz 
Zygmunt (1), Dafna Gershoony (1), Timothy J. Cardozo (1), Jesús Torres-
Vázquez (1), Deborah Yelon (1,2) 
(1) Skirball Institute of Biomolecular Medicine, New York University School of Medicine, 
New York, NY, USA (2) Division of Biological Sciences, University of California, San Diego, 
La Jolla, CA, USA 
 
The myocardium and endocardium are closely juxtaposed throughout heart 
development. Myocardial and endocardial cells originate in neighboring regions 
of the lateral mesoderm, migrate medially in a coordinated fashion, collaborate 
to create concentric layers of the heart tube, and communicate during formation 
of the atrioventricular canal. Here, we identify a novel gene, frozen ventricle (frv), 
that plays an essential role in the coordination of myocardial and endocardial 
morphogenesis in the zebrafish embryo. Zygotic frv mutants exhibit ectopic 
presence of atrioventricular characteristics throughout the ventricular 
endocardium, indicating an important role of Frv in restricting formation of the 
endocardial cushions to the atrioventricular canal. Furthermore, in maternal-
zygotic frv mutants, both myocardial and endocardial cells fail to move to the 
midline normally. Positional cloning indicates that the frv locus encodes a type II 
single-pass transmembrane protein. Homologs of frv are present in all examined 
vertebrate genomes, but nothing is known about its molecular or cellular 
function in any context. Although frv is expressed throughout the embryo, tissue-
specific rescue experiments indicate that Frv activity is required in the 
myocardium to coordinate the movement of both myocardial and endocardial 
cells. Together, our data reveal that Frv is an essential mediator of myocardial-
endocardial communication during cardiac morphogenesis. 
 
 
 
 
58. Prognostic utility of physiologic assessment of extracellular matrix 
fiber alignment and tissue biomechanics in detection of latent aortic 
disease 
Mohamad Azhar*(1), Joseph Keyes (2), Darren Haskett (2), Connie Gard (1), 
Jonathan P. Vande Geest (2), Urs Utzinger (1), Tom Doetschman (1) 
(1) BIO5 Institute, University of Arizona, Tucson, AZ, USA (2) Dept. Aerospace & 
Mechanical Engineering, University of Arizona, Tucson, AZ, USA 
 
Aneurysmal patients with mutations in Transforming Growth Factor beta 
(TGFbeta) signaling (i.e., Loey-Dietz syndrome, LDS) and collagen (i.e., Ehlers 
Danlos syndrome, EDS) have higher incidence of sudden lethal aortic rupture 
than patients of Marfan syndrome (MFS) and familial thoracic aortic aneurysm 
(TAAD). Here, we present unique opto-biomechanical approaches that had 
successfully determined the susceptibility to aortic aneurysm in mouse models 
at the pre-aneurysm stage. Briefly, our data indicated that TGFbeta2-deficient 
and TGFbeta2/TGFbeta3-deficient mouse embryos exhibited widespread aortic 
artery dilation. Although adult TGFbeta2-haploinsufficient mice appeared normal, 
a pressor dose of angiotensin-2 (ANG2) for 7-days selectively induced thoracic 
aortic aneurysm in these mice. Our newly developed microbiaxial opto-
mechanical device is capable of simultaneously and non-invasively investigating 
the macroscopic biomechanics (stress/strain: tissue-stiffness) and microscopic 
(via nonlinear multiphoton excitation) microstructural extracellular matrix (ECM) 
changes (collagen and elastin) in an unfixed biaxially-pressurized mouse aorta. 
The opto-mechanical analyses indicated that aortic walls were more compliant 
in TGFbeta2-haploinsufficient mice and that they were less compliant in both 
Fibrillin-1+/C1039 (MFS model) and ANGII-infused (TAAD model) mice as 
compared to wild-type mice. The alignment of collagen fibers in pressurized 
TGFbeta2-haploinsufficient mouse aorta remained axially oriented and that the 
elastin fibers moved more circumferentially as compared to the wild-type mice. 
Collectively, these data establish approaches capable of predicting the risk of 
aortic aneurysm, and indicate higher susceptibility of TGFbeta2-haploinsufficient 
mice to aortic aneurysm. These findings have implications in devising better 
strategies for advancing aortic rupture risk assessment in the susceptible 
pediatric aneurysmal patients. (Funding: R01HL92508-Conway-Doetschman, 
ABRC: 0901 & Schneider/Gieszl Award-Azhar. 
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59. Trigenic neural crest-restricted Smad7 over-expression results in 
congenital craniofacial and cardiovascular defects 
Sunyong Tang, Paige Snider and Simon J. Conway * 
Herman B Wells Center for Pediatric Research, Indiana University 
School of Medicine, Indianapolis, IN 46202 USA. 
For abstract, see in oral presentation section page 75 
 
 
 
 
 
60. Cardiac Neural Crest Nibble Their Way to the Heart 
Mary R. Hutson*, Ann Marie Scholl, Elizabeth B. Kuhn, Asako Sato, 
Harriett A. Stadt, Jennifer R. Decker, Kelly Pegram, and Margaret L. 
Kirby 
*Department of Pediatrics, Neonatal-Perinatal Research Institute, Duke 
University Medical Center, Durham, NC, USA 
For abstract, see in oral presentation section page 76 
 
 
 
 
 
 
 
 
 
 
 
61. Manipulation Of Notch Signaling In Neural Crest Cells In Vivo Results 
In Cardiac Outflow Tract Malformations 
Timothy J. Mead* and Katherine E. Yutzey 
Division of Molecular Cardiovascular Biology, Cincinnati Children’s Hospital 
Medical Center, Cincinnati, OH, USA 
 
The Notch signaling pathway has been implicated in cardiac congenital 
malformations and diseases including Alagille syndrome and aortic valve 
calcification. During embryogenesis, precise levels of Notch1 signaling regulate 
cell proliferation and differentiation in a variety of cell types. In the developing 
cardiac outflow tract, Notch signaling has been linked to congenital conotruncal 
malformations that are often attributed to defective neural crest cell contribution. 
While Notch signaling molecules are expressed in neural crest cells, their role is 
undefined. We hypothesize that Notch signaling regulates cardiac neural crest 
cell proliferation, migration, and differentiation thereby affecting subsequent 
investment into the cardiac outflow tract. RosaNotch mice were crossed with 
Wnt1Cre mice for over-expression of activated Notch1 in all neural crest cells 
and their derivatives in the developing embryo. Wnt1Cre;RosaNotch mice 
exhibit a reduced number of migrating cardiac neural crest cells leading to 
outflow tract malformations, including persistent truncus arteriosus, and lethality 
by embryonic day 14.5. Furthermore, Notch loss of function mice in the neural 
crest lineage (Wnt1Cre;Notch1fl/fl and Wnt1Cre;RBP-Jfl/fl) have decreased 
neural crest cell migration resulting in an array of cardiac outflow tract 
malformations including double outlet right ventricle and overriding aorta with 
ventricular septal defects and neonatal lethality. These data demonstrate that 
Notch signaling in neural crest cells is required for conotruncal development and 
that deficient Notch signaling leads to congenital cardiac malformations. Overall, 
these studies provide evidence that precise levels of Notch signaling are 
required in neural crest cells, which has critical implications in cardiac 
development and disease. 
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62. Rho kinase is required for cohesive behaviour of neural crest cells 
during outflow tract morphogenesis 
Helen Phillips*, Darren Hoyland, Veronika Boczonadi, Bill Chaudhry and 
Deborah Henderson 
Institute of Human Genetics, Newcastle University, UK 
 
Neural crest cells (NCC) are essential to the development of the cardiac outflow 
tract. However, the factors regulating the local movements and condensation of 
NCC are currently poorly understood. To address this we studied the effect of 
the conditional expression of a dominant-negative form of Rho kinase (ROCK) in 
NCC, which suppressed the activity of endogenous ROCK solely in NCC 
resulting in severe craniofacial, innervation and cardiac defects. NCC were able 
to migrate efficiently in ROCKDN;Wnt1Cre embryos although many of these 
cells died either at the periphery or within the neural tube. Close examination of 
migrating NCC and post-migratory cells as they condensed in the outflow 
cushions, revealed that whereas wild type cells migrated as a cohesive 
population, ROCKDN;Wnt1Cre NCC were disorganised and tended to clump 
together or scatter, suggesting abnormalities in NCC cell-cell adhesion. In vitro 
analyses of isolated NCC confirmed that NCC migration was not impeded by 
ROCK deficiency, although cell-cell adhesion and gap junctional proteins 
involved in cell-cell communication between neighbouring NCC were all mis-
localised within the cells. Furthermore, cell tracking experiments demonstrated 
that attenuation of ROCK signalling resulted in accelerated and more directional 
NCC movement leading to separation of leading edge cells. Thus ROCK 
appears to be essential for the behaviour of NCC by regulating their final co-
ordinated movements and condensation within target tissues. ROCK acts in a 
number of signalling pathways and this therefore explains how disruption of 
distinct upstream factors can result in the same cardiac malformations. 
 
 
 
 
 
 
63. Replacement of a large minority of smooth muscle cells by 
melanocytes in ductus arterisosus during development does not allow its 
proper closure and leads to postnatal death 
Ichiro Yajima (1), Sophie Colombo* (1), Isabel Puig (1), Mayuko Kumasaka (1), 
Makoto M. Taketo (2), Manuel Mark (3), Philippe Choquet (4), Véronique 
Delmas (1), Laurent Monassier (4) and Lionel Larue (1) 
(1) Developmental Genetics of Melanocytes, Institut Curie, Orsay, France (2) 
Center for Frontier Medicine, Kyoto University, Kyoto, Japan (3) IGBMC, Illkirch, 
France (4) INSERM U715, Strasbourg, France 
 
Melanocytes may be defined by their neural crest cell (NCC) origin and their 
ability to produce melanin using the key enzyme tyrosinase (Tyr). In vertebrates, 
these pigmented cells are classically found in the skin (classical melanocytes) 
but also in diverse sites: eyes, inner ear, meninges, bones and heart (non-
classical melanocytes). The functions of most non-classical melanocytes remain 
unknown. Mice expressing an oncogenic form of β-catenin (βcat) specifically in 
tyrosinase-producing cells were generated using the Cre/LoxP system 
(Tyr::Cre/°;∆ex3βcatflox/+). These mice unexpectedly died prematurely 
(between 8 and 18 weeks of age) from cardiac defects. They displayed a 
considerably dilatated left atrium and died consequently to the rupture of the left 
atrium with pericardial blood effusion. Moreover, most of the animals presented 
a thrombus in the left atrium. A series of Echo-Doppler and histological analysis 
was performed to determine the origin of this dilatation. We observed a high 
number of melanocytes in the mutant heart and the lack of closure of the ductus 
arteriosus (DA) at birth, thus connecting the pulmonary artery directly to the 
aorta. We could show that the wild-type DA is composed of two vagal NCC 
derivatives - smooth muscle cells (SMC) and a very small amount of 
melanocytes. At the opposite, mutant DA contained fewer SMC and a larger 
number of melanocytes. These results suggest that higher levels of β-catenin in 
vagal NCC has a possible effect on the fate of these cells, with larger numbers 
of cells differentiating into melanocytes, thus preventing the closure of the DA. 
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64. Cross-talk between T-box factors in cardiac outflow tract 
morphogenesis 
M. Sameer Rana* (1), Karim Mesbah (2), Vincent Wakker (1), Antoon F.M. 
Moorman (1), Robert G. Kelly (2) and Vincent M. Christoffels (1) 
(1) Heart Failure Research Center, Academic Medical Center, University of 
Amsterdam, Amsterdam, The Netherlands (2) Developmental Biology Institute 
of Marseille-Luminy, Centre National de la Recherche Scientifique-Université de 
la Méditerranée, Campus de Luminy, Marseille, France 
 
Proper cardiac outflow tract (OFT) morphogenesis is a complex process that is 
crucial for the formation of the aortic and pulmonary outlets. The addition of cells 
from two cell populations, the second heart field (SHF) and cardiac neural crest 
(NC) cells, to the developing heart is required for OFT development and 
septation. T-box transcription factor Tbx1 is expressed in the SHF and is known 
to be important for SHF and OFT development. Tbx2 is expressed in both SHF 
and cardiac NC cells, while Tbx3 is mainly expressed in cardiac NC cells. Both 
factors are required during OFT remodeling. However, little is known about their 
putative hierarchical places in gene regulatory networks and signaling pathways 
controlling OFT development. Here, we made 3D-reconstructions of Tbx1, Tbx2 
and Tbx3 expression patterns in the SHF and NC region and found that 
Tbx1/Tbx2 and Tbx1/Tbx3 are largely complementary, whereas Tbx2/Tbx3 
largely overlap in the SHF, NC-derived mesenchyme, ectoderm and foregut 
endoderm. In Tbx1-deficient mice, pharyngeal expression of Tbx2 and Tbx3 was 
found to be deviant, suggesting regionalized interactions. To study in vivo 
interactions and define the combinatorial roles, we have generated compound 
Tbx1;Tbx2 and Tbx2;Tbx3 mutant mice. Tbx2;Tbx3 double mutant mice display 
a shortened OFT, hypoplastic right ventricle and abnormal patterning of the 
pharyngeal arch arteries. Tbx1;Tbx2 double mutants showed arrested 
development from E8.75 onwards and a primitive and dysmorphic heart tube. 
Our data suggest that Tbx1 is required upstream of and in synergy with Tbx2 
and Tbx3 for proper cardiac and pharyngeal arch development, and that 
interactions between Tbx1-expressing and Tbx2/3-expressing cells may play a 
crucial role in this process. 
 
 
 
 
65. The role of AP-2α in the neural crest cells for cardiovascular 
development 
Amy-Leigh Johnson*, Divya Venkatesh & Simon D Bamforth 
Institute of Human Genetics, Newcastle University, Newcastle upon Tyne, UK. 
 
Congenital cardiovascular malformations (CCVM) are the most common human 
birth defects and are associated with multiple human syndromes. Many CCVMs 
affect the pharyngeal arch arteries (PAA) and the outflow tract (OFT) of the 
heart. During development the PAAs undergo extensive remodelling from a 
symmetrical structure into the highly asymmetric aortic arch arteries. Faults in 
the formation and rearrangement of these vessels result in severe aortic arch 
malformations. Neural crest cells (NCCs) play an integral role in the 
development of these structures, producing the smooth muscle wall of the PAAs 
and infiltrating the distal OFT to initiate the formation of the aorticopulmonary 
septum. AP-2α (Tcfap2a) is a transcription factor associated with cell 
proliferation. Embryos deficient in AP-2α are characterised externally by 
craniofacial abnormalities and ventral body wall defects, and display 
cardiovascular defects such as double outlet right ventricle, ventricular septal 
defects (VSD), interrupted aortic arch (IAA) and anomalous right subclavian 
artery (A-RSA). As this phenotype partly affects neural crest-derived structures, 
we wanted to investigate the role of AP-2α within NCC for cardiovascular 
development. To achieve this, we are selectively deleting Tcfap2a from NCC 
using the cre-LoxP system. Preliminary data shows that the NCC-specific 
ablation of Tcfap2a, in mice on a congenic C57Bl/6 background, causes VSD, 
A-RSA and transposition of the great arteries, in addition to exencephaly. 
Understanding the requirement for AP-2α in the NCCs may provide insight into 
the genetic pathways involved in cardiovascular development, which are 
affected in human syndromes showing CCVM. 
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66. Twist-Family Member Interactions Regulate Cardiac Neural Crest 
Morphogenesis 
Joshua W. Vincentz*, Ralston M. Barnes, Beth A. Firulli, Simon J. Conway, 
Anthony B. Firulli 
Riley Heart Research Center, Indiana University School of Medicine, 
Indianapolis, IN, USA 
 
Members of the Twist-family of basic helix-loop-helix (bHLH) transcription 
factors, including Twist1, Hand1 and Hand2, have been shown to perform 
essential functions during cardiac neural crest cell (cNCC) development. 
Systemic ablation of Twist1 causes cNCC-associated abnormalities in the dorsal 
neural tube, pharyngeal arches, and a subpopulation of OFT cNCCs expressing 
Hand1 and Hand2. The use of tissue-specific gene ablation models has 
deepened our understanding of the roles these factors play in cNCC migration, 
adhesion, patterning and differentiation and, ultimately, congenital heart disease. 
Deletion of Hand2 specifically in the neural crest has been shown to result in 
OFT defects including aortic arch mispatterning and double outlet right ventricle. 
Conditional inactivation of Twist1 in the premigratory neural crest demonstrates 
that Twist1 function is necessary for aortico-pulmonarty septation and for proper 
cNCC contribution to the OFT cushions. A hallmark of Twist-family members is 
their ability to form homo- and heteromeric molecular complexes with unique 
transcriptional properties. Relative gene dosage of Twist1 and Hand2 within the 
developing limb is critical, as genetic disruption of the balance of these two 
factors causes polydactyly. Current studies employing systemic and NCC-
specific inactivation of these factors will define cooperative and/or antagonistic 
Twist1 and Hand2 functions within cNCCs. Together, these data will broaden 
out understanding of the mechanisms by which bHLH factors molecularly 
interact and transcriptionally regulate cNCC contribution to the developing OFT, 
and define, in terms of gene transcription and both cellular and genetic 
interaction, the role of the bHLH code in OFT development. 
 
 
 
 
 
 
 
 
67. A New Perspective on the Origin and Derivatives of Cardiac Neural 
Crest in Zebrafish 
Martha R. Alonzo* (1) and Margaret L. Kirby (2) 
(1) Department of Biology, Duke University, Durham, NC, USA (2) Department 
of Pediatrics (Neonatology), Duke University Medical Center, Durham, NC, USA 
 
Cardiac neural crest cells (CNCC) in mice and chick give rise to the smooth 
muscle of the aortic arch arteries and form the aorticopulmonary septum. 
Zebrafish develop aortic arch arteries and have conserved arterial pole 
development. Two previous studies in zebrafish reported the origin of CNCC, 
but the maps were very different. In addition, these studies found CNCC 
throughout the heart that co-localized with a striated muscle marker, an 
unexpected cell fate for CNCC. Although these studies were done carefully, 
neither took a direct approach of tracing genetically labeled neural crest cells. 
Using the neural crest transgenic reporter sox10:egfp line, we used uncageable 
red dye to map the origin and destination of green fluorescent neural crest cells 
as they began to migrate in the three cranial streams and adjacent to somite 
one. Our results showed that neural crest cells from the first cranial stream and 
somite one do not populate any structures near the heart. Neural crest cells 
from the second and third cranial streams come in close proximity to the 
developing heart fields in early migration at 16 hours post-fertilization (hpf) and 
are heavily concentrated in the caudal branchial arches at 48 hpf; but no cells 
were ever found to co-localize with a myocardial marker. These preliminary 
studies suggest CNCC originates from the second and third cranial streams and 
that CNCC do not differentiate into myocardial cells prior to 48 hpf. We have not 
yet ruled out whether CNCC are added later. 
 
  Poster session A Thursday 20 May 
   
page 116 
68. The neural crest-enriched microRNA, miR-452, regulates epithelial-
mesenchymal interactions in cranial neural crest derivatives 
Neil T. Sheehy (1,2,3)*, Kimberly R. Cordes (1,2,3), Mark P. White (1,2,3), and 
Deepak Srivastava (1,2,3) 
(1) Gladstone Institute of Cardiovascular Disease, San Francisco, CA, USA. (2) 
Department of Pediatrics, University of California, San Francisco, CA, USA. (3) 
Department of Biochemistry & Biophysics, University of California, San 
Francisco, CA, USA. 
 
Neural crest cells (NCCs) are a subset of multipotent, migratory stem cells that 
populate myriad tissues during development and are important for craniofacial 
and cardiac morphogenesis. Although microRNAs (miRNAs) have emerged as 
important regulators of development and disease, little is known about their role 
in NCC development. Here, we show that loss of miRNA biogenesis by NCC-
specific disruption of Dicer results in embryos lacking craniofacial cartilaginous 
structures, cardiac outflow tract septation, thymus, and dorsal root ganglia. Dicer 
mutant embryos had reduced expression of Dlx2, a transcriptional regulator of 
pharyngeal arch development, in the first pharyngeal arch (PA1). miR-452 was 
enriched in NCCs, was sufficient to rescue Dlx2 expression in Dicer mutant 
pharyngeal arches, and regulated a signaling cascade involving Wnt5a, Shh, 
and Fgf8 in PA1 that converged on Dlx2 regulation. Correspondingly, knock-
down of miR-452 in vivo decreased Dlx2 expression in the mandibular 
component of PA1, leading to minor craniofacial defects. These results suggest 
that post-transcriptional regulation by miRNAs is required for differentiation of 
NCC-derived tissues and that miR-452 is involved in epithelial-mesenchymal 
signaling in the pharyngeal arch. 
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69. MiR-23 is essential to restrict endothelial-to-mesenchymal transition 
during cardiac valve formation. 
Anne Karine Lagendijk* (1), Jeroen Bakkers (1,2) 
(1)Cardiac development and genetics group, Hubrecht Institute-KNAW & 
University Medical Center Utrecht, Utrecht, NL (2)Interuniversity Cardiology 
Institute of the Netherlands, Utrecht, NL 
For abstract, see in oral presentation section page 67 
 
 
70. Cardiac valve malformations: new insights from Pdlim7, an unexpected 
suspect in heart development 
Jennifer Krcmery* (1), Rudyard Sadleir (1), Rajesh Gupta (2), Chrissy Kamide 
(2), Sol Misener (2), Doug Losordo (2), and Hans-Georg Simon (1) 
(1) Department of Pediatrics, Northwestern University Feinberg School of 
Medicine, and Children’s Memorial Research Center, Chicago, IL, USA (2) 
Department of Medicine, Northwestern University Feinberg School of Medicine, 
and Feinberg Cardiovascular Research Institute, Chicago, IL, USA 
For abstract, see in oral presentation section page 68 
 
 
71. Krox20 is required during valve remodeling and maturation 
Sarah Arab (1), Frank Kober (2), Piotr Topilko (3), Monique Bernard (2), Patrick 
Charnay (3), Patrick Cozzone (2) and Stéphane Zaffran* (1) 
(1) Inserm UMR_S910, Faculté de Médecine de Marseille, 27 Bd Jean Moulin, 
13005 Marseille, France. (2) Centre de Résonance Magnétique Biologique et 
Médicale, CNRS, Faculté de Médecine de Marseille, 27 Bd Jean Moulin, 13005 
Marseille, France. (3) Biologie Moléculaire du Développement, Inserm U784, 
ENS, 75005 Paris, France. 
For abstract, see in oral presentation section page 69 
 
 
72. The Metalloprotease ADAMTS5 Plays A Critical Role In ECM 
Stratification And Cusp Sculpting During Semilunar Valve Maturation 
Christine B. Kern* (1), Daniel R. McCulloch (2), Jessica D. McGarity (1), 
Alexandra Bahan (1), Loren E. Danese (1), Courtney M. Nelson (3), Andy 
Wessels (1), and Suneel S. Apte (3) 
(1) Department of Regenerative Medicine and Cell Biology, 171 Ashley Avenue, 
Medical University of South Carolina, Charleston, SC 29425, USA (2) Deakin 
University, Geelong Victoria 3217, Australia (3) Department of Biomedical 
Engineering, Lerner Research Institute (ND-20), Cleveland Clinic, 9500 Euclid 
Avenue, Cleveland OH 44195, USA 
For abstract, see in oral presentation section page 70 
 
 
73. Induction of a developmental gene program in pediatric and adult 
aortic valve disease 
Elaine Wirrig* (1), Jonathan Cheek (1), Christina Alfieri (1), Walter Merrill (2), 
Robert Hinton (1), Katherine Yutzey (1) 
(1) The Heart Institute, Cincinnati Children's Hospital Medical Center (2) 
Department of Surgery, University of Mississippi Medical Center, USA 
For abstract, see in oral presentation section page 71 
 
 
74. Reduced Sox9 function promotes heart valve calcification in vivo 
Jacqueline D Peacock*, Agata K Levay, and Joy Lincoln 
Molecular and Cellular Pharmacology, University of Miami Miller School of 
Medicine, Miami, Florida, USA 
For abstract, see in oral presentation section page 72 
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75. TGF-β3 and MMP3 contribute to the pathogenesis of a myxomatous 
mitral valve in canines. 
Koji Obayashi* (1,2), Sachiko Miyagawa-Tomita (2), Hirotaka Matsumoto (1), 
Hidekazu Koyama (1), Toshio Nakanishi (2), Hisashi Hirose (1) 
(1) Veterinary Internal Medicine, Nippon Veterinary and Life Science University, Tokyo, 
Japan (2)Department of Pediatric Cardiology, Tokyo Women’s Medical University, Tokyo, 
Japan 
 
Myxomatous degeneration of the mitral valve is observed in primary mitral valve 
prolapse (MVP) or marfan syndrome (MFS) in humans. The myxomatous 
changes are characterized by an accumulation of proteoglycans and a 
disruption of the collagenous and elastin matrix architecture. The studies of a 
murine model of MVP and MFS suggested that either enhanced matrix 
metalloproteinases (MMP) or transforming growth factor-beta (TGF-β) signaling 
may be related to the pathogenesis of myxomatous mitral valve. It has been 
reported that canine myxomatous mitral valve disease is similar to MVP in 
humans, and could be used as the models of human MVP. We compared TGF-
βs and MMPs expressions in the normal mitral versus myxomatous valves in 
canines. Expressions of TGF-β3, TGF-β receptor II, smooth muscle α-actin 
(αSMA) and matrix metalloproteinase 3 (MMP3) were only observed in 
myxomatous valves. In vitro culture system, TGF-β3 induced significantly 
increase levels of αSMA protein and proteoglycans. TGF-β3 activation and 
secretory rates were stimulated by MMP3 treatment. Total amount of TGF-β3 in 
valve interstitial cells (ICs) significantly decreased by angiotensin-converting 
enzyme inhibitor (ACEI) and angiotensin II receptor blocker (ARB). Our findings 
suggest that increased TGF-β3 and MMP3 contribute to the pathogenesis of a 
myxomatous degeneration. In addition, it is possible that ACEI and ARB could 
effectively block the degeneration of mitral valves. 
 
 
 
 
 
76. A Novel Role for Tie1 in Late Gestational Semilunar Valve Remodeling 
Kate Violette (1, 2), Xianghu Qu (2), Stan Hoffman (3), Peggi Angel (5), 
Hyunsoo Kim (6) Bin Zhou (4) Daniel O’Connell (6) Richard Maas (6) Chris 
Brown (2) and H. Scott Baldwin (1, 2) 
(1). Department of Cell and Developmental Biology and (2). Department of Pediatric 
Cardiology Vanderbilt University Medical School; (3). Medical University of South Carolina; 
(4). Albert Einstein College of Medicine; (5). Vanderbilt Mass Spectrometry Research 
Center; (6). Harvard Medical School, Brigham and Women’s Hospital. 
 
Tie1 is an endothelial specific receptor tyrosine kinase required for developing 
stable vasculature, endothelial cell survival and quiescence. Global knockouts of 
Tie1 result in embryonic lethality at about E13.5 due to vascular defects. No 
ligand for Tie1 has been identified, and downstream targets of receptor 
activation remain unknown. To circumvent early embryonic lethality and 
decipher the role of Tie1 in latter stages of valve development, our laboratory 
has developed a floxed Tie1 allele and a Cre transgenic line (NFATc-P2Cre) 
that is specific for the endocardium overlying the endocardial cushions and not 
in mesenchyme derived from EMT or other endothelial populations. Having 
documented efficient Cre mediated excision of Tie1 in the endocardium, we 
observed that aortic valves lacking Tie1 are hypertrophic. Mutant mice have an 
aortic valve area up to 2X greater than WT littermates from E14.5 through 
adulthood, though overall cell number remains unchanged. Interesting, no effect 
on pulmonary valve development was observed. Approximately half of the 
mutant mice die between E16.5 and P0. No alterations in endocardial or 
mesenchymal cell proliferation or apoptosis were detected, nor were 
abnormalities in endocardial cell morphology observed. However, extracellular 
matrix production of the valvular interstitium was clearly perturbed and an 
increase of proteoglycans and glycosoaminoglycans were visualized by Movat’s 
pentachrome stain. Immunostaining for periostin, a mesenchymal cell specific 
pericelluar matrix protein, suggested a delay in matrix remodeling. Because Cre 
mediated gene deletion was restricted to the endocardium and not detected in 
any mesenchymal cells, these data suggest that active endocardial to 
mesenchymal signaling, at least partially mediated by Tie1, is required for 
normal remodeling of the valves in the late gestation embryo. 
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77. FGF-BMP signaling axis in the valve development 
Jue Zhang*(1), , Julia Y. F. Chang(1,2),Yanqing Huang(1) Xiang Lin(1), Yongde 
Luo(1), Robert J. Schwartz(3,#), James F. Martin(1,3), and Fen Wang(1) 
(1)Center for Cancer and Stem Cell Biology, (3)Center for Molecular Development and 
Disease,Institute of Biosciences and Technology, (2)Department of Biochemistry, Baylor 
College of Dentistry, Texas A&M Health Science Center, 2121 W. Holcombe Blvd., 
Houston, TX 77030-3303. (#)Current address: Biology and Biochemistry Department, 
University of Houston, Houston, Texas 77204-5001, USA 
 
Congenital valve defects are common birth defects, but the underlying 
mechanism is poorly understood. Both OFT septum and OFT valve are derived 
from OFT cushion. However, how OFT cushion gives raise to these two distinct 
structure is unclear. In this report, we demonstrated that muscularization 
regulates the formation of OFT valve. By combination of multiple mouse genetic 
manipulations, cell lineage tracing, ex vivo heart culture, and molecular biology 
approaches, we showed fibroblast growth factor (FGF) signaling regulates valve 
formation through BMP4. Uncoupling these two signaling axes by double 
ablation of Fgfr1 and Fgfr2, single ablation of Frs2α or Bmp4, disrupted 
muscularization and resulted in enlarged OFT valves. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
78. Snai1 is required for MMP15 expression during endothelial to 
mesenchymal transformation and endocardial cushion formation 
Ge Tao*, Agata K. Levay, Jacqueline D. Peacock, Joy Lincoln 
Department of Molecular and Cellular Pharmacology, Leonard M. Miller School of 
Medicine, University of Miami, Miami, FL, USA 
 
Mature heart valve structures are derived from endocardial cushions (ECs) that 
form during embryonic development as a result of endothelial to mesenchymal 
transformation (EMT). This EMT process involves several phenotypic changes 
in endothelial cells including loss of cell-cell interactions and the acquisition to 
transform and migrate through matrix-rich tissue. The transcription factor Snai1 
has previously been shown to be required for EMT in many developmental 
systems through the repression of cell adhesion molecules, however its direct 
function in EC EMT has not been examined. In this study, we observed Snai1 
expression in endothelial and newly transformed mesenchyme cells of the ECs 
prior to and during EMT processes. To determine its function, Snai1 was 
overexpressed in avian EC explants in vitro, and conditionally knocked down in 
vivo using murine models. We show that increased Snai1 function is sufficient to 
promote EMT processes as indicated by significantly increased cell migration 
and transformation. In support, mice with reduced Snai1 function in endothelial-
derived cells exhibit a 39% (p=0.04) reduction in the number of mesenchymal 
cells within the ECs compared to controls. At the molecular level, this phenotype 
is associated with a 4.8-fold decrease (p=0.02) in MMP15 expression. 
Interestingly, EC explants treated with recombinant active MMP15, show 
increased cell migration with no change in cell transformation. This study shows 
that Snai1 is required for EC EMT, and identifies a new mechanism of Snai1-
mediated function for cell migration during this developmental process. 
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79. The Role of microRNA-21 in Zebrafish Cardiac Valve Formation. 
Toshihiro Banjo*(1), Minoru Omi(1), Kota Y. Miyasaka(1), Yasuyuki S. Kida(2), 
Toshihiko Ogura(1) 
(1) Institute of Development, Aging and Cancer (IDAC), Tohoku University, Japan (2) The 
Salk Institute, USA 
 
Recent research has revealed that atrioventricular valves (AVV) formation 
requires mechanical forces such as heart beating and blood flow. AVVs are lost 
when heart beat is disturbed by knocking down cardiac troponin T (Tnnt2) or 
treating embryos with BDM, cardiac ATPase inhibitor. The aim of our current 
research is to reveal what mediates mechanical forces with valvulogenesis. We 
hypothesized microRNAs (miRs) are one of the possible candidates from two 
reasons. First, some miRs are involved in cardiac defects and dysfunctions. 
Secondly, some miRs are up (down) regulated during cardiac hypertrophy 
implying their mechano-dependent expression. Hence, we searched miRs 
expressed in zebrafish hearts and found z-miR-21 expression in cardiac valves. 
MiR-21 is specifically expressed in endocardium of developing AVV. Moreover, 
miR-21 expression is downregulated by blocking heart beat suggesting miR-21 
expression depends on mechanical force. To confirm whether the mechanical 
force is involved in miR-21 expression, we conducted promoter assay on miR-
21 genomic region. MiR-21 promoter contains serum response factor (SRF) and 
E26 transforming sequence1 (ETS1) binding sites, which are highly conserved 
among various vertebrates. RhoA activates miR-21 expression through SRF site, 
and ETS1 also increased promoter activity. Previous reports suggest these 
signaling have responsiveness for mechanical force. Knock down by antisense 
morpholino oligo against miR-21 invites AVV formation defects. Furthermore, 
epithelial to mesenchymal transition (EMT) during valve formation fails to occur 
in miR-21 morphants. Taken together, miR-21 expression triggered by 
mechanical stress contributes to AVV formation. We’ll show updated datum on 
the function of miR-21 promoter responding to mechanical stress. 
 
 
 
 
 
80. Loss of the Type III Transforming Growth Factor-β Receptor is 
associated with enlarged AV cushions 
Jonathan H. Soslow* (1), Joseph D. Love (2), Brian C. Culbreath (3), Todd A. 
Townsend (2), and Joey V. Barnett (2) 
(1) Department of Pediatrics, Vanderbilt University Medical Center, Nashville, TN, USA (2) 
Department of Pharmacology, Vanderbilt University Medical Center, Nashville, TN, USA (3) 
Meharry Medical College, Nashville, TN, USA 
 
Transforming Growth Factor β (TGFβ) regulates endocardial cell epithelial-
mesenchymal transformation (EMT) in vitro and valvular remodeling during 
development in vivo. The Type III TGFβ receptor (TGFβR3) binds all TGFβ 
ligands and several BMP ligands. Gain- and loss-of-function experiments have 
demonstrated a requirement for TGFβR3 in TGFβ-stimulated EMT. Tgfbr3-/- 
mice have double outlet right ventricle, ventricular septal defects, and a thinned 
myocardium. Tgfbr3-/- embryos die at E14.5 due to failed coronary vessel 
development. Tgfbr3-/- embryos at stage E13.5 have enlarged atrioventricular 
(AV) cushion volumes compared with Tgfbr3+/+ and Tgfbr3+/- littermates. Given 
this finding, we asked if AV cushions were hypercellular or simply enlarged due 
to an increase in, or dysregulation of, the extracellular matrix. We used ImageJ 
software to calculate the AV cushion areas of 10 serial sections from E13.5 
Tgfbr3+/+ and Tgfbr3-/- littermates and counted the total number of cells. No 
significant difference was seen in the number of cells per square micron in the 
Tgfbr3-/- embryos (0.0034 ± 0.0013) and Tgfbr3+/+ embryos (0.0031 ± 0.0011) 
(n=3, p=0.06). These data suggest that the enlarged cushion volume is 
accompanied by an increase in total cell number. We next examined the rate of 
proliferation in AV cushions in E13.5 littermates. Tgfbr3-/- AV cushions showed 
decreased proliferation (19.7% ± 9.8%) when compared with Tgfbr3+/+ embryos 
(30.3% ± 9.8%) (n=2, p=0.02). Taken together, these data show that E13.5 
Tgfbr3-/- embryos, when compared to Tgfbr3+/+ embryos, have increased AV 
cushion volume, equivalent cell density in the cushions, and a decreased rate of 
cell proliferation. 
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81. Shear stress induced endoMT: the role of endothelial cilia. 
Anastasia D. Egorova* (1), Simone van de Pas (1), Marie-Jose T. H. Goumans 
(2), Surya M. Nauli (3), Robert E. Poelmann (1), Beerend P. Hierck (1). 
(1) Anatomy and Embryology, Leiden University Medical Center, The Netherlands (2) 
Molecular Cell Biology, Leiden University Medical Center, The Netherlands (3) 
Pharmacology and Medicine, College of Pharmacy and Medicine, University of Toledo, 
Ohio, OH, USA 
 
Primary cilia are mechanosensors for fluid shear stress and sensitize endothelial 
cells (EC) for shear. A flow related distribution of ciliated endothelial cells in the 
embryonic cardiovascular system has previously been described, with ciliated 
endothelial cells restricted to the areas of low shear in the embryonic heart. In 
the adult, primary cilia are located in areas of disturbed flow, a distribution 
reminiscent of atherosclerosis predisposition sites. In vitro cilia can be induced 
by flow disturbances, suggesting a role for primary cilia in endothelial activation 
and dysfunction. We studied the functional effect of cilia on the shear response 
of embryonic endothelial cells. To this aid, transgenic mouse embryonic 
endothelial cells (Tg737orpk/orpk) which are not able to build functional cilia 
were exposed to shear stress in a dedicated bioreactor. The morphological and 
functional response to flow was assessed by analyzing a set of shear and 
EndoMT markers. The response of Tg737orpk/orpk cells was compared to that 
of wild type ciliated embryonic EC. Wild type EC showed a normal response to 
shear accompanied by induction of the transcription factors Klf2 and Klf4, whilst 
Tg737orpk/orpk EC underwent EndoMT to gain a fibroblast like phenotype. This 
shear stress induced transition could be prevented by either interfering with the 
Tgf-β or shear induced Klf signaling. In the current study we provide evidence 
for the role of cilia in defining a functional response of endothelial cells to fluid 
flow. 
 
 
 
 
 
 
 
 
 
82. Position of coronary artery ostia in conotruncal defects 
Lucile Houyel* (1), Fanny Bajolle (2), Damien Bonnet (2). 
(1) Centre Chirurgical Marie-Lannelongue M3C, Université Paris-Sud, Paris, France (2) 
Necker-M3C, Université Paris Descartes, Paris, France 
 
Abnormal coronary ostia are frequently associated with conotruncal defects 
particularly with common arterial trunk (CAT). Recent study in mouse has shown 
that Tbx1 controls outflow tract development and coronary artery patterning, 
with subaortic coronary-permissive and subpulmonary coronary-refractory 
myocardial domains. In order to determine if abnormal outflow tract 
development influences coronary ostia position, we rewieved heart specimens 
with conotruncal defects : 46 CAT, 29 tetralogy of Fallot with pulmonary atresia 
(TOF&PA), 15 tetralogy of Fallot (TOF), 11 double-outlet right ventricle with 
subaortic ventricular septal defect (DORV) and 17 normal anatomy (control). 
Position of the coronary ostia over the aortic or truncal circumference was 
measured in degrees as the direction from the middle of the valvar orifice. The 
left coronary ostium was more posterior in conotruncal defects vs control (mean 
angle : control=0°, TOF=31°, TOF&PA=47°, DORV=44°, CAT=65°, p<0.005) 
especially in CAT vs other conotruncal defects (p<0.05). The right coronary 
ostium was more anterior in TOF, TOF&PA and DORV vs control (mean angle : 
control=213°, TOF=242°, TOF&PA=245°, DORV=271°, p<0.05) especially in 
DORV vs TOF and TOF&PA (p<0.05), but not in CAT (195°). The anterior 
intercoronary angle, which corresponds to the pulmonary identity domain, was 
similar in TOF, TOF&PA, DORV and control (133°-162°) but significantly larger 
in CAT (229°, p<0.0001). Anomalies of outflow tract rotation responsible for 
conotruncal defects significantly affect the position of the coronary ostia. The 
marked difference between CAT and other conotruncal defects could reflect the 
impact of associated septation anomaly on the width of the subpulmonary 
coronary-refractory domain. 
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83. Anomalies of coronary artery ostia in common arterial trunk. 
Lucile Houyel (1), Fanny Bajolle* (2), Damien Bonnet (2). 
(1) Centre Chirurgical Marie-Lannelongue M3C, Université Paris-Sud, Paris, France (2) 
Necker-M3C, Université Paris Descartes, Paris, France 
 
Tbx1 controls outflow tract development and coronary artery patterning in 
mouse, with subaortic coronary-permissive and subpulmonary coronary-
refractory myocardial domains. Our hypothesis is that the potential “pulmonary 
identity” of the common arterial trunk (CAT) influences coronary ostia anomalies. 
Thus, we reviewed 46 heart specimens with CAT and 17 with normal anatomy 
(control). Position of the coronary ostia over the truncal circumference was 
measured in degrees as the direction from the middle of the valve orifice. CAT 
types were: 28 type I, 8 type II, 3 type III, 7 type IV. The truncal valve was 
bicuspid in 2, tricuspid in 36, quadricuspid in 7. Overall, 87% cases had 
malformations of the coronary ostia size, shape, location relative to the 
commissures or sinotubular junction. Left coronary ostium had abnormal shape 
or size in 33/46, right coronary ostium in 20/46 (p<0.01). Left coronary ostium 
was located above a commissure in 17% vs 2% for right coronary ostium 
(p<0.05) and above the sinotubular junction in 28% vs 10% (p=0.053). Left 
coronary ostium was more posterior than in control (65° vs 0°, p<0.0001), right 
coronary ostium was located similar to control (195° vs 213°). The anterior 
intercoronary angle, reflecting pulmonary identity domain, was 229° in CAT vs 
147° in control (p<0.0001). Left coronary ostium in CAT is more frequently 
abnormal than right coronary ostium. This might be due to the obligatory dorsal 
connection of left coronary ostium because of the large coronary-refractory 
subpulmonary domain in the ventral left part of the CAT. 
 
 
 
 
 
 
 
 
 
 
 
 
 
84. Notch and Bmp2 signaling integration during valve formation 
Luis Luna-Zurita (1), Belén Prados (1), Joaquim Grego-Bessa (1), Gonzalo del 
Monte (1), Guillermo Luxán (1), Alberto Benguria (1), Ralf H Adams (3), Jose 
María Pérez-Pomares (4) and Jose Luis de la Pompa* (1) 
(1) Cardiovascular Developmental Biology Centro Nacional de Investigaciones 
Cardiovasculares (CNIC) Melchor Fernández Almagro 3, 28029 Madrid SPAIN (2) Max-
Planck-Institute for Molecular Biomedicine and University of Mu ̈nster, Faculty of Medicine, 
Mu ̈nster, Germany. (3) Departamento de Biología Animal, Facultad de Ciencias, 
Universidad de Málaga E-29071 Málaga, Spain 
 
Despite the prevalence of cardiac valve disease, little is known about the 
molecular circuitry regulating heart valve morphogenesis. We find that Notch 
and Bmp2 act coordinately to establish a valve-forming field between two 
chamber developmental domains. Patterning occurs via the activation of 
epithelial-to-mesenchymal-transition (EMT) in non-chamber endocardium. Mice 
with constitutive endocardial Notch1 expression activate a mesenchymal gene 
program in ventricles (Snail1-2, Twist2, Tgfß2) and a partial ectopic EMT in vitro 
that becomes invasive upon BMP2 treatment. Inhibition of Snail1, Tgfβ2 or 
Notch1 reduces BMP2-induced ventricular transformation and invasion, while 
BMP2 treatment inhibits endothelial Gsk3β, stabilizing Snail1 and promoting 
invasiveness. Integration of Notch and Bmp2 signals is demonstrated by 
attenuated Notch1 transcription and signaling after Bmp2 myocardial deletion, 
while Notch1 myocardial activation extends Hey1 expression to non-chamber 
myocardium, represses Bmp2 and impairs EMT. We propose that the interplay 
between myocardial-Bmp2 and endocardial-Notch1 restricts EMT to prospective 
valve territory. 
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85. PLD1 is required for endocardial cell transformation in vitro 
Dan M. DeLaughter*(1), H. Alex Brown (2), H. Scott Baldwin (3), Joey V. Barnett 
(2) 
(1) Department of Cell and Developmental Biology, Vanderbilt University Medical Center, 
Nashville, TN, USA (2) Department of Pharmacology, Vanderbilt University Medical 
Center, Nashville, TN, USA (3) Department of Pediatrics, Vanderbilt University Medical 
Center, Nashville, TN, USA 
 
A pivotal early step in valvulogenesis occurs when a subpopulation of 
endocardial cells overlaying the pro-valvular cardiac cushions undergo an 
epithelial to mesenchymal transformation (EMT). These mesenchymal cells 
seed the cardiac cushions, eventually remodeling the extracellular matrix and 
contributing to the valves and septa of the adult heart. Phospholipase D (PLD) 
catalyses the hydrolysis of phosphatidylcholine into phosphatidic acid (PA) and 
choline. PA acts as a lipid second messenger to regulate cell processes 
including adhesion, migration, cytoskeleton organization, and cancer 
progression. Although PLD1 and PLD2 are linked to EMT in cancer cells and 
migration in adult endothelial cells, the role of PLD in endothelial cell EMT is 
unknown. To address the role of PLD in endocardial cell EMT, atrioventricular 
cushions were explanted from Hamburger-Hamilton Stage 14 chicken embryos 
onto collagen 1 gels and incubated with small molecule inhibitors specific for 
PLD1 (VU0155069, 5µM), PLD2 (VU0285655-1, 5µM), or a pan PLD inhibitor 
(VU0155056, 5µM). The number of cells entering the gel was decreased by 
87.5% ±3.10% (n=3) with PLD1 inhibition, 18.2% ±12.6% (n=3), with PLD2 
inhibition, and 72.8% ±3.90% (n=3) with pan inhibition. Similar results were 
obtained with 500nM of inhibitor. To confirm the involvement of PLD, incubation 
with 1-butanol (0.6%) resulted in a 75.6% ±3.86% (n=3) decrease in cell 
invasion while 3-butanol (0.6%) had no effect when compared to vehicle alone. 
These data are the first to implicate PLD in endocardial cell EMT in vitro and 
suggest PLD1 as a candidate downstream effector for growth factors that 
regulate valvulogenesis. 
 
 
 
 
 
 
86. Arsenic Exposure Perturbs Epithelial-Mesenchymal Cell Transition 
(EMT) and Gene Expression In a Collagen Gel Assay 
Alejandro Lencinas*(1,2), Derrick M. Broka(1), Jay H. Konieczka(3), Scott E. 
Klewer(4), Parker B. Antin(2), Todd D. Camenisch(1), Raymond B. Runyan(2). 
(1)Departments of Pharmacology and Toxicology, (2)Cell Biology and Anatomy and 
(3)Molecular and Cellular Biology, 4Pediatrics, The University of Arizona, Tucson , AZ, 
USA. 
 
Arsenic is a naturally occurring metalloid and environmental contaminant. 
Arsenic exposure in drinking water is reported to cause cancer of the liver, 
kidneys, lung, bladder and skin as well as birth defects including neural tube, 
facial and vasculogenic defects. The early embryonic period most sensitive to 
arsenic includes a variety of cellular processes. One key cellular process is 
epithelial-mesenchymal transition (EMT) where epithelial sheets develop into 
three-dimensional structures. An embryonic prototype of EMT is found in the 
atrioventricular (AV) canal of the developing heart, where endothelia 
differentiate to form heart valves. Effects of arsenic on this cellular process were 
examined by collagen gel invasion assay (EMT assay) using explanted AV 
canals from chicken embryo hearts. AV canals treated with 12.5-500 ppb 
arsenic, showed a loss of mesenchyme at 12.5 ppb and mesenchyme formation 
was completely inhibited at 500 ppb. Altered gene expression in arsenic-treated 
explants was investigated by microarray analysis. Genes whose expression was 
altered consistently at exposure levels of 10, 25, 100 ppb were identified and 
results showed that 25 ppb in vitro was particularly effective. 382 genes were 
significantly altered at this exposure level. Cytoscape analysis of the microarray 
data using the chicken interactome identified 4 clusters of altered genes based 
upon published relationships and pathways. This analysis identified cytoskeleton 
and cell adhesion-related genes whose disruption is consistent with an altered 
ability to undergo EMT. These studies show that EMT is sensitive to arsenic, 
and that an interactome-based approach can be useful in identifying targets. 
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87. Developmental Basis of Myxomatous Mitral Valve Disease 
Russell Norris*, Ricardo Moreno-Rodriguez, Andy Wessels, Roger Markwald 
Department of Regenerative Medicine and Cell Biology, Cardiovascular Developmental 
Biology Center, Children's Research Institute, Medical University of South Carolina, 
Charleston, SC, USA 
 
Myxoid cardiac valves is a common feature in a heterogeneous group of 
disorders that includes Marfan syndrome and isolated valvular diseases. Mitral 
valve prolapse is the most common outcome of these and remains one of the 
most common indications for valvular surgery. While the etiology of the disease 
is unknown, recent genetic studies have demonstrated that an X-linked form of 
familial cardiac valvular dystrophy can be attributed to mutations in the Filamin-
A gene. Since these inheritable mutations are present from conception, we 
hypothesize that filamin-A mutations present at the time of valve morphogenesis 
lead to dysfunction that progresses postnatally to clinically relevant disease. 
Therefore, by carefully evaluating genetic factors (such as filamin-A) that play a 
substantial role in MVP, we can elucidate relevant developmental pathways that 
contribute to its pathogenesis. In order to understand how developmental 
expression of a mutant protein can lead to valve disease, the spatio-temporal 
distribution of filamin-A during cardiac morphogenesis was characterized. We 
demonstrate that filamin-A is robustly expressed in non-myocyte cells 
throughout cardiac morphogenesis including epicardial and endocardial cells, 
and mesenchymal cells derived by EMT from these two epithelia, as well as 
mesenchyme of neural crest origin. In postnatal hearts, expression of filamin-A 
is significantly decreased in the atrioventricular and outflow tract valve leaflets 
and their suspensory apparatus. Mechanistic studies have suggested that 
filamin-A can be post-translationally modified by a post-EMT, valve-specific 
enzyme and in doing so, promotes the compaction and organization of the 
extracellular matrix. These studies provide mechanistic insight into how 
cytoskeletal changes, mediated by enzymatic post-translational modifications 
can drive maturation of the valve. 
 
 
 
 
88. Bmp-2 And Tgfβ2 Shared Pathways Regulate Endocardial Cell 
Epithelial-Mesenchymal Transformation 
Todd A. Townsend (1), Jamille Y. Robinson* (1), Christopher R. Deig (1), 
Cynthia R. Hill (1), Andrew Misfeldt (2), Gerard C. Blobe (3), and Joey V. 
Barnett (1) 
(1) Departments of Pharmacology, Vanderbilt University Medical Center, Nashville, TN 
37232-6600 USA (2) Departments Cell & Developmental Biology, Vanderbilt University 
Medical Center, Nashville, TN 37232-6600 USA (3) Departments of Pharmacology and 
Cancer Biology and Medicine Duke University, Durham, North Carolina USA 27708 
 
Valvular heart disease is a major cause of mortality and morbidity. Revealing the 
cellular processes and molecules that regulate valve formation and remodeling 
is required to develop effective therapies. A key step in valve formation during 
heart development is epithelial-mesenchymal transformation (EMT) of a 
subpopulation of endocardial cells in the atrioventricular cushion (AVC). The 
Type III Transforming Growth Factor β Receptor (TGFβR3) regulates AVC 
endocardial cell EMT in vitro and mesenchymal cell differentiation in vivo. 
Relatively little is known concerning the signaling mechanisms downstream of 
TGFβR3. Here we use endocardial cell EMT in vitro to determine the role of two 
well characterized downstream TGFβ signaling pathways in TGFβR3-mediated 
endocardial cell EMT. Targeting of Smad4, the common mediator Smad, 
demonstrated that Smad signaling is required for EMT in the AVC and TGFβR3-
mediated EMT stimulated by TGFβ2 or BMP-2. Although we show that Smads1, 
2, 3, and 5 are required for AVC EMT, overexpression of Smad1 or Smad3 is 
not sufficient to induce EMT. Consistent with the activation of the 
Par6/Smurf1/RhoA pathway downstream of TGFβR3, targeting ALK5, Par6, or 
Smurf1 significantly inhibited EMT in response to either TGFβ2 or BMP-2. The 
demonstrated requirement for ALK5 activity, Par6, and Smurf1 for TGFβR3-
mediated endocardial cell EMT is consistent with the documented role of this 
pathway in the dissolution of tight junctions after RhoA degradation. Taken 
together, our data demonstrate that TGFβR3-mediated endocardial cell EMT 
stimulated by either TGFβ2 or BMP-2 requires Smad4 and activation of the 
Par6/Smurf1/RhoA pathway. 
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89. Periostin mediates Transforming Growth Factor beta2 function in valve 
development 
Mohamad Azhar* (1, 2), Nathan Kim (1), Edward Distler (1), Connie Gard (1), 
Raymond Runyan (2), Simon J. Conway (3), Tom Doetschman (1, 2) 
(1) BIO5 Institute, University of Arizona, Tucson, AZ, USA (2) Dept. Cell Biology & 
Anatomy, University of Arizona, Tucson, AZ, USA (3) Riley Heart Research Center, 
Herman B. Wells Center for Pediatric Research, Indiana University School of Medicine, 
Indianapolis, IN, USA. 
 
Transforming Growth Factor beta (TGFbeta) play important role in cardiac 
cushion epithelial-mesenchymal transition (EMT) and cushion remodeling, and 
Periostin (POSTN) which is a fasciclin-containing adhesive glycoprotein 
facilitates the differentiation of cells that have undergone EMT during cushion 
remodeling and maturation. In situ hybridization revealed that TGFbeta2 and 
TGFbeta3 genes were expressed in complementary fashion to POSTN gene in 
developing cardiac valves. Both TGFbeta2-deficient and POSTN-deficient mice 
exhibited cushion remodeling defects. Here, we present in vitro and in vivo data 
which are consistent with the notion that an elevated TGFbeta signaling which 
induces POSTN is involved in valve thickening in TGFbeta2-deficient mice. 
Immunohistochemical analysis showed that TGFbeta2-deficient, and not 
TGFbeta1- or TGFbeta3-deficient, valvular fibroblasts had increased levels of 
POSTN in cardiac valves. In vitro studies using mouse embryonic fibroblasts 
(MEFs) showed that POSTN gene expression was similarly increased in 
TGFbeta2-deficient MEFs. Further experiments showed that elevated POSTN 
gene expression seen in TGFbeta2-deficient MEFs was significantly reduced by 
TGFbeta signaling inhibitor (SB-431542). The data also revealed the existence 
of a feedback mechanism. Briefly, TGFbeta2-deficient MEFs induced TGFbeta1 
gene expression when challenged with the exogenous TGFbeta1. In addition, 
TGFbeta signaling effectors pSMAD2 and pSMAD1/5 increased sharply in 
response to TGFbeta treatment in TGFbeta2-deficient MEFs as compared to 
wild-type MEFs. Finally, these findings were consistent with the elevated levels 
of TGFbeta1 in cardiac cushions of TGFbeta2-deficient mice. In conclusion, 
these data provide evidence that Periostin is a downstream target gene of 
TGFbeta signaling and that it mediates TGFbeta2 function during 
valvulogenesis. (Funding-R01HL92508-Conway-Doetschman. 
 
 
 
 
 
90. Origin, Development, and Fate of the Dorsal Mesenchymal Protrusion 
Marie Lockhart*, Brian Snarr, Laura Briggs, Brett Harris, Chip Norris, Andy 
Wessels 
Regenerative Medicine and Cell Biology, Medical University of South Carolina, 
Charleston, SC, USA 
 
Proper septation and segmentation of the 4-chambered heart is critically 
dependent on the development of the atrioventricular mesenchymal complex 
(AVMC). The AVMC is formed by the fusion of several mesenchymal tissues in 
the developing heart, including the major atrioventricular (AV) cushions, the 
mesenchymal cap on the leading edge of the primary atrial septum, and the 
dorsal mesenchymal protrusion (DMP). Immunohistochemical studies, in 
combination with lineage tracing using Tie2-cre and Mef2C-AHF-cre mouse 
models, have demonstrated that while the AV cushions and “cap” are 
endocardially-derived, the DMP is an anterior (or second) heart field-derived 
tissue. Our recent studies on the Ts16 mouse and Crtl1 knock-out mouse, and 
studies by others using different mouse models, demonstrate that abnormal 
development of the DMP is associated with the pathogenesis of atrioventricular 
septal defect (AVSD; Snarr et al., 2007b; Wirrig et al., 2007; Goddeeris et al., 
2008). AVSD is a congenital heart malformation characterized by an ostium 
primum atrial septal defect, and in many cases ventricular septal defect, a 
common AV valve, and a persistent AV canal. AVSDs are found in 
approximately 5% of the general population of all patients suffering from 
congenital heart disease and in 20-25% of individuals with Down Syndrome. Our 
lab is interested in elucidating the role of the DMP in valvuloseptal 
morphogenesis. Here we will present new data that will further understanding of 
the origin, development and fate of the DMP. 
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91. Elastin Haploinsufficiency is Associated with Progressive Aortic Valve 
Malformation, Latent Valve Disease and Decreased TGF-beta Signaling in 
a Mouse Model 
Robert B. Hinton* (1), Jennifer Adelman-Brown (1), Sandra Witt (1), Hanna 
Osinska (2), Bhuvaneswari Sakthivel (3), Jeanne James (2), Robert P. Mecham 
(4), D. Woodrow Benson (1) 
Divisions of Cardiology (1), Molecular Cardiovascular Biology (2), Bioinformatics (3), 
Cincinnati Children’s Hospital Medical Center, Cincinnati, Ohio, and Department of Cell 
Biology and Physiology (4), Washington University, St Louis, Missouri 
 
Elastin is an extracellular matrix (ECM) component of heart valves. Based on 
findings in a patient with elastin haploinsufficiency and valve disease, we 
hypothesized that elastin insufficient mice (Eln+/-) would manifest viable heart 
valve disease. Heterozygous mutant mice were analyzed at neonatal, juvenile, 
adult and aged adult stages; homozygous mutants were analyzed at the 
neonatal stage only. Valve function was evaluated in vivo using 
echocardiography (VisualSonics). Juvenile mice demonstrated normal valve 
function, but valve disease was identified in 17% adult and 70% aged adult 
Eln+/- mice (predominantly aortic insufficiency). Histochemical analysis 
demonstrated normal morphology and ECM organization at the neonatal stage, 
attenuation of the annulus including fragmented elastin infiltration of the annulus 
at the juvenile stage, thin elongated cusps and ECM disorganization at the adult 
stage, and overgrowth of the annulus with proteoglycan accumulation at the 
aged adult stage. Ultrastructure analysis in Eln+/- mice demonstrated loss of 
ECM stratification, increased proteoglycans, and annular elastin fragmentation. 
Neonatal Eln+/- mice demonstrated increased valve interstitial cell (VIC) 
proliferation (p-HistoneH3), and neonatal juvenile and adult mice showed VIC 
activation (SMA, SMemb). Interestingly, TGF-beta signaling (p-Smad2) was 
decreased in neonatal Eln-/- mice; there was a modest but not statistically 
significant decrease in Eln+/- mice. However, gene expression analysis 
(Affymetrix) identified a significantly decreased TGF-beta mediated fibrogenesis 
signaling pathway in juvenile Eln+/- mice. These findings identify the Eln+/- 
mouse as a model of latent valve disease, implicate decreased TGF-beta as an 
underlying mechanism of maladaptive ECM remodeling, and establish a role for 
elastin in valve pathogenesis. 
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Session B - Cardiac Progenitor Cells 
 
92. Endothelial progenitors contribute to the heart endocardium and play 
key roles in cardiac development 
Michal Milgrom-Hoffman*(1), Napoleone Ferrara(3), Elazar Zelzer(2) and Eldad 
Tzahor(1) 
(1) Department of Biological Regulation,Weizmann Institute of Science, Rehovot, 
Israel (2) Department of Molecular Genetics, Weizmann Institute of Science, 
Rehovot, Israel (3) Genentech, Inc., San Francisco, California, USA 
For abstract, see in oral presentation section page 37 
 
 
 
 
 
 
 
 
 
93. Identification of micro RNAs involved in cardiac specification in 
mESCs 
Alexandre Colas*, Wesley McKeithan, Mark Mercola 
Muscle Development and Regeneration Program, Sanford|Burnham Medical 
Research Institute, La Jolla, CA, USA 
For abstract, see in oral presentation section page 38 
 
 
 
 
 
 
 
 
 
94. Regulation of cardiac progenitor cells during heart development 
Francesca Rochais* and Robert G. Kelly 
Developmental Biology Institute of Marseilles-Luminy, CNRS UMR 6216-
Université de la Méditerranée, 13288 Marseille, France. 
For abstract, see in oral presentation section page 39 
 
 
 
 
 
 
 
 
95. Hematopoietic cell contribution to embryonic mouse valve 
development and adult valve homeostasis 
Zoltan Hajdu* (1), Roger R Markwald (1), Christopher C Drake (1), Imre Olah (2), 
Richard P Visconti (1) 
(1) Regenerative Medicine & Cell Biology and the Cardiac Developmental 
Biology Center, Medical University of South Carolina, Charleston, SC, USA (2) 
Human Morphology and Developmental Biology, Semmelweis University, 
Budapest, Hungary 
For abstract, see in oral presentation section page 40 
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96. Intrinsic Fluorescence: Non-invasive Signatures of Embryonic Stem 
Cells and the Implications for Multiphoton Flow Cytometry 
Jayne M. Squirrell* (1,2), David G. Buschke (2,1), Amber Mael (3), Kevin W. 
Eliceiri (1,2), Gary E. Lyons (4,1), Nirupama Shevde (3), Timothy J. Kamp (5,1), 
and Brenda M. Ogle (2,1) 
(1) Laboratory of Optical and Computational Instrumentation, University of Wisconsin, 
Madison, WI, USA (2) Biomedical Engineering, University of Wisconsin, Madison, WI, 
USA (3) WiCell Research Institute, Madison, Wisconsin, WI, USA (4) Department of 
Anatomy, University of Wisconsin, Madison, WI, USA (5) Department of Medicine, 
University of Wisconsin, Madison, WI, USA 
 
Advances in cell research and cell therapies, such as repair of cardiac tissue 
following infarction, depend on technologies that accurately and non-invasively 
assess cell state, both as single cells and as 3D entities. Defining intrinsic 
biomarkers that characterize stem cell state advances this goal by reducing the 
need for extrinsic labels. Several pieces of evidence suggest that pluripotent 
cells are metabolically distinct from differentiated cells. Since autofluorescent 
metabolites can be noninvasively detected by advanced optical methods, we 
reasoned that these endogenous fluorophores might serve as unique, intrinsic 
indicators of differentiation state. Indeed, we have identified changes in the 
autofluorescent properties of embryonic stem cells during differentiation, utilizing 
multiphoton laser scanning microscopy (MPLSM), with its ability to probe deep 
within multicellular aggregates, and fluorescence lifetime imaging (FLIM), for 
detecting changes in the fluorescence microenvironment. Using a wavelength to 
excite the metabolic intermediate nicotinamide adenine dinucleotide (NADH), we 
found that the fluorescence lifetime of NADH decreases during the initiation of 
differentiation, in both mouse and human embryonic stem cells. Furthermore, 
cardiomyocytes developed from human embryonic stem cells exhibit longer 
fluorescence lifetimes than non-beating cells. These differences could be 
exploited by screening and sorting technologies. We are currently combining 
these observations with a modular, stage-mounted multiphoton flow cytometry 
(MPFC) system that could ultimately sort cellular aggregates, such as embryoid 
bodies or engineered constructs, based on their specific endogenous 
fluorescence signatures. 
 
 
97. Endogenous Retinoic Acid Regulates Cardiac Progenitor 
Differentiation 
Song-Chang Lin (1), Pascal Dollé (2), Lucile Ryckebusch (3), Michela Noseda 
(4), Stéphane Zaffran(3), Michael D. Schneider (4), and Karen Niederreither* (1) 
(1) Baylor College of Medicine & I.B.T., Houston, Texas , USA (2) IGBMC, Strasbourg, 
France (3) Université de la Méditerranée, Marseille, France (4) Imperial College London, 
UK 
 
Retinoic acid (RA) has several established functions during cardiac 
development, including actions in the fetal epicardium required for myocardial 
growth. An open question is if retinoid effects are limited to growth factor 
stimulation pathway(s) or if additional actions on uncommitted progenitor/stem 
populations might drive cardiac differentiation. Here we present the first report of 
dual effects of RA-deficiency on cardiac growth factor signaling and 
progenitor/stem biology using the mouse retinaldehyde dehydrogenase 2 
(Raldh2) knockout model. While early heart defects in Raldh2-/- embryos result 
from second heart field abnormalities, it is unclear whether this role is transient 
or whether RA has sustained effects on cardiac progenitors. To address this, we 
employed transient maternal RA supplementation to overcome early Raldh2-/- 
lethality. By E11.5-14.5 Raldh2-/- hearts exhibit reduced venticular compact 
layer outgrowth and defective coronary artery development. While reductions in 
-catenin expressionβFgf2 and target pERK levels occur, no alterations in Wnt/ 
are observed. Cell proliferation is increased in compact zone myocardium, while 
cardiomyocyte differentiation is reduced, alterations suggesting progenitor 
defects. We report that the fetal heart contains a reservoir of stem/progenitor 
cells, which can be isolated by their ability to efflux a fluorescent dye, and that 
retinoid signaling acts on this fetal cardiac side population (SP). Raldh2-/- hearts 
display increased SP cell numbers, with selective increases in expression of 
cardiac progenitor cell markers and reduced differentiation marker levels. Hence, 
while lack of RA signaling increases cardiac SP numbers, simultaneous 
reductions in Fgf signaling reduce cardiomyocyte differentiation, possibly 
accounting for long-term defects in myocardial growth. 
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98. Notch Post-translationally Regulates β-Catenin Protein in Stem Cells 
and Human Cancer Cells 
Chulan Kwon§*, Paul Cheng§, Isabelle King, Vishal Nigam and Deepak 
Srivastava 
Gladstone Institute of Cardiovascular Disease and Departments of Pediatrics 
and Biochemistry & Biophysics, University of California, San Francisco, 1650 
Owens Street, San Francisco, CA 94158, USA §These authors contributed 
equally to this work 
 
Human stem cells and cancer cells are characterized by self-renewing 
properties, but can be induced to differentiate with appropriate cues. Notch and 
Wnt signaling often play critical yet antagonistic roles in such cell fate decisions, 
suggesting the presence of reciprocal regulation. Wnt signals promote self-
renewal of stem and cancer cells by inhibiting the APC-dependent destruction 
complex, thereby post-translationally stabilizing β-Catenin protein. Human 
mutations in APC result in excess β-Catenin and are linked to development of 
colorectal cancer. Here, we describe a second, APC-independent mechanism 
for post-translational regulation of β-Catenin that involves the 
receptor/transcription factor, Notch. In vitro, Notch negatively regulated β-
Catenin protein and Wnt activity in embryonic stem cells, lineage-specific 
progenitor cells as well as human APC-mutant colorectal cancer cells. In vivo, 
expression of Notch in cardiac progenitor cells countered the excess 
proliferation induced by mutant β-Catenin protein resistant to APC-mediated 
degradation. This study reveals a previously unrecognized function of Notch in 
negatively regulating active β-Catenin protein levels, independent of the APC-
degradation complex, in stem and cancer cells. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
99. Characterization of RCSD1 during heart development 
Michael Kühl*, Susanne Gessert, Tata Puruhosthama Rao, Ovidiu Sirbu 
Institute of Biochemistry and Molecular Biology, Ulm University, 89069 Ulm, 
Germany 
 
Duboraya has recently been shown to be important for zebrafish left-right 
asymmetry via non-canonical Wnt signalling. In human, the Duboraya 
homologue CapZIP (CapZ interacting protein) is a key player in modulating the 
actin cytoskeleton during stress. In this study, we have identified the Duboraya 
homologue in Xenopus laevis and mouse, named RCSD1. In both organisms, 
several splice variants could be detected by RT-PCR and sequencing. RCSD1 
is localized in the cytoplasm as well as in the nucleus in cell lines. Nuclear 
import of RCSD1 depends on phosphorylation by JNK. In mouse, RCSD1 is 
expressed in the developing heart as well as in neural tissue and paraxial 
mesoderm. In Xenopus, the first heart-specific expression can be detected at 
stage 20 in the cardiac progenitor cell population. Loss of function studies in 
murine ES cells indicate a requirement for RCSD1 during cardiac development. 
Similar, loss of function analysis in Xenopus using a specific antisense 
morpholino oligonucleotide revealed that RCSD1 is required for normal heart 
development but not left-right asymmetry or cilia formation. Our data identify 
RCSD1 as a novel key molecule for early cardiac development. 
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100. A new model to determine cardiomyocyte progenitor cell 
differentiation and function 
Anke Smits (1), Lisa van den Hengel (2), Corina Metz (2), Stieneke van den 
Brink (3), Pieter Doevendans (2, 4) , Marie-Jose Goumans (1) 
(1) Molecular Cell Biology, Leiden University Medical Center Leiden (2) Department of 
Cardiology, University Medical Center Utrecht. (3) Hubrecht Institute-KNAW & University 
Medical Center Utrecht. (4) Interuniversity Cardiology Institute, the Netherlands (ICIN) 
 
Purpose: The origin and potential of cardiomyocyte progenitor cells (CMPCs) in 
the adult heart remains unclear. The aim of this project is to study if CMPCs, 
recruited from the circulation or resident in the heart, contribute to myocardial 
repair after damage. Methods: Mouse models are generated that can be used to 
visualize differentiation of progenitor cells into a specific cell type, whilst at the 
same time allowing controlled removal of these cells. A β-actin-promoter drives 
the expression of a flox-eGFP-stop-cassette, nitroreductase (NTR) and IRES-
LacZ (ActENIL). NTR itself is harmless, but converts the pro-drug CB1954 into 
an apoptosis-inducing agent. By placing Cre-recombinase under control of an 
early cardiac enhancer element, the expression of LacZ and NTR is targeted to 
CMPCs. Results: Mouse embryonic stem cells (mESC), stably expressing 
ActENIL, were transfected with CMV-Cre, leading to LacZ and NTR expression. 
Addition of CB1954 resulted in death of LacZ+ cells. To test cell-type specificity, 
Tie-2-Cre was transfected into ActENIL-mESC to target endothelial cells. After 
embryoid body formation, addition of CB1954 resulted in abrogated vessel 
formation. Chimeric mice were produced using ActENIL-mESC. Additionally, to 
target developing cardiomyocytes, nkx-enhancer element (NEE)-Cre and 
tamoxifen inducible NEE-mER-Cre-mER mice were generated. We are currently 
validating these mouse lines for the presence of eGFP, and Cre mediated 
expression of LacZ and NTR. Furthermore, we are determining the time-frame 
of the NEE-promoter activity during embryonic development. Ultimately, these 
newly developed mouse lines will provide a system to observe the contribution 
of CMPCs to cardiac repair after MI. 
 
 
 
 
101. Isolation and characterization of multipotent human NKX2-5 
cardiovascular progenitors 
David A. Elliott 1*, Stefan R. Braam2*, Elizabeth S. Ng1, Dorien Ward van 
Oostwaard2, Katerina Koutsis1, Tanya Hatzistavrou1, Leon Tertoolen1, Robert 
Passier2, Christine L. Mummery2, Andrew G. Elefanty1 and Eduard G. Stanley 
1. 
1 Monash Immunology and Stem Cell Laboratories, Lvl 3, Building 75, Monash 
University, Victoria, 3800, Australia. 2 Department of Anatomy and Embryology, 
Leiden University Medical Center, Einthovenweg 20, 2333 ZC Leiden, The 
Netherlands. (*) These authors contributed equally 
Cardiac progenitor cells give rise to the major cellular components of the heart. 
Understanding how they form and what they can become has important 
implications for elucidating the mechanisms underlying (abnormal) heart 
development. In addition, the ability to isolate these cells from pluripotent stem 
cells allows characterization of their properties and possibly expansion in culture, 
a crucial step for advancing cardiac translational medicine. Functional analysis 
of these cells has been hampered by the paucity of lineage specific markers and 
inefficient, undefined differentiation procedures. Here we describe the targeted 
modification of two independent human embryonic stem cell (hESC) lines in 
which EGFP was inserted into the locus of NKX2-5, one of the earliest 
transcription factors expressed in heart development. EGFP fluorescence driven 
by the endogenous NKX2-5 promoter faithfully reported cardiovascular lineage 
commitment of differentiating hESC under defined culture conditions. The early 
NKX2-5 positive cell population showed multilineage differentiation potential to 
cardiomyocytes, endothelial and vascular smooth muscle cells. NKX2.5 
overlapped only partially with previously reported selection markers for the 
cardiovascular lineage. These data are compatible with expectations from heart 
development and identify a progenitor population that can give rise to the three 
major cell types of the heart. Taken together, these experiments demonstrate 
the utility of hESC for analyzing the previously inaccessible events of human 
cardiac lineage specification. 
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102. The origin and migration of secondary heart field progenitors 
Esther Camp* and Andrea Munsterberg 
School of Biological Sciences. The University of East Anglia. Norwich, UK 
 
In vertebrates, the progenitor cells that will become the heart are among the first 
cell lineages to be established and to gastrulate through the primitive streak. In 
the chicken embryo cardiac progenitors that form the myocardium have been 
mapped to the anterior two thirds of the primitive streak. Lineage analyses have 
demonstrated the presence of primary and secondary heart field progenitor cells, 
which contribute to different parts of the heart. The ‘two heart field’ analogy 
describes two waves of cardiac progenitor cell migration into the heart, which 
occur at different times. The cardiac progenitors that primarily contribute to the 
outflow tract of the heart are termed the anterior or secondary heart field cells 
(AHF/SHF). In the chicken embryo, AHF/SHF progenitors have been located in 
the splanchnic mesoderm of HH stage 8 embryos. However it is not known 
where these cells originate from in the earlier embryo, how they migrate or what 
key factors control their migration. Heart malformations in human are generally 
due to defects in heart tissue formed by the secondary heart field, thus studies 
investigating the processes that regulate secondary heart field development are 
essential for understanding and potential treatment of heart disease. We have 
used DiI and DiO labeling and immunohistochemistry techniques to map the 
origins of AHF/SHF progenitor cells along the primitive streak in chicken 
embryos. Live video microscopy has shown that the migration of these cells 
mirrors that of other cardiac progenitors, however, their route is slightly wider. 
Current experiments investigate whether ASF/SHF progenitors respond to 
extrinsic cues, with a focus on the potential role of Wnt11B in cardiac progenitor 
cell movements. 
 
 
 
 
 
 
 
103. Identification of human embryonic stem cell-derived early 
cardiomyocytes based on CAG promoter driven GFP expression 
Kornélia Szebényi* (1), Ágota Apáti (2), Zsuzsa Erdei (1), Anita Schamberger 
(1), Zsuzsanna Izsvák (3), Zoltán Ivics (3), Elen Gócza (4), György Várady (2), 
Tamás Orbán (1), Balázs Sarkadi (1,2) 
(1) Membrane Research Group of the Hungarian Academy of Sciences and 
Semmelweis University, Hungary (2) National Blood Center, Hungary (3) Max 
Delbrück Center, Germany (4) Agricultural Biotechnology Center, Hungary 
 
Human embryonic stem cell (hESC)-derived cardiomyocytes and cardiac 
progenitors are promising models for pharmaceutical studies and may provide 
new possibilities in therapeutic approaches. We have applied the transposon 
based Sleeping Beauty (SB) system to introduce a GFP reporter construct into 
hESCs. The SB system is a non-viral gene delivery method that has been used 
to introduce a selectable marker for transgene expressing undifferentiated 
hESCs. The gene-modified hESCs expressed all the accepted stem cell marker 
proteins. We induced spontaneous differentiation of the transfected hESCs into 
cardiomyocytes by using the embryoid body (EB) system. EB formation and the 
subsequent spontaneous differentiation were not altered by the reporter gene 
delivery. The intensity of GFP expression was found to be exceptionally high in 
hESC derived cardiomyocytes when the reporter gene was driven by the CAG 
promoter (Orbán et al., Stem Cells 2009). We found that a positive correlation 
between the CAG promoter-driven high GFP expression and the expression of 
cardiomyocyte-specific genes also existed in the case of early cardiomyocytes. 
The cell population with extra high GFP expression also expressed the activated 
leukocyte cell adhesion molecule (ALCAM) at a high level. During spontaneous 
differentiation, ALCAM expression reached a maximum level on the cell surface 
when the "GFP extra high" population appeared, prior to the appearance of 
spontaneously contracting areas. mRNA levels of ALCAM and of early cardiac 
specific transcription factors were also expressed at a maximum level prior to 
early cardiomyocyte formation. Our results suggest that these markers may be 
applicable to identify cardiac progenitors. 
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104. Development of the Preseptation Cardiac Arterial Pole is Conserved 
in Zebrafish 
Danyal Hami* (1), Adrian C. Grimes (2), Margaret L. Kirby (1). 
(1) Department of Pediatrics, Duke University, Durham, NC, USA (2) 
Departmento de Biología del Desarrollo Cardiovascular, Centro Nacional de 
Investigaciones Cardiovasculares Carlos III (CNIC), Madrid, Spain 
 
The cardiac arterial pole consists of the myocardium surrounding the semilunar 
valve and the smooth muscle just distal to it in the vertebrate heart. These 
tissues are derived from the secondary heart field (SHF), which adds to the 
cranial heart tube to form the arterial pole before septation in animals with 
divided circulation. Regardless of septation, the morphology of the myocardial-
smooth muscle junction has been preserved throughout vertebrate evolution. 
We hypothesize that the SHF is an evolutionarily conserved developmental field 
that contributes the arterial pole of the zebrafish heart. Using tracing techniques, 
we mapped cells in the medial portion of the heart field and show that these 
cells contribute to the arterial pole. After early heart tube formation in zebrafish, 
cells in the ventral pharynx were labeled and followed into the arterial pole of the 
heart tube. Additionally, we used cardiac precursor markers to identify this 
population. Because arterial pole development in higher vertebrates is 
dependent on tbx1 and hedgehog signaling for proper development we 
examined tbx1 and smoothened (hedgehog receptor) mutant zebrafish. Both 
myocardial and smooth muscle components of the arterial pole are disrupted in 
these mutants. Using DiI-labeling of the SHF, we show that these progenitors do 
not move into the heart in these mutants. This data suggests that morphology, 
transcriptional regulation and signaling pathways important in arterial pole 
development are conserved. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
105. Characterization of myocardial progenitor cells derived from mouse 
embryonic stem cells 
Gary Lyons*, Brent White, and Daryl Nelson 
Department of Anatomy, University of Wisconsin School of Medicine & Public 
Health Madison, WI. USA 
 
Mouse ESCs provide a potentially unlimited supply of cells that are capable of 
differentiating into all of the cell types necessary for myocardial repair. We 
hypothesize that mESC-derived cells that are committed to a cardiac 
mesodermal fate will be able to exhibit significant myocardial repair in a mouse 
model of myocardial infarction. Since our focus is to characterize a ventricle-
specific precardiac lineage, we are using two transgenic mESC lines that 
express either ECFP under the control of the MLC2v promoter or EmGFP under 
the control of the Irx4 promoter. Both of these genetic markers are ventricular-
specific. At 3 and 4 days of differentiation as embryoid bodies in hanging drops, 
the cells were isolated by FACS either for either Flk1+/CD31- surface markers 
(2V cell line) or EmGFP expression (Irx4 line). These purified cell populations 
were expanded on feeder layers of mouse fibroblasts (STO). We are analyzing 
the cell-surface protein markers of these cells in vitro, and testing the ability of 
these cells to restore function to damaged mouse myocardium in vivo. 
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106. Developmental role for voltage-gated calcium channel beta subunit 
CACNB2 in cardiomyocyte number and adhesion. 
Yelena Chernyavskaya and Deborah M. Garrity* 
Department of Biology, Colorado State University, Fort Collins, CO, USA 
 
Voltage-gated calcium channels (VGCCs) are oligomeric complexes composed 
of pore-forming CACNA subunits and several auxiliary proteins. Auxiliary 
CACNB subunits regulate VGCC electrophysiology and chaperone CACNA 
subunits to the cell membrane. In humans, mutations in CACNA subunits are 
associated with congenital cardiac arrhythmia, but the developmental functions 
of the CACNB subunits are poorly understood. To determine the contributions of 
CACNB2 to cardiac development, we depleted zebrafish embryos of CACNB2 
transcripts using morpholinos. Morphants showed no difference in fgf8 
expression, suggesting that adequate numbers of cardiomyocytes were initially 
specified. However, later markers of cardiac progenitors in the heart field (vhmc 
and cmlc2), were expressed in reduced domains, suggesting fewer specified 
cells were present just prior to formation of the heart tube. Currently we are 
investigating whether altered proliferation or survival may account for the 
difference. Despite overt normal formation of the heart tube, cell proliferation at 
later stages did not fully compensate for reduced cardiomyocyte number; heart 
tubes in morphants contained 30% fewer cardiomyocytes at 48 hpf. Looping 
was reduced and cells in the outer curvature failed to undergo cell shape 
changes normally associated with this area of the heart. The adhesion among 
cardiomyocytes appeared weaker, and morphant heart tubes fragmented more 
easily than controls when placed under modest pressure. Thus, CANCB2 is 
important for assuring correct number and adhesion of cardiac progenitors; 
these roles might or might not be related to VGCC activity. The CACNBs, as 
MAGUK-family proteins, may interact with multiple protein partners via their SH3 
or guanylate kinase domains. 
 
 
 
 
107. Nkx Genes Are Essential for Maintenance of Ventricular Identity 
Targoff, K.L.* (1), Schell, T. (1), Solnica-Krezel, L. (2), and Yelon, D. (1,3) 
(1) Developmental Genetics Program and Department of Cell Biology, Kimmel 
Center for Biology and Medicine, Skirball Institute of Biomolecular Medicine, 
New York University School of Medicine, New York, NY, 10016, USA. (2) 
Department of Biological Sciences, Vanderbilt University, Nashville, TN, 37232, 
USA. (3) Division of Biological Sciences, University of California, San Diego, La 
Jolla, CA, 92093, USA. 
 
Establishment of the specific characteristics of each embryonic cardiac chamber 
is crucial for development of a fully functional adult heart. While recent studies in 
mouse highlight cooperative interactions of Nkx2-5 during ventricular formation, 
we have yet to understand its precise function in determining chamber-specific 
identity. Here, we show that nkx genes are necessary to sustain molecular 
attributes exclusive to the ventricle. The zebrafish genome contains two NKX2-5 
homologs, nkx2.5 and nkx2.7. We have recently isolated a mutant allele of 
nkx2.5, a nonsense mutation that truncates the protein within the homeodomain. 
This mutation disrupts cardiac morphogenesis, creating diminutive ventricular 
and bulbous atrial chambers. Investigation of underlying cellular mechanisms 
reveals that the initial number of differentiated cardiomyocytes in nkx2.5 mutants 
is indistinguishable from that in wild-type embryos. As cardiac looping proceeds, 
nkx2.5 mutants first exhibit a severe collapse in the number of ventricular 
cardiomyocytes and an excess of atrial cardiomyocytes. To uncover shared 
roles of nkx genes, we employed anti-nkx2.7 morpholinos in nkx2.5 mutants and 
thereby reduced ventricular cell number to zero and obliterated the ventricle 
morphologically. In these embryos, expression of ventricular markers fades as 
development proceeds and is replaced by markers of atrial identity. Genetic fate 
map experiments are underway to confirm that ventricular cardiomyocytes 
transform into atrial cardiomyocytes in the absence of nkx gene function. 
Together, our data suggest a pivotal role for nkx genes in maintaining ventricular 
identity and offer a basis for investigation of therapeutic implications for patients 
with NKX2-5 mutations. 
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108. Deciphering the cellular and transcriptional hierarchy acting during 
the earliest step of multipotent cardiovascular progenitor specification. 
Antoine Bondue*, Simon Tännler, Giuseppe Chiaparro, Benjamin Beck, Samira 
Schabab, Cédric Blanpain 
IRIBHM, Université Libre de Bruxelles, Brussels, Belgium 
 
During embryonic development and embryonic stem cell (ESC) differentiation, 
the different cell types of cardiovascular lineage arise from differentiation of two 
types of multipotent cardiovascular progenitors (MCPs). It is still unclear whether 
these two sources of MCPs arise from the differentiation of a common 
progenitor and what are the molecular mechanisms that allow the specification 
and differentiation of these primitive MCPs. We and others have recently shown 
that Mesp1 acts as a master regulator of cardiovascular differentiation during 
ESC differentiation. Here, we generated an ESC lines expressing GFP under 
the regulatory region of Mesp1. We showed that Mesp1 expressing cells 
represent the earliest source of MCPs that are common for the primary and 
second heart field during ESC differentiation. By transcriptionally profiling these 
earliest MCPs, we uncovered different transcription factors that are co-
expressed together with Mesp1 during MCPs specification. Using gain and loss 
of functions in ESC, we showed that the co-expression of Mesp1 with these 
newly identified transcription factors allowed the specification of the early 
cardiovascular progenitors, whereas Mesp1 and its downstream target genes 
are required to promote the functional maturation of MCP toward the cardiac 
and vascular lineages. Our study provides important insights into the cellular 
hierarchy that operate during cardiovascular differentiation and uncover novel 
regulatory mechanisms that govern intrinsically cardiovascular progenitor 
specification and lineage differentiation from ESCs. 
 
 
 
 
 
 
 
109. Niche Microenvironments as Blueprint for Tissue Engineering 
Applications 
Katja Schenke-Layland* (1, 2), Ali Nsair (1), Ben Van Handel (3), Hanna K. 
Mikkola (3), W. Robb MacLellan (1) 
(1) Dept. of Medicine/ Cardiology at UCLA, Los Angeles, CA, USA (2) Dept. of 
Cell and Tissue Engineering, Fraunhofer IGB Stuttgart, Germany (3) Dept. of 
Molecular, Cell and Developmental Biology, Los Angeles, CA, USA 
 
Stem cell-derived differentiated cells and tissues have the potential to 
revolutionize the field of regenerative medicine; however, transforming the 
promise of stem cells into therapeutically relevant treatments will require new 
approaches that utilize microenvironmental conditions, which are conducive to 
regeneration. Here we aimed to address the current limitations in our 
understanding of the basic biology of cardiovascular progenitor cells (CPCs). 
We determined the nature of the CPC niche in developing hearts and studied its 
role in regulating CPC self-renewal and differentiation. Using routine histology 
and immunohistochemistry, we identified specific extracellular matrix (ECM) 
molecules surrounding the CPCs in their native microenvironment in first-
trimester human hearts. To explore the specific role of these ECMs, we exposed 
pluripotent embryonic stem (ES) cells and ES cell-derived Flk1-expressing 
progenitor cells that possess cardiovascular differentiation potential to collagen 
types I (ColI) and IV (ColIV), laminin as well as fibronectin. Utilizing flow 
cytometry (FACS) and gene expression analysis, we showed that exposure to 
ColIV as well as laminin significantly enhanced the differentiation of ES cells into 
Flk1-expressing CPCs when compared to cells cultured on either ColI or 
fibronectin. In order to be able to investigate the impact of the cardiovascular 
niche on CPCs in vitro as close to reality as possible, we employed 
electrospinning technologies to engineer three-dimensional (3D) niche 
substrates that served as cell culture inserts. We performed FACS analyses and 
found that three-dimensionality promoted cardiovascular differentiation 
significantly when compared to 2D control cultures. Our results will impact future 
approaches to regenerative cell therapy. 
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110. The origin of endothelial and hematopoietic cells: cell lineage 
analysis. 
Laura Padrón-Barthe*, Silvia Vela, Miguel Torres 
Cardiovascular Developmental Biology, Centro Nacional de Investigaciones 
Cardiovasculares-CNIC, Madrid, Spain 
 
In the early 20th century, Florence Sabin observed close spatial and temporal 
associations between endothelial and hematopoietic cells in avian species. 
These two cell types associate in the yolk-sac to give rise to blood islands, 
structures long recognized as the first site for blood cell emergence during 
mammalian and avian embryogenesis. The haemangioblast model was 
proposed, in which endothelial and hematopoietic lineages arise from a common 
precursor. Recent molecular and differentiation potential studies suggest the 
haemangioblast would be a mesodermal precursor established at the primitive 
streak before ingressing into the yolk-sac; however, these hypotheses have not 
been addressed in vivo. We established a mouse two-reporter genetic clonal 
analysis method and explored in vivo the relationship at the origin of 
hematopoietic and endothelial lineages. Using time- and frequency-controlled 
genetic induction of random-labelled cells, we have analyzed a large collection 
of different developmental stage embryos with clones induced pre-gastrulation. 
The distribution of labelled cells in blood islands at E8,5 indicates complete 
segregation of blood and endothelial lineages, suggesting a model in which 
these two lineages derive from independent epiblast populations. Blood and 
endothelial cell specification therefore does not involve transit through a 
haemangioblast precursor. The observed frequency of blood clones is 4-times 
that of endothelial clones, suggesting that at the time of clone induction there 
are 4-times more blood progenitors than endothelial progenitors. Nonetheless, 
the presence of massive blood cell clones in considerable numbers of embryos 
suggests that primitive blood cells derive from a small number of epiblast cells. 
 
 
 
 
 
 
 
 
111. Opposing effects of Wif1 and Frzb on cardiomyogenesis 
Buermans HP *(1), van Wijk B (2), Hulsker MA (1), Smit N (1), den Dunnen JT 
(1), van Ommen GJ (1), Moorman AF (2), van den Hoff MJ (2), 't Hoen PA (1) 
(1) Human and Clinical Genetics, Leiden University Medical Center, 
Einthovenweg 20, 2333 ZC Leiden, ZH, The Netherlands (2) Heart Failure 
Research Center, Academic Medical Center, Meibergdreef 15, 1105 AZ 
Amsterdam, NH, The Netherlands 
 
During chicken cardiac development the proepicardium (PE) forms the 
epicardium (Epi), which contributes to several non-myocardial lineages within 
the heart. In contrast to Epi-explant cultures, PE explants can differentiate into a 
cardiomyocyte phenotype. By temporal microarray expression profiles of PE-
explant cultures and maturing Epi cells, we identified genes specifically 
associated with differentiation towards either of these lineages and genes that 
are associated with the Epi-lineage restriction. We found a central role for Wnt 
signaling in the determination of the different cell lineages. Immunofluorescent 
staining after recombinant-protein incubation in PE-explant cultures indicated 
that the early upregulated Wnt inhibitory factor-1 (Wif1), but not the late 
upregulated Wnt antagonist frizzled-related protein (Frzb), stimulates 
cardiomyocyte differentiation. Concordingly, in the mouse pluripotent 
embryogenic carcinoma cell line p19cl6, early and late Wif1 exposure enhances 
and attenuates differentiation, respectively, while Frzb was shown to attenuate 
differentiation. In ovo exposure of the HH12 chicken embryonic heart to Wif1 
increases the Tbx18-positive cardiac progenitor pool, confirming the stimulatory 
role of Wif1 on early cardiomyogenesis. These data indicate distinct regulatory 
roles for Wif1 and Frzb in cardiomyocyte differentiation different from those 
reported for other Wnt-signaling antagonists in embryonic stem cell models for 
cardiomyogenesis. 
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112. Endocardial/Myocardial Progenitor Cell Interactions during Zebrafish 
Heart Tube Formation 
Justus Veerkamp, Florian Priller, Franziska Rudolph, Salim Abdelilah-Seyfried* 
Cardiovascular and Metabolic Diseases Program, Max-Delbrück-Center for 
Molecular Medicine, Berlin, Germany 
 
In vertebrates, the heart is the first organ to develop asymmetrically. Recent 
work in zebrafish has begun to elucidate the link between L/R signaling via a 
Nodal-BMP signaling cascade and tissue morphogenetic events involved in 
cardiogenesis. While these factors have been mainly implicated in cell fate 
specification, newly emerging evidence suggests that Nodal and Bmp signaling 
regulates cell behaviors including cell migration and epithelial tissue 
morphogenesis. High-resolution time-lapse analyses reveal that dynamic 
cellular rearrangements of endocardial and myocardial cells occur during the 
initial stages of cardiac tube formation. Whereas cardiomyocytes within lateral 
positions of the heart field display mesenchymal-like squamous cell shapes and 
are highly motile, cardiomycytes in medial positions acquire cuboidal-to-
columnar epithelial shapes. Highly motile endocardial cells are in close 
association with cardiomyocytes throughout heart tube formation. Modulation of 
Nodal-BMP signaling affects endo-/myocardial cell migration. Disruption of L/R 
asymmetric Nodal or BMP expression causes randomized myocardial tissue 
involution or inhibition of heart tube formation altogether. In functional studies, 
we show that BMP and Nodal signaling are essential in controlling tissue 
polarization and cardiac morphogenesis. To further elucidate the control of 
endo-/myocardial behaviors by Nodal-Bmp signaling, we have performed micro-
array experiments comparing endo-/myocardial expression of wild-type, 
Nodal/BMP signaling-deficient, or BMP overexpressing embryos using the 
Agilent 44K zebrafish array. These genome-wide analyses provide a first 
glimpse at the potential target genes that mediate the responses of endo-
/myocardial cells to Nodal-BMP signaling during cardiogenesis. 
 
 
 
 
 
113. Three-dimensional computer imaging of adrenergic cell-derived 
myocardium in the adult mouse heart reveals predominantly left-sided 
distribution. 
K Osuala*(1), K Telusma(1), S Kahn(2), S Wu(2), M Shah(2), C Baker(1), SN 
Ebert(1) 
(1)Burnett School of Biomedical Sciences, Univ. of Central Florida (2)Computer 
Science & Electrical Engineering, Univ. of Central Florida 
 
To identify adrenergic derived cells in the adult mouse heart, we performed 
genetic fate-mapping experiments in which Cre-recombinase gene was inserted 
into the phenylethanolamine-n-methyltransferase locus then cross mated with 
the homozygous Rosa26 reporter mouse strain. This mating resulted in offspring 
that produced βGAL in cells of an adrenergic lineage. XGAL+ staining revealed 
adrenergic-derived cells throughout the adult mouse heart, however, the 
distribution of XGAL+ cells was predominately in the left atrium (LA) and 
ventricle (LV) of the heart. The XGAL+ staining in the left heart accounted for 
89% of the total XGAL+ staining. The LV free wall showed intermittent staining, 
extending from the apex to the base of the heart, and included heavy staining of 
the anterior papillary muscle, along its perimeter. The right atrium (RA) and 
ventricle (RV) collectively showed significantly less XGAL+ staining when 
compared to the LA and LV (P=0.001). In addition, we examined the three-
dimensional (3-D) distribution of XGAL+ cells using computer-aided 
reconstruction of our photomicrographs. This representation confirmed our 
results showing that adrenergic derived cells primarily populate the left heart. 
This 3-D representation is the first look at the structural architecture and 
localization of adrenergic derived cells within the adult mouse myocardium. 
Together these results demonstrate that adrenergic-derived myocardial cells 
contribute primarily to left heart development and may play a significant role in 
patterning, structural assembly, and left heart function. This novel finding could 
lead to developments in understanding the role of transiently adrenergic cells in 
the dynamic structural and functional development of the heart. 
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114. Induced Pluripotent Stem Cell-Derived Cardiomyocytes Exhibit 
Limited Gene Expression Variance and Survive after Intramyocardial 
Transplantation 
L.W. Van Laake*# (1,2), L. Qian# (1), P. Cheng (1), Y. Huang (1), E.C. Hsiao (1), 
B. Conklin (1), D. Srivastava (1) 
(1) Gladstone Institute of Cardiovascular Disease and Departments of Pediatrics and 
Biochemistry & Biophysics, University of California San Francisco, CA 94158, United 
Stated of America (2) Heart Lung Center Utrecht, the Netherlands. #These authors 
contributed equally to this work. 
 
Purpose: To investigate 1) how much variability exists between differentiated 
lineages from independent induced pluripotent stem cell (iPSC) lines and, 
specifically, how similar iPSC-derived cardiomyocytes are to embryonic stem 
cell-derived cardiomyocytes and 2) if iPSCs could replace ESCs in regenerative 
therapy for myocardial infarction. Methods: In order to facilitate isolation of 
comparable cardiomyocytes and progenitor populations, we generated mouse 
iPSCs in which expression of Nkx2-5, an early cardiac transcription factor, is 
marked by transgenic GFP. GFP+ cells were selected by FACS and their gene 
expression was compared to GFP+ cells from 2 ESC lines containing the same 
reporter, using microarrays. Differentiated cells were injected in the hearts of 
NOD-SCID mice after coronary artery ligation, and identified by epifluorescence 
and immunofluorescence (n=17). Results: The Nkx2-5-GFP iPSCs formed 
cardiomyocytes in vivo (in chimeric embryos and teratomas) and in vitro by 
several induction protocols. Isolation of the iPSC-derived Nkx2-5-GFP+ cardiac 
progenitor pool revealed striking similarity in gene expression between 
independent lines (R=0.99). Only 38 annotated genes out of over 28,000 
transcripts were altered greater than 2-fold compared with the ESC-derived 
GFP+ cells. Upon injection in the infarcted mouse heart, unselected 
differentiated iPSCs formed teratomas but selected Nkx2-5-GFP+ iPSC-derived 
cells formed cardiomyocytes only. Conclusions: Our findings suggest that 
despite the variability of gene expression in iPSC lines, the variance narrows 
significantly in specific iPSC-derived cardiac progenitors, which can be isolated 
and used for transplantation without generation of unwanted cell types. 
 
 
 
 
 
 
 
 
 
115. Myocardin regulates the cardiac-smooth muscle bipotency of 
Isl1/SLN atrial progenitors in cardiac inflow tract 
Haruko Nakano (1), Estrelania S. Williams (1), Masahiko Hoshijima (2), Susumu 
Minamisawa (3), Gary K. Owens (4), Kenneth R. Chien (5), Atsushi Nakano (1) 
(1) Molecular Cell Developmental Biology, Broad Stem Cell Institute, UCLA, Los Angeles, 
CA, USA (2) The Center for Research in Biological Systems, UCSD, La Jolla, CA, USA (3) 
Life Science and mediacl bioscience, Waseda University, Tokyo, Japan (4) Robert M. 
Berne Cardiovascular Research Center, University of Virginia, Charlottesville, VA, USA (5) 
Cardiovascular Research Center, Massachusetts General Hospital, Boston, MA, USA 
 
The heart chambers and the great vessels have distinct developmental origins, 
yet form anatomical and functional continuity at the arterial and venous poles of 
the heart tube to establish and maintain the dynamism of the central circulatory 
system. Elucidating the mechanisms of the heart-vessel junction formation is a 
key to understanding the pathogenesis of the congenital and adult diseases 
affecting the outflow and inflow tracts. We and others have shown that early 
cardiac progenitors display cardiac-smooth muscle bipotency. However, it is 
unclear how long these cardiac progenitors maintain their bipotency and how 
their plasticity impacts heart-vessel boundary formation during cardiogenesis. 
Here we report the identification of Isl1/SLN atrial progenitors in the venous pole 
of the heart tube, their smooth muscle differentiation capability, and its 
myocardin-dependent mechanism. (1) Newly generated atrial-specific Sarcolipin 
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(SLN)-Cre knockin mice enabled us to identify Isl1/SLN atrial progenitors, the 
late subset of cardiac progenitors in the cardiac inflow tract at E10.5-13.5. (2) 
Isl1/SLN atrial progenitors showed cardiac-smooth muscle bipotency on cardiac 
mesenchymal feeder layer. (3) The muscular wall of the cardiac inflow tract 
consists of two layers; the inner smooth muscle layer and the outer myocardial 
sleeve. The atrial progenitors contributed to both cardiac and smooth muscle 
cells in vivo based on the lineage tracing analysis. (4) Overexpression of 
Myocardin in the atrial progenitors enhanced smooth muscle differentiation in 
vitro. (5) Myocardin-null ES cells show little contribution to the smooth muscle 
layer in the cardiac inflow tract but preferential contribution to the atrial 
myocardium in ES aggregation chimera analysis, suggesting the requirement of 
Myocardin in the smooth muscle differentiation of the atrial progenitors. These 
data indicate that the bipotency of the late cardiac progenitors is regulated by 
Myocardin, and suggest a possible role of the cardiac progenitor plasticity during 
cardiovascular morphogenesis. 
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Session B - Epigenetics 
 
116. Epigenetic control of cardiac gene expression in development and 
disease 
Calvin T. Hang (1), Pei Han (1), Jin Yang (1), Hsiu-Ling Cheng (1), Euan Ashley 
(1), Bin Zhou (2), Ching-Pin Chang* (1) 
(1) Division of Cardiovascular Medicine, Department of Medicine, Stanford 
University, California, USA (2) Department of Genetics, Albert Einstein College 
of Medicine, New York, USA 
 
Cardiac hypertrophy is characterized by transcriptional reprogramming and fetal 
gene activation, which correlate with cardiac performance and clinical outcome. 
Adult cardiomyocytes in mice are post-mitotic and express mainly α-myosin 
heavy chain (α-MHC), whereas embryonic cardiomyocytes are proliferative and 
express primarily β-MHC. Adult hearts under stress develop hypertrophy, 
accompanied by a shift from α-MHC to fetal β-MHC, leading to contractile 
dysfunction and heart failure. Mechanisms bridging the developmental and 
pathological gene expression are not well understood. We show that Brg1, a 
core ATPase component of the BAF chromatin-remodeling complex, plays 
critical roles in regulating gene expression, tissue growth and differentiation in 
embryonic hearts and adult hearts under stress. In embryos, Brg1 promotes 
myocardial proliferation by maintaining BMP10 and suppressing a CDK inhibitor, 
p57kip2. In parallel, Brg1/BAF preserves fetal cardiac differentiation by 
interacting with HDACs and PARP1 to transcriptionally repress α-MHC and 
activate β-MHC. In adults, Brg1 expression is turned off in cardiomyocytes. It is 
reactivated by cardiac stresses and complexes with its embryonic partners, 
HDACs and PARP1, to induce a pathological shift from α- to β-MHC. Preventing 
Brg1 re-expression decreases hypertrophy, and reverses the pathological MHC 
switch. Our studies uncover a role of Brg1 in maintaining cardiomyocytes in an 
embryonic state, and an epigenetic mechanism by which three chromatin-
modifying factors, Brg1/BAF, HDACs and PARP1, cooperate to control 
developmental and pathological gene expressions. Furthermore, Brg1 is 
activated in certain patients with hypertrophic cardiomyopathy. Its level 
correlates with disease severity and MHC changes, suggesting a role of Brg1 in 
human hypertrophic heart disease. 
 
117. Jmjd6 regulates the splicing of sFlt1 and modulates angiogenesis 
Jes-Niels Boeckel (1), Tino Röxe (1), Masamichi Koyanagi (1), Andreas 
Lengeling (2) Andreas M. Zeiher (1), Stefanie Dimmeler (1) 
(1) Institute for cardiovascular regeneration, University Frankfurt, Germany(2) 
Roslin Institute, University Edinburgh, UK 
 
Proteins containing a Jumonji C (JmjC) domain have a central role in the 
epigenetic control of gene expression. This enzyme family can either act as 
protein hydroxylases or histone demethylases as well as by regulating splicing. 
The hydroxylation reaction catalyzed by jumonji proteins is depended on oxygen. 
Therefore, we examined the function of Jmjd6 in angiogenesis. RNAi mediated 
inhibition of Jmjd6 lead to a significant reduction of angiogenesis in endothelial 
cells (EC) in vitro (tube formation: 46±18% reduction; spheroid formation: 
74±9% reduction). Moreover, silencing of Jmjd6 was associated with impaired 
migration (43±1% reduction). These findings were confirmed in matrigel plug 
assay in vivo. Jmjd6+/- mice exhibit 68±9% less FITC-lectin perfused vessels 
compared to wild type mice. To further elucidate the function of Jmjd6, an exon-
array was performed. A dysregulation in several differential spliced gene 
variants including soluble Flt1 were detected. sFlt1 is an alternative splice 
product of the VEGF-receptor 1 (Flt1) that acts as anti-angiogenic trap for VEGF 
and PLGF. These findings were validated by using specific taqman probes and 
by measuring sFlt1 protein in the supernatant (+1045±316pg/ml). In addition, 
RNA pull-down experiments revealed that the Jmjd6 regulated splicing factor 
U2AF65 endogenously binds to sFlt1 mRNA. Exogenous added VEGF or PLGF 
or a specific antibody against sFlt1 significantly reduced the anti-angiogenic 
effect of Jmjd6 knockdown (p<0.05). In conclusion, these results show that 
Jmjd6 has an essential role in the regulation of angiogenesis by enhancing the 
splicing of Flt1 mRNA leading to increased levels of the anti-angiogenic short 
form sFlt1. 
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118. Imprinting mechanisms and function of Ddc, a candidate 
developmental gene in heart 
Adam Prickett*, Ruth B. McCole, Reiner Schulz and Rebecca J. Oakey 
Department of Medical & Molecular Genetics, King’s College London, 8th Floor 
Tower Wing, Guys Hospital, London, UK. 
 
Dopa Decarboxylase (Ddc) is an enzyme that plays a fundamental role in the 
biosynthesis of catecholamine neurotransmitters and serotonin. A short form 
transcriptional variant of Ddc called Ddc_exon1a, which originates from an 
alternative promoter at exon 1a, is highly expressed in the trabecular 
cardiomyocytes during development of pre-natal heart and is progressively 
silenced during post natal development. Ddc_exon1a has recently been shown 
by our group to be epigenetically regulated via genomic imprinting in mouse 
heart in a tightly regulated tissue-specific and transcriptional variant-specific 
manner. Ddc and Ddc_exon1a show bi-allelic expression in all other tissues. 
There is growing evidence that DDC may also be imprinted in human. We aim to 
show, by analysing Ddc+/- and Ddc-/+ knockout mice, how ablation of 
Ddc_exon1a affects heart-specific development. We also will look at 
downstream target genes using microarray analysis. We predict that the 
knockout may affect compaction of the myocardium during mid-gestation, which 
could lead to cardiomyopathies in adults. It has recently been shown that Ddc 
imprinting is controlled by epigenetic mechanisms via a differentially methylated 
region located in CGI2 of adjacent Grb10, another gene imprinted in 
development, CGI2 contains a putative CTCF binding site. We present our 
current findings examining the role of the insulator protein CTCF using ChIP 
analysis to assay binding this protein at this gene locus and a potential role in 
imprinting. 
 
 
 
 
 
 
 
 
 
 
 
 
119. Imprinting of dopadecarboxylase is conserved between mouse and 
human trabecular cardiomyocytes 
Adam Prickett and Rebecca J. Oakey* 
King's College London, Depoartment of Medical & Molecular Genetics, London, 
SE1 9RT United Kingdom 
 
Epigenetic mechanisms such as DNA methylation and histone modifications 
regulate gene expression and influence myocardial morphogenesis. Imprinting 
is a parent-of-origin specific mode of gene regulation governed by epigenetic 
mechanisms and we have shown that an isoform of Dopadecarboxylase (Ddc), 
an enzyme involved in the biosynthesis of catecholamine neurotransmitters and 
serotonin is imprinted. Ddc_exon1a is expressed tissue-specifically and 
exclusively from the paternal allele in murine cardiomyocytes. The temporal and 
spatial expression characteristics of Ddc_exon1a suggest a link between 
imprinting and cardiac development. Other catecholamine/monoamine pathway 
enzymes have established roles in cardiogenesis and serotonin signalling 
pathways, which are dependent upon Ddc activity, play pivotal roles in 
myocardial proliferation and differentiation and in cardiac function in adults. We 
are examining the role of Ddc_exon1a to understand what epigenetic 
mechanisms are controlling this gene in the mouse heart. We are performing 
comparative studies in the human heart and have evidence that the expression 
of the gene is conserved and that DDC_EXON1A is also imprinted in human 
cardiomyocytes. 
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120. Tbx5 is required in the Second Heart Field for Atrioventricular 
Septation 
Linglin Xie, Joshua M. Friedland-Little, Andrew D. Hoffmann, and Ivan P. 
Moskowitz* 
Departments of Pediatrics and Pathology, Committees on Genetics and 
Developmental Biology, The University of Chicago, Chicago, IL, 60637, USA 
For abstract, see in oral presentation section page 73 
 
 
 
 
 
 
121. Cooperative roles of Tbx1 and Tbx3 during early outflow tract 
development 
Karim Mesbah (1), M. Sameer Rana (2), Laure Lo Ré (1), Virginia Papaioannou 
(3), Vincent M. Christoffels (2), Robert G. Kelly (1) 
(1) Developmental Biology Institute of Marseilles - Luminy, UMR 6216 CNRS-
Université de la Méditerranée, Campus de Luminy, Case 907, 13288 Marseille 
Cedex 9, France (2) Department of Anatomy, Embryology & Physiology, 
Academic Medical Center, University of Amsterdam, Meibergdreef 15   L2-108, 
1105 AZ Amsterdam, The Netherlands (3) Department of Genetics and 
Development, Columbia University, 701 W 168th St., New York, USA 
For abstract, see in oral presentation section page 74 
 
 
 
 
 
 
122. Clonal analysis reveals common lineage relationships between head 
muscles and second heart field derivatives in the mouse embryo 
Fabienne Lescroart* (1), Sigolène M. Meilhac (1), Jean-François Le Garrec (1), 
Jean-François Nicolas (2), Robert G. Kelly (3) and Margaret Buckingham (1) 
(1) Institut Pasteur, Unité de Génétique Moléculaire du Développement, CNRS URA 2578, 
25 rue du Dr. Roux, 75724 Paris Cedex 15 (2) Institut Pasteur, Unité de Biologie 
Moléculaire du Développement ; CNRS URA 2578, 25 rue du Dr. Roux, 75724 Paris 
Cedex 15 (3) Developmental Biology Institute of Marseilles-Luminy, UMR CNRS 6216 
Université de la Méditerranée, Campus de Luminy, Case 907, 13288 Marseille Cedex 9, 
France. 
 
Head muscle progenitors in pharyngeal mesoderm are present in close 
proximity to cells of the second heart field, and show overlapping patterns of 
gene expression. However it is not clear whether a single progenitor cell gives 
rise to both heart and head muscles. We now show that this is the case, using a 
retrospective clonal analysis in which an nlaacZ, converted to functional nlacZ 
after a rare intragenic recombination event, is targeted to the αc-actin gene, 
expressed in all developing skeletal and cardiac muscle. We distinguish two 
branchiomeric head muscle lineages, both of which also contribute to 
myocardium. The first gives rise to the temporalis and masseter muscles of the 
jaw and also to extraocular muscles, thus demonstrating a contribution from 
pharyngeal as well as prechordal mesoderm to this anterior muscle group. 
Unexpectedly, this first lineage, which contributes to first branchial arch 
derivatives, also contributes to myocardium of the right ventricle. The second 
lineage gives rise to muscles of facial expression, regarded as second branchial 
arch derivatives. It also contributes to myocardium at the base of the arteries, 
that derives from the outflow tract, at the arterial pole of the heart. Further sub-
lineages distinguish myocardium at the base of the aorta or pulmonary trunk, 
with a clonal relationship to right or left head muscles respectively. We thus 
establish a lineage tree and demonstrate distinct clonal relationships linking 
groups of head muscles to different parts of the heart, reflecting the posterior 
movement of the arterial pole during pharyngeal morphogenesis. 
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123. Cardiac malformations in Pdgfrα knockout embryos are mediated by 
altered second heart field development 
Noortje A.M. Bax* (1), Steven S. Bleyl (2,3), Radiosa Gallini (5), Bert Wisse (1), 
Jennifer Hunter (3), , Edris Mathab (1), Heleen Lie-Venema (1), Marie Jose 
Goumans (4), Christer Betsholtz (5), Adriana C. Gittenberger-de Groot (1) 
(1)Department of Anatomy & Embryology, Leiden University Medical Center, Leiden, The 
Netherlands (2)Department of Human Molecular Biology and Genetics,University of Utah 
School of Medicine, Salt Lake City, USA, (3)Department of Neurobiology and Anatomy, 
University of Utah School of Medicine, Salt Lake City, USA, (4)Department of Molecular 
Cell Biology, Leiden University Medical Center, Leiden, The Netherlands (5)The Vascular 
Biology Laboratory, Division of Matrix Biology, Department of Medical Biochemistry and 
Biophysics, Karolinska Institute, Stockholm Sweden 
 
Platelet-derived growth factors (PDGFs) are known for their role in 
cardiovascular development. The PDGFR-α expression pattern in normal 
development was studied with immunohistochemistry and in embryos in which 
an allele of the PDGFR-α expresses a nuclear localized green fluorescent 
protein from the PDGFR-α locus. These data showed expression of PDGFR-α in 
various parts of the heart and in second heart field (SHF) derived mesoderm at 
the venous pole. We analyzed hearts of Pdgfrα knockout mouse embryos 
between embryonic day (E) 9.5 and E14.5 for malformations at the venous pole. 
Immunohistochemical staining, morphometry analysis and 3D-reconstruction 
were performed to characterize cardiac malformations. The results showed that 
Pdgfrα-/- have cardiac malformations related to altered addition of myocardium 
from the SHF. First, Pdgfrα mutants showed hypoplasia and altered 
differentiation of the sinoatrial node and venous valves. Hypoplasia of the 
primary atrial septum, mesenchymal cap and dorsal mesenchymal protrusion 
resulted in failed fusion of the atrioventricular (AV) septal complex. The 
pulmonary vein (PV) remained connected to the non-incorporated sinus 
venosus, indicative of development of total abnormal pulmonary venous 
connection (TAPVC). Second, impairment in the development of the 
proepicardial organ, epicardial adhesion with severe blebbing and migration of 
epicardial cells, coincided with hypoplasia of ventricular compact and septal 
myocardium and AV valve abnormalities. Our results demonstrate that PDGFR-
α expression is necessary for addition of the myocardial and mesenchymal 
components of the SHF at the venous pole of the heart. The data support a 
crucial role for PDGFR-α in cardiac development, through mesenchymal-
myocardial and epicardial-myocardial interaction. 
 
 
 
124. Determining the Genetic Requirement of Mouse Castor during 
Cardiac Development 
Kerry Dorr* (1,3), Kathleen Christine (1,2), Larysa Pevny (3,4), and Frank 
Conlon (1,2,3) 
(1) McAllister Heart Institute, The University of North Carolina at Chapel Hil, Chapel Hill, 
NC , USA (2) Department of Biology, The University of North Carolina at Chapel Hill, 
Chapel Hill, NC , USA (3) Department of Genetics, The University of North Carolina at 
Chapel Hill, Chapel Hill, NC , USA (4) UNC Neuroscience Center, The University of North 
Carolina at Chapel Hill, Chapel Hill, NC , USA 
 
To identify the mechanisms that regulate the onset of cardiomyocyte 
differentiation, we are characterizing the role of the zinc finger transcription 
factor, Castor. Castor was initially identified for its role in maintaining stem cell 
competence in the Drosophila dorsal midline, and recently has been shown by 
studies in our lab to be involved in cardiogenesis. We have demonstrated that 
Xenopus Castor is expressed in the developing heart and is required for the 
differentiation of cardiomyocyte progenitor cells at the ventral midline. We have 
gone on to identify Castor orthologues in mouse and human. In the mouse, we 
have demonstrated that Castor is expressed during heart development, 
beginning with a high level of expression in the forming tubular heart and later in 
the ventricles and atria. To define the specific role of mammalian Castor in 
cardiac progenitor cells, we have generated a conditional knock-out in ES cells 
and are now using these to generate mouse strains. In parallel, to determine the 
fate of Castor positive cells in the developing mouse heart, we have knocked 
CreERT2 into the Castor locus. Specifically, we will use these novel tools and 
strains to identify the cells types and structures Castor positive cells give rise to 
and if they mark a novel cardiogenic precursor population. 
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125. Mechanism of CASTOR function in early heart development 
Stephen Sojka* (1, 2), Kathleen Christine (1, 2), Frank Conlon (1, 2, 3) 
(1) McAllister Heart Institute, University of North Carolina-Chapel Hill, Chapel Hill, NC, 
USA (2) Department of Biology, University of North Carolina-Chapel Hill, Chapel Hill, NC, 
USA (3) Department of Genetics, University of North Carolina-Chapel Hill, Chapel Hill, NC, 
USA 
 
An understanding of the molecular pathways that trigger differentiation during 
heart development is critical for uncovering the pathologies and treatment of 
congenital heart disease. To address these issues, we cloned and characterized 
the Xenopus orthologue of a zinc finger transcription factor, CST. In the absence 
of CST, cells at the ventral midline fail to differentiate and remain as cardiac 
precursors. Conversely cardiac progenitor cells in the more dorsal portion of the 
developing heart over-proliferate yet undergo proper cardiac differentiation. 
Collectively, these defects abrogate the proper formation of the linear heart tube, 
lead to aberrant heart looping and morphogenesis, and ultimately result in 
embryonic lethality. To determine the function of CST in the heart at the 
molecular level, a yeast two-hybrid screen was performed to identify protein 
partners of Xenopus CST using a cardiac specific library. From this screen we 
identified congenital heart disease 5 protein (CHD5)/tryptophan rich basic 
protein (WRB), a protein of unknown function encoded from the genomic locus 
linked to congenital heart disease in Down Syndrome patients. We have shown 
that CHD5 is co-localized with CST in Xenopus cardiomyocytes within the 
developing heart. Critically CHD5 depletion in Xenopus leads to a bifurcation of 
the heart fields, a phenotype similar to CST depletion. The similarities in 
phenotype between these co-localized proteins indicate that they may interact 
directly in regulating cardiac differentiation. 
 
 
 
126. Endothelin type-A receptor expression defines a distinct subdomain 
within the crescent-forming heart field contributing to chamber 
myocardium 
Rieko Asai*(1), Yukiko Kurihara(1), Takahiro Sato(1), Yumiko Kawamura(1), 
Kou Fujisawa(1), Hiroki Kokubo(2,3), Kazuo Tonami(1), Koichi Nishiyama(1), 
Yasunobu Uchijima(1), Yumiko Saga(2,3), Sachiko Miyagawa-Tomita(4), Hiroki 
Kurihara(1) 
(1)Department of Physiological Chemistry and Metabolism, Graduate School of Medicine, 
The University of Tokyo, Tokyo, Japan (2)Division of Mammalian Development, National 
Institute of Genetics, Shizuoka, Japan (3)Department of Genetics, The Graduate 
University for Advanced studies, Shizuoka, Japan (4)Department of Pediatric Cardiology, 
The Heart Institute of Japan, Tokyo Women's Medical University, Tokyo, Japan 
 
The endothelin-1 (Edn-1)/endothelin type-A receptor (EdnrA) signaling is now 
implicated in craniofacial and cardiovascular development. To identify target 
cells of the ET-1/EdnrA signaling in heart development, we knocked-in lacZ 
(EGFP) marker genes into the EdnrA locus. In developing heart, lacZ (EGFP) 
was expressed in cardiac neural crest-derived structures in the outflow tract and 
pharyngeal arteries. In addition, lacZ (EGFP) expression was also found in the 
inflow tract at primitive heart tube through looping/ballooning stages. This 
expression overlapped partially with expression of first heart field marker, 
Nkx2.5 and Mlc2a, in the ventral side from early heat developing stage. These 
results suggest that Ednra-lacZ (EGFP)-expressing cells might be a subset of 
the first heart field. Ednra-lacZ (EGFP)-expressing cells are located in the 
ventrocaudal region of the crescent/linear heart tube, and then distribute 
anteriorly along the outer curvature, contributing to the formation of chamber 
myocardium mainly in the left ventricle and both atria. This apparent upward 
movement was confirmed by fluorescent dye labeling experiments. These 
findings indicate how subpopulations within the crescent-forming heart field 
contribute to coordinate heart morphogenesis through spatiotemporally defined 
cell movements. Furthermore, Ednra-null embryonic hearts often demonstrate 
ventricular hypoplasia, indicating that the Ednra-mediated signal is involved in 
normal myocardial growth and chamber morphogenesis. Ednra-null embryonic 
hearts also showed decreased bromodeoxyuridine uptake and Erk1/2 
phosphorylation at E9.5, indicating that mitotic activity of early cardiomyocytes 
are downregulated by Ednra-null mutation. These findings lead us to speculate 
that Edn1/EdnrA may be involved in early myocardial development as a 
mitogenic signal. 
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127. The Secondary Heart Field: A Proposed Common Theme Among 
Vertebrates 
Adrian C. Grimes* (1), Ana Carmen Durán (2), Valentin Sans-Coma (2), Danyal 
Hami (3) and Miguel Torres (1) 
(1) Departamento de Biología del Desarrollo Cardiovascular, Centro Nacional de 
Investigaciones Cardiovasculares Carlos III (CNIC), Madrid, Spain. (2) Departamento de 
Biología Animal, Facultad de Ciencias, Universidad de Málaga, Malaga, Spain (3) Duke 
University Medical Center, Department of Pediatrics (Neonatology), Durham, North 
Carolina, USA 
 
In chick and mouse embryogenesis, a population of cells described as the 
secondary heart field (SHF) adds both myocardium and smooth muscle to the 
developing cardiac outflow tract (OFT). Following this addition, at approximately 
HH stage 10 in chick embryos, for example, the SHF can be identified 
architecturally by an overlapping seam at the arterial pole, where beating 
myocardium forms a junction with the smooth muscle of the arterial system. 
Previously, using either immunohistochemistry or nitric oxide indicators such as 
diaminofluorescein 2-diacetate, we have shown that a similar overlapping 
architecture also exists in the arterial pole of zebrafish and some shark species. 
However, although recent work suggests that development of the zebrafish OFT 
may also proceed by addition of a SHF-like population of cells, the presence of 
a true SHF in zebrafish and in many other developmental biological models 
remains an open question. We performed a comprehensive morphological study 
of the OFT of a wide range of vertebrates. Our data suggest that all vertebrates 
possess three fundamental OFT components. A proximal myocardial 
component, a distal smooth muscle component, and a middle component that in 
most cases contains overlapping myocardium and smooth muscle surrounding 
and supporting the outflow valve(s). Because the middle OFT component of 
avians and mammals is derived from the SHF, these observations suggest that 
a SHF may be a common theme in vertebrate embryogenesis. 
 
 
 
 
128. The Hox fate map reveals common origin of both the venous and 
arterial poles of the forming heart tube 
Nicolas Bertrand* (1), Lucile Ryckebusch (1), Marine Roux (1), Karen 
Niederreither (2), Pascal Dollé (3), Anne Moon (4), Mario Capecchi (5) and 
Stéphane Zaffran (1) 
(1) Inserm UMR_S910, Faculté de Médecine de Marseille, 27 Bd Jean Moulin, 13005 
Marseille, France. (2) Departments of Medicine and Molecular and Cellular Biology Center 
for Cardiovascular Development Baylor College of Medicine, One Baylor Plaza, Houston, 
Texas 77030. (3) Institut de Génétique et de Biologie Moléculaire et Cellulaire, 67404 
Illkirch, France. (4) Program in Molecular Medicine, Departments of Pediatrics, 
Neurobiology and Anatomy, and Human Genetics, University of Utah, Salt Lake City, UT, 
USA. (5) Howard Hughes Medical Institute, University of Utah, Salt Lake City, UT, USA. 
 
One important issue concerning heart development is the identification of the 
mechanisms that instruct cardiac progenitors, which contribute to different 
functional heart compartments. The retinoic acid (RA) signaling pathway is 
known to be involved in such process. Our recent study showed that RA-
deficient embryos (Raldh2-/-) exhibit an expansion of the second heart field 
(SHF), resulting in arterial and venous poles morphogenesis defects. Some Hox 
genes have been identified as RA-responsive genes. To assess the role of Hox 
genes in defining subpopulations of cardiac progenitors we used double in situ 
hybridization and genetic lineage tracing analysis. We found that Hoxa1, Hoxa3 
and Hoxb1 were expressed in the most posterior region of the SHF (pSHF) as 
early as E7.5, and their expression is dependent on RA signaling. Cre-lox 
lineage tracing analysis with Hoxa1Cre, Hoxa3Cre and Hoxb1IRESCre alleles 
reveals that Hoxa1- and Hoxb1-positive cells contribute to both the venous and 
arterial poles of the forming heart tube. We observed a difference in the 
contribution of these populations along the proximal and distal outflow tract 
(OFT) myocardium. Reduction and excess of RA signaling established that this 
contribution is RA sensitive. Taken together, our results show that Hox genes 
are likely to be downstream targets of RA in heart development and that cells 
initially located in the pSHF contribute to the OFT. We are employing transgenic 
and null mutant alleles to examine effect of increase and loss of Hox activity 
respectively on heart development. 
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129. Right ventricle and outflow tract development are dependent on Bmp 
Type I receptor Alk2 (Acvr1) expression by second heart field cells 
Penny S. Thomas* (1), Brian L. Black (2), Vesa Kaartinen (1) 
(1) Biologic and Materials Sciences, University of Michigan, MI, USA (2) 
Cardiovascular Research Institute, University of California, San Francisco, CA, 
USA 
 
Important roles for Bmp signaling have been implicated in many aspects of 
cardiac morphogenesis. Expression of Bmp4 by cells of the second heart field 
(SHF aka anterior heart field, AHF) has been shown to be required for normal 
outflow tract and great vessel development. It remains unknown to what extent 
SHF cells themselves respond to such signals. To determine the mechanisms 
underlying Bmp function in the cells of the second heart field themselves, we 
have functionally removed their functional Alk2 (Bmp Type I receptor AcvrI) 
activity using the Mef2c-AHF-Cre driver. Aortico-pulmonary and/or outflow tract 
septation was abnormal in these conditional Alk2-null embryos, which displayed 
double outlet right ventricle (DORV) or common arterial trunk (CAT) phenotypes 
with variable abnormalities in downstream great arteries. All had ventricular 
septal defects. The single outflow tract valve in CAT mutants had six leaflets. 
Some mutant embryos of each phenotype survived to birth but became cyanotic 
and did not live for more than 24 hours. Prior to septation, the mutant embryos 
could be distinguished by their smaller, abnormally-shaped, right ventricle. Their 
outflow tract cushion morphology was abnormal but the cushions were not 
generally hypocellular. Highly regional differences in gene expression were 
detected in outflow tract myocardium of mutant versus control embryos. These 
results demonstrate a role in the morphogenesis of the right ventricle and 
outflow tract for Alk2-mediated BMP signalling in the SHF. 
 
 
 
 
 
 
 
130. Transforming Grwoth Factor beta2 is expressed in the second heart 
field and is required for outflow tract and right ventricular development 
Mohamad Azhar* (1), Simon J. Conway (2), Tom Doetschman (1) 
(1) BIO5 Institute, University of Arizona, Tucson, AZ, USA (2) Riley Heart 
Research Center, Herman B. Wells Center for Pediatric Research, Indiana 
University School of Medicine, Indianapolis, IN, USA. 
 
The cells of the second heart field (SHF) predominantly contribute to the outflow 
tract (OFT) and the right ventricle (RV). TGFbeta2-deficient embryos had a 
spectrum of conotruncal defects and defects in valve formation. In situ 
hybridization at E9.5-E10.5 showed significant gene expression of TGFbeta2 
and TGFbeta1 in the splanchnic mesoderm and dorsal mesocardium. Although 
TGFbeta3 gene was not expressed in the SHF during early heart development, 
there was a significant overlap of the TGFbeta2 and TGFbeta3 gene expression 
at E11.5 and onward during heart development. Here, we demonstrated a novel 
function of TGFbeta2 in SHF. Histological and morphometric analysis at E10.5 
indicated altered cardiac looping and significant reduction of the OFT 
lengthening in TGFbeta2-deficient embryos. Interestingly, simultaneous gene-
targeted deletion of both TGFbeta2 and TGFbeta3 exacerbated OFT septation 
defects and resulted in a smaller RV at E14.5. Since RV was significantly 
smaller and hypoplastic in both TGFbeta2-null/TGFbeta3-null and TGFbeta2-
null/TGFbeta3-haploinsufficient embryos but not in TGFbeta2-
haploinsufficient/TGFbeta3-null embryos, these data indicated a dominant role 
of TGFbeta2 in the development of RV. Consistent with the overlapping gene 
expression of TGFbeta2 and TGFbeta1 in the SHF the TGFbeta2/TGFbeta1-
defcient embryos exhibited cardiac abnormalities and died at E10.5. The cardiac 
phenotypic characterization of TGFbeta2/TGFbeta1-deficient embryos and how 
TGFbeta2 regulates SHF function are currently under investigation. Overall, 
these studies revealed novel function of TGFbeta2 in the SHF and SHF-derived 
cardiac segments, including OFT and RV. This will provide new understanding 
of the etiology of conotruncal heart defects and hypoplastic right heart syndrome. 
(Funding: R01HL92508-Conway-Doetschman; ABRC:0901 & Schneider/Gieszl 
Award-Azhar_ 
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131. A strict lineage boundary between the first and second heart fields is 
defined by the contribution of the Tbx5 lineage. 
Joshua D. Wythe*, Kazuko Koshiba-Takeuchi, Kyonori Togi, Benoit G. Bruneau. 
Gladstone Institute of Cardiovascular Disease, University of California, San 
Francisco. 1650 Owens Street. San Francisco, CA 94158, USA 
 
The theory that the heart ¬arises from two distinct heart fields has suggested 
important clues as to how the heart is patterned. Determining the contributions 
of the first heart field (FHF) and second heart field (SHF) cell populations to the 
fully formed heart is central to understanding heart development and the 
etiology of congenital heart defects (CHDs). Haploinsufficiency of the 
transcription factor TBX5 causes Holt-Oram Syndrome, which includes CHDs. 
Tbx5 expression outlines a region of the heart that is presumed to correspond to 
the FHF, and Tbx5 is required in the posterior half of the heart. However, it is 
not known what structures within the heart the Tbx5 lineage gives rise to, or 
whether it is important to Tbx5’s prevalence in CHDs. Using an inducible Cre 
recombinase inserted at the murine Tbx5 locus, we have mapped the 
descendents of the Tbx5-expressing FHF lineage and are determining their 
intersection with the second heart field (SHF) to discern each field’s respective 
contribution to the heart. We find that from the earliest stages of Tbx5 
expression, prior to formation of the linear heart tube, the Tbx5 lineage 
contributes to the posterior segments of the heart, ending at a sharp boundary 
at the interventricular septum. We propose that in the developing heart these 
earliest Tbx5 expressing cells define the FHF lineage, and that a strict lineage 
boundary is created between the FHF and SHF prior to any morphogenic 
distinction between their descendents. Understanding the contribution of Tbx5 to 
the FHF, in conjunction with identifying the cardiac gene program regulated by 
Tbx5, will contribute to our knowledge of heart development and CHDs. 
 
 
 
 
 
 
132. Tyrosine Hydroxylase is expressed during early heart development 
and is required for cardiac chamber formation 
Óscar Bártulos (1), Carmen López-Sánchez (2), Enrique Martínez-Campos (1), 
Carlos Gañán (2), Ana I. Valenciano (3), Virginio García-Martínez (2), Flora De 
Pablo (1) and Catalina Hernández-Sánchez* (1). 
(1)3D Lab, Dept. of Cellular and Molecular Medicine, Centro de Investigaciones 
Biológicas (CSIC), Madrid, Spain (2)Human Anatomy and Embryology, Facultad 
de Medicina, Universidad de Extremadura, Badajoz, Spain (3)Department of 
Animal Physiology II, Facultad de C. Biológicas, Universidad Complutense de 
Madrid, Madrid, Spain. 
 
Aims: Tyrosine Hydroxylase (TH) is the first and rate-limiting enzyme in 
catecholamine biosynthesis. Whereas the neuroendocrine roles of 
cathecolamines postnatally are well known, the presence and function of TH in 
organogenesis is unclear. The aim of this study is to define the expression of TH 
during cardiac development and to gain insight into the role it may play in heart 
formation. Methods and Results: We studied TH expression in chick embryo by 
whole mount in situ hybridization and by quantitative RT-PCR, and analyzed TH 
activity by high-performance liquid chromatography. We used gain and loss-of-
function models to characterize the role of TH in early cardiogenesis. We found 
that TH expression was enriched in the cardiac field of gastrulating chick 
embryos. By stage 8, TH mRNA was restricted to the splanchnic mesoderm of 
both endocardial tubes and was subsequently expressed predominantly in the 
myocardial layer of the atrial segment. L-DOPA and Dopamine induced ectopic 
expression of cardiac transcription factors and the atrial myosin heavy chain 
(AMHC1), as well as sarcomere formation. Overexpression of TH led to 
increased AMHC1 and Tbx5 expression in the ventricular region, and induced 
bradiarrythmia. Conversely, blockage of Dopamine biosynthesis and loss of TH 
activity decreased AMHC1 and Tbx5 expression, while exposure to retinoic acid 
induced TH expression in parallel to that of AMHC1 and Tbx5. Conclusions: TH 
is expressed in a dynamic pattern during the primitive heart tube formation. TH 
induces cardiac differentiation in vivo and it is a key regulator of the heart 
patterning, conferring atriogenic identity. 
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133. MEF2C is Required in the Anterior Heart Field for Outflow: Tract 
Endocardial Cushion Remodeling  
Ian S. Harris1, Eric J. Jaehnig1, Anabel Rojas1, Linh Vong2, John J. Schwarz2, 
and Brian L. Black1 
1Cardiovascular Research Institute, University of California San Francisco, San 
Francisco, CA 94158-2517 
2Center for Cardiovascular Sciences, Albany Medical College, Albany, NY 
12208 
 
The mammalian heart is formed from at least two distinct populations of 
mesodermal precursors.  Cells from the anterior heart field (AHF) are 
progressively added to the heart at the time of cardiac looping and lineage 
tracing has revealed that these cells give rise to the right ventricle, outflow tract, 
and ventricular septum. The MADS box transcription factor MEF2C is required 
for proper heart development, and targeted inactivation of Mef2c in the mouse 
results in embryonic lethality at midgestation.  Mutant embryos display profound 
abnormalities of the outflow tract and right ventricle.  These studies suggest that 
MEF2C plays an important role in the AHF and its derivatives.   Here, we 
describe the conditional inactivation of Mef2c in the AHF. Mef2c AHF conditional 
knockout mice are born at Mendelian ratios, but half die within the first day of life 
with profound cyanosis.  Histological analyses revealed a spectrum of 
conotruncal defects and the common features of semilunar valve leaflet 
thickening and membranous ventricular septal defects suggested aberrant 
remodeling of the outflow tract endocardial cushions.  The transcription factor 
NFATc1 is known to be required for semilunar valve leaflet remodeling and 
membranous ventricular septal formation.  Immunofluorescence studies 
revealed a marked reduction in expression of NFATc1 in the pro-valve 
endocardium of the outflow tract in Mef2c AHF conditional knockout mice.  
Interestingly, a previously described intronic enhancer from the Nfatc1 gene 
contains a conserved MEF2 site, and mutation of the Nfatc1 MEF2 site 
abolished activity of the enhancer in transgenic embryos in vivo.  These studies 
demonstrate that MEF2C is required in the AHF for proper conotruncal 
development.  They further establish Nfatc1 as a direct transcriptional target of 
MEF2C in a transcriptional hierarchy controlling semilunar valve leaflet and 
membranous ventricular septal remodeling. 
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Session B - Miscellaneous 
 
134. Temperature-controlled Operating Work Station for the Chick Embryo 
Christoph M. Happel * (1), Michael Breyvogel (2), Jan Thommes (3), Armin 
Wessel (1), T. Mesud Yelbuz (1) 
(1) Pediatric Cardiology and Intensive Care Medicine, Hannover Medical School, 
Hannover, Germany (2) Department of Medical Device Construction, Hannover 
Medical School, Hannover, Germany (3) Institute for Mechatronic Systems, 
IMES, Leibniz Universität Hannover, Hannover, Germany 
During various experimental manipulations in preparation for studies in 
cardiovascular development chick embryos as a model system are often 
exposed to an unfriendly environment consisting of a lower humidity and 
temperature. This is especially true for and thus very critical in studies that 
involve in vivo imaging of the beating embryonic heart. Although different 
measures are implemented to prevent a drop in temperature, significant 
changes of physiological parameters, e.g. heart rate, still remain a challenge. So 
far, in use are mainly warmed sand boxes, warm air streams or heating blankets 
or pads to provide some temperature control. Nevertheless in most cases a 
significant depression of heart rate is inevitable. Here we present a modified 
PID-controlled heating device that delivers a stable temperature allowing 
manipulations of the chick embryo maintaining a physiological heart rate over 
longer time periods. As humidity is not controlled, this system is not a 
replacement for an environmental chamber for long-term studies, but combines 
the advantages of temperature control and ease of use for manipulations. Once 
the embryos are prepared using this new temperature-controlled operating work 
station, they can be easily transferred for further studies over longer time 
periods in an environmental chamber with stable conditions for temperature, 
humidity and oxygen control (1) as it is conducted in our lab. The modified PID-
controlled heating device is optimized for chick embryos in shell-less culture but 
could easily be modified and used also for studies with zebrafish or mouse 
embryos. (1) Orhan et al. (2007): Microsc Microanal. 13(3): 204-10. 
 
 
 
 
 
 
 
135. Phylogeny of the reptile heart 
Bjarke Jensen Tobias Wang 
Department of Biological Sciences, Zoo-physiology, Aarhus University, Denmark 
The reptile heart constitutes 0.25 % of the body mass and beats at frequencies 
approximately 5 fold lower than in similar sized mammals and birds. Systemic 
and pulmonary venous blood is structurally separated by the two atria but mix 
within the incompletely divided ventricles of snakes, lizards and turtles. Only in 
crocodiles is there a complete interventricular septum. The ventricle exhibits the 
most interspecies variation with septa of variable sizes and a slender outline in 
snakes while broad in turtles. Nevertheless, there is constant volume 
relationship between the left ventricle (40 %) and the right (60 %) in snakes, 
lizards and turtles. Accordingly, the inevitably mix, shunt, of blood within the 
ventricles of these groups seem to be by default predominantly right-to-left, i.e. 
pulmonary bypass. We therefore argue that the hearts of snakes, lizards and 
turtles are essentially the same. Python snakes and varanid lizards, however, 
have mammal-like blood pressures and their ventricular chamber volumes 
deviate from the 40-60 % relationship and their septa are clearly specialized. 
The heart of the Tuatara, possibly the evolutionary oldest reptile alive, has 
ventricular septa that show very little specialization. Crocodiles on the other 
hand, grouped in the archeosaur clade together with dinosaurs and birds, has 
the heart that shows the strongest resemblance to the four-chamber heart of 
mammals and birds. The ventricles of snakes, lizards and turtles then represent 
the transitional state where pythons and varanid lizards are the advanced 
exceptions to the rule. 
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136. Conditional Disruption of Phosphoregulation of Hand1 Results in 
Outflow Tract Defects 
Beth Firulli*, Joshua W. Vincetz, Ralston M. Barnes, Anthony B. Firulli 
Riley Heart Research Center, Wells Center for Pediatric Research, Division of 
Pediatric Cardiology, Indiana Medical School 
For abstract, see in oral presentation section page 27 
 
 
 
 
 
 
137. Tbx2 and Tbx3 induce cushion formation and are required for AVC 
patterning 
Reena Singh* (1), Willem M.H. Hoogaars (2), Thomas Grieskamp (1), Sameer 
Rana (2), Vincent M. Christoffels (2) and Andreas Kispert (1) 
(1) Institut für Molekularbiologie, Medizinische Hochschule Hannover, Hannover, 
Germany (2) Heart Failure Research Center (T.H., V.W., A.F.M.M., V.M.C.), 
Academic Medical Center, Amsterdam, The Netherlands. 
For abstract, see in oral presentation section page 28 
 
 
 
 
 
 
138. The Cardiac Transcription Network Driven by the Interplay of 
Transcription Factors, Histone Modifications and microRNAs 
Jenny Schlesinger* (1), Markus Schueler (1,2), Marcel Grunert (1), Jenny J. 
Fischer (1), Qin Zhang (1), Tammo Krueger (1), Martin Lange (1), Martje Tönjes 
(1), Ilona Dunkel (1), Silke R. Sperling (1) 
(1) Group Cardiovascular Genetics, Department of Vertebrate Genomics, Max 
Planck Institute for Molecular Genetics, Germany (2) Department of 
Computational Molecular Biology, Max Planck Institute for Molecular Genetics, 
Germany 
For abstract, see in oral presentation section page 29 
 
 
 
 
 
 
139. A MEF2C-Myocardin complex directly regulates the cardiac metabolic 
master regulatory gene Ampka2 through a conserved myocardial-specific 
enhancer  
Courtney M. Anderson*, Analeah B. Heidt, Shan-Mei Xu, Brian L. Black 
Cardiovascular Research Institute, University of California, San Francisco, USA 
For abstract, see in oral presentation section page 30 
 
 
 
 
 
 
140. Inhibition of cardiac myocyte apoptosis by Zac1, an essential cardiac 
transcription factor 
Shinsuke Yuasa*, Takahiko Nishiyama, Owen W.J. Prall, Richard P. Harvey, 
Keiichi Fukuda 
Department of Cardiology, Department of Internal Medicine Center for 
Integrated Medical Research, Keio University School of Medicine Victor Chang 
Cardiac Research Institute University of New South Wales 
For abstract, see in oral presentation section page 31 
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141. Hand2 loss-of-function in Hand1-expressing cells Reveals Distinct 
Roles In Heart And Coronary Vascular Development 
Ralston M. Barnes*(1), Beth A. Firulli(1), Josh W. Vincentz(1), Peter Cserjesi(2), 
Simon J. Conway(1), Anthony B. Firulli(1) 
(1) Riley Heart Research Center, Wells Center for Pediatric Research, Division 
of Pediatric Cardiology, Indiana Medical School (2) Department of Cell & 
Molecular Biology, Tulane University, New Orleans, LA 
For abstract, see in oral presentation section page 32 
 
 
 
 
 
 
142. Direct Reprogramming of Cardiac Fibroblasts into Functional 
Cardiomyocytes by Defined Factors 
Masaki Ieda* (1,2,3), Jidong Fu (1,2,3), Vasanth Vedantham (1,2,3), Benoit G. 
Bruneau (1,2,4), and Deepak Srivastava (1,2,3) 
(1)Gladstone Institute of Cardiovascular Disease; (2)Department of Pediatrics; 
(3)Department of Biochemistry and Biophysics, (4)Cardiovascular Research 
Institute, University of California, San Francisco, CA 94158, USA. 
For abstract, see in oral presentation section page 33 
 
 
 
 
 
 
143. Sox4 cooperates with Tbx3 in the regulation of T-box-gene targets 
C.J.J. Boogerd* (1), L.Y.E. Wong (1), M. van den Boogaard (1), M.L. Bakker (1), 
P.A.C. ’t Hoen (2), A.F. Moorman (1), V.M. Christoffels (1) and P. Barnett (1). 
(1) Heart Failure Research Centre, Academic Medical Centre, University of 
Amsterdam, Meibergdreef 15, 1105AZ Amsterdam, The Netherlands. (2) Center 
for Human and Clinical Genetics, Leiden University Medical Center, P.O. Box 
9600, 2300 RC Leiden, The Netherlands. 
For abstract, see in oral presentation section page 34 
 
 
 
 
 
 
144. Prdm1, encoding the Blimp1 transcriptional repressor, genetically 
interacts with Tbx1 during distal outflow tract morphogenesis. 
Stéphane D. Vincent* (1), Sachiko Miyagawa-Tomita (2) and Margaret 
Buckingham (1) 
(1) Institut Pasteur, Departement of Developmental Biology, Paris, France (2) 
Tokyo Women's Medical University, Pediatric Cardiology, Tokyo, Japan 
For abstract, see in oral presentation section page 35 
 
 
 
 
 
 
145. A Direct microRNA Target Screen Reveals Alternate Regions of 
Complementarity that Mediate Repression in cardiac homeostasis 
Eva Samal* (1, 4), Vasanth Vedantham (1,2), Ru-Fang Yeh (3), Nathan 
Salomonis (1), YuanYuan Xiao (3), Morgan Von-Drehle (1), Linda van Laake (5), 
Yong Zhao (6), David J. Erle (2) Deepak Srivastava (1,4) 
(1) Gladstone Institute of Cardiovascular Disease and Departments of 
Biochemistry and Biophysics (2) Medicine (3) Biostatistics (4) Pediatrics, 
University of California, San Francisco, CA, 94158, (5) University of Utrecht, The 
Netherlands. (6) Department of Genetics and Genomic Sciences, Mt Sinai 
School of Medicine, NY, USA 
For abstract, see in oral presentation section page 36 
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146. Interplay of TBX5 and MEF2C during early heart development 
Tushar K Ghosh*(1), Fei Fei Song(1), Elizabeth A Packham(1), Sarah Buxton(1), 
Thelma E Robinson(1), Jonathan Ronksley(1), Tim Self(2), Andrew J Bonser(1) 
and J David Brook(1) 
(1)Institute of Genetics, School of Biology, (2)Institute of Cell Signalling, 
University of Nottingham, Queen’s Medical Centre, Nottingham NG7 2UH, UK 
 
TBX5 is a transcription factor which plays important roles in the development of 
the heart and upper-limbs. Mutations in this gene produce the inherited disorder 
Holt-Oram syndrome. During heart development TBX5 associates with various 
factors including NKX2.5, GATA4, TAZ and orchestrates gene transcription. 
Here we report a novel interaction between TBX5 and MEF2C leading to a 
synergistic activation of a cardiac myosin heavy chain (MYH6). We also show 
that they physically associate through their DNA-binding domains to form a 
complex on the MYH6 promoter. TBX5 mutants; TBX5G80R and TBX5R279X 
that produce severe cardiac phenotypes impair the synergy. Morpholino- 
mediated knockdown of Tbx5 and Mef2c in zebrafish suggests that the genetic 
interaction of these proteins is not only required for MYH6 expression, but also 
is essential for the early stages of heart development and survival. 
 
 
 
 
 
 
 
 
 
 
 
 
147. Identification of Twist1 Target Genes in Heart Valve Development 
Mary P. Horn*, Katherine E. Yutzey 
Division of Molecular Cardiovascular Biology, Cincinnati Children's Hospital 
Medical Center, Cincinnati, OH, USA 
 
Congenital heart defects, including valve malformations, are among the most 
common birth defects in the United States. During early embryonic heart 
formation, valvulogenesis begins with the formation of endocardial cushions 
(ECs) in the atrioventricular canal and outflow tract as a result of an endothelial 
to mesenchymal transition (EMT) of the endocardium. EC mesenchymal cells 
are highly proliferative, migratory, and reside in a primitive ECM. The bHLH 
transcription factor Twist1 is expressed preferentially in the EC mesenchyme 
and promotes proliferation, migration, and a primitive ECM of EC cells in culture, 
yet the mechanism by which this occurs remains unclear. We hypothesize that 
Twist1 maintains EC mesenchymal cell population by directly activating genes 
promoting cell proliferation, migration, and a primitive ECM. The transcription 
factor, Tbx20 and adhesion molecule, Cadherin-11 (Cdh11) are two candidate 
genes modulated by manipulation of Twist1 in EC explant cultures. Regulatory 
regions containing E-boxes, consensus-binding sites for Twist1, were identified 
in Tbx20 (Tbx20boxA) and Cdh11 (Cdh11-Intron1). Luciferase assays confirmed 
that Twist1 drives expression from both regulatory regions, and site-directed 
mutagenesis of the E-box in Tbx20boxA abolishes Twist1 activation. Additional 
candidate downstream targets have been identified through Affymetrix 
microarray analysis of MC3T3-E1 preosteoblast cells treated with control siRNA 
or Twist1 siRNA. Loss of Twist1 results in decreased expression of genes 
associated with cell proliferation, migration, and components of the ECM. These 
experiments will further elucidate transcriptional hierarchies downstream of 
Twist1 that control proliferation, migration, and primitive ECM gene expression 
in EC mesenchymal cells. 
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148. Systems level analysis of cardiac transcription factor networks using 
DamID 
Richard P. Harvey *, Romaric Bouveret and Tram Doan 
Developmental Biology Division, Victor Chang Cardiac Research Institute, 
Darlinghurst, Sydney, Australia 
 
We have begun to formally dissect mammalian cardiac regulatory pathways at a 
systems biology level using genomic tools and genetically manipulated mice and 
cells. Our initial focus is to develop the Dam methylation identification (DamID) 
method for genome-wide cardiac transcription factor (TF) target gene 
identification, a technique that overcomes some of the limitations of the ChIP-
on-chip and ChIP-seq techniques currently used for similar purposes. We have 
performed first pass proof-of-principal experiments to validate the DamID 
method, applying it first to a differentiated atrial cardiac cell line (HL-1) and 
isolating data sets for Nkx2-5, Gata4, Isl1, Tbx5, Tbx20, Tbx1 and Tbx2. Data 
sets have been collected largely using Affymetrix promoter tiling microarrays, 
although for Nkx2-5 targets we have also interrogated whole-genome arrays for 
chromosomes 4, 11 and 17. We will provide an update on our explorations thus 
far. The DamID method should provide a valuable template and complement to 
ChIP data for analysis of gene regulatory networks in mammalian cardiac 
development and physiology, with applications to understanding cardiac disease 
mechanism and progression. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
149. P38alfa-mediated Cited2 phosphorylation is required for Pitx2 
expression in cardiomyocytes 
Francisco Navarro*, Francisco Hernández-Torres and Amelia E. Aránega 
Departamento de Biología Experimental, Facultad de Ciencias Experimentales, 
Universidad de Jaén, Paraje de las Lagunillas, s/n, 23071, Jaén, Spain. 
 
Cited2 encodes for a transcriptional co-factor that appears to participate in many 
biological processes through negative or positive regulation of p300/CBP-
dependent gene transcription. Cited2 binds Tfap2 and CBP/p300, a coactivator 
phosphorylated by the MAPK P38.Very recent reports show that Cited2 and 
Tfap2 were detected at the Pitx2c promoter in embryonic hearts and propose 
that Cited2 acts directly upstream of Pitx2c. In addition, embryos null for either 
Cited2 or Pitx2c develop similar cardiac defects with abnormal left-right  has 
been established to causeαpatterning. Finally, loss of function of p38 embryonic 
lethality at midgestation due to a placental defect, similarly than Cited2 -/- null 
mouse embryos. To further analyse Cited2-mediated Pitx2 transcriptional 
regulation we used mouse immortalised p38alfa-/- and wild-type embryonic 
cardiomyocytes cell lines obtained from E 9.5. Our results demonstrated that 
p38alfa deficiency abolish expression of the three Pitx2 isoforms, Pitx2a, b, and 
C. In addition, lack of p38alfa impairs Cited nuclear localization in 
cardiomyocytes, colocalising with vimentin at the perinuclear region, while P300 
nuclear localisation was not altered. Taken together, we mediated Cited2 
phosphorylation is required to regulate−propose that p38alfa- its nuclear 
localisation and allows Pitx2 expression in embryonic cardiomyocytes. 
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150. Wt1 and retinoic acid signaling in the subcoelomic mesenchyme 
control the development of the pleuropericardial membranes and the 
sinus horns 
Julia Norden* (1), Thomas Grieskamp (1), Ekkehart Lausch (2), Bram van Wijk 
(3), Maurice J. B. van den Hoff (3), Christoph Englert (4), Marianne Petry (1), 
Mathilda T.M. Mommersteeg (3), Vincent M. Christoffels (3), Karen Niederreither 
(5), and Andreas Kispert (1) 
(1) Institut für Molekularbiologie, OE5250, Medizinische Hochschule Hannover, Carl-
Neuberg-Str.1, D-30625 Hannover, Germany (2) Centre for Pediatrics and Adolescent 
Medicine, University of Freiburg, Mathildenstraße 1, D-79106 Freiburg, Germany (3) 
Department of Anatomy, Embryology and Physiology, Academic Medical Center, 
University of Amsterdam, Meibergdreef 15 L2-108, 1105 AZ Amsterdam, The Netherlands 
(4) Molecular Genetics Group, Leibniz Institute for Age Research – Fritz Lipmann Institute, 
Beutenbergstr. 11, D-07745 Jena, Germany (5) Departments of Medicine and Molecular 
and Cellular Biology, Center for Cardiovascular Development, Baylor College of Medicine, 
One Baylor Plaza, Houston, Texas 77030, USA 
 
The cardiac venous pole is a common focus of congenital malformations and 
atrial arrhythmias, yet little is known about the cellular and molecular 
mechanisms that regulate its development. The systemic venous return 
myocardium (fetal sinus horns) forms only late in cardiogenesis from a pool of 
pericardial mesenchymal precursor cells. Here, we show that expression of the 
Wilms tumor 1 gene (Wt1) in the subcoelomic mesenchyme surrounding the 
cardinal veins is important for sinus horn development. In Wt1-deficient hearts, 
the cardinal veins fail to expand into the pericardial cavity and to differentiate to 
myocardium, but become embedded laterally in the pleuropericardial 
membranes. These membranes remain tethered to the lateral body wall by the 
persisting subcoelomic mesenchyme, a finding that correlates with decreased 
apoptosis in this region. Expression of the aldehyde dehydrogenase family 1, 
subfamily A2 gene (Raldh2) was lost from this mesenchyme in Wt1-deficient 
embryos, and Raldh2- and Wt1-mutant mice display similar defects of the 
venous pole and pericardium, suggesting that retinoic acid signaling mediates 
the function of Wt1 in this tissue. We show by lineage tracing studies that the 
Wt1-positive subcoelomic mesenchyme does not present a cellular source of 
sinus venosus progenitors, indicating that formation of pericardium and sinus 
horns depends on the expansion and correct temporal release of the 
pleuropericardial membranes by apoptosis from the underlying subcoelomic 
mesenchyme. These results provide novel insight into the genetic and cellular 
pathways regulating the posterior extension of the mammalian heart and the 
formation of its coelomic lining. 
 
 
 
 
 
151. Cardiac Gene regulatory network driving differentiation in the 
drosophila embryo 
Adrien Salmand (1), Delphine Potier (1, 2), Nathalie Lalevée (1), Carl Herrmann 
(2), Laurent Perrin (1)* 
(1) Developmental Biology Institute of Marseille Luminy, Parc Scientifique de Luminy, 
Marseille France (2) Techniques Avancées pour le Génome et la Clinique, Parc 
Scientifique de Luminy, Marseille France 
A great number of reports have demonstrated a clear conservation of genetic 
control of cardiogenesis, from Drosophila to mammals. However, what the 
involved transcription factors control in terms of downstream gene networks to 
control the successive steps that progressively drive the diversification and the 
differentiation of cardiomyocytes, largely remains unknown. Still, a detailed 
understanding of cardiac differentiation processes should provide important 
insights about normal and pathological heart development. Our research 
projects use genetics, developmental biology and genomics to decipher cardiac 
Gene Regulatory Networks (GRN) involved in cardiac cell diversification and 
differentiation in Drosophila. Our approach also includes the development and 
use of bio informatics tools to unravel the cis regulatory code from set of co 
expressed genes. In addition, we are interested in understanding how shape 
and function are acquired downstream the cardiac GRN. Reverse genetic 
screens are under way to identify genes involved in establishment of cardiac 
tube shape and acquisition of automatic beating. 
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152. MiR423-5p as a circulating biomarker for heart failure 
Anke J. Tijsen* (1), Esther E. Creemers (1), Perry D. Moerland (2), Leon J. de 
windt (3), Allard C. van der Wal (4), Wouter E. Kok (1), Yigal M. Pinto (1) 
(1) Heart Failure Research Center, Academic Medical Center, University of Amsterdam, 
Amsterdam, The Netherlands. (2) Department of Clinical Epidemiology Biostatistics and 
Bioinformatics, Academic Medical Center, University of Amsterdam, Amsterdam, The 
Netherlands. (3) Department of Cardiology, University Maastricht, Maastricht, The 
Netherlands. (4)Department of Pathology, Academic Medical Center, University of 
Amsterdam, Amsterdam, The Netherlands. 
 
Rationale: Aberrant expression profiles of circulating microRNAs (miRNAs) have 
been described in various diseases and provide high sensitivity and specificity. 
We explored circulating miRNAs as potential biomarkers in patients with heart 
failure (HF). Objective: The goal of this study was to determine whether miRNAs 
allow to distinguish clinical HF not only from healthy controls but also from non-
HF forms of dyspnea. Methods and results: A miRNA array was performed on 
plasma of 12 healthy controls and 12 HF patients. From this array we selected 
16 miRNAs for a second clinical study in 39 healthy controls and in 50 cases 
with reports of dyspnea, of whom 30 were diagnosed with HF and 20 were 
diagnosed to have dyspnea due to non-HF related causes. This revealed that 
miR423-5p was specifically enriched in blood of HF cases and receiver-
operator-characteristics (ROC) curve analysis showed miR423-5p to be a 
diagnostic predictor of HF, with an area under the curve of 0.91 (p<0.001). Five 
other miRNAs were elevated in HF cases, but also slightly increased in non-HF 
dyspnea cases. Conclusion: We identify 6 miRNAs that are elevated in patients 
with HF, among which miR423-5p is most strongly related to the clinical 
diagnosis of HF. These 6 circulating miRNAs provide attractive candidates as 
putative biomarkers for HF. 
 
 
 
 
 
 
 
 
 
 
153. Bioinformatics approach to identify direct downstream T-box target 
genes 
Ping Kong (1), Silvia E. Racedo* (1), Raquel Castellanos (1), Deyou Zheng (2), 
Bernice E. Morrow (1) 
(1) Departments of Genetics, Obstetrics and Gynecology & Women’s Health, Pediatrics, 
Albert Einstein College of Medicine, Bronx, NY, USA (2) Departments of Neurology and 
Genetics, Albert Einstein College of Medicine, Bronx, NY, USA 
 
T-box genes have been involved in early cardiac lineage determination, 
chamber specification, valvuloseptal development and diversification of the 
specialized conduction system in vertebrate embryos. This gene family is 
present in all metazoans, and they are expressed throughout embryonic 
development in a spatial-temporal coordinated manner. They share a T-box 
DNA binding domain and many can bind a T-site consensus sequence on DNA. 
Mutations in T-box genes are responsible for developmental defects with a 
dosage dependent severity. Particularly, TBX1, has been identified as a critical 
gene in the chromosome 22q11 region deleted in individuals with velo-cardio-
facial/DiGeorge syndrome characterized by craniofacial and heart defects. To 
find direct transcriptional target genes for Tbx1, we performed SELEX 
(Systematic Evolution of Ligands by Exponential enrichment) with the T-box 
portion of the murine Tbx1 protein. A dimer and also monomer site of 
AGGTGTGA was identified. The site is highly similar to the published Brachyury 
(T protein) binding site. With this in mind we did a bioinformatics analysis 
searching for this site in regions of the mouse genome with high evolutionary 
conservation. We identified 200 sites highly conserved in vertebrates and 500 
belonging to the next level of conservation. Many could be direct downstream 
targets of several T-box genes. Ones expressed in heart were Bhlhe40, ESSRG, 
Hiflan, Kcnd2, BMP10, Runx11, Slc8a1, Vcl and Egr3, among others. This 
coupled with ChIP-seq or other ChIP type experiments could help narrow 
possible candidates to pursue. 
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154. Regulation of conduction genes by TBX3 
L.Y. Elaine Wong* (1), Malou van den Boogaard (1), Martijn L. Bakker (1), Peter 
A. C. ‘t Hoen (2), Antoon F. Moorman (1), Vincent M. Christoffels (1) and Phil 
Barnett (1) 
(1) Heart Failure Research Center, Academic Medical Center Amsterdam, 
University of Amsterdam, the Netherlands (2) Center for Human and Clinical 
Genetics, Leiden University Medical Center, the Netherlands 
 
Previous studies showed that T-box transcription factor TBX3 is important for 
the formation of the cardiac conduction system. Microarray analysis in 
transgenic mice with TBX3 over-expression in the atria showed that Scn5a and 
Scn10a, two important cardiac sodium channel genes, are down-regulated. 
Down-regulation of Scn5a may predispose to channelopathies, and recently 
Scn10a has been linked to cardiac conduction in genome-wide association 
studies. Hence, the regulation of these genes is important for normal cardiac 
conduction. In order to find out more about the function of TBX3 in gene 
regulation, we performed an in vivo TBX3 ChIP-seq (chromatin 
immunoprecipitation coupled to massively parallel sequencing) in adult mouse 
hearts with TBX3 over-expression. Using this ChIP approach we have now been 
able to map all potential and open TBX3 binding sites, in vivo, within and far 
beyond the Scn5a and Scn10a encoding region. In addition to genome-wide 
mapping of protein binding, ChIP-seq also allows us to predict enhancers in the 
genome. By means of the occupancy of TBX3 in Scn5a and Scn10a genes, a 
number of sequences in these genes were chosen and analysed in vitro using a 
luciferase reporter assay. Taking this approach we identified several potential 
enhancers that could be down-regulated by TBX3 and up-regulated by addition 
of GATA4 and NKX2.5. We go on and verify these binding sites as being 
occupied by TBX3 and GATA4/NKX2.5/(p300) during embryonic development. 
We are currently examining the spatiotemporal expression patterns these 
enhancers control during embryogenesis. 
 
 
 
 
 
 
 
 
 
 
155. Gli2 and Mef2C interact on genetic and protein levels during stem cell 
differentiation 
Anastassia Voronova*, Ashraf Al-Madhoun, Anna Fischer, Ilona S. Skerjanc 
Biochemistry, Microbiology and Immunology Department, Faculty of Medicine, 
University of Ottawa, Canada 
 
Gli2 is a primary mediator of the sonic hedgehog (Shh) signaling pathway during 
myogenesis and neurogenesis in developing embryos. Previously, Gli2 has 
been shown to play a role in cardiomyogenesis and skeletal myogenesis in vivo 
and to induce cardiac and skeletal myogenesis in vitro in P19 cells, an 
established stem cell model for muscle and neuronal cell differentiation. We 
found that in addition to myogenesis, expression of Gli2 resulted in the induction 
of neurogenesis in P19 cells. This is the first observation of the neurogenic 
effect of Gli2 in stem cells. Similar to Gli2, Mef2C is also important in 
myogenesis and neurogenesis in vivo, and its expression resulted in induction of 
cardiac and skeletal muscle as well as neurons in P19 cells. We found that Gli2 
and Mef2C upregulated each other’s transcription by directly binding to their 
respective gene elements, indicating a novel positive regulatory loop between 
Gli2 and Mef2C. Moreover, we found that Gli2 and Mef2C form a protein 
complex during P19 cellular differentiation. Gli2 and Mef2C proteins showed 
synergistic activation of the Nkx2.5 promoter, a factor playing a major role in 
cardiomyogenesis both in vitro and in vivo. Our findings shed light on 
transcriptional regulation as well as protein complex formation and function 
during myogenesis and neurogenesis by Shh signaling in vitro. 
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156. The Iroquois homeobox gene 3 regulates functional maturation of the 
His-Purkinje Network 
Shan-Shan Zhang* (1, 2), James Smyth (4, 5), Nathalie Gaborit (1, 2), Tatyana 
Sukonnik (1, 2), Paul Delgado-Olguin (1, 2), John N. Wylie (1, 2), Koroboshka-
Arzamendi Brand (4), Yonghong Zhu (7), Rui Sakuma (8), Neil C. Chi (9), Robin 
Shaw (4, 5), Chi-Chung Hui (6, 8) & Benoit G. Bruneau (1, 2, 3, 4) 
(1) Gladstone Institute of Cardiovascular Disease, San Francisco, USA (2) Department of 
Pediatrics, (3) Institute for Regeneration Medicine, (4) Cardiovascular Research Institute, 
(5) Department of Medicine, University of California, San Francisco, USA (6) Program in 
Developmental and Stem Cell Biology, (7) The Mouse Imaging Centre, The Hospital for 
Sick Children, Toronto, Canada (8) Department of Molecular Genetics, University of 
Toronto, Canada (9) Department of Medicine, University of California, San Diego, USA 
 
Integral to cardiac function are the fast-conducting myocytes of the His-Purkinje 
network that drive ventricular activation. Here we show that the Iroquois 
homeobox gene 3 (Irx3) is essential for establishing conduction properties of 
this specialized cellular network. Genetic ablation of Irx3 in mice resulted in 
impaired ventricular activation, measured as QRS prolongation and bundle 
branch block. The zebrafish homolog Ziro3a is highly expressed in the ventricle 
and atrioventricular canal. Optical mapping of its morpholino knockdown also 
showed slowed and asynchronous impulse propagation. Further studies in Irx3 
null mice revealed that impaired conduction is attributable to reduced cellular 
excitability and altered intercellular coupling. In the absence of Irx3, we 
observed changes in ion channel genes that underlie the depolarizing phase of 
the action potential, and ectopic connexin 43 (Cx43) expression in the proximal 
bundle branches. Adenoviral overexpression of Irx3 in neonatal ventricular 
myocytes led to marked decrease of Cx43 mRNA and protein. We have 
determined that Cx43 is a direct transcriptional target, and that Irx3 represses 
Cx43 activation by Nkx2-5 and Tbx5. Together these results suggest that Irx3 is 
required for His-Purkinje functional maturation as an evolutionarily conserved 
regulator of impulse conduction. Using a 3myc-6his-Irx3 knockin mouse line, we 
are currently investigating additional Irx3 protein partners and its endogenous 
consensus DNA binding sequence. 
 
 
 
 
 
 
 
157. Transcriptional Regulation of Fgf10 Gene in the Anterior Heart Field 
Yusuke Watanabe* (1, 2), Stephane Zaffran (3), Robert Kelly (4), Atsushi 
Kuroiwa (5), Toshihiko Ogura (2), Richard Harvey (6), Margaret Buckingham (1) 
(1) Department of Developmental Biology, CNRS URA2578, Pasteur Institute, Paris, 
France (2) Department of Developmental Neurobiology, Institute of Development, Aging 
and Cancer, Tohoku University, Sendai, Miyagi, Japan (3) Medical Genetics and 
Functional Genomics, INSERM UMR S910 School of Medicine of Marseille, France (4) 
Developmental Biology Institute, Marseille-Luminy UMR6216, Centre National de la 
Recherche Scientifique-Universite de la Mediterranee, Campus de Luminy, Marseille, 
France (5) Division of Biological Science, Graduate School of Science, Nagoya University, 
Japan. (6) Victor Chang Cardiac Research Institute, Sydney, Australia 
 
The anterior part of the second heart field (AHF) contributes to the arterial pole 
of the heart. In the AHF, Fgf10 is expressed and functions for formation of the 
outflow tract and right ventricle. To elucidate signaling cascade in the AHF, we 
identified and analyzed AHF enhancer of Fgf10 gene. Fgf10 AHF-enhancer has 
multiple binding sites for Nkx2.5, which is a homeobox transcription factor and is 
predominantly expressed in the heart. EMSA showed Nkx2.5 binding to those 
sites, and Fgf10 AHF-enhancer activity was ectopically induced in the single 
ventricle of Nkx2.5 mutants, suggesting that Nkx2.5 is a suppressor for Fgf10 
AHF-enhancer. We next tested Isl1 regulation to the enhancer. Isl1 is a LIM-
homeobox transcription factor, and a key regulator for the AHF development. 
Isl1 shares some of its binding sites with Nkx2.5. In Isl1-overexpressing heart, 
Fgf10 AHF-enhancer activity was ectopically induced in the heart. Taken 
together, we conclude that Nkx2.5 and Isl1 bind to same sites in Fgf10-AHF 
enhancer, and they probably regulate Fgf10 transcription competitively in the 
heart. 
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158. Platelets play an essential role in separating the blood and lymphatic 
vasculatures during embryonic angiogenesis 
Laura Carramolino (1), Joana Fuentes (1), Clara García-Andrés (1), Valeria 
Azcoitia (1), Dieter Riethmacher (2), Miguel Torres* (1) 
(1) Departamento de Biología del Desarrollo Cardiovascular, Centro Nacional 
de Investigaciones Cardiovasculares, Instituto de Salud Carlos III, 28029 Madrid, 
Spain (2) Division of Human Genetics, School of Medicine, University of 
Southampton, Southampton SO16 6YD, UK 
 
Rationale: Several mutations that impair the development of blood lineages in 
the mouse also impair the formation of the lymphatic vasculature and its 
separation from the blood vasculature. However, the basis for these defects has 
remained unknown because the mutations characterized affect more than one 
blood lineage. Objective: We tested the hypothesis that 
megakaryocytes/platelets are required for the formation of the lymphatic 
vasculature and its separation from the blood vascular system. Methods and 
Results: We characterized the vascular patterning defects of mice deficient for 
the homeodomain transcription factor Meis1, which completely lack 
megakaryocyte/platelets. Meis1 null embryos fail to separate the blood and 
lymphatic vasculature, showing blood-filled primary lymphatic sacs and 
superficial lymphatic vessels. To test the involvement of 
megakaryocytes/platelets in this phenotype, we generated 
megakaryocyte/platelet-specific deficient mice by targeted lineage ablation, 
without affecting other blood lineages. This model reproduces the 
lymphatic/blood vasculature separation defects observed in Meis1 mutants. A 
similar phenotype was induced by antibody-mediated ablation of circulating 
platelets in wild type mice. Strong association of platelets with vascular 
endothelium at regions of contact between lymphatic sacs and veins confirmed 
a direct role of platelets in the separation of the two vasculatures. Conclusions: 
In addition to their known protective function in the response accidental vascular 
injury, platelets are also required during embryonic lymphangiogenesis for the 
separation of the nascent lymphatic vasculature from blood vessels. 
 
 
 
 
 
 
 
 
 
 
 
 
 
159. Co-operative and synergistic actions of Tbx5 and MRTF-B in zebrafish 
cardiogenesis 
Kota Miyasaka*, Shuhei Kakizaki, Kiura Masato, Yusuke Watanabe, Yasuyuki 
Kida, Toshihiko Ogura 
Dept. of Developmental. Neurology., IDAC, Tohoku University., Japan 
 
In response to hemodynamic forces, vascular endothelial cells remodel their 
cytoskeleton and change their gene expression profiles. Alterations of cardiac 
hemodynamics produce defects in heart morphology and gene expression. 
Hence, formation of a functional heart is dependent on a tight interplay between 
genetics and hemodynamics, both of which are emerging as indivisible 
parameters for cardiogenesis and circulatory homeostasis. Nonetheless, a 
molecular link between them is unknown. Tbx5, a key transcription factor, also 
functions as an epigenetic factor, making a robust transcriptional activation 
complex with MRTF-B in response to the heartbeat. Our data argue for the 
importance of a novel epigenetic mechano-transduction pathway mediated by 
heartbeat-dependent nucleo-cytoplasmic shuttling. We found that correct cyto-
architecture and cardiomyocyte contraction were also dependent on the 
heartbeat, revealing physical force as an epigenetic morphogen. 
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160. Characterization of cardiac enhancers of the Drosophila Dorsocross 
T-box gene cluster 
Dorothea Schultheis, Hong Jin, Manfred Frasch, Ingolf Reim* 
Department of Biology/Developmental Biology, University of Erlangen-
Nuremberg 
 
A critical aspect of heart formation is the precise control of the spatio-temporal 
expression of key regulatory genes of the cardiac gene regulatory network. 
Members of the T-box gene family, which encode transcription factors, are 
crucial components of this network in both vertebrate and invertebrate 
organisms. In Drosophila, the T-box genes Dorsocross (Doc1-3) act in 
conjunction with the Nkx2-5 family-founding member tinman (tin) and the 
GATA4 homologue pannier (pnr) to specify cardiac progenitors at an early stage 
of cardiogenesis. Accordingly, these cardiogenic factors are co-expressed in the 
early cardiogenic mesoderm. However, during subsequent stages tin represses 
Doc and, consequently, Doc and tin assume mutually exclusive expression 
patterns in developing cardioblasts. Thus, Doc gets restricted to the myocardial 
cells that will form the inflow valves and tin to the working myocardial cells. For a 
more detailed view of the molecular pathways of cardiac specification and heart 
cell diversification we have scanned the entire Doc locus of the Doc1-3 gene 
cluster for enhancers using a transgenic reporter gene approach. We have 
identified regulatory elements for the expression in the early cardiogenic 
mesoderm and others that drive expression of Doc in inflow valve-forming 
cardioblasts. ChIP-on-Chip data suggest that these elements are bound by Tin 
in vivo. We are currently investigating whether this binding is functional in an 
activating and repressing fashion, respectively, and which other transcription 
factors and signaling effectors may target these elements. 
 
 
 
 
 
 
 
 
 
 
 
 
 
161. Genome-wide identification of NKX2-5 binding sites and target genes 
in the developing heart using ChIP-chip 
Catherine Shang*, Stuart Smith, Norma Towers, Tim Mohun 
CANCELLED 
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162. Etv2 regulation of endothelial development in the Xenopus embryo. 
Candace T. Myers* (1), Matthew C. Salanga (2), Paul A. Krieg (2) 
(1) Molecular and Cellular Biology, University of Arizona, Tucson, AZ, USA (2) 
Cell Biology and Anatomy, University of Arizona, Tucson, AZ, USA 
 
Transcription factors of the ETS family are important regulators of endothelial 
gene transcription. We have determined that one of the ETS family members, 
etv2, is essential for vascular development in the Xenopus embryo. Loss of etv2 
results in loss of detectable expression of every vascular marker examined, 
including all endothelial transcription factors. In overexpression experiments, 
etv2 is sufficient to activate transcription of a large range of endothelial markers, 
again including endothelial transcription factors. These results suggest that etv2 
functions at the very top of the transcriptional hierarchy that controls endothelial 
cell specification. We want to further explore the mechanism by which etv2 
regulates endothelial gene expression during vascular development. 
Overexpression of etv2 specifically activates endothelial genes, even in non-
mesodermal tissues like gut endoderm or ectodermal explants. The DNA 
binding site specificity of etv2 alone is not sufficient to explain how the protein 
can be so precise in activating endothelial genes. We hypothesize that etv2 
cooperates with other transcription factors and these co-regulatory partner 
proteins provide at least some additional specificity. First, we are using a 
candidate approach in an effort to identify functional partner proteins. Second, 
we are using structure-function studies to dissect a unique conserved sequence 
in etv2 that may allow for protein interactions. Finally, we will perform co-
immunoprecipitation followed by Mass Spec analysis, to identify proteins that 
physically complex with etv2 in the cell. Since no functional partners of etv2 
have been identified at this time, our proposed studies will broaden our 
understanding of the mechanisms of transcriptional regulation by ETS 
transcription factors during endothelial development. 
 
 
 
 
 
 
 
 
163. The ETS family protein, etv2, is necessary and sufficient for activation 
of the endothelial transcription factors, fli1, elk3 and sox18. 
Matthew C. Salanga* (1), Candace T. Myers (2), Paul A. Krieg (1) 
(1) Cell Biology and Anatomy, The University of Arizona, Tucson, AZ, USA (2) 
Molecular and Cellular Biology, The University of Arizona, Tucson, AZ, USA 
 
Transcription factors of the ETS family play an extremely important role in 
regulation of endothelial and hematopoietic genes. We have identified and 
characterized the Xenopus orthologue of the ETS transcription factor, etv2/er71. 
Expression analysis shows that etv2 transcripts are highly expressed in 
hematopoietic and endothelial precursor cells in the Xenopus embryo. In gain-
of-function experiments, overexpression of etv2 strongly activates expression of 
vascular markers in ectopic regions of the Xenopus embryo using multiple 
assays including microarray analysis, quantitative RT-PCR and whole mount in 
situ hybridization. Upregulated genes include a number of endothelial and 
hematopoietic transcription factors. Inhibition of etv2 function using antisense 
morpholino oligonucleotides results in dramatic reduction in expression of 
endothelial marker genes, but expression of hematopoietic markers are not 
affected. To investigate the potential of etv2 to directly activate endothelial 
genes, we utilized a steroid inducible etv2 fusion protein, in the presence or 
absence of protein synthesis inhibition, demonstrating that the endothelial 
transcription factors, fli1, elk3, and sox18 are direct targets of etv2 regulation. 
These studies place etv2 at the beginning of the transcriptional program 
essential for development of the endothelial lineage in the Xenopus embryo. 
However, these studies do not explain how etv2 directly activates endothelial 
genes or the regulatory regions of target genes where etv2 binds. To approach 
these questions we have constructed an epitope-tagged etv2 for use in 
chromatin immunoprecipitation experiments with the ultimate goal of revealing 
novel etv2-specific cis-regulatory elements on target endothelial genes. 
 
  Poster session B Friday 21 May 
 
page 162 
164. Drosophila microRNA let-7 deficiency results in compromised heart 
function 
Jerome Cartry*, Nikki Alayari, Timothy Iafe and Rolf Bodmer 
Development and Aging Program, Sanford-Burnham Institute for medical 
Research, La Jolla, CA, USA 
 
MicroRNAs (miRNAs) are a class of highly conserved non-coding RNAs that 
have been recently recognized as majorly implicated in cardiovascular diseases. 
We are using the genetic power of the fly and an optical method for analyzing 
and quantifying heart contraction parameters to investigate the role of miRNAs 
in the adult heart function. A cardiac specific miRNA expression profile revealed 
let-7 as one of the miRNAs expressed in the adult heart. Investigating the 
requirement for let-7 in cardiac physiology, we found that let-7 mutants display a 
slower, highly arrhythmic heartbeat, including a high incidence of non-beating 
(asystoly), as well as structural defects reminiscent of ‘hypertrophy’. To better 
characterize the role of let-7 in the heart, we performed heart-specific Q-PCR for 
many (direct or indirect) candidate targets of let-7, including ion channel genes. 
Indeed, we observed that several genes that have previously been found to be 
critical for heart function are up-regulated in let-7 hearts, including the Calcium 
channel cacophony, the K-ATP channel subunit dSur and the Ks channel KCNQ. 
These results demonstrate the importance of let-7 miRNA in the regulation and 
maintenance of adult cardiac function. We are in the process of investigating the 
functions of other cardiac-expressed miRNAs in the Drosophila heart model. 
 
 
 
 
 
 
 
 
 
 
 
165. Functional analysis of genomic regions identified by genome-wide 
Tinman ChIP-chip in Drosophila 
Hong Jin* (1), Robert Stojnic (2), Boris Adryan (2), Angela Stathopoulos (3), 
Manfred Frasch (1) 
(1) University of Erlangen-Nuremberg, Department of Biology, Division of 
Developmental Biology, Erlangen, Germany (2) University of Cambridge, 
Cambridge Systems Biology Centre, Cambridge, UK (3) California Institute of 
Technology, Division of Biology, Pasadena, California, USA 
 
The formation of the heart and other musculatures from the dorsal mesoderm of 
Drosophila has provided an excellent model for dissecting how signal molecules 
and transcription factors cooperate to control organogenesis. Genetic studies 
identified the NK homeodomain transcription factor Tinman (Tin) as a key 
regulator in this system. In the absence of tin function, there is a complete loss 
of all dorsal mesodermal derivatives, including cardiac, visceral and certain 
somatic muscles. However, so far relatively few direct target genes of Tin have 
been identified. To better understand the functions of tin in the regulatory 
network, we performed whole-genome ChIP-chip analysis for Tin in vivo binding 
sites with embryos of two distinct developmental periods, which cover early 
cardiac induction and the specification of various types of heart progenitors, 
respectively. Among the ca. 3500 partially overlapping Tin-bound regions from 
the two stages several dozens of highly prioritized regions were chosen for 
functional analysis in both wild type and tin mutant embryos. The Tin-binding 
sites of several fragments were mutated to examine their roles in the respective 
enhancer activities. Our results show that most tested Tin-bound regions are 
able to drive reporter expression in the mesoderm or distinct muscle tissues, 
and often their enhancer activities completely or partially depend on the 
presence of functional Tin protein. Our poster will focus on Tin-targeted 
enhancers and some of their associated genes that are active during various 
stages of cardiogenesis. 
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166. Transcriptional repression by the highly redundant Irx4 and Irx5 
transcription factors maintains the normal growth properties of the heart. 
Tatyana Sukonnik* (1), Shan-Shan Zhang (1,2), Nathalie Gaborit (1), John N. 
Wylie (1), Chi-Chung Hui (3,4), & Benoit G. Bruneau (1,2,5,6) 
(1) Gladstone Institute of Cardiovascular Disease, San Francisco, CA 94158 (2) Program 
in Biomedical Sciences, University of California, San Francisco, CA 94143 (3) Program in 
Developmental and Stem Cell Biology, The Hospital for Sick Children, Toronto, ON M5G 
1X8, Canada (4) Department of Molecular Genetics, University of Toronto, Toronto, ON 
M5S 3E2, Canada (5) Department of Pediatrics, University of California, San Francisco, 
CA 94143 (6) Cardiovascular Research Institute, University of California, San Francisco, 
CA 94158 
 
The growth of the heart around birth is strictly regulated, especially as the 
various cell types transition from a fetal proliferative phenotype to a mature 
differentiated program. Here we show that in mice lacking the Iroquois 
homeobox (Irx) transcription factors Irx4 and Irx5 the growth properties of the 
heart are disrupted. Overall, neonatal lethality was observed, with severe 
myocardial disarray especially pronounced in the interventricular septum. 
Furthermore, the monolayer properties of the endocardium were disrupted, 
occasionally leading to thickening of the endocardium up to 20 layers, mimicking 
endocardial fibroelastosis, a human disease of unknown etiology. Gene profiling 
revealed that Irx4 and Irx5 are highly redundant, and in their combined absence 
hundreds of genes are derepressed. Statistical overrepresentation of genes 
implicated in chromatin remodeling and RNA metabolism were observed, 
indicating that a broad program incorporating transcriptional and post-
transcriptional regulation is affected in Irx4;Irx5 double KO hearts. This shows 
that the combined role of Irx4 and Irx5 is transcriptional repression of gene 
programs that regulate the growth and functional properties of the heart. Other 
Irx genes are also highly redundant, and our preliminary results from Irx3;Irx4 
double knockout mice indicate lethality by mid-gestation. These findings have 
implications for the regulation of growth properties in organogenesis, as well as 
in the pathology of cardiac disease. 
 
 
167. FOXO3a negatively regulates the transcriptional activity of Dok-5 
Jianyan Wen a,b, Qing Xiac, Cheng Wangd, Wei Liub, Yang Chenb, Jing Gaob, 
Yanhua Gongb, Bin Yinb,Yuannan Kea, Boqin Qiang b, Jiangang 
Yuanb,Xiaozhong Peng b. 
a National Integrative Medicine Center for Cardiovascular Disease, China-Japan 
Friendship Hospital, Beijing 100029, China b National Key Laboratory of Medical 
Molecular Biology, Institute of Basic Medical Sciences, Chinese Academy of Medical 
Sciences and Peking Union Medical College, Beijing 100005, China c Department of 
Molecular Immunology, Beijing Institute of Basic Medical Science, Beijing 100850, China d 
Department of Physiology and Pathophysiology, Peking University Health Science Center, 
Key Laboratory of Molecular Cardiovascular Sciences, Ministry of Education, Beijing 
100191, China 
 
A clonal derivative named P19CL6 has been isolated from pluripotent P19 
mouse embryonic carcinoma cells, and this subline efficiently differentiates into 
beating cardiomyocytes when treated with 1% dimethyl sulfoxide (DMSO). It 
offers a valuabe model to study cardiomyocytes differentiation in vitro. 
Comparative proteomic analysis was used to characterize the protein profiles 
associated with the DMSO-induced cardiomyocytes differentiation of P19CL6 
cells. We also found that Dok-5 expression level significantly increased during 
this process. Dok-5 is a member of the insulin receptor substrates family, which 
play important roles in the cellular growth, signaling, and survival of cells. But 
the mechanism of Dok5 upregulation is still unclear. In this study, we first 
mapped the transcription start site of the mouse Dok-5 gene and characterized 
its promoter regions. Truncation and mutation analysis of the Dok-5 promoter 
identified the forkhead binding element responsible for the repression of Dok-5 
promoter region. The co-localization of FOXO3a and Dok-5 in the mouse heart 
allows FOXO3a to be a transcriptional regulator of Dok-5. Electrophoretic 
mobility shift assay and chromatin immunoprecipitation assay confirmed that 
FOXO3a could bind to the Dok-5 promoter, accompanied by FOXO3a 
translocation from the nucleus to cytoplasm. FOXO3a overexpression could 
inhibit Dok-5 promoter activity. Silencing FOXO3a expression by siRNA 
upregulated the expression of Dok-5. Our results provide the first evidence that 
FOXO3a, the PI3K/PKB downstream substrate, acts as a transcriptional 
repressor to inhibit the expression of Dok-5. 
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168. Pitx2 Insuficiency Leads To Atrial Remodelling Prone To 
Arrythmogenesis 
Ana Chinchilla (1), Daimi Houria(1), Estefania Lozano-Velasco (1), Jorge N 
Dominguez (1), Ricardo Caballero (2), Eva Delpón (2), Juan Tamargo (2), Leif 
Hove-Madsen (3), Amelia E Aranega (1), Diego Franco (1) 
(1)Department of Experimental Biology, University of Jaén, Jaén, Spain (2) 
Department of Pharmacology, Complutense University of Madrid, Madrid, Spain, 
(3) Cardiovascular Research Centre, Hospital de la Santa Creu i Sant Pau, 
Barcelona, Spain 
 
Pitx2 is a homeobox transcription factor that plays a pivotal role in the early 
left/right determination, downstream of the nodal/lefty signaling pathway. Pitx2 
expression is confined to the left side of the embryo within the lateral plate 
mesoderm and it remains to be expressed in the cardiac crescents and early 
heart tube. Germ line Pitx2 loss-of-function mouse mutants displayed early 
embryonic lethality with severe cardiac malformations, demonstrating the 
importance of Pitx2 during cardiogenesis. Recently, genome-wide association 
studies have independently reported several risk variants on chromosome 4q25 
that are strongly associated with atrial fibrillation. These variants did not show 
association to known risk factors for atrial fibrillation such as obesity, 
hypertension or myocardial infarction, but are adjacent to the gene PITX2, 
providing new links with cardiac physiopathology. We demonstrate herein that 
PITX2C expression is significantly impaired in human patients with sustained 
atrial fibrillation. We also report morphological, molecular and 
electrophysiological characterization of atrial and ventricular chamber specific 
Pitx2 conditional mouse mutants. Electrophysiological studies in atrial, but not 
ventricular, Pitx2 chamber-specific adult hearts reveal AV block and alteration of 
the action potential. Furthermore we have evidences that lack of Pitx2 in the 
developing and adult atria impairs ion channel expression in line with the 
electrophysiological findings. Such ion channel impairment is, in part, modulated 
by miR-1 misexpression. Thus, we provide herein compiling evidences of Pitx2 
as an upstream transcriptional regulator which mediates distinct signaling 
pathways resulting in cellular and molecular changes that are prone to lead 
arrythmogenic events, such as atrial fibrillation. This work is supported by the VI 
EU Integrated Project “Heart Failure and Cardiac Repair” LSHM-CT-2005-
018630 and by the CNIC grant CNIC-08-2009. 
 
 
  Poster session C Saturday 22 May 
 
page 165
 
 
 
SATURDAY 22 MAY - SESSION C 
 
 
Time:   13.05 - 14.30 hours 
Location:  Marble Hall  
   1st floor and basement 
 
 
 
Session Topics 
3D-Techniques & Imaging [posters 169 - 183] 
Cardiac Growth   [posters 184 - 192] 
Conduction System   [posters 193 - 203] 
Genetics & Cardiovascular Malformations  
      [posters 204 - 246] 
  Poster session C Saturday 22 May 
 
page 166
 
  Poster session C Saturday 22 May 
 
page 167 
Session C: 3D-Techniques & Imaging 
 
169. 3D Modelling of heart development: looking to the future 
Tim Mohun  
Developmental Biology Division, MRC National Institute for Medical Research, 
London, UK 
For abstract, see in oral presentation section page 59 
 
 
 
170. Imaging in the Embryonic Heart: morphodynamic studies with Optical 
Coherence Tomography (OCT) 
Mesud Yelbuz 
Pediatric Cardiology & Intensive Care, Hannover Medical School, Hannover, 
Germany 
For abstract, see in oral presentation section page 60 
 
 
 
171. How to quantify in 3D: imaging of gene expression patterns and 
morphogenetic parameters in the embryonic heart. 
Jan M. Ruijter, Alexandre T. Soufan, Jaco Hagoort, Bouke A. de Boer and 
Antoon F.M. Moorman 
Department of Anatomy, Embryology & Physiology, Heart Failure Research 
Center , Academic Medical Center, Amsterdam, NL 
For abstract, see in oral presentation section page 61 
 
 
 
172. Automated fitting of histological sections into a high resolution 3D 
reference model of a developing mouse heart  
Bouke A de Boer* (1,2), Frans PJM Voorbraak (2), Maurice JB van den Hoff (1), 
Antoon FM Moorman (1), Jan M Ruijter (1) 
(1) Heart Failure Research Center, Dept. Anatomy, Embryology & Physiology, 
Academic Medical Center, Amsterdam (2) Dept. Medical Informatics, Academic 
Medical Center, Amsterdam, NL 
For abstract, see in oral presentation section page 62 
 
 
173. From 3D-reconstruction to interactive 3D-pdf; a protocol for 
biologists. 
Jaco Hagoort*, Alexandre Soufan, Bouke de Boer, Antoon Moorman 
Department of Anatomy, Embryology & Physiology, Heart Failure Research 
Center, Academic Medical Center, Amsterdam, NL 
For abstract, see in oral presentation section page 63 
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174. Rotationally acquired 4D-optical coherence tomography of embryonic 
chick hearts using retrospective gating on the common central A-scan 
Jan Thommes # (1), Christoph M. Happel *# (2), Lars Thrane (3), T. Mesud 
Yelbuz (2) # authors contributed equally 
(1) Institute of Mechatronic Systems, IMES, University of Hannover, Hannover, 
Germany (2) Pediatric Cardiology and Intensive Care Medicine, Hannover 
Medical School, Hannover, Germany (3) DTU Fotonik, Department of Photonics 
Engineering, Technical University of Denmark, Denmark 
In vivo analysis of cardiac physiology and non-invasive imaging of the beating 
early embryonic heart in 2 and 3D remain a challenge in cardiovascular 
development research. 3D-imaging of the beating heart relies on gating of the 
acquired images according to the cardiac cycle. Mostly ECG triggering is used 
for this purpose, e.g. in MRT or CT of human hearts. For visualization of 
embryonic chick hearts with high-resolution optical coherence tomography 
(OCT), a gating trigger generated by laser Doppler velocimetry has been 
successfully demonstrated (1). But this takes time and adds to system 
complexity. More recently, retrospective gating technologies were described (2; 
3). In these studies, a time series of 2D images at several positions along the 
heart volume was used to produce a time sequence of 3D volumes of the 
beating heart. Rearrangement and validation of the asynchronously acquired 
input data are based on image similarity of adjacent pictures and a 
perpendicularly recorded B-scan or a repetitive low-resolution 3D-volume-scan. 
In our study, we introduce a novel technique that uses a rotational scan mode of 
a swept-source OCT system (Thorlabs) for imaging the beating embryonic heart. 
The central A-scan is identical with the rotational axis. Thus, the heart phase 
can be synchronized in every rotated image plane from the central A-scan. A 
rotation of 180° allows to create a complete 4D dataset of the beating embryonic 
chick heart. (1) Jenkins et al. (2007): J Biomed Opt. 12(3):030505 (2) Liu et al. 
(2009): J Biomed Opt. 14(4):044020. (3) Gargesha et al. (2009): Opt Express. 
17(13):10786-99. 
 
 
 
 
175. Integration of an optical coherence tomography (OCT) system into a 
new environmental chamber to facilitate long term in vivo imaging of 
cardiovascular development in higher vertebrate embryos 
Lars Thrane# (1), Jan Thommes# (2), Christoph M. Happel (3), Jörg Männer (4), 
T. Mesud Yelbuz* (3) # authors contributed equally 
(1) DTU Fotonik, Department of Photonics Engineering, Technical University of 
Denmark, Denmark (2) Institute of Mechatronic Systems, Leibniz Universität 
Hannover, Hannover, Germany (3) Pediatric Cardiology and Intensive Care 
Medicine, Hannover Medical School, Hannover, Germany (4) Department of 
Anatomy and Embryology, Georg-August-University of Göttingen, Göttingen, 
Germany 
High-resolution 3-D in vivo imaging of embryonic development over long periods 
of time under constant physiological conditions (e.g. temperature, humidity) was 
a challenging task for researchers working on early cardiovascular development. 
Without appropriate maintenance of temperature, for example, the embryonic 
heart rate declines rapidly and often results in an increase in regurgitant flow. 
However, preload, afterload, and the effects of blood flow on cardiac 
morphodynamics are critical parameters that have to be examined more closely 
for a better understanding of normal and abnormal cardiovascular development. 
Here we demonstrate, to the best of our knowledge, the first realization of an 
optical coherence tomography (OCT) system integrated into a new 
environmental incubation chamber (EIC) to facilitate real-time in vivo imaging of 
cardiovascular development in chick embryos. The EIC provides stable 
conditions for embryonic development with respect to temperature, humidity, 
and oxygen levels. An OCT probe is integrated into the EIC and facilitates 
visualization of embryos at micrometer resolution, including the acquisition of M-
mode, Doppler OCT, and Doppler M-mode data. 
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176. Three-dimensional measurement and visualization of morphogenesis 
applied to cardiac embryology 
Alexandre T. Soufan* (1), Gert van den Berg (1), Perry D. Moerland (2), 
Maarten M. G. Massink (1), Maurice J. B. van den Hoff (1), Antoon F. M. 
Moorman (1) and Jan M. Ruijter (1) 
(1) Heart Failure Research Center, Department of Anatomy and Embryology, 
Academic Research Center, Amsterdam, The Netherlands (2) Department of 
Clinical Epidemiology, Biostatistics and Bioinformatics, Academic Medical 
Center, Amsterdam, The Netherlands 
Volume growth and proliferation are key processes in heart morphogenesis, yet 
their regionalization during development of the heart has been described only 
anecdotally. To study the contribution of cardiomyocyte proliferation to heart 
development, a quantitative reconstruction method was designed, allowing the 
local mapping of this morphogenetic process. First, a morphological surface 
reconstruction is made of the heart, using sections stained specifically for 
cardiomyocytes. Then, by a comprehensive series of image processing steps, 
local three-dimensional (3D) information of proliferation is obtained. These local 
quantitative data are then mapped onto the morphological surface 
reconstruction, resulting in a reconstruction that not only provides morphological 
information (qualitative), but also displays local information on proliferation rate 
(quantitative). The resulting 3D quantitative reconstructions revealed novel 
observations regarding the morphogenesis of the heart. 
 
 
 
 
 
177. High-resolution 3-D imaging of the anatomy of normal and malformed 
embryonic chick hearts through Micro-Computed Tomography (Micro-CT) 
of critical point-dried heart specimens 
Christoph M. Happel* # (1), Christian Klose # (2), Gabriele Witton (2), Gian L. 
Angrisani (2), Soenke Wienecke (3), Stephanie Groos (4), Friedrich-Wilhelm 
Bach (2), Dirk Bormann (2), Jörg Männer (5), T. Mesud Yelbuz (1) # authors 
contributed equally 
(1) Pediatric Cardiology and Intensive Care Medicine, Hannover Medical School, 
Hannover, Germany (2) Institute of Materials Science & (3) Institute for Multiphase 
Processes, Leibniz Universität Hannover, Hannover, Germany (4) Institute for Cellular 
Biology in the Centre for Anatomy, Hannover Medical School, Hannover, Germany (5) 
Department of Anatomy and Embryology, Georg-August-University of Göttingen, 
Göttingen, Germany 
In the past, several non-destructive imaging techniques (e.g. Magnetic 
Resonance Microscopy, Optical Coherence Tomography) were tested for their 
suitability to visualize the 3-D morphology of embryonic hearts. Most of these 
imaging tools have their drawbacks with respect to resolution and penetration 
depth. Here we present, to the best of our knowledge, the first high-resolution 3-
D images at 10 µm level of normal and malformed embryonic chick hearts 
(double outlet right ventricle, juxtaposition of atrial appendages) generated by 
Micro-CT examination of critical point-dried heart specimens. Day 9 embryonic 
chick hearts are shown in rotating 3-D images and in fly-through movies. 
Cardiac anatomy is demonstrated in great details with respect to myocardial 
fiber arrangement and trabeculations as well as atrioventricular and semilunar 
valves. Malalignment of great vessels with associated ventricular septal defects 
are visualized in high quality in malformed hearts, too. Embryonic chick hearts 
grown in shell-less culture were removed and fixed in dilated state at incubation 
day 9. Subsequent to critical point drying, the heart specimens were scanned 
within a Scanco Medical CT 80 workstation (SCANCO Medical, Zürich, 
Switzerland). For production of malformed hearts, chick embryos were treated 
on incubation day 2 (HH-stage 15) with Bis-diamine. Further details of the Micro-
CT unit, methodology, 2-D and 3-D images, and fly-through movies with a digital 
journey in 3-D through normal and malformed hearts will be demonstrated 
during the meeting. 
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178. Genetic annotation of the developing heart 
Christian Wallner*, Bouke A. de Boer, Antoon F. Moorman, Vincent M. 
Christoffels, Jan M. Ruijter 
Department of Anatomy, Embryology & Physiology, Heart Failure Research Center, 
Academic Medical Centre, University of Amsterdam, The Netherlands 
When describing cardiac development, difficulties arise from naming the 
different anatomical compartments. This has several causes: 1. the common 
use of anatomical names by different researchers is too inconsistent to provide 
an adequate reference, 2. naming of compartments is historically based on the 
luminal configurations while the development of the chamber walls can be much 
more complicated and 3. embryonic cardiac compartments are not fully 
homologous to the similarly named adult compartments. To overcome these 
difficulties, we will pursue a novel approach to describe cardiac development, 
dubbed “genetic annotation”. In this approach the associations between 
expression domains of genes are used to discriminate different cardiac 
components during development. A limited number of marker genes can be 
used to genetically annotate cardiac compartments. This has been 
demonstrated previously, for example for the sinus node, which has a 
Cx30.2/Hcn4/Tbx3-high, Cx40/Cx43/Scn5a-low gene expression profile, and for 
the atrial wall myocardium for which the combination of Cx40 and Nppa can 
discriminate between appendage (Cx40+/Nppa+), primary (Cx40-/Nppa-) and 
dorsal (Cx40+/Nppa-) myocardium. The genetic annotation will be validated by 
mapping genes with a known role in cardiac development. We are currently 
collecting 3D expression patterns that will be mapped into a developmental 
reference series of 3D heart reconstructions. The resulting genetically annotated 
3D reference models will also serve as a morphological framework to generate 
novel hypothesis on gene interactions, as positive gene interactions might be 
seen through gene co-localization (e.g. Cx40 is only expressed in Tbx5-positive 
myocardium) and negative interactions as complimentary gene expression 
patterns (e.g. Cx40 is not expressed in Tbx2-positive myocardium). 
 
179. Optical pacing of the embryonic heart 
Michael W. Jenkins* (1), Austin R. Duke (2), Shi Gu (1), Yong-Qiu Doughman 
(3), Hillel J. Chiel (4), Michiko Watanabe (3), E. Duco Jansen (2) and Andrew M. 
Rollins (1) 
(1) Department of Biomedical Engineering, Case Western Reserve University, Cleveland, 
Ohio, USA (2) Departments of Biomedical Engineering, Vanderbilt University, Nashville, 
Tennessee, USA (3) Department of Pediatrics, Case Western Reserve University, 
Cleveland, Ohio, USA (4) Department of Biology, Case Western Reserve University, 
Cleveland, Ohio, USA 
Light has been used to noninvasively alter the excitability of both neural and 
cardiac tissue. Recently, pulsed laser light has been shown to be capable of 
eliciting action potentials in peripheral nerves and in cultured cardiomyocytes. 
Here, we demonstrate the first optical pacing of an intact heart ex ovo in a 
method we call optical pacing (OP). Embryos were cultured in Petri dishes in 
both shell-less cultures and New cultures. Pulsed 1.875 µm infrared laser light 
was employed to lock the heart rate to the pulse frequency of the laser. A laser 
Doppler velocimetry (LDV) signal was used to verify the pacing. At low radiant 
exposures, embryonic quail hearts were reliably paced without detectable 
damage to the tissue at stages 12 to 18. Compared to electrical pacing, OP 
does not require contact, has high spatial precision and avoids stimulation 
artifacts in electrode recordings. In the early embryo electrical pacing is invasive 
and difficult to achieve consistently and without tissue damage. In the future we 
will incorporate OP into our environmentally-controlled optical coherence 
tomography imaging chamber to study mechanotransduction (i.e. shear stress 
on the endocardium) by altering the heart rate of the embryo, thereby altering 
mechanical stress levels. OP will not only allow for a new class of experiments 
in developmental cardiology, but also may play a significant role in 
understanding cardiac electrophysiology, single-cell (cardiomyocyte) dynamics, 
and cardiac tissue engineering. Also, OP has the potential to pace an adult 
heart, which may be useful clinically. OP has the potential to become a robust 
technology for multiple medical and scientific applications in cardiology. 
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180. Imaging early development by High Resolution Episcopic Microscopy 
Robert Wilson (1), Wolfgang Weninger (2) Shoumo Bhattacharya (3) and Tim 
Mohun* (1) 
(1) MRC National Institute for Medical Research, London, UK (2) Centre for 
Anatomy and Cell Biology, Vienna, Austria (3) Wellcome Trust Centre for 
Human Genetics, Oxford, UK 
The ability to analyse tissue and organ morphology (including cell proliferation 
and gene expression) in 3D is increasingly important for providing new insights 
into embryo development. Whilst technical difficulties in obtaining and 
manipulating 3D models have largely been resolved by advances in computing, 
obtaining high resolution data suitable for modelling remains a challenge. High 
Resolution Episcopic Microsocopy (HREM) is a relatively new episcopic 
(blockface) imaging technique that is ideally suited to computer modelling, 
providing 3D datasets that approach the resolution of conventional 2D histology. 
HREM relies upon the capture of sequential images of the embedded specimen 
block face during the sectioning process, rather than imaging individual sections 
that have been subject to histological staining. Inclusion of fluorescent dyes in 
the embedding medium provides a uniform background that effectively 
eliminates imaging of tissue below the surface of the sample block. HREM 
images retain their relative alignment without the need for reference markers 
and the resolution of each 3D dataset is determined by the combination of 
optical resolution and section thickness. 2D Image resolutions of less than 1 
µm/pixel are readily achieved using plastic-embedded samples, with 3D 
isotropic resolutions of 1-3 µm. As part of a Wellcome Trust-sponsored initiative 
to establish an imaging pipeline for systematic analysis of mutant mouse 
embryos, we have used HREM to image normal mouse embryos at isotropic 
resolutions of 2-3 µm and present the data online (http://embryoimaging.org/). 
Each embryo has been sectioned in the transverse plane and data from any 
region of the embryo, including the heart, can be viewed at varying resolution, 
up to full scale. The same technique has been used to image the developing 
heart and the resulting models provide a unique resource for studying cardiac 
morphogenesis. 
 
181. A new method for automated segmentation of the beating embryonic 
chick heart 
Jan Thommes (1), Christoph M. Happel (2), T. Mesud Yelbuz* (2) 
(1) Institute of Mechatronic Systems, Leibniz Universität Hannover, Hannover, 
Germany (3) Pediatric Cardiology and Intensive Care Medicine, Hannover 
Medical School, Hannover, Germany 
Functional analysis of beating embryonic hearts, for instance in chick embryos, 
is frequently conducted by generating real-time video recordings and 
subsequent computer aided manual examination of these recorded files with 
optimized software. During analysis images of the heart in end-systole and end-
diastole are selected, predefined landmarks are located and traced manually in 
both heart phases. These landmarks allow calculation of cardiac function 
parameters such as shortening fraction or fractional area change. Paramaters 
such as the ejection fraction, stroke volume or cardiac output are estimated 
based on an elliptic or spherical volume model adapted to the manually 
identified landmark. Although some labs have implemented semi-automated 
analysis systems, it is desirable to develop new systems for a standardized and 
full-automated cardiac function analysis in large samples of embryos over 
significant periods of time and for all heart beats in a record. In this study, we 
present the first results of a new approach for full-automated segmentation of 
the beating embryonic chick heart which offers a time-continuous segmentation 
of image sequences of the heart during the cardiac cycle. Because the 
boundaries of the myocardium are barely visible in video recordings, it is 
impossible to segment the heart without using a-priori-knowledge. Thus, the 
embryonic heart is modeled as an active appearance model, consisting of a 
shape and texture model trained from various manual segmentations. The 
model parameters are iteratively adapted to video frames leading to a time-
continuous segmentation of the beating heart that enables to extract cardiac 
function parameters. 
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182. Morphogenesis of cardiac chambers : integrating intrinsic cell 
behavior and external forces by computer modeling 
Jean-François Le Garrec*(1), Chiara Ragni (1), Michel Kerszberg, Andrew 
Bangham (2), Enrico Coen (2), Margaret Buckingham (1) , Sigolène M. Meilhac 
(1) 
(1) Institut Pasteur, Department of Developmental Biology, CNRS URA 2578, F-
75015 Paris, France (2) Department of Cell and Developmental Biology, John 
Innes Centre, Colney Lane, Norwich NR4 7UH, UK 
Mammalian heart morphogenesis involves looping and regionalized expansion 
of the initial tube, eventually leading to the fully functional four-chambered organ. 
Although many mutants defective for heart morphogenesis have been studied, 
how cell behavior and tissue mechanics combine to shape the heart remains 
poorly understood. We have previously analyzed the characteristics of clones of 
myocardial cells and shown that they grow with a preferential orientation, which 
is specific to each cardiac region. It is however difficult to disentangle how 
polarized growth, proliferation rate and external forces each contribute to the 
final shape. To understand the mechanics of the early myocardium and test the 
importance of oriented growth in shaping the heart, we combine image analysis 
and computer modelling. Quantitative analysis of confocal microscopy images 
allows us to assess the polarity of myocardial cells and their divisions as well as 
the relative rates of proliferation. We aim to integrate these experimental data, 
together with morphological observations and earlier results on patterns of 
clones, with the help of computer modeling. We present a Finite Element 
Analysis model, which simulates growth with regional differences in both rates 
and preferential directions, taking also into account external forces that might 
bear upon looping of the heart and chamber expansion. This model also permits 
simulation of the growth response to diffusing signals and thus should provide 
insight into how regionalization and polarity of the initial tube influence the final 
shape of the heart. Ultimately, it will be used to predict mutant shapes. 
 
 
183. Automated recognition of the gene expression types in sections of 
embryonic mouse hearts. 
R.M.W. Fincken Bsc.* (1), dr. J. M. Ruijter. (1), dr. G.J. Louter (2), B.A. de Boer 
Msc. (1, 2) 
(1) Heart Failure Research Centre, Academic Medical Centre, Amsterdam, The 
Netherlands (2) Department of Medical Informatics, Academic Medical Centre, 
Amsterdam, The Netherlands 
In cardiac embryology, research into the role of genes in development is of 
crucial importance. To study the function of genes, embryonic mouse hearts are 
fixated, sectioned and stained to visualise gene activity. This staining can either 
be done by using antibodies (ICC), or DNA probes (ISH). Gene expression can 
be described in terms of type and strength. The distribution of cells with a 
positive, above background, expression and the density of those cells result in 
the gene expression type. Currently the main gene expression types in use are: 
No expression, Scattered, Regional, and Ubiquitous. These expression types 
are mostly assigned by manual annotation, which is not only time consuming but 
also subjective. These issues can be resolved by automated recognition of the 
gene expression types. In order to create an automatic method, a survey has 
been performed to determine the definitions of gene expression types in use in 
the field of cardiac development. The results of this first survey were used to 
create a second survey in which experts were asked to annotate expression 
types of mouse-heart sections. These results, and the determination of a 
number of image features in the same heart sections, will serve as a learning-
set to create classification rules. These rules then form the foundation for the 
automated recognition of gene expression types. In a pilot experiment based on 
virtual sections, which was also based on classification rules, we have shown to 
be able to automatically annotate gene expression patterns in embryonic mouse 
heart sections. 
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Session C - Cardiac Growth 
 
184. Knockdown of the orphan G protein-coupled receptor 126 reduces 
heart rate and influences ventricular morphogenesis in zebrafish 
Machteld J. van Amerongen*, Chinmoy Patra, Benno Jungblut, Felix B. Engel 
Cardiac Development and Remodelling, Max Planck Institute for Heart and Lung 
Research, Bad Nauheim, Germany 
 
Gpr126 is an orphan G protein-coupled receptor (GPCR). The lack of 
knowledge regarding its natural or synthetic ligands makes it difficult to 
determine its biological function. Based on an mRNA expression screen we 
have identified gpr126 as a gene that is transiently expressed during embryonic 
rat heart development. gpr126 mRNA is highest expressed in the heart from 
E13.5 to E17.5 and declines thereafter. RT-PCR showed that gpr126 mRNA is 
also expressed in the zebrafish embryo. gpr126 mRNA is absent in the early 
zebrafish embryo (1 and 9 hours post fertilization (hpf)) and its expression starts 
around 24 hpf. By in situ hybridization at 44 hpf, we observed expression of 
gpr126 mRNA in the heart ventricle and atrium. To investigate how gpr126 may 
function in heart development we injected translation- and splice-inhibiting 
morpholino antisense oligonucleotides (MOatg and MOsplice respectively) to 
knockdown gpr126 in zebrafish embryos. MOsplice resulted in deletion of exon 
13 which was readily detectable by RT-PCR at 80h hpf. Following injection of 
either MOatg or MOsplice, cmcl2-GFP transgenic embryos exhibiting heart 
specific fluorescence were collected from different stages and screened for 
morphological and functional defects. gpr126 knockdown resulted in a 
significantly reduced heart rate and blood accumulation between the sinus 
venosus and the atrium, which was first observed around 34 hpf. Furthermore, 
at 56 hpf gpr126 knockdown embryos exhibited a dysmorphic ventricle and 
apparent cardiac edema with otherwise normal overall morphology. In 
conclusion, this study reveals an essential role for gpr126 in cardiac 
development. 
 
185. VEGF Gene Therapy Revives Coronary Artery Development in the 
Conotruncal Banded Chick Embryo 
Norman Hu* (1,2), Kyle H Sabey (1), Arlo N. McGinn (3,4), James W. Yockman 
(4), Tae-il Kim (4), Sung Wan Kim (4) and David A. Bull (1) 
(1) Division of Cardiothoracic Surgery, Department of Surgery, University of Utah, Salt 
Lake City, UT (2) Department of Pediatrics, University of Utah, Salt Lake City, UT (3) 
Department of Pharmacology and Toxicology, University of Utah, Salt Lake City, UT (4) 
Department of Pharmaceutics and Pharmaceutical Chemistry, University of Utah, Salt 
Lake City, UT 
 
Constriction of the conotruncus (CT) during early embryonic development alters 
the migration of mesenchymal tissue into the heart causing failure of absorption 
in bulbus arteriosus, misalignment of both great vessels, and reduction of 
coronary vascularization. We hypothesized that the non-viral transfection of 
VEGF would have a beneficial role in vascular repair and proliferation following 
mechanical injury to the developing heart. The CT of a stage 21 (3½-d) chick 
embryo was tied with an overhand knot using 10-0 nylon suture. Hypoxia-
responsive pRTP801-VEGF plasmid was complexed with the reducible cationic 
polymer, CBA-DAH-R (ABP), in HEPES buffer (5 ng/5 mL), and infused into the 
compact layer of CT-banded heart at stage 29 (6-d). Normal embryos did not 
undergo operation. At stage 36 (10-d), India ink in PBS (1:5) was injected into 
the left ventricle and subsequently filled the coronary arteries. The heart was 
fixed in diastole with 1 mg/Kg diltiazem in 4% paraformaldahyde and imaged 
under a stereophotomicroscope. Morphometric analysis was performed to 
determine the maximum coronary artery distance, and ventricular vertical length. 
Data are presented as mean±SEM (n≥8), and analyzed by ANOVA. Ventricular 
lengths showed no statistical difference (p>0.05) among normal, CT-banded, 
and CT-banded with pRTP801-VEGF/ABP hearts. Coronary artery length 
indexed by ventricular length was similar between CT-banded VEGF-transfected 
hearts (0.47±0.04, p>0.05) and normal embryos (0.50±0.02). This stands in 
contrast to a marked decrease in CT-banded hearts (0.34±0.05, p<0.05) when 
compared to normal control. Coronary arteries in CT-banded hearts with 
pRTP801-VEGF/ABP treatment undergo proportionate vascularization and 
penetration comparable to normal development. 
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186. Nephronectin is required to restrict the differentiation 
Chinmoy Patra* (1), Florian Diehl (1), Fulvia Ferrazzi (2), Machteld J. van 
Amerongen (1), Tatyana Novoyatleva (1), Benno Jungblut (1) Felix B. Engel (1) 
(1) Department of Cardiac Development and Remodelling, Max-Planck-Institute for Heart 
and Lung Research, Parkstrasse 1, 61231 Bad Nauheim, Germany (2) Dipartimento di 
Informatica e Sistemistica, Università degli Studi di Pavia, via Ferrata 1, 27100 Pavia, Italy 
 
The extracellular matrix plays an important role in morphogenesis, tissue repair 
and disease. Here, we show that the gene npnt encoding the extracellular matrix 
protein Nephronectin is transiently expressed in the myocardium of the 
developing zebrafish heart. To further explore the role of nephronectin in cardiac 
development, we knocked down npnt expression through translation and splice 
inhibitory morpholinos. Nephronectin morphants exhibited cardiac edema and 
severe defects in cardiac looping that could be rescued by injection of npnt 
mRNA. Moreover, npnt knockdown caused expansion of the cardiac jelly, which 
is similar to defects observed in a tbx2 overexpression mouse model. 
Interestingly, expression of has2 and its upstream regulators tbx2 and bmp4 that 
usually are restricted to the atrio-ventricular boundary was expanded in npnt 
morphants. Detailed morphological analyses suggested further that the 
knockdown of npnt caused an extension of the atrio-ventricular canal. This was 
in accordance with an increased number of cuboidal-shaped and Alcam-positive 
differentiated endocardial cells as well as an expanded expression of notch1b. 
Our results identify nephronectin as a new regulator of cardiac development 
playing a crucial role in the differentiation of the atrio-ventricular canal of the 
zebrafish heart. 
 
 
 
 
 
 
 
 
187. Three-Dimensional and Molecular Analysis of the Venous Pole of the 
Developing Human Heart 
Aleksander Sizarov (1), Robert H. Anderson (2), Vincent M. Christoffels (1), 
Antoon F.M. Moorman (1) 
(1) Heart Failure Research Center, Academic Medical Center, Amsterdam, the 
Netherlands (2) Cardiac Unit, Institute of Child Health, University Colledge London, UK 
 
Various congenital malformations, as well as many abnormal rhythms, originate 
from the venous pole of the heart. Due to rapid changes during morphogenesis, 
lack of molecular and lineage data, along with miscommunications owing to 
difficulties in forming a mental image of the complex morphogenetic changes in 
the developing heart, the development of this region in human is difficult to 
grasp. To get more insight into the development of the different types of 
myocardium forming the venous pole of the heart, we perfermed an 
immunohistochemical analysis on serial sections of early human embryos and 
prepaired the three-dimensional models. As in the mouse, the systemic venous 
myocardium expresses the transcription factor TBX18, while the pulmonary 
venous myocardium expresses NKX2-5; however, in contrast to mouse, both 
structures express ISL1. In human embryos, prior to appearance of venous 
valves, a systemic venous sinus is identified upstream from the atrial chambers, 
albeit initially with non-myocardial walls. From the outset, as in the mouse, the 
pulmonary vein empties to a chamber with atrial, rather than systemic venous, 
characteristics. When compared to the mouse, the vestibular spine is a more 
prominent structure. The remarkable similarities in gene expression in the 
distinctive types of myocardium surrounding the systemic and pulmonary 
venous tributaries in man and mouse permit extrapolation of the conclusions 
drawn from transgenic and lineage studies in the mouse to the human, showing 
that the systemic and pulmonary venous myocardial sleeves are derived from 
distinct developmental lineages, and lends no support to the notion that the 
pulmonary myocardium originates from the systemic venous sinus. 
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188. Activation of various stress response pathways in cardiomyocytes 
during embryonic heart regeneration 
Manuela Magarin* (1), Timothy C. Cox (2), Ludwig Thierfelder (1), Jörg-Detlef 
Drenckhahn (1) 
(1) Max-Delbrück-Center for Molecular Medicine, Berlin, Germany (2) Department of 
Pediatrics, University of Washington, Seattle, USA 
 
Utilizing a heart conditional Knock-out of the X-linked Holocytochrome c 
synthase (Hccs) gene in mice we previously reported a remarkable regenerative 
potential of the embryonic heart in response to tissue mosaicism for 
mitochondrial dysfunction. Despite the functional loss of 50% of Hccs deficient 
cardiomyocytes at midgestation, compensatory hyperproliferation of healthy 
myocardial cells ensures the generation of a functional heart by birth. To 
investigate the underlying molecular and cellular mechanisms we performed 
RNA expression analyses in regenerating hearts at various stages of 
development. These data revealed activation of the endoplasmic reticulum (ER) 
stress and unfolded protein response (UPR), as characteristic genes involved in 
translational control as well as amino acid metabolism were significantly 
upregulated (e.g. Atf-4, Atf-5, Asns, Slc7a3). Induction of p21/Cip1 and p27/Kip1 
furthermore suggests activation of cell cycle inhibitors in response to cell stress. 
Additionally, expression of several proapoptotic genes was increased in 
regenerating hearts (e.g. Gadd-153, Noxa, Edr2a, Chac-1) which might be 
attributed to Hccs deficient cardiomyocytes as these cells supposedly 
experience excessive stress. Given that there is no evidence for apoptosis in 
regenerating hearts this argues for additional cell protective mechanisms. 
Indeed, expression of heat shock protein (Hsp) 60 as well as the reactive 
oxygen species (ROS) converting enzyme superoxide dismutase (Sod)-2 and 
gap junction protein connexin 43 was specifically induced in Hccs deficient cells. 
Taken together, our data reveal activation of various cell stress and survival 
mechanisms in cardiomyocytes during embryonic heart regeneration which 
putatively contribute to the generation of functional hearts by birth. 
 
 
 
189. Cyclin D2 is a GATA-4 cofactor involved in cardiac growth 
Abir Yamak* (1,2), Rana Temsah (1), Anne Aries (1), Sophie Caron (1), Mona 
Nemer (1,2) 
(1) Research Unit in Cardiac Growth and Differentiation, Institut de Recherches Cliniques 
de Montréal, (IRCM), Montréal, QC H2W 1R7, Canada (2) Department of Biochemistry, 
Microbiology and Immunology, University of Ottawa, 550 Cumberland (246), Ottawa, ON 
K1N 6N5, Canada 
 
For decades, postnatal cardiomyocytes have been considered as terminally 
differentiated cells that lost their ability to proliferate; thus, the mature 
mammalian heart has very limited regenerative capacity. Persistent cardiac 
stress causes myocyte loss that often leads to heart failure. Recent studies 
uncovered limited proliferative capacity of cardiomyocytes albeit the underlying 
mechanism is poorly understood. Transcription factor GATA-4 is a key regulator 
of cardiomyocyte growth and differentiation. Lack of GATA-4 impairs adaptive 
growth response and upregulated expression of GATA-4 is sufficient to induce 
myocyte hypertrophy. Search for GATA-4 targets/effectors revealed cyclin D2 
(CD2), a member of the D-type cyclins (D1, D2, and D3) that play a vital role in 
differentiation and cell cycle regulation, as a direct transcriptional target and an 
effector of GATA-4. Biochemical analysis revealed that CD2 enhances GATA-4 
activation of target promoters. Our results explain, in part, why upregulation of 
either protein is sufficient to turn on myocyte growth. To check which action of 
GATA-4 is mediated by CD2, we developed lines of transgenic mice with 
myocardial specific expression of CD2. These mice had normal cardiac 
functions aside from evidenced increase in left ventricular mass. 
Immunohistochemical staining revealed increased expression of two 
proliferation markers. When crossed with GATA-4+/- mice, myocardial CD2 was 
able to rescue, at least partially, cardiac growth of GATA-4 heterozygotes. 
These data suggest that myocardial CD2 has beneficial effects on the heart and 
will shed more light on the role of cell cycle proteins, particularly cyclin Ds, in the 
expansion of differentiated cells and provide novel avenues for heart failure 
therapy. 
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190. Follistatin-like 3 contributes to cardiac hypertrophy and remodelling 
Kalyani D. Panse (1), Reneé Germack (1), Leanne E. Felkin (1), Kazuto 
Nakamura (2), Kenneth Walsh (2), Paul J. Barton (1), Nadia Rosenthal (1,3) and 
Enrique Lara-Pezzi* (1, 4) 
(1) Imperial College London, UK; (2) Whitaker Cardiovascular Institute, Boston University, 
USA (3) EMBL Monterotondo, Italy (4) Centro Nacional de Investigaciones 
Cardiovasculares, Madrid, Spain 
 
The balance between activins and their inhibitors regulates cardiac growth and 
the response of the heart to stress. Follistatin-like 3 (Fstl3) is a potent inhibitor of 
activin signalling that antagonises the cardioprotective role of activin A after 
myocardial infarction. We have previously reported that Fstl3 expression is 
elevated in patients with heart failure and upregulated by hypertrophic stimuli. 
However its role in cardiac remodeling is largely unknown. Here we show that in 
hypertrophic hearts Fstl3 is mainly produced by cardiomyocytes. Fstl3 is 
sufficient to induce cardiomyocyte hypertrophy in culture, as demonstrated both 
by increased cell surface area and protein synthesis. Cardiomyocyte-specific 
Fstl3 knockout (KO) mice show improved cardiac function following pressure 
overload and reduced expression of heart failure markers compared to wild type 
mice. In addition, Fstl3 KO mice develop less fibrosis and express lower levels 
of fibrosis markers than wild type mice. Yeast two hybrid experiments suggest 
that Fstl3 acts at least in part through binding to proteins of the extracellular 
matrix (ECM) as well as pro-fibrotic factors, including connective tissue growth 
factor. In summary, our data suggest that Fstl3 is secreted by cardiomyocytes in 
the failing myocardium and plays a role in cardiac hypertrophy and fibrosis 
through autocrine and paracrine mechanisms. Fstl3 may therefore represent a 
novel therapeutic target for the treatment of heart failure. 
 
 
 
191. Ordered assembly of the adhesive and electrochemical connections 
within newly formed intercalated disks 
Sarah B. Geisler (1), Kathleen J. Green (2), Lori L. Isom (3,4), Sasha Meshinchi 
(5), Jeffery R. Martens (4) , Mario Delmar (3,6) , Mark W. Russell* (1) 
(1) Department of Pediatrics and Communicable Diseases, University of Michigan, Ann 
Arbor, MI 48109, USA (2) Department of Pathology, Northwestern University Feinberg 
School of Medicine, Chicago, IL 60611, USA (3) Department of Molecular and Integrative 
Physiology, University of Michigan, Ann Arbor, MI 48109, USA (4) Department of 
Pharmacology, University of Michigan, Ann Arbor, MI 48109, USA (5) Department of Cell 
and Developmental Biology, University of Michigan, Ann Arbor, MI 48109, USA (6) 
Department of Internal Medicine, University of Michigan, Ann Arbor, MI 48109, USA 
 
The functional coupling of immature cardiac myocytes during development 
requires the establishment of new electromechanical connections between 
neighboring cells to form a functional syncitium. The primary site of coupling 
occurs at the terminal ends of the myofibrils in direct cell-cell contacts termed 
intercalated disks (IDs). The ID is composed of adhesive elements, including 
fascia adherens and desmosomes, and electrochemical communications, 
including ion channels and gap junctions. The integrity of the disk is essential for 
normal cardiac development and function, but how its diverse elements are 
assembled into a fully integrated structure is not well understood. In this study, 
we examined the assembly and organization of cardiac intercalated disks in 
primary cultures of adult rat cardiac myocytes. As the cells remodeled and made 
contact with their neighbors, transmembrane adhesion proteins, including N-
cadherin and desmocollin, localized along the line of apposition. After 
development of the adhesion plaque, Cx43 gap junctions and ankyrin-G, an 
essential cytoskeletal component of the voltage-gated sodium channel, were 
secondarily recruited to the new intercalated disks, selectively localizing to 
membrane domains involved in cell-cell contacts. The precise order of the 
assembly process suggests that there are specific scaffolding requirements for 
the integration of the mechanical and electrochemical elements of the disk. 
Defining these relationships will be important for promoting the functional 
integration of immature cardiomyocytes into injured myocardium during cellular 
cardiomyoplasty and for treating the mechanical dysfunction and cardiac 
arrhythmias that accompany alterations of intercalated disk architecture during 
heart failure. 
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192. Heterogeneity of vessels within the mouse myocardium identified by 
lymphatic markers 
Akshay Thomas (1), Ganga Karunamuni (1,2), Yong Qiu Doughman (1), 
Madhusudhana Gargesha (3), David Wilson (3), Michiko Watanabe (1,2)* 
(1) Department of Pediatrics, (2) Anatomy, (3) Biomedical Engineering, Case 
Western Reserve University, Cleveland OH 44106 
 
Introduction: The arterial supply and venous drainage of the 4-chambered heart 
are well characterized. The lymphatic drainage of the heart has received less 
attention. Our previous analysis indicated that vessels and cells within the 
developing myocardium express a subset of lymphatic markers but may not be 
lymphatics. To deduce their final distribution and fate, we extended our analysis 
to the adult mouse heart. Materials and Methods: Serial sections of adult mouse 
hearts were immunostained for (1) PECAM, to identify all endothelial cells and 
markers of lymphatic endothelial cells (2) Prox1, (3) LYVE-1, (4) Podoplanin and 
(5) VEGFR3. Results: As expected, we found a lymphatic system within the 
epicardium co-expressing Prox-1, LYVE-1, Podoplanin and VEGFR3. However, 
even in the adult, vessels in the myocardium stained for PECAM, LYVE-1 and 
VEGFR3 but not Prox1 or podoplanin. These vessels also immunostained for 
ephrinB4, a venous endothelial cell marker. Serial sections revealed that these 
vessels contained blood cells and were continuous with the ventricular lumen. 
Conclusions/Discussion: In combination with data regarding lymphatic markers 
in developing hearts, our findings suggest that lymphatic markers identify bona 
fide epicardial lymphatics. Surprisingly such lymphatics were largely absent from 
the myocardium. Myocardial vessels expressing a subset of the lymphatic 
markers and having venous characteristics connect directly to the lumen of the 
heart. These may have arisen from invaginations of the endocardium and may 
be Thebesian vessels that are involved in the regulation of fluid balance in the 
heart. 
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193. Origins of Cardiac Pacemaking Cells in Avians 
Michael Bressan*, Alicia Navetta, Takashi Mikawa 
Cardiovascular Research Institute, University of California San Francisco, San 
Francisco, CA, USA 
For abstract, see in oral presentation section 77 
 
 
194. The role of Tbx3 and Nkx2-5 in the adult atrioventricular conduction 
system 
Mathilda T.M. Mommersteeg* (1), Bas J. Boukens (1), Saskia van der Velden 
(1), Corrie de Gier-de Vries (1), Richard P. Harvey (2), Antoon F.M. Moorman 
(1), Vincent M. Christoffels (1) 
(1) Heart Failure Research Center, Academic Medical Center, Amsterdam, The 
Netherlands (2) Victor Chang Cardiac Research Institute, University of New 
South Wales, Darlinghurst, Australia. 
For abstract, see in oral presentation section page 78 
 
 
195. Delayed atrioventricular conduction in adrenergic-deficient 
embryonic mouse hearts: Uncovering a role for retinoic acid 
Kingsley Osuala (1), David G. Taylor (1), Celines Martinez (1), Ha-Long Nguyen 
(1), Tu-Suong Nguyen (1), Anupama Natarajan (2), Peter Molnar (2), James 
Hickman (2), and Steven N. Ebert* (1) 
(1) Burnett School of Biomedical Sciences, University of Central Florida College 
of Medicine, Orlando, FL (2) Nanoscience Technology Center, University of 
Central Florida, Orlando, FL, USA 
For abstract, see in oral presentation section page 79 
 
 
 
196. Development and Electrical Activation of Sinus Venosus Myocardium 
in the Avian Embryo 
Rebecca Vicente-Steijn* (1,2), Denise P. Kolditz (1,2), Edris A.F. Mahtab (1), 
Saïd F.A. Askar(2), Noortje A.M. Bax (1), Robert Passier (1), Daniël A. 
Pijnappels (2), Martin J. Schalij (2), Robert E. Poelmann (1), Adriana C. 
Gittenberger-de Groot (1), Monique R.M. Jongbloed (1) 
(1) Department of Anatomy and Embryology, (2) Department of Cardiology, 
Leiden University Medical Center, Leiden, The Netherlands. 
 
Purpose: The sinus venosus myocardium, including the sinoatrial node (SAN), is 
recruited to the primary heart tube during development. Podoplanin is expressed 
in this myocardial area and can interact with RhoA. Additionally, alteration of 
RhoA expression leads to defective conduction. We aim to elucidate the 
development of sinus venosus myocardium, including the SAN, by studying 
expression patterns of RhoA in relation to other differentiation markers and by 
studying electrical activation patterns during development. Methods: Expression 
of RhoA, cTnI and Nkx2.5, Isl-1 and Tbx18, and cation channel HCN4, were 
examined in sequential stages in chick. Electrical activation patterns were 
studied using ex-ovo local micro-electrode recordings and optical mapping. 
Results: Sinus venosus myocardium is cTnI and HCN4 positive but Nkx2.5 
negative and is complemented by distinct Isl-1 and Tbx18 patterns. Initial 
myocardium-wide expression of RhoA becomes restricted to the right-sided 
sinus venosus myocardium, comprising the SAN. This shift coincides with the 
persistence of RhoA, Tbx18 and HCN4 expression and absence of Nkx2.5 in 
the definitive SAN. Electrophysiological measurements reveal initial capacity of 
both left and right sinus venosus myocardium to show the first electrical activity 
that in time shifts to a right-sided dominance. Conclusion: Our results suggest a 
role for RhoA in conduction system development. Additionally, given the 
observed electrical potential of the sinus venosus myocardium, we propose an 
initial sinus venosus wide capacity to generate pacemaker signals, becoming 
confined to the definitive SAN. Lack of differentiation towards a chamber 
phenotype would explain ectopic pacemaker foci. 
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197. Mechanical loading is required for early conduction system 
development 
David Sedmera* (1, 2), Barbora Sankova (1, 2) 
(1) Institute of Anatomy, First Faculty of Medicine, Charles University in Prague, 
Prague, Czech Republic (2) Institute of Physiology, Academy of Sciences of the 
Czech Republic, Prague, Czech Republic 
 
Increased hemodynamic loading in vivo has been shown to accelerate normal 
cardiac morphogenesis as well as conduction system maturation in the chick 
embryos. To test the effect of hemodynamic unloading, we employed whole 
heart culture of chick and mouse embryonic hearts at different developmental 
stages and analyzed ventricular activation sequence and morphology. Epicardial 
activation patterns were assessed by optical mapping. In control, freshly isolated 
hearts of Cx40:GFP heterozygous mouse embryos between E10.5 and E11.5 
there are two dominant preferential activation pathways: the first utilizes the 
primary ring, while the more mature one employs the His bundle and its 
branches for ventricular activation from apex to base. In experimental hearts 
cultured for 24 hours we observed a regression in normal developmental 
timeline with appearance of ventricular activation patterns from base to apex. 
Total ventricular activation time was also prolonged in culture. Even more 
pronounced effect was observed in chick embryonic hearts isolated at E3 and 
E4, where dedifferentiation of the ventricular activation sequence could be 
rescued by artificial ventricular loading with a droplet of silicon oil imposing 
passive stretch. Morphogenesis of hearts in culture was arrested at the time of 
explantation. We conclude that appropriate mechanical loading is a prerequisite 
for ventricular conduction system maturation during the early phases of 
development in both birds and mammals. Supported by MFM VZ 0021620806, 
AV0Z50450515 and AV0Z50110509, and GACR 304/08/0615. 
 
 
 
 
198. Cardiac conduction system anomalies associated to ion channels 
remodeling during development in a transgenic model of Long QT-
Syndrome. 
Ángel J. de la Rosa (1), Jorge N. Domínguez (1), David Sedmera 2), Diego 
Franco (1), Amelia E. Aránega* (1). 
(1) Department of Experimental Biology, Faculty of Experimental Sciences, 
University of Jaén, 23071, Jaén, Spain. (2) Laboratory of Cardiovascular 
Morphogenesis (Prague). 277 21 . Czech Republic 
 
Long QT syndrome (LQTS) is characterised by an increase of the cardiac action 
potential duration and it has been related to cases of sudden death in newborns. 
LQTS has been linked to mutations in distinct ion-channel-coding genes, such 
as KCNQ1 and SCN5A. The mouse transgenic line α-MHC-KvLQT1-iso2-T7 
shares phenotypic characteristics with the LQTS. These mice display molecular 
and morphological characteristic of hypertrophic cardiomyopathy (HCM). 
Because hypertrophic process in the heart has been previously related with 
sodium channel remodeling, we analyzed sodium channel gene expression in 
LQTS mouse model and show that Scn5a and Scn1b up-regulation occurs at 
embryonic stage (i.e. E13.5), before the HCM phenotype is established. 
Moreover, optical mapping analyses evidenced a delayed electric impulse 
propagation thought the cardiac conduction system at adult and fetal stages. 
Intercrossing these transgenic mice with Cx40-GFP mice, we found an increase 
of spread out fibers in the apical part of the Left Bundle Branch (LBB) as well as 
changes in the number of the fibers that achieve the free LV wall from LBB. 
Similar results were observed for Right Bundle Brunch (RBB) in Cx40-GFP+/- α-
MHC-KvLQT1-iso2-T7 mice respect to Cx40-GFP+/- littermates. These 
morphological alterations in cardiac conduction system were already detected at 
fetal stages. In summary, we provide evidence for the first time that cardiac 
conduction system malformations are associated to ion channel remodeling 
during heart development. This study may open new ways to better understand 
clinical pathologies such as cardiac congenital anomalies, arrhythmias and 
perinatal sudden death. 
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199. Trabecular fate mapping using a Cx40-CreERT2 mouse line 
Sabrina Beyer*, Robert G. Kelly, and Lucile Miquerol 
Developmental Biology Institute of Marseilles-Luminy (IBDML), CNRS 
UMR6216 Université de la Méditerranée, Campus de Luminy, Marseille, France 
 
The rapid propagation of electrical activity in the ventricles is executed by the 
ventricular conduction system (VCS), composed of the His bundle, left and right 
bundle branches and the peripheral Purkinje fiber network. In adult hearts of 
Cx40GFP/+ mice, the GFP reporter gene is specifically expressed throughout 
the VCS. During embryonic development, GFP is expressed in trabecular cells, 
which are considered to be precursors of conductive myocytes. The aim of our 
study is to define the fate of trabeculae during normal heart development. Using 
a prospective cellular lineage analysis we investigated whether trabeculae give 
rise to contractile cardiomyocytes as well as Purkinje fibers using a novel 
transgenic mouse line (Cx40KI-CreERT2-RFP) expressing the tamoxifen-
inducible Cre recombinase specifically in the trabeculae and developing VCS. 
The RFP reporter gene (CreERT2-RFP transgene) is expressed in the same 
tissues as described for the endogenous Cx40 gene during embryonic 
development including endothelial cells, muscle and heart. We next carried out 
prospective Cre lineage mapping by crossing the Cx40Cre/+ with R26R mice. 
After injection of tamoxifen, β-galactosidase expression is detected in Cx40 
expressing cells and their derivatives. Pregnant females were injected with 
tamoxifen at different timepoints, in order to monitor different steps of trabecular 
development and define the time window in which the VCS differentiates. Our 
preliminary results reveal progressive restriction of myocardial fate to the VCS, 
and support the existence of distinct developmental phases during 
establishment of the VCS. In addition, these mice will be useful for conditional 
gene expression and inactivation in the definitive VCS. 
 
 
 
 
 
 
 
200. Cell death in the atrioventricular canal myocardium determines 
ventricular activation patterns 
Ondřej Naňka*(1), David Sedmera(1,2), Miloš Grim(1) 
(1) Institute of Anatomy, First Faculty of Medicine, Charles University in Prague, 
Prague, CZ (2) Institute of Physiology, Academy of Sciences of the Czech 
Republic, Prague, CZ 
 
Based on our previous study showing accelerated conversion of ventricular 
activation sequence during hypoxic incubation correlating with increased 
apoptosis in the atrioventricular canal, we hypothesized that this slight increase 
in apoptosis could lead to an accelerated pruning of myocardial atrioventricular 
connections, which would manifest as earlier appearance of mature apex-to-
base activation patterns. To test this hypothesis, we blocked apoptosis using an 
established caspase inhibitor in chick embryonic heart and analyzed the effects 
of this treatment on cell death and ventricular activation patterns. ED4 chick 
embryonic hearts were treated with the peptide Caspase inhibitors zVAD-fmk by 
intrapericardial injection in ovo. Spontaneously beating embryonic hearts 
isolated at ED8 were stained with voltage-sensitive dye C with Ultima L high-
speed camera at 1 kHz. Amount°Di-4-ANEPPS and imaged at 37  of apoptotic 
cells was analyzed at ED 7 by whole mount LysoTracker Red staining and 
confocal microscopy. Hearts of embryos treated with zVAD showed a 
significantly increased proportion of immature (base to apex) activation patterns 
at ED8, including ventricular activation originating from right atrioventricular 
junction, a pattern never observed in control hearts. The number of apoptotic 
cells in atrioventricular canal myocardium was decreased at ED7 in the treated 
hearts. Apoptosis in the atrioventricular canal myocardium is thus an important 
contributor to ventricular activation pattern. Its inhibition at critical stages can 
lead to persistence of accessory atrioventricular connections, which form a 
morphological substrate for ventricular pre-excitation. Supported by project of 
MSMT VZ 0021620806, LC 06061, and by grant of AS CR AV0Z50450515 
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201. Electrophysiological Mapping of Embryonic Mouse Hearts: 
Mechanisms of Dominant Pacemaker Switch during Early Cardiogenesis 
H.-S. Vincent Chen* (1,2), Tongying Yi (1), Eric Feller (1), Johnson Wong (1) 
(1) Development and Aging Program, NASCR Center, Sanford-Burnham Medical 
Research Institute, La Jolla, CA, USA (2) Department of Cardiology, University of 
California-San Diego, San Diego, CA , USA 
 
Introduction: Pacemaker activity originated from the left sinus venosus (LSV) 
area of embryonic mouse hearts at 8.5 days post coitus (E8.5). This dominant 
pacemaker activity switches to the right-sided sinoatrial node (SAN) with further 
cardiac development. The underlying molecular mechanism of pacemaker 
location switch during cardiogenesis remains poorly understood. An 
electrophysiological (EP) mapping method of embryonic hearts without any non-
physiological influences from dye-loading processes will yield most reliable 
information regarding the true mechanism underlying pacemaker location switch. 
Methods: EP recordings with multi-electrode array (MEA) on acutely isolated 
mice heart preparations at E8.5-E12.5 were performed. Results: Using 
pharmacological agents and EP recordings, we found that intracellular Ca2+-
mediated mechanisms (including Ryanodine receptors and Na+/Ca2+ 
exchangers) developed early and dominated the control of automaticity in LSV 
of E8.5 hearts. With pharmacological blockers, an immature pacemaker located 
at RSV could be demonstrated at E8.5 after complete arrest of the LSV 
pacemaker. With further embryonic development, clear SAN signals could be 
recorded in E11.5-12.5 hearts. Importantly, a mature form of dominant 
automaticity, involving both sarcolemmal ion channels and intracellular Ca2+ 
handling apparatus, evolved in SAN upon further differentiation at E12.5. This 
mechanistic maturation of automaticity appeared to accompany the location 
switch of dominant pacemaker regions during early cardiogenesis from E8.5 to 
E12.5. Loss of left-sided dominance of automaticity coincided with down-
regulation of HCN4 channels, suggesting inhibitory signals exist at LSV area 
during development. Conclusions: Intracellular Ca2+ handling apparatus 
developed early in LSV at E8.5 for controlling automaticity. However, an 
immature and non-dominant pacemaker could be demonstrated in RSV at E8.5. 
Voltage-dependent HCN and Ca2+ channels evolve at SAN to play increasing 
roles in pulse generation, which permits faster responses to rising metabolic 
demands. This mechanistic maturation confers the pacemaker location switch. 
 
202. Myocardial specific deletion of Tbx2 leads to ventricular preexcitation 
Wim TJ Aanhaanen*, Bastiaan JD Boukens, Janynke F Brons, Vincent Wakker, 
Corrie de Gier-de Vries, Antoni CG van Ginneken, Antoon FM Moorman, Ruben 
Coronel and Vincent M Christoffels 
Heart Failure Research Center, Academic Medical Center, University of Amsterdam, 
Amsterdam, The Netherlands 
 
Atrioventricular (AV) reentrant arrhythmias are caused by accessory myocardial 
pathways between the atria and ventricles that cross the annulus fibrosus. In the 
normal pre- and early postnatal heart, however, these AV myocardial 
connections are common, yet AV arrhythmias are rare, indicating that the basis 
of the formation of functional arrhythmogenic pathways is not understood. 
Transcription factor Tbx2 is expressed in the AV myocardium and endocardial 
cushions, and is critical for AV canal formation. Here, we show that global and 
myocardium-specific inactivation of Tbx2 causes formation of an accessory 
pathway in the AV junction and malformation of the annulus fibrosus. These 
pathways cause ventricular preexcitation, and, consistently, ectopically express 
high conductance gap-junctions Cx40 and Cx43 and cardiac sodium channel 
Scn5a. A fraction of fetal Tbx2-mutants did not display arrhythmias despite the 
presence of these pathways, suggesting a Tbx2-independent mechanism that 
prevents functionality at that stage. AV canal-specific proteins including Cx30.2, 
which decelerates the impulse in the adult AV node, were found to be expressed 
in the AV canal myocardium and maintained in Tbx2-deficient fetuses in variable 
patterns. The role of Cx30.2 in the functionality of the accessory pathway of 
Tbx2-mutants was investigated. Our data indicate three processes preventing 
the formation of functional accessory pathways: 1) correct patterning and 
morphogenesis of the AV canal myocardium to guide annulus fibrosus formation, 
2) repression of the working myocardial gene program, and 3) loss of the AV 
canal specific gene program. Myocardial specific loss of Tbx2 affects these 
processes leading to the formation of functional accessory bundles. 
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203. Atrial Myocyte Heterogeneity in Connexin Expression and Action 
Potential Conduction during Chick Cardiac Development. 
Paulina Delgado Cuenca*, Alicia Navetta, Michal Bressan, Takashi Mikawa 
Cardiovascular Research Institute, University of California San Francisco, San 
Francisco, USA 
 
The cardiac conduction system (CCS) consists of several distinct 
subcomponents, including the pacemaking SA node, internodal tract (INT), AV 
node, and Purkinje fibers. While differentiation of Purkinje fibers from ventricular 
myocytes has extensively been studied, little is know about mechanisms that 
induce or pattern other CCS components. For example, mounting physiological 
evidence indicates the presence of fast INT pathways in the atrium, however, 
there is little evidence indicating the presence of a morphologically or 
molecularly distinct cell population that comprises the INT. Here we report 
optical mapping data which demonstrate that, during heart looping, action 
potentials propagate across the atria in a non uniform pattern, instead showing 
tracts of cells with increased conduction velocity. Coinciding with these 
preferential conduction tracts, embryonic atria display molecular heterogeneity 
in their expression of several connexins including fast conducting Cx40 and slow 
conducting Cx45. Collectively these data suggest that a molecularly distinct 
subpopulation of cx40 positive atrial myocytes is present during INT tract 
development in chick. Supported in part by grants from the NIH-NHLBI. 
 
 
 
  Poster session C Saturday 22 May 
 
page 183 
 
Session C - Genetics & Cardiovascular 
Malformations 
 
204. Dysregulation of the PDGFRA gene causes inflow tract anomalies 
including TAPVR: Integrating evidence from human genetics and model 
organisms 
Steven B. Bleyl* (1,3), Yukio Saijoh (2,3), Noortje A.M. Bax (4), Adriana C. 
Gittenberger-de Groot (4), Lambertus J. Wisse (4), Shigehito Yamada (5), Kohei 
Shiota (5) and Gary C. Schoenwolf (3). 
(1) Departments of Pediatrics, (2) Human Molecular Biology and Genetics, and 
(3) Department of Neurobiology and Anatomy, University of Utah School of 
Medicine, Salt Lake City, UT, USA. (4) Department of Anatomy & Embryology, 
Leiden University Medical Center, Leiden, The Netherlands. (5) Department of 
Anatomy and Developmental Biology, Graduate School of Medicine, Kyoto 
University, Kyoto, Japan. 
For abstract, see in oral presentation section page 53 
 
 
 
 
205. Effects of conditional deletion of hypoxia-inducible factor (hif) and 
hypoxic stress on mouse heart morphogenesis 
Hongbin Liu and Steven A. Fisher* 
Depts of Medicine (Cardiology) and Physiology, Case Western University, 
Cleveland, Ohio, USA 
For abstract, see in oral presentation section page 54 
 
 
 
206. p53-related p63 transcription factor is essential for cardiac 
morphogenesis 
Alain Medawar(1,2), Matthieu Rouleau(1,2), Laurent Hamon(3), Huiqing Zhou(4), 
Hans van Bokhoven(4), Caterina Missero(5,6), Eleonora Candi(7), Cedric 
Blanpain(8), Gerry Melino(7,9), Michel Puceat(3) and Daniel Aberdam* (1,2,10) 
(1) INSERM U898, Nice, France (2) University of Nice-Sophia Antipolis, Nice, 
France (3) INSERM avenir team Evry, France (4) Department of Human 
Genetics, Nijmegen Centre for Molecular Life Sciences, Radboud University 
Nijmegen Medical Centrum, Geert Grooteplein Zuid 10, 6525 GA Nijmegen, The 
Netherlands (5) Fondazione SDN, Napoli, Italy (6) CEINGE Biotecnologie 
Avanzate, Napoli, Italy (7) Biochemistry Laboratory IDI-IRCCS and University of 
Rome "Tor Vergata", 00133 Rome, Italy (8) Université Libre de Bruxelles, 
Belgium (9) MRC Toxicology Unit, Leicester LE1 9HN, UK (10) INSERTECH, 
Bruce Rappaport Institute of the Technion, Haifa, Israel 
For abstract, see in oral presentation section page 55 
 
 
 
207. Copy Number variations (CNV) in left sided congenital heart disease 
Marc-Phillip Hitz* (1), Louis-Philippe Lemieux-Perreault (2), Christian R. 
Marshall (3), Bert Overduin (4), Maryse Thibeault (1), Alexandre F. R. Stewart 
(5), Stephen W. Scherer (3), Andrea Richter (6), Marie-Pierre Dubé (2), Gregor 
Andelfinger (1) 
(1) Cardiovascular Genetics, Sainte Justine Hospital, Montreal, Quebec, 
Canada (2) Research Centre, Montreal Heart Institute, Montreal, Quebec, 
Canada (3) Centre for Applied Genomics, Hospital for Sick Children, Toronto, 
Ontario, Canada (4) European Bioinformatics Institute, Hinxton, Cambridge, UK 
(5) Heart Institute, University of Ottawa, Ottawa, Ontario, Canada (6) Medical 
Genetics, Sainte Justine Hospital, Montreal, Quebec, Canada 
For abstract, see in oral presentation section page 56 
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208. The role of FKbp12-notch1 mediated regulation in ventricular 
trabeculation and compaction 
Hanying Chen* (1), Wenjun Zhang(1), Xiao-Xin Sun(1), Zhuang Chen(1), Kryn 
Stankunas(2), Yongzhen He(1), Weidong Yong(1), Wuqiang Zhu(1), Simon 
Conway(1), Ching-Pin Chang(2), Loren J. Field, Nadia Carlesso, Weinian 
Shou(1) 
(1)Riley Heart Research Center, Herman B Wells Center for Pediatric Research, 
Department of Pediatrics, Indiana University School of Medicine, Indianapolis, 
USA (2)Division of Cardiovascular Medicine, Stanford University, USA 
For abstract, see in oral presentation section page 57 
 
 
 
 
 
 
 
209. MCTP2 is a novel gene causing aortic coarctation 
S.M. Ware (1)*, X. Wang (2), L. Potocki (2), G. Zapata (2), M. Bray (2), A.C. 
Chinault (2), B.A. Boggs (2), E.K. Brundage (2), J.A. Towbin (1), A. Patel (2), 
S.D. Fernbach (2), S.L. Hamilton (3), K.L. McBride (4), J.W. Belmont (2), S.R. 
Lalani (2). 
(1) Division of Molecular Cardiovascular Biology, Cincinnati Children's Hospital, 
Cincinnati, OH (2) Dept of Molecular and Human Genetics; Baylor College of 
Medicine, Houston, TX (3) Dept of Molecular Physiology and Biophysics; Baylor 
College of Medicine, Houston, TX (4) Nationwide Children’s Hospital, Columbus, 
OH, USA 
For abstract, see in oral presentation section page 58 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
210. Loss of Akt1 causes intra-uterine stress leading to heart defects 
Zai Chang, Qin Zhang, Qiuting Feng, Teng Teng, Qing Luan, Zhongzhou Yang 
MOE Key Laboratory of Model Animal and Disease Study & Model Animal 
Research Center, Nanjing University, Nanjing, China 
 
In a C57/B6 genetic background, the majority of Akt1-deficient mice display 
post-natal mortality. Histological analysis of Akt1-deficient embryos and 
newborns revealed congenital heart defects, decreased cell proliferation and 
vascular intensity. Echocardiographic study of young Akt1-deficient mice 
indicated decreased heart function. Loss of Akt1 caused substantial activation of 
the p38MAPK pathway. Breeding the Akt1-deficient mice to mice that were 
heterozygous for a null p38α allele partially rescued the congenital heart defects, 
significantly decreased post-natal mortality, and restored normal patterns of 
cardiomyocyte proliferation. Our study suggests that Akt1 is essential for heart 
development and function, in part, through suppression of p38MAPK activation. 
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211. Regulation of Hand1 by Akt/PKB is involved in pathological cardiac 
remodeling 
Shuangshuang Lu(1), Junwei Nie(1), Qiuting Feng(1), Zai Chang(1), Qing 
Luan(1), Congjia Shan(1), Daniel Hess(2), BrainA. Hemmings(2), Zhongzhou 
Yang(1) 
(1) Ministry of Education Key Laboratory of Model Animal for Disease Study, the 
Model Animal Research Center of Nanjing University, Nanjing, China 210061 (2) 
Friedrich Miescher Institute for Biomedical Research, Basel, CH-4058, 
Switzerland 
 
Aberrant activation of Akt signaling causes pathological cardiac remodeling, 
such as hypertrophy and heart enlargement leading to heart failure. However, 
the downstream players of Akt signaling remain elusive. Here, we reported that 
Hand1, a basic helix-loop-helix (bHLH) transcription factor essential for heart 
development, could be a downstream target of Akt signaling involved in 
pathological heart remodeling. A well-conserved Akt substrate consensus motif 
has been identified in Hand1 proteins from different species suggesting Hand1 
as a putative Akt substrate. Using biochemical analysis, we demonstrated that 
Hand1 was phosphorylated by Akt at threonine 107(T107) and serine 109(S109) 
in the basic-helix domain. Phosphorylation of Hand1 regulates its transcriptional 
activation of luciferase reporter genes, DNA binding ability and cellular 
localization. Furthermore, transgenic mice with over-expression of Hand1 
mutants (to mimic or to abolish phosphorylation) in cardiomyocytes developed 
pathological cardiac remodeling. This study provides novel insights into Akt 
signaling in cardiac remodeling and Hand1 regulation in post-natal heart 
function. 
 
 
 
 
 
 
 
 
212. 14-3-3 epsilon is essential for heart morphogenesis and involved in 
human left ventricular noncompaction 
Ling Li (1), Katarzyna A. Cieslik (2), Bo Chang (3), Carlos Gorbea (1), George 
Lezin (1), Kazuhito Toyo-oka (4), Neil Bowles (1), Fukiko Ichida (3), Anthony 
Wynshaw-Boris (4), Antonio Baldini (5), H. Joseph Yost (2), and Luca Brunelli* 
(1) 
(1) Department of Pediatrics, and (2) Department of Neurobiology and Anatomy, 
The University of Utah School of Medicine, Salt Lake City, UT; (2) Department 
of Pediatrics, University of Texas Medical School, Houston, TX; (3) Department 
of Pediatrics, University of Toyama, Toyama City, Japan; (4) Department of 
Pediatrics, University of California, San Francisco, CA; (5) IGB, CNR; and 
University Federico II, Naples, Italy, and IBT, Texas A&M University, Houston, 
TX, USA 
 
Left ventricular noncompaction (LVNC) is a human cardiomyopathy resulting 
from defective ventricular morphogenesis, a process regulated by 
cardiomyocyte proliferation. 14-3-3ε (encoded by Ywhae) is an adapter protein 
involved in cell proliferation, and Miller-Dieker syndrome, a severe human 
lissencephaly. We hypothesized that Ywhae modulates cardiogenesis because 
of its characteristic embryonic expression pattern. Ywhae homozygote mutant 
mouse hearts presented specific features of LVNC, and a selective defect of the 
ventricular compact myocardium. Ywhae is essential for cardiac proliferation, 
maintaining low levels of the cell cycle inhibitor p27Kip1 by promoting its 
ubiquitination. Because of Ywhae dosage effects in the mouse heart, we 
screened seventy seven LVNC patients for YWHAE mutations. We identified 
two probands with a novel heterozygous substitution in a CCAAT/enhancer 
binding protein site of YWHAE which represses its promoter activity. This work 
uncovers a novel role of Ywhae in mammalian heart development, and provides 
the first evidence implicating YWHAE in cardiomyopathies. 
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213. Periconceptional nutrient intakes and risks of conotruncal heart 
defects 
Edward J. Lammer*(1), Gary M. Shaw(2), Suzan L. Carmichael(3), Wei Yang(3) 
(1) Children’s Hospital Oakland Research Institute, Oakland, CA, USA (2) Dept. 
of Pediatrics, Stanford University, Stanford, CA, USA (3) March of Dimes 
California Research Division, Oakland, CA, USA 
 
We investigated associations between conotruncal heart defects and 
periconceptional multi-vitamin use and intakes of dietary nutrients. Data derived 
from a population-based case-control study of fetuses and liveborn infants 
among almost a million California births between July 1999 and June 2004. 
Cases included 140 with d-transposition of great arteries (dTGA), and 163 with 
tetralogy of Fallot (TOF). Total number of controls was 698. Use of vitamins was 
elicited by questionnaire for the periconceptional period. Dietary nutrient intake 
was elicited by a well-known food frequency questionnaire. Results showed that 
the odds ratio for dTGA associated with supplemental multivitamin use was 1.0 
(95% confidence interval, 0.7-1.5) and for TOF was 0.9 (0.6-1.3). We observed 
increased risks associated with lower dietary intakes of linoleic acid, total 
carbohydrate, and fructose for dTGA. Among women who did not use vitamin 
supplements periconceptionally, we found increased risks of dTGA associated 
with lower dietary intake of several micronutrients -- folate, niacin, riboflavin, and 
vitamins B12, A, and E, even after simultaneous adjustment for other studied 
nutrients. We did not find similar associations among mothers who delivered 
infants with TOF. Analytical consideration of several potential confounders did 
not reveal alternative interpretations of the results. Evidence continues to 
accumulate to show that nutrients, particularly folate, influence risks of structural 
birth defects. Our results extend observations that other nutrients may also be 
important in heart development. 
 
 
 
 
 
 
214. Novel and common chromosomal imbalances associated with 
congenital heart defects. 
Damian Heine-Suñer* (1,4), Fernando García-Algas (2), Maria Angeles de la 
Fuente (2), Miquel Juan (3), Albert Tubau (3), Estefanía Piñero (4), Alexandra 
Schmidt (4), Maria Oliver (4), Jordi Rosell(1) 
(1) Secció de Genètica, Hospital Universitari Son Dureta, Palma de Mallorca, Spain (2) 
Servei Pediatria, Hospital Universitari Son Dureta, Palma de Mallorca, Spain (3) Servei 
d’Obstetricia i Ginecologia, Hospital Fundació Son Llatzer, Palma de Mallorca, Spain (4) 
Unitat d’Investigació, Hospital Universitari Son Dureta, Palma de Mallorca, Spain 
 
In an effort to identify new genetic factors associated with congenital heart 
defects (CHD) we have studied 328 prenatal and postnatal DNA samples of 
patients with syndromic and isolated CHD. We selected a subset of 63 patients 
on which we typed 660.000 SNPs for intensity and genotype using the Illumina 
660W beadchip. 20 of the 63 patients were syndromic and 43 suffered of an 
isolated CHD. As a result of this study we detected 6 chromosomal 
abnormalities that are the putative cause of the observed CHD: 1) 2 
chromosomal abnormalities of chromosome 22; an atypical duplication of 
22q11.2 associated with a ventricular septal defect (VSD) and cleft palate, and 
an atypical deletion of the same region associated with an isolated Tetralogy of 
Fallot (TOF). This region does not contain genes known to be implicated in 
DiGeorge syndrome or with heart development. 2) A duplication of the 17q12 
region associated with a TOF. This region not previously contains the LHX1 
gene that is known to be involved in mesoderm and neural development. 3) A 
patient with an apparently equilibrated reciprocal translocation between 
chromosome 2 and 7 with an isolated TOF was found to have deletions on both 
chromosomes affecting a series of novel candidate genes. 4) Finally, we also 
detected a deletion of 11q24-25 which identifies the patient as suffering from 
Jacobsen syndrome (CIV and developmental delay); and a 17q21.31 deletion 
that identifies the patient as suffering of the 17q21.31 syndrome (CIV and 
multiple other abnormalities). 
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215. Identification Of An Essential Gene For Cardiovascular Development 
From Studies On The L11jus8 Mutant Mouse 
Christopher Clowes, Kathryn E. Hentges* 
Faculty of Life Sciences, University of Manchester, Manchester, UK 
 
The l11Jus8 recessive mutation was isolated from a balancer chromosome 
mutagenesis screen on mouse chromosome 11. Macroscopically, l11Jus8 
mutants exhibit thoracic haemorrhage, impaired yolk sac vascular maintenance, 
and mid-gestation lethality. Histological analysis revealed loss of atrial and 
outflow tract myocardial integrity, potential apoptosis of atrial cardiomyocytes, 
and excessive blood pooling in l11Jus8 mutant heart chambers. Thin ventricular 
myocardium and reduced trabeculation are exhibited in ~30% of l11Jus8 
mutants. Immunohistochemical analyses demonstrate progressive reduction in 
mutant yolk sac vascular diameter whilst embryonic vasculature appears 
unaffected. The nature and temporal occurrence of abnormalities in l11Jus8 
mutants implies a primary cardiac defect with secondary yolk sac vascular 
defects. Ultrasound will be utilised to evaluate cardiac function throughout 
development in mutant embryos. The gene containing the l11Jus8 mutation is 
unknown. Meiotic mapping has refined the l11Jus8 mutation to a ~2.3Mb region 
including ~45 predicted transcripts. Exonic and splice junction genomic DNA of 
20 high priority genes associated with cardiovascular development or embryonic 
lethality have been sequenced, although the l11Jus8 causative mutation 
remains to be discovered. Future work will employ genome capture and high-
throughput sequencing to identify the l11Jus8 causative mutation. As no similar 
phenotypes have been attributed to mutations of genes in the l11Jus8 candidate 
region, positional cloning of the l11Jus8 mutation will provide a new link 
between a gene in the candidate region and cardiac development. Study of the 
atrial abnormalities in l11Jus8 mutants will allow a better understanding of the 
general process of atrial development, which is poorly characterised at present. 
 
 
 
 
 
216. Great vessel development requires biallelic expression of Chd7 and 
Tbx1 in pharyngeal ectoderm in mice 
Karen McCue* (1), Victoria Randall (1), Catherine Roberts (1), Vanessa 
Kyriakopoulou (1), Sarah Beddow (1), Angela Barrett (1), Francesca Vitelli (2), 
Katrina Prescott (1), Koen Devriendt (3), Charles Shaw-Smith (1), Erika Bosman 
(4), Georg Steffes (4), Karen Steel (4), Subreena Simrick (5), M. Albert Basson 
(5), Elizabeth Illingworth (6) and Peter Scambler (1). 
(1) Molecular Medicine Unit, Institute of Child Health, London, UK (2) Texa A&M Health 
Science Center, Houston, USA (3) Center for Human Genetics, Catholic University of 
Leuven, Leuven, Belgium (4) Wellcome Trust Sanger Institute, Hinxton, UK (5) 
Department of Craniofacial Development, King's College London, London, UK (6) 
Department of Chemistry, Universta Studi di Salerno, Fisciano, Italy 
 
CHARGE syndrome is characterised by coloboma, heart defects including 
Tetralogy of Fallot, choanal atresia, retarded growth and development, genital 
and ear abnormalities. Deletion or mutation of chromodomain protein CHD7 is 
the major cause of this syndrome. Di George syndrome is frequently associated 
with a deletion of 22q11.2 and haploinsufficiency of T-box transcription factor 
TBX1 causes a number of symptoms including great vessel defects particularly 
of the outflow tract and aortic arch. Such cardiovascular malformations arise 
from defective remodelling of the pharyngeal arch arteries (PAA). The significant 
phenotypic overlap of these disorders and the fact that Chd7 is the only gene 
other than Tbx1 reported to affect 4th PAA development by haploinsufficiency, 
led us to investigate the embryological relationship between the two syndromes 
using mouse models. Hypo/aplasia was observed in both Tbx1 and Chd7 
heterozygote mice at E10.5 with resulting interruption of the aortic arch 
observed at later stages. Double heterozygous mice displayed a synergistic 
interaction for this phenotype. Restoration of Chd7 in the neural crest or 
mesoderm did not rescue PAA morphogenesis, however dizygous expression of 
Chd7 and Tbx1 in the pharyngeal ectoderm was required for normal PAA 
development. 
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217. Genetic analysis of the role of Nodal-related southpaw in the 
regulation of cardiac asymmetry 
Emily S. Noël* (1), Manon Verhoeven (1), Jeroen Bakkers (1, 2) 
(1) Hubrecht Institute-KNAW & University Medical Center Utrecht and (2) 
Interuniversity Cardiology Institute of the Netherlands, 3584CT Utrecht, The 
Netherlands 
 
In all vertebrates, the heart is the first organ to establish left-right asymmetry 
during development, and defects in L/R asymmetry may result in congenital 
cardiac defects. During zebrafish embryonic development, asymmetric gene 
expression drives leftward displacement of the linear heart tube, and is followed 
by heart looping, which is crucial for proper alignment of the cardiac segments 
and subsequent heart function. The first known asymmetrically expressed gene 
in zebrafish is southpaw (spaw), a Nodal-related gene whose expression is 
propagated from posterior to anterior in the left LPM during somitogenesis. In a 
forward genetic screen we have identified a zebrafish mutant carrying a 
mutation in the spaw gene. Spaw mutants display a failure of cardiac 
displacement, and subsequent randomisation of and/or incomplete cardiac 
looping. While it is clear that spaw is required to regulate initial cardiac 
asymmetry, it is unclear how asymmetric spaw expression translates into 
asymmetric cardiac morphogenesis. To determine the downstream factors 
required for translating the spaw signal into asymmetric cardiac morphogenesis, 
we have performed microarrays to analyse differential gene expression between 
wild type and spaw mutant embryos at 10, 15 and 23 somite stages, prior to 
initiation of cardiac asymmetry. Furthermore, in situ analyses reveal that Spaw 
function is required to propagate asymmetric spaw expression in the left LPM. 
To determine the mechanism by which the spaw signal is asymmetrically 
enhanced, we have performed a mosaic analysis of spaw activation in wild type 
and mutant clones. These studies, combined with functional analysis of 
downstream components, will further our understanding of the mechanisms by 
which asymmetric gene expression regulates cardiac morphogenesis. 
 
 
 
 
 
 
 
 
218. Tbx1 interferes with Tgf-β signalling through the inhibitor Smad7 and 
impacts on great vessel development. 
Irinna Papangeli, Kelly Lammerts van Bueren, Peter J. Scambler 
Molecular Medicine Unit, Institute of Child Health, 30 Guilford Street, London 
WC1N 1EH, United Kingdom 
 
DiGeorge syndrome is the most common microdeletion syndrome in humans, 
frequently caused by a 3Mb deletion of chromosome 22. The phenotype is 
characterized by craniofacial, cardiovascular, thymus, parathyroid and 
psychiatric defects. TBX1 localises within the commonly deleted region on 
22q11 and is considered the major genetic determinant of the syndrome. 
Deletion of Tbx1 in animal models results in pharyngeal and cardiovascular 
defects, highlighting its role in the development of these structures. In an effort 
to study the pathways involved in these processes, we determined potential 
Tbx1 target genes through a microarray screen. Smad7 is an inhibitor of the Tgf-
β pathway, and so far, several Tgf-β signalling genes have been described in 
heart development. We confirmed that Smad7 expression is diminished in Tbx1-
/- mouse embryos and used a gene-trap mouse model to investigate the 
glandular, craniofacial and cardiovascular phenotype. We show an overlap 
between the Tbx1 null and Smad7 null phenotype as well as a genetic 
interaction between the two genes in great vessel development. Currently we 
are studying the mechanism involved in the morphogenesis of the symmetric 
embryonic arch arteries into the asymmetric mature vascular structure. 
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219. Genetic interaction of tbx1 with the Notch pathway effector her6 is 
required for pharyngeal development in the zebrafish 
Catherine Roberts* (1), Bertrand Vernay (2), Kelly Lammerts van Bueren(1) and 
Peter J. Scambler(1) 
(1) Molecular Medicine Unit, Institute of Child Health, London, UK (2) 
Developmental Biology Unit, Institute of Child Health, London, UK. 
 
Notch-pathway effector gene Hes1 is a putative down-stream target gene for 
Tbx1, which in turn is strongly implicated as a candidate gene for 
DiGeorge/Velocardiofacial Syndrome (DGS/VCFS). Using the zebrafish as a 
model, we show that tbx1 and her6 (zebrafish homologue of Hes1) are 
expressed in the pharyngeal tissues of zebrafish embryos. Furthermore, her6 
expression is down-regulated in this region in both tbx1 mutant fish van gogh 
(vgo) and tbx1 morphants. Morpholino (MO)-based knock-down of her6 
produces a similar phenotype to both the vgo mutant and tbx1 morphants, with 
embryos exhibiting comparable loss/abnormal patterning of caudal pharyngeal 
arch structures. Tg(sox10:gfp) fish exhibit abnormalities of neural crest migration 
with both morpholinos. Injecting sub-phenotypic doses of the tbx1 and her6 MOs 
in a simultaneous pair-wise fashion generates a synergistic increase in the 
observed pharyngeal defects. This implies a genetic interaction exists between 
her6 and tbx1, which was confirmed by rescue of the tbx1 morphant pharyngeal 
phenotype with injection of her6 mRNA. We are currently investigating whether 
this interaction between tbx1 and her6 is Notch-pathway mediated, or whether it 
is a further example of Notch-independent activation of her6. 
 
 
 
 
 
 
220. A new locus for a syndromic form of Thoracic Aortic Aneurysms 
maps to chromosome 15q 
Ingrid M.B.H. van de Laar* (1), Rogier A. Oldenburg (1), Bianca de Graaf (1), 
Judith A.M.Verhagen (1),Yvonne M. Hoedemaekers(1), Ingrid Frohn-Mulder (2), 
Jolien Roos-Hesselink (3), Johan M. Kros (4), Ben A. Oostra (1), Marja 
W.Wessels (1), Aida M. Bertoli-Avella (1) 
(1) Department of Clinical Genetics, Erasmus Medical Center, Rotterdam, the Netherlands 
(2) Department of Pediatric Cardiology, Erasmus Medical Center- Sophia, Rotterdam, the 
Netherlands (3) Department of Cardiology, Erasmus Medical Center, Rotterdam, the 
Netherlands (4) Department of Pathology, Erasmus Medical Center, Rotterdam, the 
Netherlands 
 
Background: Thoracic aortic aneurysms (TAA) are familial in at least 15-20% of 
the cases and can be classified in syndromic and non-syndromic forms. The 
TGF-beta signalling pathway plays a central role in the pathogenesis of both 
syndromic and non-syndromic TAA. Methods and results: We present a large 
four-generation family with a syndromic form of TAA. Thirty family members had 
an extensive physical and cardiologic examination. Eleven familymembers were 
considered affected on the basis of cardiac and/or skeletal and connective 
tissue abnormalities. Nine patients had an aortic or other large artery aneurysm. 
TAA patients had a high risk of aortic dissection or rupture at an early age. Many 
TAA patients had additional heart malformations, including mitral valve 
abnormalities, persistent ductus arteriosus and pulmonary valve stenosis. 
Histological examination of the aorta showed medial fragmentation, disarray of 
elastic fibres and excess of collagen deposition. After excluding mutations in the 
known syndromic TAA genes (FBN1, TGFBR1, TGFBR2, COL3A1), we 
performed a genome wide linkage analysis in this family using the Affymetrix 
250K Nsp arrays. A new locus on chromosome 15q with a significant LOD score 
of 3.6 was identified within a critical region containing 120 genes. Sequencing of 
positional candidate genes is ongoing. Conclusions: The clinical phenotype 
overlaps with known TAA syndromes such as Marfan syndrome, Loeys-Dietz 
syndrome and vascular type Ehlers-Danlos syndrome. Our data provide 
evidence for a new locus for a syndromic form of TAA. Identification of this novel 
gene will provide insight into the pathogenesis of arterial aneurysms. 
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221. The ace-of-hearts mutant is defective in the establishment of cardiac 
left-right asymmetry 
Federico Tessadori*(1), Manon Verhoeven (1), Inkie van Gogh (1), Sonja 
Chocron (1) and Jeroen Bakkers (1,2) 
(1) Cardiac Development and Genetics group, Hubrecht Institute-KNAW & University 
Medical Center Utrecht, Utrecht, The Netherlands (2) Interuniversity Cardiology Institute of 
the Netherlands, Utrecht, The Netherlands 
 
In most vertebrate embryos, the heart is the first organ to display left-right 
asymmetry. During zebrafish embryonic development, asymmetric gene 
expression drives leftward displacement of the linear heart tube, and is followed 
by heart looping, which is crucial for proper alignment of the cardiac segments 
and subsequent heart function. To this day, our knowledge of the genes and 
mechanisms regulating the establishment of cardiac asymmetry remains limited. 
To uncover novel players and get insight into the molecular mechanisms 
controlling heart morphogenesis, we perform forward genetic screens for 
zebrafish mutants exhibiting heart asymmetry defects. Zebrafish offers 
significant genetic and embryological advantages, such as large progeny, fast 
development and straightforward microscopic observation. Additionally, the 
zebrafish two-chambered heart provides a simpler, though fully genetically 
relevant system for studying processes otherwise complex in many model 
organisms. We have identified ace-of-hearts, a mutant exquisitely defective for 
cardiac displacement and looping. Detailed analysis revealed that ace-of-hearts 
acts downstream of Nodal signaling and mutant embryos display no asymmetry 
defects in other organs. The mutation in ace-of-hearts was mapped to a 
premature stop codon on a gene encoding a protein convertase. Protein 
convertases activate proteolytically numerous proproteins amongst which BMP4, 
tgf-beta and nodal factors. However, their role in heart morphogenesis remains 
unclear. By assaying genetic interactions in mutants defective for predicted ace-
of-hearts substrates and examining expression patterns of heart 
morphogenesis-specific factors in ace-of-hearts mutants amongst others, we are 
uncovering the place of ace-of-hearts in the pathways driving heart 
morphogenesis. 
 
222. CRELD1, a genetic risk factor for congenital heart defects in humans, 
is essential for cardiovascular development. 
Jennifer Redig* (1), Gameil Fouad (1), Darcie Babcock (2), Benjamin Reshey 
(2), Cheryl Maslen (2) 
(1) Molecular and Medical Genetics, Oregon Health & Science University, Portland, OR, 
USA (2) Cardiovascular Medicine, Oregon Health & Science University, Portland, OR, 
USA 
 
Previously our laboratory described the first genetic risk factor associated with 
atrioventricular septal defects(AVSD), called CRELD1. Recent work in our 
laboratory shows that CRELD1 may be working in concert with VEGF to 
regulate cardiovascular development. To determine the role of CRELD1 in 
development, we created a Creld1-knockout mouse. Characterization of the 
mouse demonstrates that Creld1 is required for proper cardiovascular 
development. Creld1 was found to be necessary for both normal development of 
the atrioventricular(AV) endocardial cushions, and for proper vascular modeling 
in both the embryo and yolk sack. We hypothesized that these cardiovascular 
abnormalities may be due to the misregulation of VEGF, an important factor in 
cardiovascular development. The ability of CRELD1 to regulate VEGF was 
supported by a human epidemiological study in which we found an association 
between AVSD cases, CRELD1 mutations and the VEGF-634C allele, a 
polymorphism associated with increased VEGF expression. This proposed 
CRELD1/VEGF interaction was further supported by employing a mouse 
endocardial cushion explant assay to determine if Creld1 controls the epithelial-
to-mesenchymal transformation(EMT) required for valvuloseptal morphogenesis. 
We found that although EMT proceeds normally, the transformed cells respond 
differentially to VEGF when Creld1 is deficient. This indicates that Creld1 is a 
regulator of VEGF activity. The recent results from our human association 
studies in combination with data from our in-vivo and in-vitro mouse model 
studies support our hypothesis that CRELD1 controls cardiovascular 
development through modulation of VEGF activity. This novel CRELD1/VEGF 
interaction may explain the developmental origins of a subset of sporadic AVSD 
cases. 
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223. Increased Wnt signalling in early vertebrate development promotes 
atrial fate independently of head formation. 
Nicholas Child, Tania Papoutsi, David Burns, Deborah Henderson and Bill 
Chaudhry*. 
Institute of Human Genetics, Newcastle University, UK. 
 
Increased canonical Wnt signalling is suggested to produce a biphasic response 
in vertebrate cardiac development but also plays important roles in specifying 
the anterior embryonic structures. The effects on the morphology of the heart 
are poorly described. We evaluated the effect of increased Wnt signalling in 
vertebrate heart development using the zebrafish embryo and a mouse 
embryonic stem cell (ESC) assay of cardiogenesis. Although a biphasic 
response was seen for some genes in the ESC assay in response to the GSK3 
inhibitor 6-bromoindirubin-3'-oxime (BIO), this was not seen for others and 
overall there was a reduction in numbers of embryoid bodies with spontaneous 
beating at all treatment stages. In zebrafish embryos, treated before completion 
of gastrulation, Wnt signalling produced the expected disturbances in body plan 
such that embryos either died or did not form normal cranial structures. In 
contrast, although embryos treated at the end of gastrulation appeared 
morphologically normal, there was a persisting reduction in total numbers of 
cardiomyocytes, combined with increased numbers of atrial cells. This 
correlated with a disturbance in the relationship between Nkx2.5 gene 
expression in the anterior lateral plate mesoderm and the expression of Ntl in 
the notochord. A corresponding increase in Mlc2a expression level was seen in 
the ESC assay. We have demonstrate that any positive effects of increased 
canonical Wnt signaling on production of cardiomyocytes are counter-balanced 
by severe disturbance of body plan. Moreover, even if cranial development is 
preserved ventricular hypoplasia and a shift towards increased atrial 
cardiomyocytes are still observed. 
 
 
 
 
 
 
224. Time-regulation of cardiac chromatin remodeling complexes 
maintains a healthy heart 
Kazuko Koshiba-Takeuchi* (1), Yasuyuki Sakai (2), Yosuke Sasaoka (2), 
Mizuyo Kojima (1), Hiroe Sugizaki (1), and Jun K Takeuchi (1,2) 
(1) IMCB, Univ of Tokyo, (2) Grad. Sch. of Bioscience and Biotechnology, Tokyo 
Tech, Japan 
 
In the heart, several stresses induce re-induction of fetal genes in association 
with cardiac hypertrophy and heart failure. However, no significant factors that 
regulate fetal genes expression via modulating chromatin structures have been 
identified. Here we show that NurD repressor-type chromatin remodeling 
complexes and their associated transcriptional repressor, Sall4 synergistically 
repress in progressive hypertrophic ventricles. In Sall4 mutant adult heart, fetal 
activator-type chromatin remodeling complexes, SWI/SNF-Baf was upregulated. 
To address whether abnormal expression of Smarcd3 directly caused heart 
failure, we generated two transgenic mice lines to overexpress Smarcd3 with α-
MHC and CAG-CAT promoters. α-MHC-Smarcd3 TG mice caused abnormal 
hyper-trabeculare with ten times high number of cardiomyocytes in postnatal 
hearts exposed to hypertrophic stimuli. In these hearts, strong phospho-Histone 
H3–positive cells were observed with up-expression of several fetal genes, 
suggesting that stable Smarcd3 expression might block cardiomyocytes 
maturation. Furthermore, ECG analyses in these mice showed that the T-wave 
was completely down regulated. These results indicate that the new molecular 
pathway to cause cardiac hyperplasia relating with the chromatin remodeling 
factors in adult. We propose that Time- and Dose-dependent epigenetic signal 
pathway as chromatin/histone remodelers control healthy heart via regulating 
specific promoter regulation on genome in cardiomyocytes trabeculare and fetal 
gene program. 
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225. Mutation of the C-terminus of titin Leads to Hypertrophic 
Cardiomyopathy in Medaka Fish 
Shinji Makino*(1), Yuta Higashikuse(2), Song han Yoon(1), Mayumi Oda(1), 
Toshimi Kageyama(1),Shinsuke Yuasa(1), Ruri Kaneda(1), Mitsushige 
Murata(1), Motoaki Sano(1), Akira Kudo(3), Atsushi Kawakami(3), Shintaro 
Morizane(2), Takeshi Suzuki(2), Keiichi Fukuda(1) 
(1)Department of Cardiology, Keio University School of Medicine, Tokyo, Japan 
(2)Division of Basic Biological Sciences, Faculty of Pharmacy Keio University, Tokyo, 
Japan (3)Department of Biological Information, Tokyo Institute of Technology, Kanagawa, 
Japan 
 
[Background] The Medaka fish represents an excellent model system for 
studying the cardiovascular system, since oxygen is delivered by diffusion and 
the embryo can tolerate the absence of blood flow. The aim of this study was to 
identify the gene responsible for hypertrophic cardiomyopathy. [Methods and 
Results] We used a chemical mutagenesis screen to identify the Medaka red 
blood island (rbi) mutant, which exhibited hypertrophic atrium and ventricle and 
lacked blood circulation, so that blood cells pooled in the blood island. 
Morphologically, the rbi heart developed normally. However, in the rbi embryo at 
72 hours post-fertilization, the heart had lost elasticity and showed evidence of 
hypertrophic atrium and ventricle, and the heartbeat was weak from the first 
beat. These phenotypes were inherited as a recessive trait. Transmission 
electron microscopy of the rbi revealed reduced numbers of myofibrils and 
disrupted sarcomeric structures. Positional cloning revealed that rbi resulted 
from a 'causative' mutation in the titin gene. Titin, which is the largest known 
protein, binds myosin to the Z-disc in the sarcomere. We narrowed the critical 
region down to a 19-kb region of the C-terminus, which is important for myosin 
binding. RT-PCR analysis indicated higher expression levels of titin in the rbi. 
[Conclusion] Missense mutation of the C-terminal sequence of titin results in 
abnormal sarcomere assembly and hypertrophic cardiomyopathy in Medaka fish. 
 
226. Comprehensive candidate approach for identification of sequence 
variants in cardiac transcription factors in patients with congenital heart 
defects 
Kazuki Kodo(1,2), Tsutomu Nishizawa(1), Michiko Furutani(1,3), Shoichi Arai(1), 
Rumiko Matsuoka(1,3), Hiroyuki Yamagishi(1,2) 
(1)Department of Pediatrics, Division of Pediatric Cardiology, Keio University School of 
Medicine, Tokyo, Japan (2)International Research and Educational Institute for Integrated 
Medical Sciences (IREIIMS), 3Division of Pediatric Cardiology, Tokyo Women’s Medical 
University, Tokyo, Japan 
 
Congenital heart defects (CHD) occur in nearly 1% of all live births and are the 
major cause of infant mortality and morbidity. Although improved understanding 
of genetic causes would provide insight into the pathobiological basis of CHD, 
the underlying genetic etiology of most CHD are still unknown. In order to 
explore genetic causes of CHD, we screened DNA derived from immortalized 
cell-line of 21 patients with non-syndromic persistent truncus arteriosus, and 
identified two GATA6 mutations. Both GATA6 mutant proteins lost 
transcriptional activity and failed to regulate downstream target genes 
associated with the outflow tract development. We have further screened DNA 
from immortalized cell-line of 516 patients with various non-syndromic CHD, and 
found nine sequence variants in four genes encoding cardiac transcription 
factors NKX2.5, MEF2C, GATA4 and GATA6 in eleven independent probands. 
These sequence variants were confirmed by analysis of patients’ original 
genome and were not found in control population. Some of the mutant proteins 
showed significant decrease in transcriptional activity for the NPPA and other 
promoters for the cardiac development, and also decreased synergistic activity 
with other transcriptional factors. These findings suggest that the disturbance of 
regulatory circuit of these transcription factors may cause a subset of non-
syndromic CHD. On the other hand, healthy family members of probands with 
some sequence variants of GATA4 and GATA6 had same nucleotide changes. 
It may be possible that secondary genetic and/or environmental factors may 
affect the penetration of CHD in these families. A comprehensive candidate 
approach for identification of sequence variants using immortalized cell-lines in 
combination with in vitro/vivo functional analyses would provide a way to clarify 
the pathogenesis of non-syndromic CHD that are considered to be multifactorial 
inheritance disorders. 
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227. Molecular patterning of the arterial trunk in early mouse embryos 
Magali Théveniau-Ruissy*, Pauline Parisot, Robert G. Kelly. 
Developmental Biology Institute of Marseilles-Luminy, UMR 6216 CNRS-
Université de la Méditerranée, Campus de Luminy, Marseille Cedex 9, France. 
 
TBX1, encoding a T-box transcription factor, is the major DiGeorge (del22q11.2) 
syndrome candidate gene and is required for pharyngeal and cardiovascular 
development. Tbx1+/- mice present a high frequency of fourth arch artery 
anomalies and Tbx1-/- embryos have severe cardiac anomalies including a 
common arterial trunk and ventricular septal defect. DiGeorge syndrome 
patients present a high incidence of conotruncal defects including common trunk 
and tetralogy of Fallot. We have shown that the common arterial trunk in Tbx1-/- 
embryos has an aorta-like phenotype associated with severe reduction of a 
subpopulation of second heart field progenitor cells normally contributing to 
myocardium at the base of pulmonary trunk. Underdevelopment of 
subpulmonary myocardium is thought to be the primary defect in common 
human conotruncal defects including tetralogy of Fallot. Anomalous coronary 
artery patterning is observed in Tbx1-/- hearts: the left coronary artery courses 
ventrally, across a normally coronary-free region, to connect with an ostium 
overlying the right/ventral sinus of the arterial trunk. Semaphorin3c, encoding a 
neurovascular guidance molecule is expressed in a Tbx1-dependent domain in 
subpulmonary myocardium. Sema3c-/- embryos also display common arterial 
trunk although coronary artery patterning appears normal. Here we present a 
comparative analysis of the evolution of common trunk in these two models and 
investigate potential genetic interaction between these genes. Future subaortic 
and subpulmonary regions are prefigured in the E10.5 outflow tract. Using a 
candidate gene approach and microarray analysis at E10.5 we aim to identify 
additional genes expressed in subpulmonary myocardium that may contribute to 
conotruncal and coronary artery development. 
 
 
 
 
228. Systematic survey of variants in TBX1 in non-syndromic Tetralogy of 
Fallot identifies a novel 57 base pair deletion that reduces transcriptional 
activity 
Ana Topf* (1), Helen R. Griffin (1), Elise Glen (1), Christiane Zweier (8), A. 
Graham Stuart (2), Jonathan Parsons (3), Ian Peart (4), John Deanfield (5), 
John O’Sullivan (6), Anita Rauch (8), Peter Scambler (7), John Burn (1), 
Heather J. Cordell (1), Bernard Keavney (1), Judith A. Goodship (1) 
(1) The Institute of Human Genetics, Newcastle University, Newcastle-upon-Tyne, UK (2) 
Bristol Children’s Hospital, Bristol, UK (3) Leeds General Infirmary, Leeds, UK (4) Alder 
Hey Hospital, Liverpool, UK (5) Great Ormond Street Hospital, London, UK (6) Freeman 
Hospital, Newcastle-upon-Tyne, UK (7) Institute of Child Health, London, UK (8) Institute 
of Human Genetics, Friedrich-Alexander-University Erlangen-Nuremberg, Erlangen, 
Germany 
 
Tetralogy of Fallot (TOF) is common in individuals with hemizygous deletions of 
Chromosome 22q11.2 that remove the cardiac transcription factor TBX1. Here, 
we assess the contribution of common and rare genetic variants in TBX1 to TOF. 
We sought rare TBX1 variants by resequencing coding exons and splice-site 
boundaries. We investigated common TBX1 variants by genotyping 20 
haplotype-tagging SNPs capturing all the common variation present at the locus. 
Association analysis was performed using the programme UNPHASED. TBX1 
exons were sequenced in 93 non-syndromic TOF cases. SNP analysis was 
performed in 356 TOF cases, their parents, and healthy controls. Three novel 
variants not present in 1000 chromosomes from healthy ethnically-matched 
controls were identified. One of these variants, an in-frame 57 base-pair deletion 
in the third exon which removed nineteen evolutionarily conserved residues, 
decreased transcriptional activity by 37% in a dual luciferase assay (p=0.005). 
We have demonstrated that this mutation affected TBX1 protein stability. After 
correction for multiple comparisons, no significant associations between 
common genetic variants and TOF susceptibility were found. This study 
confirms that rare TBX1 variants with functional consequences are present in a 
small proportion of non-syndromic TOF but did not find association with 
common TBX1 variants. 
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229. The pharyngeal endoderm in cardiovascular patterning 
Simon D. Bamforth* (1), Divya Venkatesh (1), Pin-Xian Xu (2), Ralf Kist (1), 
Heiko Peters (1) 
(1) Institute of Human Genetics, Newcastle University, Newcastle, NE1 3BZ, UK 
(2) Mount Sinai School of Medicine, New York, USA 
 
Cardiovascular development requires interactions between pharyngeal 
endoderm, ectoderm, endothelium and mesoderm-derived and neural crest-
derived mesenchyme. Patients with del22q11 syndrome suffer from 
cardiovascular, thymus and parathyroid abnormalities and mutations in TBX1 
have been implicated as an important genetic defect underlying the del22q11 
phenotype. In Tbx1-null mouse embryos there is a reduction in the expression of 
the transcription factor Pax9 in the pharyngeal pouch endoderm at mid-
embryogenesis. Mice lacking Pax9 are known to die perinatally with a cleft 
secondary palate and absent thymus, parathyroid glands, and ultimobranchial 
bodies. We now show that Pax9-null embryos have major cardiovascular 
defects including ventricular septal defect (VSD), double-outlet right ventricle 
(DORV), severely hypoplastic aorta, interrupted aortic arch (IAA), and aberrant 
right subclavian artery (A-RSA). The transcription factor Eya1 is thought to 
belong to the same genetic network as Pax9, and is expressed in the 
pharyngeal endoderm, mesenchyme and ectoderm in the mouse. Moreover, 
Eya1-null embryos die perinatally with abnormalities of pharyngeal pouch 
derivatives. We have found that embryos null for Eya1 also have cardiovascular 
defects including VSD, DORV, IAA and A-RSA. To investigate whether Pax9 
and Eya1 genetically interact, we intercrossed Pax9+/-;Eya+/- mice and found 
that 90% of compound mutants died at around E10.5. Lack of X-Gal staining for 
Pax9lacZ in mutant embryos revealed loss of caudal pharyngeal pouch 
structures. In the mouse, Pax9 expression in the pharyngeal endoderm is vital 
for correct cardiovascular development. Our data suggest that Pax9 and Eya1, 
possibly together with Tbx1, genetically interact in the pharyngeal endoderm to 
control cardiovascular development. 
 
 
 
 
 
230. The Role of Chap, A Novel Cardiac Z-Disk Protein, In Muscle 
Development And Function 
Willemijn van Eldik* (1,2) Abdelaziz Beqqali (1), Jantine Monshouwer-Kloots (1), 
Christine Mummery (1) and Robert Passier (1) 
(1) Leids Universitair Medisch Centrum, Einthovenweg 20, 2333 ZC Leiden, The 
Netherlands (2) Interuniversitair Cardiologisch Instituut Nederland (ICIN), 
Catharijnesingel 52, 3511 GC Utrecht, The Netherlands 
 
We recently identified Cytoskeletal Heart-enriched Actin-associated Protein 
(CHAP) as a novel cardiac-enriched gene in differentiating cardiomyocytes from 
human embryonic stem cells (ESC) (Beqqali et al., 2006). We identified two iso-
forms; the longest isoform, CHAPa, contains a N-terminal PDZ-domain, a 
nuclear localization signal (NLS), and a C-terminal actin-association domain. 
The shorter isoform, CHAPb, lacks the N-terminal PDZ domain. CHAP is 
expressed in the Z-disc of striated muscle, associates with actin, binds to α-
actinin and is essential for muscle and heart development in zebrafish (Beqqali, 
JCS in press). Here, we describe the CHAP knockout in mouse ESC (mESC), 
replacing the CHAP gene for LacZ (CHAP LacZ KI). These mESC were used to 
generate chimeric mice, which are currently bred for germline transmission. To 
investigate CHAP function in vitro, we differentiated the CHAP LacZ KI mESC 
into cardiomyocytes and analyzed their structure and function. Furthermore, we 
describe the isolation and sequence of the chick CHAP (GgCHAP) gene. The 
encoded GgCHAP protein is homologous to the mouse and human CHAPa 
isoform. In situ hybridizations for GgCHAP on chick embryos of different 
Hamburger and Hamilton (HH) stages showed expression of GgCHAP in heart 
(from cardiac crescent stage onwards), somites stages (HH15 onward), and in 
muscles of legs, wings (HH25 onward) eye and tongue (HH30). In future, 
intervention studies will be performed in chick. Supported by NHF grant 
2006B218 
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231. George: A novel ENU-induced Tbx1 mouse mutation 
Julie De Mesmaeker* (1), Dorota Szumska (1), Juergen Schneider (1), Chiann-
mun Chen (1), Matthew Benson (1), Anuja Neve (1), Daniel Andrew (1), Steven 
DM Brown (2) and Shoumo Bhattacharya (1) 
(1) Department of Cardiovascular Medicine, Wellcome Trust Centre for Human 
Genetics, University of Oxford, United Kingdom (2) Medical Research Council 
(MRC), Mammalian Genetics Unit, Harwell, United Kingdom 
 
We have identified and characterized a novel ethylnitrosourea induced 
recessive mouse mutation (Geo) that has a phenotype resembling DiGeorge 
Syndrome (DGS). Phenotypic features include cardiac malformations 
(interrupted aortic arch, vascular ring, and ventricular septal defect), palatal cleft, 
inner ear defects, small or absent thymus and oedema. The mutation was 
mapped to a Chr 16 region containing Tbx1, a T-box containing gene that is a 
major candidate for DGS. Sequencing of Tbx1 revealed a non-synonymous 
point mutation at the end of exon3 that is predicted to change R160 to Q. 
Analysis of mRNA showed that the major effect of the mutation is skipping of 
exon 3, which is predicted to create an in-frame deletion of 34 residues from the 
Tbox. Geo does not complement a Tbx1 knockout confirming that it is a non-
functional allele of Tbx1. As human and mouse Tbox sequences are identical, 
we sought to determine the functional significance of these 34 residues in the 
well-characterized human Tbx1c isoform. Our results show that this deletion, as 
opposed to the R160Q mutation, surprisingly does not affect the transactivation 
capacity of Tbx1 in reporter gene assays, suggesting that other mechanisms 
that affect function may be involved. To explore this we are investigating the 
effect of the loss of exon 3 on endogenous protein expression and the effect of 
this deletion on the Tbx1 protein interaction network. 
 
 
 
 
 
232. Noninvasive, High-Resolution Ultrasound Imaging To Evaluate 
Cardiac Function In Teratogen-Exposed Rat Foetuses. 
Terence R.S. Ozolinš (1)*, Terri A. Swanson (2), Jason J. Thomson (2), Andrea 
D. Weston (2) Nigel A. Brown (3) 
(1) Department of Pharmacology and Toxicology, Queen’s University, Kingston, 
ON Canada (2) Pfizer Global Research and Development, Groton, CT USA (3) 
St. Georges, University of London, London, UK 
 
Structural defects are readily identified at parturition in native or fixed tissues; 
however, their function consequences are harder to ascertain. Our goal was to 
assess the utility of the Vevo660 high-resolution ultrasound biomicroscope 
(VisualSonics, Toronto, ON) for evaluating cardiac defects in Sprague-Dawley 
rat embryos/foetuses exposed to dimethadione, a known cardiac teratogen. 
Doppler, m-mode and b-mode images were collected from foetuses ranging 
from gestational day (GD) 14 to post-natal day (PND) 1, both in utero and 
following externalization of the rat uterus. Foetal exposure to dimethadione was 
associated with quantitative changes in morphological and functional 
(haemodynamic) parameters indicative of improper heart development, and 
consistent with post-mortem histology. The ability to monitor cardiac anomalies 
longitudinally was limited by an inability to control in situ embryo/foetal 
orientation and to accurately identify a given embryo within a litter over multiple 
days. Although externalization of the uterus enabled greater control over image 
orientation, the difficulty in controlling physiological parameters, combined with 
its invasiveness, made longitudinal studies non-feasible for our purposes. 
Despite these limitations, imaging in all three modes provided quantitative 
measures of parameters that were previously only assessed qualitatively. These 
included ventricular septal defects, persistent truncus arteriosis (PTA), thinning 
of ventricular walls and ventricular hyperplasia. In addition, high frequency 
ultrasound permitted the monitoring of functional (haemodynamic) changes not 
typically measured in post-mortem developmental toxicity safety studies. We 
conclude that high frequency ultrasound is an excellent tool to assess cardiac 
structure and function following in utero exposure to teratogens. (Funded by 
Pfizer Global Research and Development) 
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233. Genetic modifiers predisposing to congenital heart disease in a 
sensitized population 
Huiqing Li * (1), Sheila M. Cherry(1), Cheryl L. Maslen (2), Tim Wiltshire (3), 
Roger H. Reeves (1) 
(1) Department of Physiology and Institute for Genetic Medicine, Johns Hopkins 
University School of Medicine, Baltimore, MD, USA (2) Department of Medicine, 
Division of Endocrinology, Oregon Health & Science University, Portland, 
Oregon, USA (3) Eshelman School of Pharmacy, University of North Carolina, 
Chapel Hill, NC, USA  
 
Congenital heart disease (CHD), the most frequent birth defect in human beings, 
has long been associated with complex genetic syndromes. Trisomy for human 
chromosome 21 (Hsa21) is the most frequent risk factor for CHD. The frequency 
of CHD in individuals with Down syndrome (DS) is about 50 times higher than in 
the general population. However, 50% of people with DS have a normal heart, 
thus, trisomy 21 is not sufficient to cause CHD. Additional genetic components 
may contribute to the perturbations resulting from gene dosage effects in 
trisomy. We have identified polymorphisms in the CRELD1 gene that are 
associated with CHD in individuals with DS. To establish a biological basis for 
this interaction, we have initiated studies of CHD in animal models of Down 
syndrome. The Creld1 null allele was introduced into Ts65Dn mice, which are 
trisomic for orthologs of about half of the genes on Hsa21. We provide direct 
evidence that reduced Creld1 expression exacerbates septal defects in Ts65Dn, 
Creld1+/- trisomic mice. A genome scan has been undertaken to find more 
disomic CHD modifiers by comparing the genetic backgrounds of the Ts65Dn, 
Creld1+/- pups with or without septal defects. To focus the search for trisomic 
genes that interact with Creld1, we introduced the Creld1 null allele onto Ts1Cje 
mice. These mice are trisomic for about 80% of the Mmu16 genes that are over-
represented in Ts65Dn. Surprisingly, no exacerbation of septal defects was 
detected in Ts1Cje, Creld1+/- mice. This suggests that one or more of the 37 
conserved genes that is trisomic in Ts65Dn but disomic in Ts1Cje is necessary 
for the Creld1 interaction. Evidence regarding these candidate genes will be 
presented. 
 
 
 
234. Deconstructing the role of Pcsk5 in cardiovascular development. 
Dorota Szumska* (1), Milena Cioroch (1), Angela Franklyn (1), Annik Prat (2), 
Nabil Seidah (2), Shoumo Bhattacharya (1) 
(1) Department of Cardiovascular Medicine, University of Oxford, UK 
(2)Laboratory of Biochemical Neuroendocrinology, Clinical Research Institute of 
Montreal, affiliated to the University of Montreal, Quebec, Canada 
 
In a phenotype-driven recessive screen of ENU-mutagenised mice, we have 
identified a mutant (Vcc) with a pleiotropic phenotype with cardiac, tracheo-
esophageal, anorectal, axial skeletal antero-posterior patterning defects, limb 
malformations, presacral mass, renal and palatal agenesis, and pulmonary 
hypoplasia. Multiple cardiac anomalies included dextrocardia, ASD, VSD, CAT, 
vascular ring, right-aortic arch and hypoplastic arterial duct. The phenotype 
showed a recessive inheritance pattern with 100% penetrance and appeared to 
result from a C470R mutation in the proprotein convertase PCSK5 (PC5/6, 
SPC6) [Szumska et al. Genes&Dev. 2009]. To explore further the cell-
autonomous role of PCSK5 in cardiac development, we have employed a 
conditional knockout approach (in collaboration with Annik Prat & Nabil Seidah, 
who generated the Pcsk5 floxed allele). The heart, although induced by 
endodermal signals, is essentially mesodermal in origin, with a minor 
contribution from the ectodermal neural crest. These embryonic lineages arise 
from the epiblast. We have deleted Pcsk5 in the mesoderm using Mesp1Cre 
and Nkx2-5Cre, in neural crest using Wnt1Cre and in the pharyngeal arches 
using Hoxa3Cre. We also used Sox2Cre to delete Pcsk5 at an early time-point 
in all three embryonic germ layers (epiblast KO). We studied Pcsk5null/flox;Cre+ 
embryos in comparison to their Pcsk5wt/flox;Cre+ littermates. Epiblast deletion 
of Pcsk5 generated full mutant phenotype observed both in Vcc mutant and in 
Pcsk5KO. We have observed heart anomalies (VSD, ASD, DORV, TGA) in 
Pcsk5null/flox;Mesp1Cre+ and not in their control littermates. However, there 
were no obvious structural cardiac defects, detectable by MRI, in embryos with 
Pcsk5 deleted in neural crest and pharyngeal arches. 
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235. Mutations in the sarcomere protein gene MYH7 in Ebstein`s anomaly 
Alex Postma (1), Klaartje van Engelen (2), Barbara Mulder (2), Judith v. d. 
Meeraker (3), Thahira Rahman (3), Susanne Probst (4), Ulrike Bauer (5), 
Bernard Keavney (3), Judith Goodship (3), Sabine Klaassen* (4) 
(1) Dept of Anatomy and Embryology, Academic Medical Center, Amsterdam, NL (2) Dept 
of Cardiology, Academic Medical Center, Amsterdam, NL (3) Institute of Human Genetics, 
Newcastle University, Newcastle, UK (4) Max-Delbrueck-Center for Molecular Medicine, 
Berlin, Germany (5) National Registry and Competence Network for Congenital Heart 
Defects, Berlin, Germany and on behalf of “Heart Repair WP1a”, EU 6th Framework 
Program and CONCOR (National Registry and DNA bank of congenital heart defects 
Netherlands, www.concor.net) 
 
Background- Ebsteins`s anomaly is a rare congenital heart malformation 
characterized by adherence of the septal and posterior leaflets of the tricuspid 
valve to the underlying myocardium. The genetic basis of this disorder is largely 
unresolved. Associated abnormalities of left ventricular morphology and function 
have been observed. We speculated that mutations in the sarcomere protein 
gene β-myosin heavy chain (MYH7) known to cause familial cardiomyopathy - 
hypertrophic cardiomyopathy (HCM) and left ventricular noncompaction (LVNC) 
- may be associated with Ebstein`s anomaly. Methods and Results- Mutational 
analysis in a cohort of 131 unrelated probands with Ebstein´s anomaly was 
performed by next generation sequencing (Roche Genome Sequencer FLX 
system) and direct DNA sequencing of MYH7. One half of the patients had no 
associated cardiac anomalies, the most common associated cardiac 
malformation being atrial septal defect (ostium secundum type, ASDII) and 6 
patients had left-sided cardiomyopathy. Heterozygous mutations were identified 
in 8 of 131 samples (6%). 7 distinct mutations were found of which 5 were novel 
and 2 were known to cause HCM. All mutations except for one 3-bp deletion 
were missense mutations. In 5/8 probands with MYH7 mutations LVNC was 
identified additionally to Ebstein´s anomaly. In 123 probands without MYH7 
mutations there was only one patient with additional HCM. MYH7 mutations 
segregated with LVNC in 3 autosomal dominant kindreds and familial Ebstein´s 
anomaly was found in one kindred. Conclusions- Ebstein`s anomaly is within the 
diverse spectrum of cardiac morphologies associated with mutations in the gene 
encoding β-myosin heavy chain. Our findings implicate that left ventricular 
noncompaction is not uncommon in patients with Ebstein´s anomaly and MYH7 
mutations. 
 
 
 
 
 
 
236. Molecular and functional characterization of Pitx2 myocardial ko mice 
Grazia Ammirabile*, Alessandra Tessari, Fabio Sutera Sardo, Marina Campione. 
CNR Institute of Neurosciences, Department of Biomedical Sciences, University 
of Padova, Italy. 
 
Understanding the molecular pathways that regulate cardiac growth and 
function is crucial to prevent and cure heart disease. The homeobox gene Pitx2 
plays an important role in these processes, since it is required to confer left atrial 
identity and to regulate asymmetric ventricular remodelling. We have generated 
a myocardial specific Pitx2 ko by crossing Pitx2 floxed and cardiac Troponin T 
(cTnT) Cre mice, which results in loss of the gene from the very early phases of 
cardiomyogenesis. The cTnT Cre-Pitx2 ko (cTP komyo) is incompatible with life 
and recapitulates almost completely the cardiac phenotype of the constitutive 
Pitx2 null mice. We have found that myocardial deletion of the Pitx2 gene lead 
to the presence of bilateral SAN, suggesting that the presence of the gene in the 
left myocardial precursor cells plays a repressive role in the genetic pathway 
determining SAN formation. Early genetic targets of Pitx2 are currently being 
investigated. Moreover, Pitx2 myocardial mutant hearts present impaired 
maturation of the conduction system. Functional characterization of the mutant 
embryonic and adult hearts by optical mapping and ECG analysis is currently 
being performed. Comparison with the constitutive Pitx2 ko model will be 
presented. 
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237. Genome-wide screen of non-syndromic Tetralogy of Fallot patients 
identifies a duplication in Connexin40 
Ana Topf* (1), Rebecca Darlay (1), A. Graham Stuart (2), Jonathan Parsons (3), 
Ian Peart (4), John Deanfield (5), John O’Sullivan (6), Heather J. Cordell (1), 
Mark Lathrop (7), Judith A. Goodship, (1) Bernard Keavney (1). 
(1) The Institute of Human Genetics, Newcastle University, Newcastle-upon-Tyne, UK (2) 
Bristol Children’s Hospital, Bristol, UK (3) Leeds General Infirmary, Leeds, UK (4) Alder 
Hey Hospital, Liverpool, UK (5) Great Ormond Street Hospital, London, UK (6) Freeman 
Hospital, Newcastle-upon-Tyne, UK (7) Centre National de Génotypage, Evry Cedex, 
France 
 
Objective: To assess the contribution of copy number variation (CNVs) to non-
syndromic Tetralogy of Fallot (TOF) Methods: We screened 206 TOF probands 
who did not have a 22q11.2 deletion and their unaffected parents on the 
Affimetrix Genome-Wide Human SNP 6.0 Array and analysed the data using the 
Birdseye algorithm. Results were confirmed by two other independent platforms: 
Illumina 660W-Quad and custom Multiplex Ligation-dependent Probe 
Amplification (MLPA) assay. Results: Among all the copy number variation 
observed, we identified two CNVs in chromosome 1q21.1. Both were 
duplications; one de novo 0.8Mb duplication spans several genes, while the 
smallest duplication contains only GJA5/Connexin40 (CX40), a gap-junction 
protein expressed in the heart. Conclusion: Chromosome 1q21.1 deletions have 
been previously described in TOF patients (Greenway et al, 2009). This case 
narrows the region on 1q21.1 to a single gene, Connexin40. Conotruncal 
malformations, including TOF, occur in the Cx40 mouse mutant (Gu et al, 2003). 
We conclude that copy number variation of Connexin40 is likewise associated 
with Tetralogy of Fallot in humans. 
 
 
 
 
 
 
 
 
 
238. The great intrathoracal arteries of early wild type OF1, Parkes, and 
C57Bl/6 mouse fetus 
Stefan H. Geyer* (1), Barbara Maurer (1), Anita Friedl (1), Eva Reumann (1), 
Timothy J. Mohun (2), Wolfgang J. Weninger (1) 
(1) Integrative Morphology Group, Medical University of Vienna (2) 
Developmental Biology Division, MRC National Institute for Medical Research, 
Mill Hill, London 
 
Analysing the morphological phenotype of mice carrying targeted or random 
gene mutations is an useful approach for researching hereditary cardiovascular 
diseases. Homozygote offspring of such mutants, often die in utero enforcing 
morphologic analysis of embryos. Our presentation aims at presenting objective 
topological and metric descriptions of the great intrathoracal arteries of early 
mouse fetus (developmental stage 23 according to Theiler (TS23)) of the 
Him:OF1 (n=60), NIMR:Parkes (n=30), and C57Bl/6 (n=30) strains. Employing 
the “High Resolution Episcopic Microscopy” (HREM) technique, we generated 
digital volume data sets (true spatial resolution of 2x2x2 µm3/voxel) and three-
dimensional (3D) surface models of the great intrathoracal arteries. The 3D 
models were used: Firstly for topological analysis. Secondly for defining 
reproducible positions along the blood vessel trees. Thirdly for defining virtual 
section planes, which, in all spatial directions, cut through the original volume 
data exactly perpendicular to the longitudinal axis of the blood vessel segment 
to be measured. In the virtual sections the blood vessel perimeter was 
measured and the diameter was calculated from the perimeter. We present 
topologic descriptions of the great intrathoracal arteries, and measurements and 
relations of the lumen diameters of the ascending aorta, pulmonary trunk, 
ductus arteriosus, and descending aorta distal to its communication with the 
ductus arteriousus and proximal to the origin of the 1st segment artery. Finally 
we provide comparisons between the different strains and discuss the 
significance of our data for diagnosing vascular malformations in mutant mouse 
embryos. 
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239. Evaluating a novel procedure for measuring the diameters of the 
great intrathoracal arteries of mouse embryos 
Barbara Maurer*, Stefan H. Geyer, Lorenz Pötz, Jagdeep Singh, Wolfgang J. 
Weninger 
Integrative Morphology Group, Medical University of Vienna, Austria 
 
Careful topologic and numeric analysis of the morphological phenotype of 
mutant mouse embryos is the basis for researching gene function and the 
genesis of cardiovascular malformations. Objective diagnosis of the stenosis or 
dilation of embryonic blood vessels is a major challenge. In this presentation we 
evaluate a recently published procedure for measuring the dimensions of the 
great intrathoracal arteries of mouse fetus. By employing the High Resolution 
Episcopic Microscopy (HREM) technique we generated volume data (voxel size: 
1.07x1.07x2 µm3) of 60 mouse embryos of the Him:OF1 strain of early to late 
developmental stage 23 according to Theiler. Each of two independently 
working diploma students randomly received 30 of these data sets. The 
students created 3D surface models of the great intrathoracal arteries and used 
them for defining comparable measurement positions (aorta ascendens, 
pulmonary trunk, and ductus arteriosus in their middle; aorta descendens distal 
to the ductus arteriosus and proximal to the 1st segmental artery). Then they 
defined virtual planes cutting through the original volume data in all spatial 
directions perpendicular to the longitudinal axis of those blood vessel segments. 
In these planes they measured the perimeters of the blood vessel lumen. 
Comparisons with t-test revealed no significant differences between the values 
measured by each student. We consider this as proof, that the employed 
measurement procedure is capable of producing accurate, highly objective, 
reproducible results. Furthermore the measurements themselves represent 
meaningful reference data for identifying stenosis or dilation of the great 
intrathoracal arteries of early OF1 mouse fetus. 
 
 
 
 
 
 
 
 
 
240. Role of Dhand in A Familial Case of Congenital Heart Disease 
Rachel Tanos, Fadi Hariri, Nehme El-Hachem, Inaam El-Rassy, Fadi Bitar, and 
Georges Nemer 
Department of Biochemistry, DTS-4-23, American University of Beirut, Beirut, 
Lebanon 
    
Members of the basic helix-loop-helix (bHLH) transcription factor family are 
known to regulate the specification and differentiation of many cell lineages 
during embryogenesis. The bHLH proteins dHAND and eHAND are expressed 
in the cardiac tissues, craniofacial region and limbs in a complimentary and 
overlapping fashion during embryonic development. Studies using gene 
knockout have shown that dHAND and eHAND null mice embryos die early due 
to defects in the development of the right ventricle and placenta, respectively. 
As cardiac abnormalities occur with an incidence of one per 100 live births and 
represent the highest percentage of all congenital malformations accounting for 
about 30%, we decided to investigate the role of dHAND in a familial case of 
congenital heart disease. 
In this study, we report a heterozygous mutation G205V in the gene encoding 
the dHAND that has been found in 7 out of the 17 members of the family and in 
none of the 44 patients with different phenotype, nor in the 36 healthy 
individuals included in this study. Therefore, after identifying a novel missense 
heterozygous mutation, we conducted site directed mutagenesis to study the 
effect of the amino acid substitution. The mutation in the C terminal region of 
dHAND slightly reduced its binding affinity to DNA without affecting its cellular 
localization. Finally, we identified Tbx5 and Tbx20 as new partners for dHAND 
and found that the mutation affects the interaction of dHAND with Tbx5 but not 
with Tbx20. 
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241. Endocardial origin of BAVs in Gata-5 null mice 
Brigitte Laforest* (1) Mona Nemer (1, 2) 
(1) Molecular and Cellular Biology Department, University of Montreal, Montreal, 
Quebec, Canada. (2) Biochemistry, Microbiology and Immunology Department, 
University of Ottawa, Ottawa, Ontario, Canada 
 
Congenital heart defects in humans occur in 1% of live birth. The majority 
involve the valves and septa, which originate from endocardial cells. Bicuspid 
aortic valve is the most common congenital cardiac malformation in humans and 
occurs in 1-2% of the population. Although it’s clear that BAV is a heritable trait, 
few genes have been linked to this defect. In human, only one gene, Notch1 has 
been directly associated with BAV. In mice, inactivation of eNOS lead to low 
penetrance of BAVs. Thus, the genes and mechanisms that lead to BAV 
formation remain poorly understood. Over 26% of Gata5 null mice have bicuspid 
aortic valves (BAVs). The distal outflow tract cushion is made of different 
sources of mesenchyme, including neural crest mesenchyme, mesenchyme 
from pharyngeal area and mesenchyme of endocardial origin. In order to define 
the cell type that causes BAVs in Gata5 null mice, we generated mice with 
specific deletion of Gata5 in endothelial cells, using the Tie2-cre transgenic mice. 
Here, we show that a subset (21%) of Tie2-cre;Gata5Flox/Flox mice have 
bicuspid aortic valves, with a ratio that is practically identical to that of Gata5-/- 
mice. This result suggests that the presence of BAVs in Gata-5 null mice is of 
endocardial origin and point to an essential role of Gata5 in endocardial 
development and valve formation. 
 
 
 
 
 
 
242. SMAD6 Mutations in Patients with Congenital Cardiovascular 
Malformation 
Huay L. Tan* (1), Elise Glen (1), Ana Topf (1), Darroch Hall (1), John O’Sullivan 
(2) Peter Avery (3), Rick Lewis (4), Peter ten Dijke (5), Helen M. Arthur (1), 
Bernard Keavney (1), Judith A. Goodship (1) 
(1) Institute of Human Genetics, Newcastle University, Newcastle upon Tyne, UK (2) 
Freeman Hospital, Newcastle upon Tyne, UK (3) School of Mathematics & Statistics, 
Newcastle University, Newcastle upon Tyne, UK (4) Institute for Cell and Molecular 
Biosciences, Newcastle University, Newcastle upon Tyne, UK (5) Department of Molecular 
Cell Biology, Leiden University Medical Center, Leiden, Netherlands. 
 
Bone morphogenetic proteins (BMPs) regulate many processes during 
development, including cardiac development. SMAD6 functions as an inhibitory 
SMAD which preferentially inhibits BMP signalling. The SMAD6 knockout mouse 
is characterised by cardiac valve and outflow tract defects, including aortic 
ossification. We hypothesised that rare functional variation in SMAD6 could 
predispose to congenital cardiovascular malformation (CVM). Methods: We 
sequenced coding exons of SMAD6 in 459 CVM patients of white Europeans. 
To test for functional effects, wild-type and variant SMAD6 proteins were 
expressed in C2C12 cells and their capacity to inhibit ALK3 activated expression 
of a BMP-responsive reporter, or to inhibit osteogenic differentiation (using an 
alkaline phosphatase assay) was assessed. Results: We identified two novel 
non-synonymous variants, P415L and C484F, that were not present in 1000 
ethnically-matched controls. P415L was identified in a patient with congenital 
aortic stenosis and C484F was identified in a patient with coarctation and 
calcification of the aorta. Both mutations are in evolutionarily conserved amino 
acid residues and are predicted to be damaging by in silico analysis. This was 
confirmed in functional assays as both SMAD6 variants failed to inhibit BMP 
signalling compared with wild-type SMAD6. The P415L mutant appeared to be 
hypomorphic whereas C484F appeared to be a null allele. Conclusions: This is 
the first time that functional mutations in SMAD6 have been described in 
patients with CVM, specifically those with calcific aortic malformations. Our data 
suggest that dysregulation of the BMP signalling pathway may be an important 
factor in CVM. 
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243. PITX2 is highly expressed in the adult left atrium and a mouse model 
with reduced expression displays inducible atrial fibrillation and action 
potential shortening 
Peter C. Kahr* (1,2), Ilaria Piccini (2), Sven Kaese (2), Ismail Vokshi (1), Hans-
Heinrich Scheld (3), Heinrich Rotering (3), Lisa Fortmueller (2), Sandra 
Laakmann (2), Sander Verheule (4), Uli Schotten (4), Larissa Fabritz (2), Paulus 
Kirchhof (2), Nigel A. Brown (1) 
(1) Basic Medical Sciences, St George’s, University of London, United Kingdom (2) 
Department of Cardiology and Angiology, University Hospital Muenster, Germany (3) 
Department of Thoracic and Cardiovascular Surgery, University Hospital Muenster, 
Germany (4) Department of Physiology, University of Maastricht, the Netherlands 
 
Intergenic variations on chromosome 4q25, close to the PITX2 locus, are 
associated with atrial fibrillation (AF). PITX2 encodes a transcription factor, 
expressed as several protein isoforms, with roles in the development of L-R 
asymmetry, pulmonary vein myocardium and sinuatrial node. Using isoform-
specific RT-qPCR, we find the left atrium (LA) of adult human and mouse hearts 
express PITX2 at levels comparable to skeletal muscle (highest known adult 
expression),whilst the other chambers are >100 fold lower. PITX2c isoform 
predominated, with levels >100 more than a or b, in both species. Levels in atria 
from patients with sustained AF were not different to patients in sinus rhythm. 
Mice heterozygous for Pitx2c showed LA Pitx2c expression of ~60% wild-type 
(WT). Echocardiography and histology in Pitx2c+/- showed no overt abnormality 
in chamber size, morphology or function, except for slightly elevated RV 
pressure. Spontaneous AF did not occur more often in Pitx2c+/-, but isolated 
beating Pitx2c+/- hearts were susceptible to AF during programmed stimulation. 
At short paced cycle lengths, atrial action potential durations (APD) were shorter 
in Pitx2c+/-. The ß-receptor agonist orciprenaline abolished inducibility of AF 
and reduced the difference in APD. Pathway and FatiGO analyses of expression 
arrays, comparing Pitx2c+/- to WT, LA & RA separately, revealed clusters of 
genes related to gap and tight junction regulation, melanogenesis, and calcium 
ion binding affected by Pitx2. These findings demonstrate a physiological role 
for PITX2 in the adult heart, support the hypothesis that dysregulation of PITX2 
causes susceptibility to AF, and provides clues to potential molecular 
mechanisms. 
 
 
 
244. Transposon traps the heart. 
Kar-Lai Poon* (1), Michael Liebling (2), Igor Kondrychyn (1), Marta Garcia-
Lecea (1) and Vladimir Korzh (1). 
(1) Institute of Molecular and Cell Biology, Singapore (2) Department of 
Electrical and Computer Engineering, University of California, Santa Barbara, 
California, USA 
 
With the aim to maximize the experimental utility of zebrafish as a model for 
cardiovascular studies, we generated about twenty cardiac enhancer trap (CET) 
transgenic zebrafish lines using transposon-mediated enhancer trap. One 
subset of CETs defines cell layers of the heart - endocardium, myocardium and 
epicardium, whereas another CET subset defines various structural elements of 
the heart, including its chambers – the atrium, ventricle as well as the valve at 
the atrio-ventricular boundary and bulbus arteriosus. Most of these expression 
domains are maintained into adulthood. Furthermore, genomic information 
delineating the transposon insertion sites provided clues about genes which 
expression was tagged by the insertions resulting in identification of genes that 
may function in the respective cell-types or regions of the heart. The expression 
pattern of EGFP in some CETs is unique and recapitulates expression of genes 
flanking the transposon insertion site. The CETs enabled us to capture the 
dynamics of the embryonic heart beating in vivo using fast scanning confocal 
microscopy coupled with image reconstruction, producing three-dimensional 
movies in time (4D) illustrating region-specific features of heart contraction. In 
addition, some CETs provide a unique opportunity to carry out functional 
analysis on the poorly understood cardiac conduction system (CCS), which is 
pivotal to the initiation, maintenance and coordination of the rhythmic contraction 
of the heart. This collection of CET lines represents a toolbox of markers for in 
vivo studies of heart development, physiology and disease. 
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245. Genetic modifiers of intracardiac defects in humans with velo-cardio-
facial /22q11.2 deletion syndrome 
Bernice Morrow* (1), Donna McDonald McGinn (2), Anne Bassett (3), Eva Chow 
(3), Fritz Beemer (4), Koen Devriendt (5), Cristina Digilio (6), Bruno Marino (7), 
Bruno Dallapiccola (8), Anne Marie Higgins (9), Nicole Philip (10), Tony Simon 
(11), Karlene Coleman (12), Wendy Kates (13), Marcella Devoto (2), Elaine 
Zackai (2), Jurg Ott (14), Robert Shprintzen (9), Beverly Emanuel (2) and the 
International Chromosome 22q11.2 Consortium 
(1) Departments of Genetics, Obstetrics and Gynecology & Women’s Health, Pediatrics, 
Albert Einstein College of Medicine, Bronx, NY, USA (2) Division of Human Genetics, 
Children’s Hospital of Philadelphia and the University of Pennsylvania School of Medicine, 
Philadephia, PA, USA (3) Clinical Genetics Research Program, Centre for Addiction and 
Mental Health and Department of Psychiatry, University of Toronto, Toronto, Ontario, 
Canada (4) Department of Medical Genetics, University Medical Center Utrecht, Utrecht, 
The Netherlands (5) Center for Human Genetics, University of Leuven, Leuven, Belgium 
(6) Medical Genetics, Bambino Gesù Hospital, Rome, Italy (7) Department of Pediatrics, 
La Sapienza University of Rome, Rome, Italy (8) Dipartimento di Medicina, Viale Regina 
Margherita, Rome, Italy (9) Velo-Cardio-Facial Syndrome International Center, State 
University of New York Upstate Medical University, Syracuse, NY (10) Department of 
Medical Genetics, AP-HM and University of Mediterranee, Timone Children’s Hospital, 
Marseille, France (11) M.I.N.D. Institute & NeuroTherapeutics Research Institute, 
University of California, Davis, CA USA (12) Children’s Healthcare of Atlanta, Atlanta, GA, 
USA (13) Department of Psychiatry and Behavioral Sciences, and Program in 
Neuroscience, State University of New York at Upstate Medical University, Syracuse, NY, 
USA (14) Statistical Genetics Group Beijing Institute of Genomics, Chinese Academy of 
Sciences, Beijing, China 
 
Approximately 70% of 22q11.2 deletion syndrome (22q11DS; velo-cardio-
facial/DiGeorge) patients have intracardiac and/or aortic arch malformations. We 
have performed a genome-wide association study on subjects with the 22q11.2 
deletion to find genetic risk factors for intracardiac malformations using 
Affymetrix 6.0 microarrays. The arrays contain 1.8 million genetic variations 
(SNPs, CNVs). In the first set, we analyzed data from 169 subjects with 
tetralogy of Fallot (TOF) and 190 with normal intracardiac anatomy as 
determined by echocardiography. We found no association to SNPs on the 
remaining allele of chromosome 22q11.2, ruling out common variations as a 
significant contribution. We sequenced TBX1, a major gene for the syndrome, 
on the other allele, in 376, 22q11DS subjects but found no mutations. Several 
known candidate genes were ruled out by this approach. We reasoned that 
genetic risk factors might lie elsewhere in the genome. One locus on 
chromosome 12p12 showed significant association, p= 9x10-8. Other loci 
(4q12-13, 2p21) were just below significance. Besides TOF, other intracardiac 
defects (VSD, ASD, PTA) and/or aortic arch malformations (IAA-B, PS) occur in 
22q11DS patients. All are being reanalyzed with a larger dataset from 700 
Affymetrix chips on 22q11DS patient DNAs, as qualitative as well as quantitative 
traits. Large, rare copy number variations will be validated by FISH mapping. In 
addition to studies of phenotype, we performed an association study to identify 
risk factors for generating the deletion and found two loci near genome-wide 
significance (5q23, 21q22) that will be reanalyzed with the new dataset. 
Supported by NIH, HL84410. 
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246. Closure of the aortopulmonary foramen in the developing heart  
(no poster) 
Robert H. Anderson* (1,2), Deborah Henderson (1), Bill Chaudhry (1), and Nigel 
A. Brown (2) 
(1) International Centre for Life, Newcastle University, Newcastle-upon-Tyne, 
United Kingdom, (2)artment of Anatomy, St George’s Medical University, 
London, United Kingdom 
 
Theodore Kramer, writing more than 50 years ago, commented that partitioning 
of the distal outflow tract was so well-known as to preclude the need for further 
discussion. Despite his optimism, the topic remains controversial. With this in 
mind, we have reviewed development of the outflow tract in man and mouse, 
using three-dimensional reconstructions, along with scanning electron 
microscopy, to elucidate the formation of the intrapericardial components of the 
aorta and pulmonary trunk. The key step is closure of an aortopulmonary 
foramen, bounded proximally by the distal ends of the spiralling outflow 
cushions, and distally by the dorsal wall of the aortic sac between the origins of 
the arteries of the fourth and sixth pharyngeal arches. As noted by Kramer, this 
dorsal wall represents the aortopulmonary septum. Closure of the foramen 
between the wall of the aortic sac and the distal ends of the cushions, 
themselves fusing to divide the distal outflow tract, places the developing aortic 
channel in continuity with the fourth arch, and subsequent to obliteration of the 
right sixth arch, the pulmonary channel in communication with the developing 
pulmonary arteries and the arterial duct. Cells from the neural crest invade the 
cushions prior to their fusion, while additional cells from the second heart field 
invade the parietal walls of the outflow tract. Fusion of the dorsal wall of the 
aortic sac with the cushions, however, is necessary to produce the adjacent 
walls of the aorta and pulmonary trunk. Failure of fusion explains well the 
occurrence of aortopulmonary windows. 
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